How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
S. 3439/H.R. 6735, Connecting Caregivers to Medicare Act. S. 1227/H.R. 2491, Alleviating Barriers for Caregivers Act. P.L. 119-21, the One Big Beautiful Bill Act. H.R. 6766/S. 3492, the Essential Caregivers Act. H.R. 7966/S. 4118, Hospice Care Accountability, Reform, and Enforcement (Hospice CARE) Act. H.R. 7618, Stopping Addiction and Falls for the Elderly (SAFE) Act. S. 2237/H.R. 4313, Hospital Inpatient Services Modernization Act. H.R. 8100, Safe Staffing Saves Lives Act. S. 3886, Nurses Belong in Nursing Homes Act. H.R. 7966/S. 4118, Hospice Care Accountability, Reform, and Enforcement (Hospice CARE) Act. S. 3886, Nurses Belong in Nursing Homes Act. No bill number. Discussed Medicare payment models. No bill number. Discussed Medicare waste, fraud, and abuse. No bill number. Discussed health technology, data security, enrollee accounts, and access. No bill number. Discussed Medicaid and waste, fraud, and abuse. No bill number. Discussed Medicaid community engagement requirements and Data Strategy for Family Caregiver Verification. No bill number. Discussed nursing home staffing standards, safety, and quality. No bill number. Discussed nursing home transparency and ownership requirements. No bill number. Discussed home health, hospice, and long-term care. No bill number. Discussed Medicare Advantage. No bill number. Discussed the Medicare Prescription Drug Benefit Program. No bill number. Discussed the Medicare Cost Plan Program. No bill number. Discussed Medicare Advantage Capitation Rates. No bill number. Discussed Medicare Part C and Part D payment policies. No bill number. Discussed Medicare Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). No bill number. Discussed AI tools for Medicare Experience modernization. No bill number. Discussed Medicare Advantage provider networks. No bill number. Discussed fraud in Medicare and Medicaid. No bill number. Discussed long-term services and supports. No bill number. Discussed home and community-based services. No bill number. Discussed the Money Follows the Person Rebalancing Demonstration Program. No bill number. Discussed Medicaid home and community-based services (HCBS) spousal impoverishment protections. No bill number. Discussed the direct care workforce. No bill number. Discussed family caregiver exemption from Medicaid community engagement requirements. No bill number. Discussed falls prevention. No bill number. Discussed age-friendly communities. No bill number. Discussed health at home. No bill number. Discussed the National Strategy to Support Family Caregivers. No bill number. Discussed the Older Americans Act reauthorization. No bill number. Discussed Medicaid HCBS waivers. No bill number. Discussed the health care workforce.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
S. 1040, the Drug Competition Enhancement Act. S. 1041, the Affordable Prescriptions for Patients Act. S. 2620, the Reforming Evergreening and Manipulation that Extends Drug Years Act or the REMEDY Act. S. 2658, the Medication Affordability and Patent Integrity Act. S. 1095, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act. S. 1096, the Preserve Access to Affordable Generics and Biosimilars Act. S. 1784/H.R. 4191, the Mapping America's Pharmaceutical Supply Act or the MAPS Act. No bill number. Lifetime prescription drug price increases. No bill number. Discussed Medicare drug price negotiation. No bill number. Discussed Medicare Part D. No bill number. Discussed international reference pricing. No bill number. Discussed prescription drug supply chain vulnerabilities. No bill number. Discussed Most Favored Nation prescription drug model and GLOBE model. No bill number. Discussed Medicare Part D/ Most Favored Nation prescription drug model, GUARD. No bill number. Discussed pharmacy benefit manager reforms. No bill number. Discussed proposed Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program. No bill number. Discussed prescription drugs.
Source: Senate LDA
S. 1040, the Drug Competition Enhancement Act. S. 1041, the Affordable Prescriptions for Patients Act. S. 2620, the Reforming Evergreening and Manipulation that Extends Drug Years Act or the REMEDY Act. S. 2658, the Medication Affordability and Patent Integrity Act. S. 1095, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act. S. 1096, the Preserve Access to Affordable Generics and Biosimilars Act. S. 1784/H.R. 4191, the Mapping America's Pharmaceutical Supply Act or the MAPS Act. No bill number. Lifetime prescription drug price increases. No bill number. Discussed Medicare drug price negotiation. No bill number. Discussed Medicare Part D. No bill number. Discussed international reference pricing. No bill number. Discussed prescription drug supply chain vulnerabilities. No bill number. Discussed Most Favored Nation prescription drug model and GLOBE model. No bill number. Discussed Medicare Part D/ Most Favored Nation prescription drug model, GUARD. No bill number. Discussed pharmacy benefit manager reforms. No bill number. Discussed proposed Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program. No bill number. Discussed prescription drugs.
S. 3439/H.R. 6735, Connecting Caregivers to Medicare Act. S. 1227/H.R. 2491, Alleviating Barriers for Caregivers Act. P.L. 119-21, the One Big Beautiful Bill Act. H.R. 6766/S. 3492, the Essential Caregivers Act. H.R. 7966/S. 4118, Hospice Care Accountability, Reform, and Enforcement (Hospice CARE) Act. H.R. 7618, Stopping Addiction and Falls for the Elderly (SAFE) Act. S. 2237/H.R. 4313, Hospital Inpatient Services Modernization Act. H.R. 8100, Safe Staffing Saves Lives Act. S. 3886, Nurses Belong in Nursing Homes Act. H.R. 7966/S. 4118, Hospice Care Accountability, Reform, and Enforcement (Hospice CARE) Act. S. 3886, Nurses Belong in Nursing Homes Act. No bill number. Discussed Medicare payment models. No bill number. Discussed Medicare waste, fraud, and abuse. No bill number. Discussed health technology, data security, enrollee accounts, and access. No bill number. Discussed Medicaid and waste, fraud, and abuse. No bill number. Discussed Medicaid community engagement requirements and Data Strategy for Family Caregiver Verification. No bill number. Discussed nursing home staffing standards, safety, and quality. No bill number. Discussed nursing home transparency and ownership requirements. No bill number. Discussed home health, hospice, and long-term care. No bill number. Discussed Medicare Advantage. No bill number. Discussed the Medicare Prescription Drug Benefit Program. No bill number. Discussed the Medicare Cost Plan Program. No bill number. Discussed Medicare Advantage Capitation Rates. No bill number. Discussed Medicare Part C and Part D payment policies. No bill number. Discussed Medicare Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). No bill number. Discussed AI tools for Medicare Experience modernization. No bill number. Discussed Medicare Advantage provider networks. No bill number. Discussed fraud in Medicare and Medicaid. No bill number. Discussed long-term services and supports. No bill number. Discussed home and community-based services. No bill number. Discussed the Money Follows the Person Rebalancing Demonstration Program. No bill number. Discussed Medicaid home and community-based services (HCBS) spousal impoverishment protections. No bill number. Discussed the direct care workforce. No bill number. Discussed family caregiver exemption from Medicaid community engagement requirements. No bill number. Discussed falls prevention. No bill number. Discussed age-friendly communities. No bill number. Discussed health at home. No bill number. Discussed the National Strategy to Support Family Caregivers. No bill number. Discussed the Older Americans Act reauthorization. No bill number. Discussed Medicaid HCBS waivers. No bill number. Discussed the health care workforce.
S. 3439/H.R. 6735, Connecting Caregivers to Medicare Act. S. 1227/H.R. 2491, Alleviating Barriers for Caregivers Act. P.L. 119-21, the One Big Beautiful Bill Act. H.R. 6766/S. 3492, the Essential Caregivers Act. H.R. 7966/S. 4118, Hospice Care Accountability, Reform, and Enforcement (Hospice CARE) Act. H.R. 7618, Stopping Addiction and Falls for the Elderly (SAFE) Act. S. 2237/H.R. 4313, Hospital Inpatient Services Modernization Act. H.R. 8100, Safe Staffing Saves Lives Act. S. 3886, Nurses Belong in Nursing Homes Act. H.R. 7966/S. 4118, Hospice Care Accountability, Reform, and Enforcement (Hospice CARE) Act. S. 3886, Nurses Belong in Nursing Homes Act. No bill number. Discussed Medicare payment models. No bill number. Discussed Medicare waste, fraud, and abuse. No bill number. Discussed health technology, data security, enrollee accounts, and access. No bill number. Discussed Medicaid and waste, fraud, and abuse. No bill number. Discussed Medicaid community engagement requirements and Data Strategy for Family Caregiver Verification. No bill number. Discussed nursing home staffing standards, safety, and quality. No bill number. Discussed nursing home transparency and ownership requirements. No bill number. Discussed home health, hospice, and long-term care. No bill number. Discussed Medicare Advantage. No bill number. Discussed the Medicare Prescription Drug Benefit Program. No bill number. Discussed the Medicare Cost Plan Program. No bill number. Discussed Medicare Advantage Capitation Rates. No bill number. Discussed Medicare Part C and Part D payment policies. No bill number. Discussed Medicare Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). No bill number. Discussed AI tools for Medicare Experience modernization. No bill number. Discussed Medicare Advantage provider networks. No bill number. Discussed fraud in Medicare and Medicaid. No bill number. Discussed long-term services and supports. No bill number. Discussed home and community-based services. No bill number. Discussed the Money Follows the Person Rebalancing Demonstration Program. No bill number. Discussed Medicaid home and community-based services (HCBS) spousal impoverishment protections. No bill number. Discussed the direct care workforce. No bill number. Discussed family caregiver exemption from Medicaid community engagement requirements. No bill number. Discussed falls prevention. No bill number. Discussed age-friendly communities. No bill number. Discussed health at home. No bill number. Discussed the National Strategy to Support Family Caregivers. No bill number. Discussed the Older Americans Act reauthorization. No bill number. Discussed Medicaid HCBS waivers. No bill number. Discussed the health care workforce.
S. 3439/H.R. 6735, Connecting Caregivers to Medicare Act. S. 1227/H.R. 2491, Alleviating Barriers for Caregivers Act. P.L. 119-21, the One Big Beautiful Bill Act. H.R. 6766/S. 3492, the Essential Caregivers Act. H.R. 7966/S. 4118, Hospice Care Accountability, Reform, and Enforcement (Hospice CARE) Act. H.R. 7618, Stopping Addiction and Falls for the Elderly (SAFE) Act. S. 2237/H.R. 4313, Hospital Inpatient Services Modernization Act. H.R. 8100, Safe Staffing Saves Lives Act. S. 3886, Nurses Belong in Nursing Homes Act. H.R. 7966/S. 4118, Hospice Care Accountability, Reform, and Enforcement (Hospice CARE) Act. S. 3886, Nurses Belong in Nursing Homes Act. No bill number. Discussed Medicare payment models. No bill number. Discussed Medicare waste, fraud, and abuse. No bill number. Discussed health technology, data security, enrollee accounts, and access. No bill number. Discussed Medicaid and waste, fraud, and abuse. No bill number. Discussed Medicaid community engagement requirements and Data Strategy for Family Caregiver Verification. No bill number. Discussed nursing home staffing standards, safety, and quality. No bill number. Discussed nursing home transparency and ownership requirements. No bill number. Discussed home health, hospice, and long-term care. No bill number. Discussed Medicare Advantage. No bill number. Discussed the Medicare Prescription Drug Benefit Program. No bill number. Discussed the Medicare Cost Plan Program. No bill number. Discussed Medicare Advantage Capitation Rates. No bill number. Discussed Medicare Part C and Part D payment policies. No bill number. Discussed Medicare Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). No bill number. Discussed AI tools for Medicare Experience modernization. No bill number. Discussed Medicare Advantage provider networks. No bill number. Discussed fraud in Medicare and Medicaid. No bill number. Discussed long-term services and supports. No bill number. Discussed home and community-based services. No bill number. Discussed the Money Follows the Person Rebalancing Demonstration Program. No bill number. Discussed Medicaid home and community-based services (HCBS) spousal impoverishment protections. No bill number. Discussed the direct care workforce. No bill number. Discussed family caregiver exemption from Medicaid community engagement requirements. No bill number. Discussed falls prevention. No bill number. Discussed age-friendly communities. No bill number. Discussed health at home. No bill number. Discussed the National Strategy to Support Family Caregivers. No bill number. Discussed the Older Americans Act reauthorization. No bill number. Discussed Medicaid HCBS waivers. No bill number. Discussed the health care workforce.
S. 3439/H.R. 6735, Connecting Caregivers to Medicare Act. S. 1227/H.R. 2491, Alleviating Barriers for Caregivers Act. P.L. 119-21, the One Big Beautiful Bill Act. H.R. 6766/S. 3492, the Essential Caregivers Act. H.R. 7966/S. 4118, Hospice Care Accountability, Reform, and Enforcement (Hospice CARE) Act. H.R. 7618, Stopping Addiction and Falls for the Elderly (SAFE) Act. S. 2237/H.R. 4313, Hospital Inpatient Services Modernization Act. H.R. 8100, Safe Staffing Saves Lives Act. S. 3886, Nurses Belong in Nursing Homes Act. H.R. 7966/S. 4118, Hospice Care Accountability, Reform, and Enforcement (Hospice CARE) Act. S. 3886, Nurses Belong in Nursing Homes Act. No bill number. Discussed Medicare payment models. No bill number. Discussed Medicare waste, fraud, and abuse. No bill number. Discussed health technology, data security, enrollee accounts, and access. No bill number. Discussed Medicaid and waste, fraud, and abuse. No bill number. Discussed Medicaid community engagement requirements and Data Strategy for Family Caregiver Verification. No bill number. Discussed nursing home staffing standards, safety, and quality. No bill number. Discussed nursing home transparency and ownership requirements. No bill number. Discussed home health, hospice, and long-term care. No bill number. Discussed Medicare Advantage. No bill number. Discussed the Medicare Prescription Drug Benefit Program. No bill number. Discussed the Medicare Cost Plan Program. No bill number. Discussed Medicare Advantage Capitation Rates. No bill number. Discussed Medicare Part C and Part D payment policies. No bill number. Discussed Medicare Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). No bill number. Discussed AI tools for Medicare Experience modernization. No bill number. Discussed Medicare Advantage provider networks. No bill number. Discussed fraud in Medicare and Medicaid. No bill number. Discussed long-term services and supports. No bill number. Discussed home and community-based services. No bill number. Discussed the Money Follows the Person Rebalancing Demonstration Program. No bill number. Discussed Medicaid home and community-based services (HCBS) spousal impoverishment protections. No bill number. Discussed the direct care workforce. No bill number. Discussed family caregiver exemption from Medicaid community engagement requirements. No bill number. Discussed falls prevention. No bill number. Discussed age-friendly communities. No bill number. Discussed health at home. No bill number. Discussed the National Strategy to Support Family Caregivers. No bill number. Discussed the Older Americans Act reauthorization. No bill number. Discussed Medicaid HCBS waivers. No bill number. Discussed the health care workforce.
S. 3439/H.R. 6735, Connecting Caregivers to Medicare Act. S. 1227/H.R. 2491, Alleviating Barriers for Caregivers Act. P.L. 119-21, the One Big Beautiful Bill Act. H.R. 6766/S. 3492, the Essential Caregivers Act. H.R. 7966/S. 4118, Hospice Care Accountability, Reform, and Enforcement (Hospice CARE) Act. H.R. 7618, Stopping Addiction and Falls for the Elderly (SAFE) Act. S. 2237/H.R. 4313, Hospital Inpatient Services Modernization Act. H.R. 8100, Safe Staffing Saves Lives Act. S. 3886, Nurses Belong in Nursing Homes Act. H.R. 7966/S. 4118, Hospice Care Accountability, Reform, and Enforcement (Hospice CARE) Act. S. 3886, Nurses Belong in Nursing Homes Act. No bill number. Discussed Medicare payment models. No bill number. Discussed Medicare waste, fraud, and abuse. No bill number. Discussed health technology, data security, enrollee accounts, and access. No bill number. Discussed Medicaid and waste, fraud, and abuse. No bill number. Discussed Medicaid community engagement requirements and Data Strategy for Family Caregiver Verification. No bill number. Discussed nursing home staffing standards, safety, and quality. No bill number. Discussed nursing home transparency and ownership requirements. No bill number. Discussed home health, hospice, and long-term care. No bill number. Discussed Medicare Advantage. No bill number. Discussed the Medicare Prescription Drug Benefit Program. No bill number. Discussed the Medicare Cost Plan Program. No bill number. Discussed Medicare Advantage Capitation Rates. No bill number. Discussed Medicare Part C and Part D payment policies. No bill number. Discussed Medicare Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). No bill number. Discussed AI tools for Medicare Experience modernization. No bill number. Discussed Medicare Advantage provider networks. No bill number. Discussed fraud in Medicare and Medicaid. No bill number. Discussed long-term services and supports. No bill number. Discussed home and community-based services. No bill number. Discussed the Money Follows the Person Rebalancing Demonstration Program. No bill number. Discussed Medicaid home and community-based services (HCBS) spousal impoverishment protections. No bill number. Discussed the direct care workforce. No bill number. Discussed family caregiver exemption from Medicaid community engagement requirements. No bill number. Discussed falls prevention. No bill number. Discussed age-friendly communities. No bill number. Discussed health at home. No bill number. Discussed the National Strategy to Support Family Caregivers. No bill number. Discussed the Older Americans Act reauthorization. No bill number. Discussed Medicaid HCBS waivers. No bill number. Discussed the health care workforce.
S. 1040, the Drug Competition Enhancement Act. S. 1041, the Affordable Prescriptions for Patients Act. S. 2620, the Reforming Evergreening and Manipulation that Extends Drug Years Act or the REMEDY Act. S. 2658, the Medication Affordability and Patent Integrity Act. S. 1095, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act. S. 1096, the Preserve Access to Affordable Generics and Biosimilars Act. S. 1784/H.R. 4191, the Mapping America's Pharmaceutical Supply Act or the MAPS Act. No bill number. Lifetime prescription drug price increases. No bill number. Discussed Medicare drug price negotiation. No bill number. Discussed Medicare Part D. No bill number. Discussed international reference pricing. No bill number. Discussed prescription drug supply chain vulnerabilities. No bill number. Discussed Most Favored Nation prescription drug model and GLOBE model. No bill number. Discussed Medicare Part D/ Most Favored Nation prescription drug model, GUARD. No bill number. Discussed pharmacy benefit manager reforms. No bill number. Discussed proposed Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program. No bill number. Discussed prescription drugs.
S. 1040, the Drug Competition Enhancement Act. S. 1041, the Affordable Prescriptions for Patients Act. S. 2620, the Reforming Evergreening and Manipulation that Extends Drug Years Act or the REMEDY Act. S. 2658, the Medication Affordability and Patent Integrity Act. S. 1095, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act. S. 1096, the Preserve Access to Affordable Generics and Biosimilars Act. S. 1784/H.R. 4191, the Mapping America's Pharmaceutical Supply Act or the MAPS Act. No bill number. Lifetime prescription drug price increases. No bill number. Discussed Medicare drug price negotiation. No bill number. Discussed Medicare Part D. No bill number. Discussed international reference pricing. No bill number. Discussed prescription drug supply chain vulnerabilities. No bill number. Discussed Most Favored Nation prescription drug model and GLOBE model. No bill number. Discussed Medicare Part D/ Most Favored Nation prescription drug model, GUARD. No bill number. Discussed pharmacy benefit manager reforms. No bill number. Discussed proposed Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program. No bill number. Discussed prescription drugs.
S. 1040, the Drug Competition Enhancement Act. S. 1041, the Affordable Prescriptions for Patients Act. S. 2620, the Reforming Evergreening and Manipulation that Extends Drug Years Act or the REMEDY Act. S. 2658, the Medication Affordability and Patent Integrity Act. S. 1095, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act. S. 1096, the Preserve Access to Affordable Generics and Biosimilars Act. S. 1784/H.R. 4191, the Mapping America's Pharmaceutical Supply Act or the MAPS Act. No bill number. Lifetime prescription drug price increases. No bill number. Discussed Medicare drug price negotiation. No bill number. Discussed Medicare Part D. No bill number. Discussed international reference pricing. No bill number. Discussed prescription drug supply chain vulnerabilities. No bill number. Discussed Most Favored Nation prescription drug model and GLOBE model. No bill number. Discussed Medicare Part D/ Most Favored Nation prescription drug model, GUARD. No bill number. Discussed pharmacy benefit manager reforms. No bill number. Discussed proposed Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program. No bill number. Discussed prescription drugs.
S. 1040, the Drug Competition Enhancement Act. S. 1041, the Affordable Prescriptions for Patients Act. S. 2620, the Reforming Evergreening and Manipulation that Extends Drug Years Act or the REMEDY Act. S. 2658, the Medication Affordability and Patent Integrity Act. S. 1095, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act. S. 1096, the Preserve Access to Affordable Generics and Biosimilars Act. S. 1784/H.R. 4191, the Mapping America's Pharmaceutical Supply Act or the MAPS Act. No bill number. Lifetime prescription drug price increases. No bill number. Discussed Medicare drug price negotiation. No bill number. Discussed Medicare Part D. No bill number. Discussed international reference pricing. No bill number. Discussed prescription drug supply chain vulnerabilities. No bill number. Discussed Most Favored Nation prescription drug model and GLOBE model. No bill number. Discussed Medicare Part D/ Most Favored Nation prescription drug model, GUARD. No bill number. Discussed pharmacy benefit manager reforms. No bill number. Discussed proposed Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program. No bill number. Discussed prescription drugs.
S. 3439/H.R. 6735, Connecting Caregivers to Medicare Act. S. 1227/H.R. 2491, Alleviating Barriers for Caregivers Act. P.L. 119-21, the One Big Beautiful Bill Act. H.R. 6766/S. 3492, the Essential Caregivers Act. H.R. 7966/S. 4118, Hospice Care Accountability, Reform, and Enforcement (Hospice CARE) Act. H.R. 7618, Stopping Addiction and Falls for the Elderly (SAFE) Act. S. 2237/H.R. 4313, Hospital Inpatient Services Modernization Act. H.R. 8100, Safe Staffing Saves Lives Act. S. 3886, Nurses Belong in Nursing Homes Act. H.R. 7966/S. 4118, Hospice Care Accountability, Reform, and Enforcement (Hospice CARE) Act. S. 3886, Nurses Belong in Nursing Homes Act. No bill number. Discussed Medicare payment models. No bill number. Discussed Medicare waste, fraud, and abuse. No bill number. Discussed health technology, data security, enrollee accounts, and access. No bill number. Discussed Medicaid and waste, fraud, and abuse. No bill number. Discussed Medicaid community engagement requirements and Data Strategy for Family Caregiver Verification. No bill number. Discussed nursing home staffing standards, safety, and quality. No bill number. Discussed nursing home transparency and ownership requirements. No bill number. Discussed home health, hospice, and long-term care. No bill number. Discussed Medicare Advantage. No bill number. Discussed the Medicare Prescription Drug Benefit Program. No bill number. Discussed the Medicare Cost Plan Program. No bill number. Discussed Medicare Advantage Capitation Rates. No bill number. Discussed Medicare Part C and Part D payment policies. No bill number. Discussed Medicare Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). No bill number. Discussed AI tools for Medicare Experience modernization. No bill number. Discussed Medicare Advantage provider networks. No bill number. Discussed fraud in Medicare and Medicaid. No bill number. Discussed long-term services and supports. No bill number. Discussed home and community-based services. No bill number. Discussed the Money Follows the Person Rebalancing Demonstration Program. No bill number. Discussed Medicaid home and community-based services (HCBS) spousal impoverishment protections. No bill number. Discussed the direct care workforce. No bill number. Discussed family caregiver exemption from Medicaid community engagement requirements. No bill number. Discussed falls prevention. No bill number. Discussed age-friendly communities. No bill number. Discussed health at home. No bill number. Discussed the National Strategy to Support Family Caregivers. No bill number. Discussed the Older Americans Act reauthorization. No bill number. Discussed Medicaid HCBS waivers. No bill number. Discussed the health care workforce.
S. 1040, the Drug Competition Enhancement Act. S. 1041, the Affordable Prescriptions for Patients Act. S. 2620, the Reforming Evergreening and Manipulation that Extends Drug Years Act or the REMEDY Act. S. 2658, the Medication Affordability and Patent Integrity Act. S. 1095, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act. S. 1096, the Preserve Access to Affordable Generics and Biosimilars Act. S. 1784/H.R. 4191, the Mapping America's Pharmaceutical Supply Act or the MAPS Act. No bill number. Lifetime prescription drug price increases. No bill number. Discussed Medicare drug price negotiation. No bill number. Discussed Medicare Part D. No bill number. Discussed international reference pricing. No bill number. Discussed prescription drug supply chain vulnerabilities. No bill number. Discussed Most Favored Nation prescription drug model and GLOBE model. No bill number. Discussed Medicare Part D/ Most Favored Nation prescription drug model, GUARD. No bill number. Discussed pharmacy benefit manager reforms. No bill number. Discussed proposed Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program. No bill number. Discussed prescription drugs.
S. 3439/H.R. 6735, Connecting Caregivers to Medicare Act. S. 1227/H.R. 2491, Alleviating Barriers for Caregivers Act. P.L. 119-21, the One Big Beautiful Bill Act. H.R. 6766/S. 3492, the Essential Caregivers Act. H.R. 7966/S. 4118, Hospice Care Accountability, Reform, and Enforcement (Hospice CARE) Act. H.R. 7618, Stopping Addiction and Falls for the Elderly (SAFE) Act. S. 2237/H.R. 4313, Hospital Inpatient Services Modernization Act. H.R. 8100, Safe Staffing Saves Lives Act. S. 3886, Nurses Belong in Nursing Homes Act. H.R. 7966/S. 4118, Hospice Care Accountability, Reform, and Enforcement (Hospice CARE) Act. S. 3886, Nurses Belong in Nursing Homes Act. No bill number. Discussed Medicare payment models. No bill number. Discussed Medicare waste, fraud, and abuse. No bill number. Discussed health technology, data security, enrollee accounts, and access. No bill number. Discussed Medicaid and waste, fraud, and abuse. No bill number. Discussed Medicaid community engagement requirements and Data Strategy for Family Caregiver Verification. No bill number. Discussed nursing home staffing standards, safety, and quality. No bill number. Discussed nursing home transparency and ownership requirements. No bill number. Discussed home health, hospice, and long-term care. No bill number. Discussed Medicare Advantage. No bill number. Discussed the Medicare Prescription Drug Benefit Program. No bill number. Discussed the Medicare Cost Plan Program. No bill number. Discussed Medicare Advantage Capitation Rates. No bill number. Discussed Medicare Part C and Part D payment policies. No bill number. Discussed Medicare Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). No bill number. Discussed AI tools for Medicare Experience modernization. No bill number. Discussed Medicare Advantage provider networks. No bill number. Discussed fraud in Medicare and Medicaid. No bill number. Discussed long-term services and supports. No bill number. Discussed home and community-based services. No bill number. Discussed the Money Follows the Person Rebalancing Demonstration Program. No bill number. Discussed Medicaid home and community-based services (HCBS) spousal impoverishment protections. No bill number. Discussed the direct care workforce. No bill number. Discussed family caregiver exemption from Medicaid community engagement requirements. No bill number. Discussed falls prevention. No bill number. Discussed age-friendly communities. No bill number. Discussed health at home. No bill number. Discussed the National Strategy to Support Family Caregivers. No bill number. Discussed the Older Americans Act reauthorization. No bill number. Discussed Medicaid HCBS waivers. No bill number. Discussed the health care workforce.
S. 1040, the Drug Competition Enhancement Act. S. 1041, the Affordable Prescriptions for Patients Act. S. 2620, the Reforming Evergreening and Manipulation that Extends Drug Years Act or the REMEDY Act. S. 2658, the Medication Affordability and Patent Integrity Act. S. 1095, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act. S. 1096, the Preserve Access to Affordable Generics and Biosimilars Act. S. 1784/H.R. 4191, the Mapping America's Pharmaceutical Supply Act or the MAPS Act. No bill number. Lifetime prescription drug price increases. No bill number. Discussed Medicare drug price negotiation. No bill number. Discussed Medicare Part D. No bill number. Discussed international reference pricing. No bill number. Discussed prescription drug supply chain vulnerabilities. No bill number. Discussed Most Favored Nation prescription drug model and GLOBE model. No bill number. Discussed Medicare Part D/ Most Favored Nation prescription drug model, GUARD. No bill number. Discussed pharmacy benefit manager reforms. No bill number. Discussed proposed Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program. No bill number. Discussed prescription drugs.
S. 1040, the Drug Competition Enhancement Act. S. 1041, the Affordable Prescriptions for Patients Act. S. 2620, the Reforming Evergreening and Manipulation that Extends Drug Years Act or the REMEDY Act. S. 2658, the Medication Affordability and Patent Integrity Act. S. 1095, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act. S. 1096, the Preserve Access to Affordable Generics and Biosimilars Act. S. 1784/H.R. 4191, the Mapping America's Pharmaceutical Supply Act or the MAPS Act. No bill number. Lifetime prescription drug price increases. No bill number. Discussed Medicare drug price negotiation. No bill number. Discussed Medicare Part D. No bill number. Discussed international reference pricing. No bill number. Discussed prescription drug supply chain vulnerabilities. No bill number. Discussed Most Favored Nation prescription drug model and GLOBE model. No bill number. Discussed Medicare Part D/ Most Favored Nation prescription drug model, GUARD. No bill number. Discussed pharmacy benefit manager reforms. No bill number. Discussed proposed Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program. No bill number. Discussed prescription drugs.
S. 3439/H.R. 6735, Connecting Caregivers to Medicare Act. S. 1227/H.R. 2491, Alleviating Barriers for Caregivers Act. P.L. 119-21, the One Big Beautiful Bill Act. H.R. 6766/S. 3492, the Essential Caregivers Act. H.R. 7966/S. 4118, Hospice Care Accountability, Reform, and Enforcement (Hospice CARE) Act. H.R. 7618, Stopping Addiction and Falls for the Elderly (SAFE) Act. S. 2237/H.R. 4313, Hospital Inpatient Services Modernization Act. H.R. 8100, Safe Staffing Saves Lives Act. S. 3886, Nurses Belong in Nursing Homes Act. H.R. 7966/S. 4118, Hospice Care Accountability, Reform, and Enforcement (Hospice CARE) Act. S. 3886, Nurses Belong in Nursing Homes Act. No bill number. Discussed Medicare payment models. No bill number. Discussed Medicare waste, fraud, and abuse. No bill number. Discussed health technology, data security, enrollee accounts, and access. No bill number. Discussed Medicaid and waste, fraud, and abuse. No bill number. Discussed Medicaid community engagement requirements and Data Strategy for Family Caregiver Verification. No bill number. Discussed nursing home staffing standards, safety, and quality. No bill number. Discussed nursing home transparency and ownership requirements. No bill number. Discussed home health, hospice, and long-term care. No bill number. Discussed Medicare Advantage. No bill number. Discussed the Medicare Prescription Drug Benefit Program. No bill number. Discussed the Medicare Cost Plan Program. No bill number. Discussed Medicare Advantage Capitation Rates. No bill number. Discussed Medicare Part C and Part D payment policies. No bill number. Discussed Medicare Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). No bill number. Discussed AI tools for Medicare Experience modernization. No bill number. Discussed Medicare Advantage provider networks. No bill number. Discussed fraud in Medicare and Medicaid. No bill number. Discussed long-term services and supports. No bill number. Discussed home and community-based services. No bill number. Discussed the Money Follows the Person Rebalancing Demonstration Program. No bill number. Discussed Medicaid home and community-based services (HCBS) spousal impoverishment protections. No bill number. Discussed the direct care workforce. No bill number. Discussed family caregiver exemption from Medicaid community engagement requirements. No bill number. Discussed falls prevention. No bill number. Discussed age-friendly communities. No bill number. Discussed health at home. No bill number. Discussed the National Strategy to Support Family Caregivers. No bill number. Discussed the Older Americans Act reauthorization. No bill number. Discussed Medicaid HCBS waivers. No bill number. Discussed the health care workforce.
S. 3439/H.R. 6735, Connecting Caregivers to Medicare Act. S. 1227/H.R. 2491, Alleviating Barriers for Caregivers Act. P.L. 119-21, the One Big Beautiful Bill Act. H.R. 6766/S. 3492, the Essential Caregivers Act. H.R. 7966/S. 4118, Hospice Care Accountability, Reform, and Enforcement (Hospice CARE) Act. H.R. 7618, Stopping Addiction and Falls for the Elderly (SAFE) Act. S. 2237/H.R. 4313, Hospital Inpatient Services Modernization Act. H.R. 8100, Safe Staffing Saves Lives Act. S. 3886, Nurses Belong in Nursing Homes Act. H.R. 7966/S. 4118, Hospice Care Accountability, Reform, and Enforcement (Hospice CARE) Act. S. 3886, Nurses Belong in Nursing Homes Act. No bill number. Discussed Medicare payment models. No bill number. Discussed Medicare waste, fraud, and abuse. No bill number. Discussed health technology, data security, enrollee accounts, and access. No bill number. Discussed Medicaid and waste, fraud, and abuse. No bill number. Discussed Medicaid community engagement requirements and Data Strategy for Family Caregiver Verification. No bill number. Discussed nursing home staffing standards, safety, and quality. No bill number. Discussed nursing home transparency and ownership requirements. No bill number. Discussed home health, hospice, and long-term care. No bill number. Discussed Medicare Advantage. No bill number. Discussed the Medicare Prescription Drug Benefit Program. No bill number. Discussed the Medicare Cost Plan Program. No bill number. Discussed Medicare Advantage Capitation Rates. No bill number. Discussed Medicare Part C and Part D payment policies. No bill number. Discussed Medicare Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). No bill number. Discussed AI tools for Medicare Experience modernization. No bill number. Discussed Medicare Advantage provider networks. No bill number. Discussed fraud in Medicare and Medicaid. No bill number. Discussed long-term services and supports. No bill number. Discussed home and community-based services. No bill number. Discussed the Money Follows the Person Rebalancing Demonstration Program. No bill number. Discussed Medicaid home and community-based services (HCBS) spousal impoverishment protections. No bill number. Discussed the direct care workforce. No bill number. Discussed family caregiver exemption from Medicaid community engagement requirements. No bill number. Discussed falls prevention. No bill number. Discussed age-friendly communities. No bill number. Discussed health at home. No bill number. Discussed the National Strategy to Support Family Caregivers. No bill number. Discussed the Older Americans Act reauthorization. No bill number. Discussed Medicaid HCBS waivers. No bill number. Discussed the health care workforce.
S. 3439/H.R. 6735, Connecting Caregivers to Medicare Act. S. 1227/H.R. 2491, Alleviating Barriers for Caregivers Act. P.L. 119-21, the One Big Beautiful Bill Act. H.R. 6766/S. 3492, the Essential Caregivers Act. H.R. 7966/S. 4118, Hospice Care Accountability, Reform, and Enforcement (Hospice CARE) Act. H.R. 7618, Stopping Addiction and Falls for the Elderly (SAFE) Act. S. 2237/H.R. 4313, Hospital Inpatient Services Modernization Act. H.R. 8100, Safe Staffing Saves Lives Act. S. 3886, Nurses Belong in Nursing Homes Act. H.R. 7966/S. 4118, Hospice Care Accountability, Reform, and Enforcement (Hospice CARE) Act. S. 3886, Nurses Belong in Nursing Homes Act. No bill number. Discussed Medicare payment models. No bill number. Discussed Medicare waste, fraud, and abuse. No bill number. Discussed health technology, data security, enrollee accounts, and access. No bill number. Discussed Medicaid and waste, fraud, and abuse. No bill number. Discussed Medicaid community engagement requirements and Data Strategy for Family Caregiver Verification. No bill number. Discussed nursing home staffing standards, safety, and quality. No bill number. Discussed nursing home transparency and ownership requirements. No bill number. Discussed home health, hospice, and long-term care. No bill number. Discussed Medicare Advantage. No bill number. Discussed the Medicare Prescription Drug Benefit Program. No bill number. Discussed the Medicare Cost Plan Program. No bill number. Discussed Medicare Advantage Capitation Rates. No bill number. Discussed Medicare Part C and Part D payment policies. No bill number. Discussed Medicare Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). No bill number. Discussed AI tools for Medicare Experience modernization. No bill number. Discussed Medicare Advantage provider networks. No bill number. Discussed fraud in Medicare and Medicaid. No bill number. Discussed long-term services and supports. No bill number. Discussed home and community-based services. No bill number. Discussed the Money Follows the Person Rebalancing Demonstration Program. No bill number. Discussed Medicaid home and community-based services (HCBS) spousal impoverishment protections. No bill number. Discussed the direct care workforce. No bill number. Discussed family caregiver exemption from Medicaid community engagement requirements. No bill number. Discussed falls prevention. No bill number. Discussed age-friendly communities. No bill number. Discussed health at home. No bill number. Discussed the National Strategy to Support Family Caregivers. No bill number. Discussed the Older Americans Act reauthorization. No bill number. Discussed Medicaid HCBS waivers. No bill number. Discussed the health care workforce.
S. 3439/H.R. 6735, Connecting Caregivers to Medicare Act. S. 1227/H.R. 2491, Alleviating Barriers for Caregivers Act. P.L. 119-21, the One Big Beautiful Bill Act. H.R. 6766/S. 3492, the Essential Caregivers Act. H.R. 7966/S. 4118, Hospice Care Accountability, Reform, and Enforcement (Hospice CARE) Act. H.R. 7618, Stopping Addiction and Falls for the Elderly (SAFE) Act. S. 2237/H.R. 4313, Hospital Inpatient Services Modernization Act. H.R. 8100, Safe Staffing Saves Lives Act. S. 3886, Nurses Belong in Nursing Homes Act. H.R. 7966/S. 4118, Hospice Care Accountability, Reform, and Enforcement (Hospice CARE) Act. S. 3886, Nurses Belong in Nursing Homes Act. No bill number. Discussed Medicare payment models. No bill number. Discussed Medicare waste, fraud, and abuse. No bill number. Discussed health technology, data security, enrollee accounts, and access. No bill number. Discussed Medicaid and waste, fraud, and abuse. No bill number. Discussed Medicaid community engagement requirements and Data Strategy for Family Caregiver Verification. No bill number. Discussed nursing home staffing standards, safety, and quality. No bill number. Discussed nursing home transparency and ownership requirements. No bill number. Discussed home health, hospice, and long-term care. No bill number. Discussed Medicare Advantage. No bill number. Discussed the Medicare Prescription Drug Benefit Program. No bill number. Discussed the Medicare Cost Plan Program. No bill number. Discussed Medicare Advantage Capitation Rates. No bill number. Discussed Medicare Part C and Part D payment policies. No bill number. Discussed Medicare Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). No bill number. Discussed AI tools for Medicare Experience modernization. No bill number. Discussed Medicare Advantage provider networks. No bill number. Discussed fraud in Medicare and Medicaid. No bill number. Discussed long-term services and supports. No bill number. Discussed home and community-based services. No bill number. Discussed the Money Follows the Person Rebalancing Demonstration Program. No bill number. Discussed Medicaid home and community-based services (HCBS) spousal impoverishment protections. No bill number. Discussed the direct care workforce. No bill number. Discussed family caregiver exemption from Medicaid community engagement requirements. No bill number. Discussed falls prevention. No bill number. Discussed age-friendly communities. No bill number. Discussed health at home. No bill number. Discussed the National Strategy to Support Family Caregivers. No bill number. Discussed the Older Americans Act reauthorization. No bill number. Discussed Medicaid HCBS waivers. No bill number. Discussed the health care workforce.
S. 3439/H.R. 6735, Connecting Caregivers to Medicare Act. S. 1227/H.R. 2491, Alleviating Barriers for Caregivers Act. P.L. 119-21, the One Big Beautiful Bill Act. H.R. 6766/S. 3492, the Essential Caregivers Act. H.R. 7966/S. 4118, Hospice Care Accountability, Reform, and Enforcement (Hospice CARE) Act. H.R. 7618, Stopping Addiction and Falls for the Elderly (SAFE) Act. S. 2237/H.R. 4313, Hospital Inpatient Services Modernization Act. H.R. 8100, Safe Staffing Saves Lives Act. S. 3886, Nurses Belong in Nursing Homes Act. H.R. 7966/S. 4118, Hospice Care Accountability, Reform, and Enforcement (Hospice CARE) Act. S. 3886, Nurses Belong in Nursing Homes Act. No bill number. Discussed Medicare payment models. No bill number. Discussed Medicare waste, fraud, and abuse. No bill number. Discussed health technology, data security, enrollee accounts, and access. No bill number. Discussed Medicaid and waste, fraud, and abuse. No bill number. Discussed Medicaid community engagement requirements and Data Strategy for Family Caregiver Verification. No bill number. Discussed nursing home staffing standards, safety, and quality. No bill number. Discussed nursing home transparency and ownership requirements. No bill number. Discussed home health, hospice, and long-term care. No bill number. Discussed Medicare Advantage. No bill number. Discussed the Medicare Prescription Drug Benefit Program. No bill number. Discussed the Medicare Cost Plan Program. No bill number. Discussed Medicare Advantage Capitation Rates. No bill number. Discussed Medicare Part C and Part D payment policies. No bill number. Discussed Medicare Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). No bill number. Discussed AI tools for Medicare Experience modernization. No bill number. Discussed Medicare Advantage provider networks. No bill number. Discussed fraud in Medicare and Medicaid. No bill number. Discussed long-term services and supports. No bill number. Discussed home and community-based services. No bill number. Discussed the Money Follows the Person Rebalancing Demonstration Program. No bill number. Discussed Medicaid home and community-based services (HCBS) spousal impoverishment protections. No bill number. Discussed the direct care workforce. No bill number. Discussed family caregiver exemption from Medicaid community engagement requirements. No bill number. Discussed falls prevention. No bill number. Discussed age-friendly communities. No bill number. Discussed health at home. No bill number. Discussed the National Strategy to Support Family Caregivers. No bill number. Discussed the Older Americans Act reauthorization. No bill number. Discussed Medicaid HCBS waivers. No bill number. Discussed the health care workforce.
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
H. Con. Res. 14/S. Con. Res. 7, the Budget Reconciliation Resolution S. 1096, the Preserving Access to Affordable Generics and Biosimilars Act. S. 1095, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act. S. 1040, the Drug Competition Enhancement Act. H.R. 9070/S. 1041, the Affordable Prescriptions for Patients Act. S. 1097, the Interagency Patent Coordination and Improvement Act of 2025. No bill number. Discussed pharmacy benefit managers. S. 527, Prescription Pricing for the People Act of 2025. S. 526, the Pharmacy Benefit Manager (PBM) Transparency Act of 2025. S. 229, the Drug-Price Transparency for Consumers (DTC) Act of 2025. No bill number. Discussed Medicare Part D. No bill number. Discussed cap on out-of-pocket prescription drug costs. No bill number. Discussed the Medicare Prescription Payment Plan. No bill number. Discussed the Medicare drug price negotiation program.
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
H. Con. Res. 14/S. Con. Res. 7, the Budget Reconciliation Resolution S. 1096, the Preserving Access to Affordable Generics and Biosimilars Act. S. 1095, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act. S. 1040, the Drug Competition Enhancement Act. H.R. 9070/S. 1041, the Affordable Prescriptions for Patients Act. S. 1097, the Interagency Patent Coordination and Improvement Act of 2025. No bill number. Discussed pharmacy benefit managers. S. 527, Prescription Pricing for the People Act of 2025. S. 526, the Pharmacy Benefit Manager (PBM) Transparency Act of 2025. S. 229, the Drug-Price Transparency for Consumers (DTC) Act of 2025. No bill number. Discussed Medicare Part D. No bill number. Discussed cap on out-of-pocket prescription drug costs. No bill number. Discussed the Medicare Prescription Payment Plan. No bill number. Discussed the Medicare drug price negotiation program.
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
H. Con. Res. 14/S. Con. Res. 7, the Budget Reconciliation Resolution. H.R. 2491, the Alleviating Barriers for Caregivers Act. No bill number. Discussed the Connecting Caregivers to Medicare Act. H.R. 1171, the Stopping Addiction and Falls for the Elderly (SAFE) Act. H.R. 1317/S. 575, the Improving Care and Access to Nurses (I CAN) Act of 2025. H.R. 10445, Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025 No bill number. Discussed Medicare physician reimbursement reform. No bill number. Discussed Medicare telehealth access. No bill number. Discussed Medicare Advantage. No bill number. Discussed access to home and community-based services, long-term services and supports, and post-acute care. No bill number. Discussed nursing home staffing and quality. No bill number. Discussed falls prevention. No bill number. Discussed Essential Caregivers Act No bill number, discussed Medicaid self-direction programs and related data No bill number. Discussed the Care for Military Kids Act No bill number. Discussed the Ensuring Access to Medicaid Buy-in Programs Act. No bill number. Discussed hospice and advance directives. No bill number. Discussed scope of practice and bed rails in nursing homes. No bill number. Discussed Medicaid, long-term care, and family caregivers.
Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
H. Con. Res. 14/S. Con. Res. 7, the Budget Reconciliation Resolution. H.R. 2491, the Alleviating Barriers for Caregivers Act. No bill number. Discussed the Connecting Caregivers to Medicare Act. H.R. 1171, the Stopping Addiction and Falls for the Elderly (SAFE) Act. H.R. 1317/S. 575, the Improving Care and Access to Nurses (I CAN) Act of 2025. H.R. 10445, Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025 No bill number. Discussed Medicare physician reimbursement reform. No bill number. Discussed Medicare telehealth access. No bill number. Discussed Medicare Advantage. No bill number. Discussed access to home and community-based services, long-term services and supports, and post-acute care. No bill number. Discussed nursing home staffing and quality. No bill number. Discussed falls prevention. No bill number. Discussed Essential Caregivers Act No bill number, discussed Medicaid self-direction programs and related data No bill number. Discussed the Care for Military Kids Act No bill number. Discussed the Ensuring Access to Medicaid Buy-in Programs Act. No bill number. Discussed hospice and advance directives. No bill number. Discussed scope of practice and bed rails in nursing homes. No bill number. Discussed Medicaid, long-term care, and family caregivers.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
H.R. 1, the One Big Beautiful Bill Act of 2025. S. 1227/H.R. 2491, the Alleviating Barriers for Caregivers Act of 2025. S. 3766, the Connecting Caregivers to Medicare Act of 2025. H.R. 3665, the Medicare Economic Security Solutions Act of 2025. H.R. 4619, the Medicare Mental Health Inpatient Equity Act of 2025. S. 1996/H.R. 2757, the Medicare Audiology Access Improvement Act of 2025. S. 1105, the No Unreasonable Payments, Coding, or Diagnoses for the Elderly Act (No UPCODE Act of 2025). S. 1816, the Improving Seniors Timely Access to Care Act of 2025. S. 1261/H.R.4206, the CONNECT for Health Act of 2025. S. 2237/H.R. 4313, the Hospital Inpatient Services Modernization Act of 2025. H.R. 5228, the HCBS Worker Protection Act of 2025. H.R. 3954, the Improving Access to Medicare Coverage Act of 2025. No bill number. Discussed prior authorization in Medicare. No bill number. Discussed consumer protections and deceptive marketing in Medicare Advantage. No bill number. Discussed digital health technology and telehealth. No bill number. Discussed network adequacy and provider access issues in Medicare Advantage. No bill number. Discussed the proposed Medicare Physician Fee Schedule for calendar year 2026. No bill number. Discussed Long-term care ombudsman program. No bill number. Discussed the proposed Medicare Hospital Outpatient Prospective Payment System for calendar year 2026. No bill number. Discussed Medicaid work requirements. No bill number. Discussed Medicaid retroactive coverage. No bill number. Discussed Medicaid cost-sharing. No bill number. Discussed Medicaid redeterminations. No bill number. Discussed nursing home staffing and quality. No bill number. Discussed long-term care, home health, hospice, and post-acute care. No bill number. Discussed Essential Caregivers Act. No bill number. Discussed 2026 Medicare Home Health Prospective Payment System (HH PPS). No bill number. Discussed family caregivers and Medicaid. No bill number. Discussed Acute Hospital Care at Home waiver.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
H.R. 1, One Big Beautiful Bill Act. S. 1862/ H.R. 946, the Optimizing Research Progress Hope And New Cures (ORPHAN Cures) Act. S. 832, the Ensuring Pathways to Innovative Cures (EPIC) Act of 2025. H.R. 1492, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. No bill number. Discussed the Medicare drug price negotiation program. Discussed pharmacy benefit manager reforms. S. 229/ H.R. 3789, the Drug-Price Transparency for Consumers (DTC) Act of 2025. S. 1096, Preserving Access to Affordable Generics and Biosimilars Act. S. 1095, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act. S. 1097, the Interagency Patent Coordination and Improvement Act of 2025. S. 1040, Drug Competition Enhancement Act. S. 1041, Affordable Prescriptions for Patients Act.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
H.R. 1, the One Big Beautiful Bill Act of 2025. No bill number. Discussed drug supply chain and Executive Order on strategic reserve of active pharmaceutical ingredients. S. 2620, the Reforming Evergreening and Manipulation that Extends Drug Years (REMEDY) Act of 2025. S. 1784/H.R. 4191, the Mapping America's Pharmaceutical Supply (MAPS) Act of 2025. S.832/H.R. 1492, the Ensuring Pathways to Innovative Cures (EPIC) Act of 2025. No bill number. Discussed the Medicare drug price negotiation program. No bill number. Discussed pharmacy benefit manager reforms. No bill number. Discussed Most Favored Nation drug pricing proposals.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
H.R. 1, the One Big Beautiful Bill Act. No bill number. Discussed Medicaid health care services. No bill number. Discussed Medicaid expansion health care policies. No bill number. Discussed Medicaid, long-term care, and family caregivers. No bill number. Discussed Medicaid work requirements. No bill number. Discussed family caregiver exemption for Medicaid work requirements. No bill number. Discussed Medicaid retroactive coverage policies. No bill number. Discussed Medicaid FMAP policies. No bill number. Discussed nursing home staffing and quality. No bill number. Discussed long-term care, including home health, hospice, and post-acute care. No bill number. Discussed Essential Caregivers Act. No bill number. Discussed advance directives and provider accountability. No bill number. Discussed CMS Hospice Proposed Rule. H.R. 2082, the Well-Being Insurance for Seniors to be at Home (WISH) Act. S. 1105, the No Unreasonable Payments, Coding, Or Diagnoses for the Elderly (UPCODE) Act of 2025. S. 1816, the Improving Seniors Timely Access to Care Act of 2025. No bill number. Discussed long-term care. No bill number. Discussed Medicaid long-term care. H.R. 3079, Medicaid Empowerment Act of 2025. No bill number. Discussed elder abuse and elder justice. No bill number. Discussed 2026 Hospice Wage Index and Payment Rate Update. S. 1227/H.R. 2491, the Alleviating Barriers for Caregivers Act. No bill number. Discussed Medicare Advantage. No bill number. Discussed Medicaid and family caregivers. No bill number. Discussed digital health technologies in Medicare. S. 1261, the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2025. H.R. 1171, the Stopping Addiction and Falls for the Elderly (SAFE) Act. No bill number. Discussed falls prevention. No bill number. Discussed Medicare Advantage provider networks.
H. Con. Res. 14/S. Con. Res. 7, the Budget Reconciliation Resolution. H.R. 2491, the Alleviating Barriers for Caregivers Act. No bill number. Discussed the Connecting Caregivers to Medicare Act. H.R. 1171, the Stopping Addiction and Falls for the Elderly (SAFE) Act. H.R. 1317/S. 575, the Improving Care and Access to Nurses (I CAN) Act of 2025. H.R. 10445, Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025 No bill number. Discussed Medicare physician reimbursement reform. No bill number. Discussed Medicare telehealth access. No bill number. Discussed Medicare Advantage. No bill number. Discussed access to home and community-based services, long-term services and supports, and post-acute care. No bill number. Discussed nursing home staffing and quality. No bill number. Discussed falls prevention. No bill number. Discussed Essential Caregivers Act No bill number, discussed Medicaid self-direction programs and related data No bill number. Discussed the Care for Military Kids Act No bill number. Discussed the Ensuring Access to Medicaid Buy-in Programs Act. No bill number. Discussed hospice and advance directives. No bill number. Discussed scope of practice and bed rails in nursing homes. No bill number. Discussed Medicaid, long-term care, and family caregivers.
H. Con. Res. 14/S. Con. Res. 7, the Budget Reconciliation Resolution. H.R. 2491, the Alleviating Barriers for Caregivers Act. No bill number. Discussed the Connecting Caregivers to Medicare Act. H.R. 1171, the Stopping Addiction and Falls for the Elderly (SAFE) Act. H.R. 1317/S. 575, the Improving Care and Access to Nurses (I CAN) Act of 2025. H.R. 10445, Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025 No bill number. Discussed Medicare physician reimbursement reform. No bill number. Discussed Medicare telehealth access. No bill number. Discussed Medicare Advantage. No bill number. Discussed access to home and community-based services, long-term services and supports, and post-acute care. No bill number. Discussed nursing home staffing and quality. No bill number. Discussed falls prevention. No bill number. Discussed Essential Caregivers Act No bill number, discussed Medicaid self-direction programs and related data No bill number. Discussed the Care for Military Kids Act No bill number. Discussed the Ensuring Access to Medicaid Buy-in Programs Act. No bill number. Discussed hospice and advance directives. No bill number. Discussed scope of practice and bed rails in nursing homes. No bill number. Discussed Medicaid, long-term care, and family caregivers.
H. Con. Res. 14/S. Con. Res. 7, the Budget Reconciliation Resolution. H.R. 2491, the Alleviating Barriers for Caregivers Act. No bill number. Discussed the Connecting Caregivers to Medicare Act. H.R. 1171, the Stopping Addiction and Falls for the Elderly (SAFE) Act. H.R. 1317/S. 575, the Improving Care and Access to Nurses (I CAN) Act of 2025. H.R. 10445, Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025 No bill number. Discussed Medicare physician reimbursement reform. No bill number. Discussed Medicare telehealth access. No bill number. Discussed Medicare Advantage. No bill number. Discussed access to home and community-based services, long-term services and supports, and post-acute care. No bill number. Discussed nursing home staffing and quality. No bill number. Discussed falls prevention. No bill number. Discussed Essential Caregivers Act No bill number, discussed Medicaid self-direction programs and related data No bill number. Discussed the Care for Military Kids Act No bill number. Discussed the Ensuring Access to Medicaid Buy-in Programs Act. No bill number. Discussed hospice and advance directives. No bill number. Discussed scope of practice and bed rails in nursing homes. No bill number. Discussed Medicaid, long-term care, and family caregivers.
H. Con. Res. 14/S. Con. Res. 7, the Budget Reconciliation Resolution. H.R. 2491, the Alleviating Barriers for Caregivers Act. No bill number. Discussed the Connecting Caregivers to Medicare Act. H.R. 1171, the Stopping Addiction and Falls for the Elderly (SAFE) Act. H.R. 1317/S. 575, the Improving Care and Access to Nurses (I CAN) Act of 2025. H.R. 10445, Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025 No bill number. Discussed Medicare physician reimbursement reform. No bill number. Discussed Medicare telehealth access. No bill number. Discussed Medicare Advantage. No bill number. Discussed access to home and community-based services, long-term services and supports, and post-acute care. No bill number. Discussed nursing home staffing and quality. No bill number. Discussed falls prevention. No bill number. Discussed Essential Caregivers Act No bill number, discussed Medicaid self-direction programs and related data No bill number. Discussed the Care for Military Kids Act No bill number. Discussed the Ensuring Access to Medicaid Buy-in Programs Act. No bill number. Discussed hospice and advance directives. No bill number. Discussed scope of practice and bed rails in nursing homes. No bill number. Discussed Medicaid, long-term care, and family caregivers.
H.R. 1, the One Big Beautiful Bill Act. No bill number. Discussed Medicaid health care services. No bill number. Discussed Medicaid expansion health care policies. No bill number. Discussed Medicaid, long-term care, and family caregivers. No bill number. Discussed Medicaid work requirements. No bill number. Discussed family caregiver exemption for Medicaid work requirements. No bill number. Discussed Medicaid retroactive coverage policies. No bill number. Discussed Medicaid FMAP policies. No bill number. Discussed nursing home staffing and quality. No bill number. Discussed long-term care, including home health, hospice, and post-acute care. No bill number. Discussed Essential Caregivers Act. No bill number. Discussed advance directives and provider accountability. No bill number. Discussed CMS Hospice Proposed Rule. H.R. 2082, the Well-Being Insurance for Seniors to be at Home (WISH) Act. S. 1105, the No Unreasonable Payments, Coding, Or Diagnoses for the Elderly (UPCODE) Act of 2025. S. 1816, the Improving Seniors Timely Access to Care Act of 2025. No bill number. Discussed long-term care. No bill number. Discussed Medicaid long-term care. H.R. 3079, Medicaid Empowerment Act of 2025. No bill number. Discussed elder abuse and elder justice. No bill number. Discussed 2026 Hospice Wage Index and Payment Rate Update. S. 1227/H.R. 2491, the Alleviating Barriers for Caregivers Act. No bill number. Discussed Medicare Advantage. No bill number. Discussed Medicaid and family caregivers. No bill number. Discussed digital health technologies in Medicare. S. 1261, the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2025. H.R. 1171, the Stopping Addiction and Falls for the Elderly (SAFE) Act. No bill number. Discussed falls prevention. No bill number. Discussed Medicare Advantage provider networks.
H. Con. Res. 14/S. Con. Res. 7, the Budget Reconciliation Resolution. H.R. 2491, the Alleviating Barriers for Caregivers Act. No bill number. Discussed the Connecting Caregivers to Medicare Act. H.R. 1171, the Stopping Addiction and Falls for the Elderly (SAFE) Act. H.R. 1317/S. 575, the Improving Care and Access to Nurses (I CAN) Act of 2025. H.R. 10445, Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025 No bill number. Discussed Medicare physician reimbursement reform. No bill number. Discussed Medicare telehealth access. No bill number. Discussed Medicare Advantage. No bill number. Discussed access to home and community-based services, long-term services and supports, and post-acute care. No bill number. Discussed nursing home staffing and quality. No bill number. Discussed falls prevention. No bill number. Discussed Essential Caregivers Act No bill number, discussed Medicaid self-direction programs and related data No bill number. Discussed the Care for Military Kids Act No bill number. Discussed the Ensuring Access to Medicaid Buy-in Programs Act. No bill number. Discussed hospice and advance directives. No bill number. Discussed scope of practice and bed rails in nursing homes. No bill number. Discussed Medicaid, long-term care, and family caregivers.
H. Con. Res. 14/S. Con. Res. 7, the Budget Reconciliation Resolution. H.R. 2491, the Alleviating Barriers for Caregivers Act. No bill number. Discussed the Connecting Caregivers to Medicare Act. H.R. 1171, the Stopping Addiction and Falls for the Elderly (SAFE) Act. H.R. 1317/S. 575, the Improving Care and Access to Nurses (I CAN) Act of 2025. H.R. 10445, Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025 No bill number. Discussed Medicare physician reimbursement reform. No bill number. Discussed Medicare telehealth access. No bill number. Discussed Medicare Advantage. No bill number. Discussed access to home and community-based services, long-term services and supports, and post-acute care. No bill number. Discussed nursing home staffing and quality. No bill number. Discussed falls prevention. No bill number. Discussed Essential Caregivers Act No bill number, discussed Medicaid self-direction programs and related data No bill number. Discussed the Care for Military Kids Act No bill number. Discussed the Ensuring Access to Medicaid Buy-in Programs Act. No bill number. Discussed hospice and advance directives. No bill number. Discussed scope of practice and bed rails in nursing homes. No bill number. Discussed Medicaid, long-term care, and family caregivers.
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
S.3345, the PBM Price Transparency and Accountability Act of 2025. S.832/H.R. 1492, the Ensuring Pathways to Innovative Cures (EPIC) Act of 2025. No bill number. Discussed the Medicare drug price negotiation program. No bill number. Discussed pharmacy benefit manager reforms. No bill number. Discussed GLOBE, GUARD, and GENEROUS drug pricing models. No bill number. Discussed Most-favored nation prescription drugs.
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
H.R. 1, One Big Beautiful Bill Act. S. 1862/ H.R. 946, the Optimizing Research Progress Hope And New Cures (ORPHAN Cures) Act. S. 832, the Ensuring Pathways to Innovative Cures (EPIC) Act of 2025. H.R. 1492, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. No bill number. Discussed the Medicare drug price negotiation program. Discussed pharmacy benefit manager reforms. S. 229/ H.R. 3789, the Drug-Price Transparency for Consumers (DTC) Act of 2025. S. 1096, Preserving Access to Affordable Generics and Biosimilars Act. S. 1095, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act. S. 1097, the Interagency Patent Coordination and Improvement Act of 2025. S. 1040, Drug Competition Enhancement Act. S. 1041, Affordable Prescriptions for Patients Act.
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
H.R. 1, the One Big Beautiful Bill Act of 2025. No bill number. Discussed drug supply chain and Executive Order on strategic reserve of active pharmaceutical ingredients. S. 2620, the Reforming Evergreening and Manipulation that Extends Drug Years (REMEDY) Act of 2025. S. 1784/H.R. 4191, the Mapping America's Pharmaceutical Supply (MAPS) Act of 2025. S.832/H.R. 1492, the Ensuring Pathways to Innovative Cures (EPIC) Act of 2025. No bill number. Discussed the Medicare drug price negotiation program. No bill number. Discussed pharmacy benefit manager reforms. No bill number. Discussed Most Favored Nation drug pricing proposals.
H.R. 1, the One Big Beautiful Bill Act. No bill number. Discussed Medicaid health care services. No bill number. Discussed Medicaid expansion health care policies. No bill number. Discussed Medicaid, long-term care, and family caregivers. No bill number. Discussed Medicaid work requirements. No bill number. Discussed family caregiver exemption for Medicaid work requirements. No bill number. Discussed Medicaid retroactive coverage policies. No bill number. Discussed Medicaid FMAP policies. No bill number. Discussed nursing home staffing and quality. No bill number. Discussed long-term care, including home health, hospice, and post-acute care. No bill number. Discussed Essential Caregivers Act. No bill number. Discussed advance directives and provider accountability. No bill number. Discussed CMS Hospice Proposed Rule. H.R. 2082, the Well-Being Insurance for Seniors to be at Home (WISH) Act. S. 1105, the No Unreasonable Payments, Coding, Or Diagnoses for the Elderly (UPCODE) Act of 2025. S. 1816, the Improving Seniors Timely Access to Care Act of 2025. No bill number. Discussed long-term care. No bill number. Discussed Medicaid long-term care. H.R. 3079, Medicaid Empowerment Act of 2025. No bill number. Discussed elder abuse and elder justice. No bill number. Discussed 2026 Hospice Wage Index and Payment Rate Update. S. 1227/H.R. 2491, the Alleviating Barriers for Caregivers Act. No bill number. Discussed Medicare Advantage. No bill number. Discussed Medicaid and family caregivers. No bill number. Discussed digital health technologies in Medicare. S. 1261, the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2025. H.R. 1171, the Stopping Addiction and Falls for the Elderly (SAFE) Act. No bill number. Discussed falls prevention. No bill number. Discussed Medicare Advantage provider networks.
S. 3439/H.R. 6735, Connecting Caregivers to Medicare Act of 2025. S. 1227/H.R. 2491, Alleviating Barriers for Caregivers Act of 2025. P.L. 119-21, One Big Beautiful Bill Act of 2025. S. 2466/H.R. 6210, the Senior Savings Protection Act of 2025. S. 1261/H.R. 4206, the CONNECT for Health Act of 2025. S. 639/HR 227, the Clergy Act of 2026. S.1105, the No UPCODE Act of 2025. S. 1816, the Improving Seniors Timely Access to Care Act of 2025. H.R. 6766/S. 3492. Essential Caregivers Act of 2025. H.R.3954. Improving Access to Medicare Coverage Act of 2025. No bill number. Discussed family caregiver exemption from Medicaid community engagement requirements. S. 2237/H.R. 4313, the Hospital Inpatient Services Modernization Act. No bill number. Discussed prior authorization and artificial intelligence in Medicare. No bill number. Discussed Medicare fraud. No bill number. Discussed Money Follows the person Rebalancing Demonstration Program and Medicaid home and community-based services (HCBS) spousal impoverishment protections. No bill number. Discussed Medicare Part B premiums. No bill number. Discussed support for family caregivers. No bill number. Discussed respite care. No bill number. Discussed Medicaid home and community-based services (HCBS), No bill number. Discussed Medicares support for family caregivers. No bill number. Discussed Medicare open enrollment. No bill number. Discussed timing for provider claims filings. No bill number. Discussed access to digital tools. No bill number. Nursing Home staffing standards, safety, and quality. No bill number. Home Health, Hospice and Long-term care.
S. 3439/H.R. 6735, Connecting Caregivers to Medicare Act of 2025. S. 1227/H.R. 2491, Alleviating Barriers for Caregivers Act of 2025. P.L. 119-21, One Big Beautiful Bill Act of 2025. S. 2466/H.R. 6210, the Senior Savings Protection Act of 2025. S. 1261/H.R. 4206, the CONNECT for Health Act of 2025. S. 639/HR 227, the Clergy Act of 2026. S.1105, the No UPCODE Act of 2025. S. 1816, the Improving Seniors Timely Access to Care Act of 2025. H.R. 6766/S. 3492. Essential Caregivers Act of 2025. H.R.3954. Improving Access to Medicare Coverage Act of 2025. No bill number. Discussed family caregiver exemption from Medicaid community engagement requirements. S. 2237/H.R. 4313, the Hospital Inpatient Services Modernization Act. No bill number. Discussed prior authorization and artificial intelligence in Medicare. No bill number. Discussed Medicare fraud. No bill number. Discussed Money Follows the person Rebalancing Demonstration Program and Medicaid home and community-based services (HCBS) spousal impoverishment protections. No bill number. Discussed Medicare Part B premiums. No bill number. Discussed support for family caregivers. No bill number. Discussed respite care. No bill number. Discussed Medicaid home and community-based services (HCBS), No bill number. Discussed Medicares support for family caregivers. No bill number. Discussed Medicare open enrollment. No bill number. Discussed timing for provider claims filings. No bill number. Discussed access to digital tools. No bill number. Nursing Home staffing standards, safety, and quality. No bill number. Home Health, Hospice and Long-term care.
H. Con. Res. 14/S. Con. Res. 7, the Budget Reconciliation Resolution. H.R. 2491, the Alleviating Barriers for Caregivers Act. No bill number. Discussed the Connecting Caregivers to Medicare Act. H.R. 1171, the Stopping Addiction and Falls for the Elderly (SAFE) Act. H.R. 1317/S. 575, the Improving Care and Access to Nurses (I CAN) Act of 2025. H.R. 10445, Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025 No bill number. Discussed Medicare physician reimbursement reform. No bill number. Discussed Medicare telehealth access. No bill number. Discussed Medicare Advantage. No bill number. Discussed access to home and community-based services, long-term services and supports, and post-acute care. No bill number. Discussed nursing home staffing and quality. No bill number. Discussed falls prevention. No bill number. Discussed Essential Caregivers Act No bill number, discussed Medicaid self-direction programs and related data No bill number. Discussed the Care for Military Kids Act No bill number. Discussed the Ensuring Access to Medicaid Buy-in Programs Act. No bill number. Discussed hospice and advance directives. No bill number. Discussed scope of practice and bed rails in nursing homes. No bill number. Discussed Medicaid, long-term care, and family caregivers.
H. Con. Res. 14/S. Con. Res. 7, the Budget Reconciliation Resolution. H.R. 2491, the Alleviating Barriers for Caregivers Act. No bill number. Discussed the Connecting Caregivers to Medicare Act. H.R. 1171, the Stopping Addiction and Falls for the Elderly (SAFE) Act. H.R. 1317/S. 575, the Improving Care and Access to Nurses (I CAN) Act of 2025. H.R. 10445, Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025 No bill number. Discussed Medicare physician reimbursement reform. No bill number. Discussed Medicare telehealth access. No bill number. Discussed Medicare Advantage. No bill number. Discussed access to home and community-based services, long-term services and supports, and post-acute care. No bill number. Discussed nursing home staffing and quality. No bill number. Discussed falls prevention. No bill number. Discussed Essential Caregivers Act No bill number, discussed Medicaid self-direction programs and related data No bill number. Discussed the Care for Military Kids Act No bill number. Discussed the Ensuring Access to Medicaid Buy-in Programs Act. No bill number. Discussed hospice and advance directives. No bill number. Discussed scope of practice and bed rails in nursing homes. No bill number. Discussed Medicaid, long-term care, and family caregivers.
H.R. 1, the One Big Beautiful Bill Act of 2025. S. 1227/H.R. 2491, the Alleviating Barriers for Caregivers Act of 2025. S. 3766, the Connecting Caregivers to Medicare Act of 2025. H.R. 3665, the Medicare Economic Security Solutions Act of 2025. H.R. 4619, the Medicare Mental Health Inpatient Equity Act of 2025. S. 1996/H.R. 2757, the Medicare Audiology Access Improvement Act of 2025. S. 1105, the No Unreasonable Payments, Coding, or Diagnoses for the Elderly Act (No UPCODE Act of 2025). S. 1816, the Improving Seniors Timely Access to Care Act of 2025. S. 1261/H.R.4206, the CONNECT for Health Act of 2025. S. 2237/H.R. 4313, the Hospital Inpatient Services Modernization Act of 2025. H.R. 5228, the HCBS Worker Protection Act of 2025. H.R. 3954, the Improving Access to Medicare Coverage Act of 2025. No bill number. Discussed prior authorization in Medicare. No bill number. Discussed consumer protections and deceptive marketing in Medicare Advantage. No bill number. Discussed digital health technology and telehealth. No bill number. Discussed network adequacy and provider access issues in Medicare Advantage. No bill number. Discussed the proposed Medicare Physician Fee Schedule for calendar year 2026. No bill number. Discussed Long-term care ombudsman program. No bill number. Discussed the proposed Medicare Hospital Outpatient Prospective Payment System for calendar year 2026. No bill number. Discussed Medicaid work requirements. No bill number. Discussed Medicaid retroactive coverage. No bill number. Discussed Medicaid cost-sharing. No bill number. Discussed Medicaid redeterminations. No bill number. Discussed nursing home staffing and quality. No bill number. Discussed long-term care, home health, hospice, and post-acute care. No bill number. Discussed Essential Caregivers Act. No bill number. Discussed 2026 Medicare Home Health Prospective Payment System (HH PPS). No bill number. Discussed family caregivers and Medicaid. No bill number. Discussed Acute Hospital Care at Home waiver.
H.R. 1, the One Big Beautiful Bill Act. No bill number. Discussed Medicaid health care services. No bill number. Discussed Medicaid expansion health care policies. No bill number. Discussed Medicaid, long-term care, and family caregivers. No bill number. Discussed Medicaid work requirements. No bill number. Discussed family caregiver exemption for Medicaid work requirements. No bill number. Discussed Medicaid retroactive coverage policies. No bill number. Discussed Medicaid FMAP policies. No bill number. Discussed nursing home staffing and quality. No bill number. Discussed long-term care, including home health, hospice, and post-acute care. No bill number. Discussed Essential Caregivers Act. No bill number. Discussed advance directives and provider accountability. No bill number. Discussed CMS Hospice Proposed Rule. H.R. 2082, the Well-Being Insurance for Seniors to be at Home (WISH) Act. S. 1105, the No Unreasonable Payments, Coding, Or Diagnoses for the Elderly (UPCODE) Act of 2025. S. 1816, the Improving Seniors Timely Access to Care Act of 2025. No bill number. Discussed long-term care. No bill number. Discussed Medicaid long-term care. H.R. 3079, Medicaid Empowerment Act of 2025. No bill number. Discussed elder abuse and elder justice. No bill number. Discussed 2026 Hospice Wage Index and Payment Rate Update. S. 1227/H.R. 2491, the Alleviating Barriers for Caregivers Act. No bill number. Discussed Medicare Advantage. No bill number. Discussed Medicaid and family caregivers. No bill number. Discussed digital health technologies in Medicare. S. 1261, the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2025. H.R. 1171, the Stopping Addiction and Falls for the Elderly (SAFE) Act. No bill number. Discussed falls prevention. No bill number. Discussed Medicare Advantage provider networks.
H.R. 1, the One Big Beautiful Bill Act of 2025. S. 1227/H.R. 2491, the Alleviating Barriers for Caregivers Act of 2025. S. 3766, the Connecting Caregivers to Medicare Act of 2025. H.R. 3665, the Medicare Economic Security Solutions Act of 2025. H.R. 4619, the Medicare Mental Health Inpatient Equity Act of 2025. S. 1996/H.R. 2757, the Medicare Audiology Access Improvement Act of 2025. S. 1105, the No Unreasonable Payments, Coding, or Diagnoses for the Elderly Act (No UPCODE Act of 2025). S. 1816, the Improving Seniors Timely Access to Care Act of 2025. S. 1261/H.R.4206, the CONNECT for Health Act of 2025. S. 2237/H.R. 4313, the Hospital Inpatient Services Modernization Act of 2025. H.R. 5228, the HCBS Worker Protection Act of 2025. H.R. 3954, the Improving Access to Medicare Coverage Act of 2025. No bill number. Discussed prior authorization in Medicare. No bill number. Discussed consumer protections and deceptive marketing in Medicare Advantage. No bill number. Discussed digital health technology and telehealth. No bill number. Discussed network adequacy and provider access issues in Medicare Advantage. No bill number. Discussed the proposed Medicare Physician Fee Schedule for calendar year 2026. No bill number. Discussed Long-term care ombudsman program. No bill number. Discussed the proposed Medicare Hospital Outpatient Prospective Payment System for calendar year 2026. No bill number. Discussed Medicaid work requirements. No bill number. Discussed Medicaid retroactive coverage. No bill number. Discussed Medicaid cost-sharing. No bill number. Discussed Medicaid redeterminations. No bill number. Discussed nursing home staffing and quality. No bill number. Discussed long-term care, home health, hospice, and post-acute care. No bill number. Discussed Essential Caregivers Act. No bill number. Discussed 2026 Medicare Home Health Prospective Payment System (HH PPS). No bill number. Discussed family caregivers and Medicaid. No bill number. Discussed Acute Hospital Care at Home waiver.
H.R. 1, the One Big Beautiful Bill Act. No bill number. Discussed Medicaid health care services. No bill number. Discussed Medicaid expansion health care policies. No bill number. Discussed Medicaid, long-term care, and family caregivers. No bill number. Discussed Medicaid work requirements. No bill number. Discussed family caregiver exemption for Medicaid work requirements. No bill number. Discussed Medicaid retroactive coverage policies. No bill number. Discussed Medicaid FMAP policies. No bill number. Discussed nursing home staffing and quality. No bill number. Discussed long-term care, including home health, hospice, and post-acute care. No bill number. Discussed Essential Caregivers Act. No bill number. Discussed advance directives and provider accountability. No bill number. Discussed CMS Hospice Proposed Rule. H.R. 2082, the Well-Being Insurance for Seniors to be at Home (WISH) Act. S. 1105, the No Unreasonable Payments, Coding, Or Diagnoses for the Elderly (UPCODE) Act of 2025. S. 1816, the Improving Seniors Timely Access to Care Act of 2025. No bill number. Discussed long-term care. No bill number. Discussed Medicaid long-term care. H.R. 3079, Medicaid Empowerment Act of 2025. No bill number. Discussed elder abuse and elder justice. No bill number. Discussed 2026 Hospice Wage Index and Payment Rate Update. S. 1227/H.R. 2491, the Alleviating Barriers for Caregivers Act. No bill number. Discussed Medicare Advantage. No bill number. Discussed Medicaid and family caregivers. No bill number. Discussed digital health technologies in Medicare. S. 1261, the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2025. H.R. 1171, the Stopping Addiction and Falls for the Elderly (SAFE) Act. No bill number. Discussed falls prevention. No bill number. Discussed Medicare Advantage provider networks.
H.R. 1, the One Big Beautiful Bill Act of 2025. S. 1227/H.R. 2491, the Alleviating Barriers for Caregivers Act of 2025. S. 3766, the Connecting Caregivers to Medicare Act of 2025. H.R. 3665, the Medicare Economic Security Solutions Act of 2025. H.R. 4619, the Medicare Mental Health Inpatient Equity Act of 2025. S. 1996/H.R. 2757, the Medicare Audiology Access Improvement Act of 2025. S. 1105, the No Unreasonable Payments, Coding, or Diagnoses for the Elderly Act (No UPCODE Act of 2025). S. 1816, the Improving Seniors Timely Access to Care Act of 2025. S. 1261/H.R.4206, the CONNECT for Health Act of 2025. S. 2237/H.R. 4313, the Hospital Inpatient Services Modernization Act of 2025. H.R. 5228, the HCBS Worker Protection Act of 2025. H.R. 3954, the Improving Access to Medicare Coverage Act of 2025. No bill number. Discussed prior authorization in Medicare. No bill number. Discussed consumer protections and deceptive marketing in Medicare Advantage. No bill number. Discussed digital health technology and telehealth. No bill number. Discussed network adequacy and provider access issues in Medicare Advantage. No bill number. Discussed the proposed Medicare Physician Fee Schedule for calendar year 2026. No bill number. Discussed Long-term care ombudsman program. No bill number. Discussed the proposed Medicare Hospital Outpatient Prospective Payment System for calendar year 2026. No bill number. Discussed Medicaid work requirements. No bill number. Discussed Medicaid retroactive coverage. No bill number. Discussed Medicaid cost-sharing. No bill number. Discussed Medicaid redeterminations. No bill number. Discussed nursing home staffing and quality. No bill number. Discussed long-term care, home health, hospice, and post-acute care. No bill number. Discussed Essential Caregivers Act. No bill number. Discussed 2026 Medicare Home Health Prospective Payment System (HH PPS). No bill number. Discussed family caregivers and Medicaid. No bill number. Discussed Acute Hospital Care at Home waiver.
H.R. 1, One Big Beautiful Bill Act. S. 1862/ H.R. 946, the Optimizing Research Progress Hope And New Cures (ORPHAN Cures) Act. S. 832, the Ensuring Pathways to Innovative Cures (EPIC) Act of 2025. H.R. 1492, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. No bill number. Discussed the Medicare drug price negotiation program. Discussed pharmacy benefit manager reforms. S. 229/ H.R. 3789, the Drug-Price Transparency for Consumers (DTC) Act of 2025. S. 1096, Preserving Access to Affordable Generics and Biosimilars Act. S. 1095, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act. S. 1097, the Interagency Patent Coordination and Improvement Act of 2025. S. 1040, Drug Competition Enhancement Act. S. 1041, Affordable Prescriptions for Patients Act.
H.R. 1, the One Big Beautiful Bill Act of 2025. S. 1227/H.R. 2491, the Alleviating Barriers for Caregivers Act of 2025. S. 3766, the Connecting Caregivers to Medicare Act of 2025. H.R. 3665, the Medicare Economic Security Solutions Act of 2025. H.R. 4619, the Medicare Mental Health Inpatient Equity Act of 2025. S. 1996/H.R. 2757, the Medicare Audiology Access Improvement Act of 2025. S. 1105, the No Unreasonable Payments, Coding, or Diagnoses for the Elderly Act (No UPCODE Act of 2025). S. 1816, the Improving Seniors Timely Access to Care Act of 2025. S. 1261/H.R.4206, the CONNECT for Health Act of 2025. S. 2237/H.R. 4313, the Hospital Inpatient Services Modernization Act of 2025. H.R. 5228, the HCBS Worker Protection Act of 2025. H.R. 3954, the Improving Access to Medicare Coverage Act of 2025. No bill number. Discussed prior authorization in Medicare. No bill number. Discussed consumer protections and deceptive marketing in Medicare Advantage. No bill number. Discussed digital health technology and telehealth. No bill number. Discussed network adequacy and provider access issues in Medicare Advantage. No bill number. Discussed the proposed Medicare Physician Fee Schedule for calendar year 2026. No bill number. Discussed Long-term care ombudsman program. No bill number. Discussed the proposed Medicare Hospital Outpatient Prospective Payment System for calendar year 2026. No bill number. Discussed Medicaid work requirements. No bill number. Discussed Medicaid retroactive coverage. No bill number. Discussed Medicaid cost-sharing. No bill number. Discussed Medicaid redeterminations. No bill number. Discussed nursing home staffing and quality. No bill number. Discussed long-term care, home health, hospice, and post-acute care. No bill number. Discussed Essential Caregivers Act. No bill number. Discussed 2026 Medicare Home Health Prospective Payment System (HH PPS). No bill number. Discussed family caregivers and Medicaid. No bill number. Discussed Acute Hospital Care at Home waiver.
S. 3439/H.R. 6735, Connecting Caregivers to Medicare Act of 2025. S. 1227/H.R. 2491, Alleviating Barriers for Caregivers Act of 2025. P.L. 119-21, One Big Beautiful Bill Act of 2025. S. 2466/H.R. 6210, the Senior Savings Protection Act of 2025. S. 1261/H.R. 4206, the CONNECT for Health Act of 2025. S. 639/HR 227, the Clergy Act of 2026. S.1105, the No UPCODE Act of 2025. S. 1816, the Improving Seniors Timely Access to Care Act of 2025. H.R. 6766/S. 3492. Essential Caregivers Act of 2025. H.R.3954. Improving Access to Medicare Coverage Act of 2025. No bill number. Discussed family caregiver exemption from Medicaid community engagement requirements. S. 2237/H.R. 4313, the Hospital Inpatient Services Modernization Act. No bill number. Discussed prior authorization and artificial intelligence in Medicare. No bill number. Discussed Medicare fraud. No bill number. Discussed Money Follows the person Rebalancing Demonstration Program and Medicaid home and community-based services (HCBS) spousal impoverishment protections. No bill number. Discussed Medicare Part B premiums. No bill number. Discussed support for family caregivers. No bill number. Discussed respite care. No bill number. Discussed Medicaid home and community-based services (HCBS), No bill number. Discussed Medicares support for family caregivers. No bill number. Discussed Medicare open enrollment. No bill number. Discussed timing for provider claims filings. No bill number. Discussed access to digital tools. No bill number. Nursing Home staffing standards, safety, and quality. No bill number. Home Health, Hospice and Long-term care.
H.R. 1, the One Big Beautiful Bill Act of 2025. No bill number. Discussed drug supply chain and Executive Order on strategic reserve of active pharmaceutical ingredients. S. 2620, the Reforming Evergreening and Manipulation that Extends Drug Years (REMEDY) Act of 2025. S. 1784/H.R. 4191, the Mapping America's Pharmaceutical Supply (MAPS) Act of 2025. S.832/H.R. 1492, the Ensuring Pathways to Innovative Cures (EPIC) Act of 2025. No bill number. Discussed the Medicare drug price negotiation program. No bill number. Discussed pharmacy benefit manager reforms. No bill number. Discussed Most Favored Nation drug pricing proposals.
S. 3439/H.R. 6735, Connecting Caregivers to Medicare Act of 2025. S. 1227/H.R. 2491, Alleviating Barriers for Caregivers Act of 2025. P.L. 119-21, One Big Beautiful Bill Act of 2025. S. 2466/H.R. 6210, the Senior Savings Protection Act of 2025. S. 1261/H.R. 4206, the CONNECT for Health Act of 2025. S. 639/HR 227, the Clergy Act of 2026. S.1105, the No UPCODE Act of 2025. S. 1816, the Improving Seniors Timely Access to Care Act of 2025. H.R. 6766/S. 3492. Essential Caregivers Act of 2025. H.R.3954. Improving Access to Medicare Coverage Act of 2025. No bill number. Discussed family caregiver exemption from Medicaid community engagement requirements. S. 2237/H.R. 4313, the Hospital Inpatient Services Modernization Act. No bill number. Discussed prior authorization and artificial intelligence in Medicare. No bill number. Discussed Medicare fraud. No bill number. Discussed Money Follows the person Rebalancing Demonstration Program and Medicaid home and community-based services (HCBS) spousal impoverishment protections. No bill number. Discussed Medicare Part B premiums. No bill number. Discussed support for family caregivers. No bill number. Discussed respite care. No bill number. Discussed Medicaid home and community-based services (HCBS), No bill number. Discussed Medicares support for family caregivers. No bill number. Discussed Medicare open enrollment. No bill number. Discussed timing for provider claims filings. No bill number. Discussed access to digital tools. No bill number. Nursing Home staffing standards, safety, and quality. No bill number. Home Health, Hospice and Long-term care.
H.R. 1, the One Big Beautiful Bill Act of 2025. S. 1227/H.R. 2491, the Alleviating Barriers for Caregivers Act of 2025. S. 3766, the Connecting Caregivers to Medicare Act of 2025. H.R. 3665, the Medicare Economic Security Solutions Act of 2025. H.R. 4619, the Medicare Mental Health Inpatient Equity Act of 2025. S. 1996/H.R. 2757, the Medicare Audiology Access Improvement Act of 2025. S. 1105, the No Unreasonable Payments, Coding, or Diagnoses for the Elderly Act (No UPCODE Act of 2025). S. 1816, the Improving Seniors Timely Access to Care Act of 2025. S. 1261/H.R.4206, the CONNECT for Health Act of 2025. S. 2237/H.R. 4313, the Hospital Inpatient Services Modernization Act of 2025. H.R. 5228, the HCBS Worker Protection Act of 2025. H.R. 3954, the Improving Access to Medicare Coverage Act of 2025. No bill number. Discussed prior authorization in Medicare. No bill number. Discussed consumer protections and deceptive marketing in Medicare Advantage. No bill number. Discussed digital health technology and telehealth. No bill number. Discussed network adequacy and provider access issues in Medicare Advantage. No bill number. Discussed the proposed Medicare Physician Fee Schedule for calendar year 2026. No bill number. Discussed Long-term care ombudsman program. No bill number. Discussed the proposed Medicare Hospital Outpatient Prospective Payment System for calendar year 2026. No bill number. Discussed Medicaid work requirements. No bill number. Discussed Medicaid retroactive coverage. No bill number. Discussed Medicaid cost-sharing. No bill number. Discussed Medicaid redeterminations. No bill number. Discussed nursing home staffing and quality. No bill number. Discussed long-term care, home health, hospice, and post-acute care. No bill number. Discussed Essential Caregivers Act. No bill number. Discussed 2026 Medicare Home Health Prospective Payment System (HH PPS). No bill number. Discussed family caregivers and Medicaid. No bill number. Discussed Acute Hospital Care at Home waiver.
S. 3439/H.R. 6735, Connecting Caregivers to Medicare Act of 2025. S. 1227/H.R. 2491, Alleviating Barriers for Caregivers Act of 2025. P.L. 119-21, One Big Beautiful Bill Act of 2025. S. 2466/H.R. 6210, the Senior Savings Protection Act of 2025. S. 1261/H.R. 4206, the CONNECT for Health Act of 2025. S. 639/HR 227, the Clergy Act of 2026. S.1105, the No UPCODE Act of 2025. S. 1816, the Improving Seniors Timely Access to Care Act of 2025. H.R. 6766/S. 3492. Essential Caregivers Act of 2025. H.R.3954. Improving Access to Medicare Coverage Act of 2025. No bill number. Discussed family caregiver exemption from Medicaid community engagement requirements. S. 2237/H.R. 4313, the Hospital Inpatient Services Modernization Act. No bill number. Discussed prior authorization and artificial intelligence in Medicare. No bill number. Discussed Medicare fraud. No bill number. Discussed Money Follows the person Rebalancing Demonstration Program and Medicaid home and community-based services (HCBS) spousal impoverishment protections. No bill number. Discussed Medicare Part B premiums. No bill number. Discussed support for family caregivers. No bill number. Discussed respite care. No bill number. Discussed Medicaid home and community-based services (HCBS), No bill number. Discussed Medicares support for family caregivers. No bill number. Discussed Medicare open enrollment. No bill number. Discussed timing for provider claims filings. No bill number. Discussed access to digital tools. No bill number. Nursing Home staffing standards, safety, and quality. No bill number. Home Health, Hospice and Long-term care.
H.R. 1, the One Big Beautiful Bill Act of 2025. S. 1227/H.R. 2491, the Alleviating Barriers for Caregivers Act of 2025. S. 3766, the Connecting Caregivers to Medicare Act of 2025. H.R. 3665, the Medicare Economic Security Solutions Act of 2025. H.R. 4619, the Medicare Mental Health Inpatient Equity Act of 2025. S. 1996/H.R. 2757, the Medicare Audiology Access Improvement Act of 2025. S. 1105, the No Unreasonable Payments, Coding, or Diagnoses for the Elderly Act (No UPCODE Act of 2025). S. 1816, the Improving Seniors Timely Access to Care Act of 2025. S. 1261/H.R.4206, the CONNECT for Health Act of 2025. S. 2237/H.R. 4313, the Hospital Inpatient Services Modernization Act of 2025. H.R. 5228, the HCBS Worker Protection Act of 2025. H.R. 3954, the Improving Access to Medicare Coverage Act of 2025. No bill number. Discussed prior authorization in Medicare. No bill number. Discussed consumer protections and deceptive marketing in Medicare Advantage. No bill number. Discussed digital health technology and telehealth. No bill number. Discussed network adequacy and provider access issues in Medicare Advantage. No bill number. Discussed the proposed Medicare Physician Fee Schedule for calendar year 2026. No bill number. Discussed Long-term care ombudsman program. No bill number. Discussed the proposed Medicare Hospital Outpatient Prospective Payment System for calendar year 2026. No bill number. Discussed Medicaid work requirements. No bill number. Discussed Medicaid retroactive coverage. No bill number. Discussed Medicaid cost-sharing. No bill number. Discussed Medicaid redeterminations. No bill number. Discussed nursing home staffing and quality. No bill number. Discussed long-term care, home health, hospice, and post-acute care. No bill number. Discussed Essential Caregivers Act. No bill number. Discussed 2026 Medicare Home Health Prospective Payment System (HH PPS). No bill number. Discussed family caregivers and Medicaid. No bill number. Discussed Acute Hospital Care at Home waiver.
H.R. 1, the One Big Beautiful Bill Act of 2025. S. 1227/H.R. 2491, the Alleviating Barriers for Caregivers Act of 2025. S. 3766, the Connecting Caregivers to Medicare Act of 2025. H.R. 3665, the Medicare Economic Security Solutions Act of 2025. H.R. 4619, the Medicare Mental Health Inpatient Equity Act of 2025. S. 1996/H.R. 2757, the Medicare Audiology Access Improvement Act of 2025. S. 1105, the No Unreasonable Payments, Coding, or Diagnoses for the Elderly Act (No UPCODE Act of 2025). S. 1816, the Improving Seniors Timely Access to Care Act of 2025. S. 1261/H.R.4206, the CONNECT for Health Act of 2025. S. 2237/H.R. 4313, the Hospital Inpatient Services Modernization Act of 2025. H.R. 5228, the HCBS Worker Protection Act of 2025. H.R. 3954, the Improving Access to Medicare Coverage Act of 2025. No bill number. Discussed prior authorization in Medicare. No bill number. Discussed consumer protections and deceptive marketing in Medicare Advantage. No bill number. Discussed digital health technology and telehealth. No bill number. Discussed network adequacy and provider access issues in Medicare Advantage. No bill number. Discussed the proposed Medicare Physician Fee Schedule for calendar year 2026. No bill number. Discussed Long-term care ombudsman program. No bill number. Discussed the proposed Medicare Hospital Outpatient Prospective Payment System for calendar year 2026. No bill number. Discussed Medicaid work requirements. No bill number. Discussed Medicaid retroactive coverage. No bill number. Discussed Medicaid cost-sharing. No bill number. Discussed Medicaid redeterminations. No bill number. Discussed nursing home staffing and quality. No bill number. Discussed long-term care, home health, hospice, and post-acute care. No bill number. Discussed Essential Caregivers Act. No bill number. Discussed 2026 Medicare Home Health Prospective Payment System (HH PPS). No bill number. Discussed family caregivers and Medicaid. No bill number. Discussed Acute Hospital Care at Home waiver.
H.R. 1, the One Big Beautiful Bill Act of 2025. S. 1227/H.R. 2491, the Alleviating Barriers for Caregivers Act of 2025. S. 3766, the Connecting Caregivers to Medicare Act of 2025. H.R. 3665, the Medicare Economic Security Solutions Act of 2025. H.R. 4619, the Medicare Mental Health Inpatient Equity Act of 2025. S. 1996/H.R. 2757, the Medicare Audiology Access Improvement Act of 2025. S. 1105, the No Unreasonable Payments, Coding, or Diagnoses for the Elderly Act (No UPCODE Act of 2025). S. 1816, the Improving Seniors Timely Access to Care Act of 2025. S. 1261/H.R.4206, the CONNECT for Health Act of 2025. S. 2237/H.R. 4313, the Hospital Inpatient Services Modernization Act of 2025. H.R. 5228, the HCBS Worker Protection Act of 2025. H.R. 3954, the Improving Access to Medicare Coverage Act of 2025. No bill number. Discussed prior authorization in Medicare. No bill number. Discussed consumer protections and deceptive marketing in Medicare Advantage. No bill number. Discussed digital health technology and telehealth. No bill number. Discussed network adequacy and provider access issues in Medicare Advantage. No bill number. Discussed the proposed Medicare Physician Fee Schedule for calendar year 2026. No bill number. Discussed Long-term care ombudsman program. No bill number. Discussed the proposed Medicare Hospital Outpatient Prospective Payment System for calendar year 2026. No bill number. Discussed Medicaid work requirements. No bill number. Discussed Medicaid retroactive coverage. No bill number. Discussed Medicaid cost-sharing. No bill number. Discussed Medicaid redeterminations. No bill number. Discussed nursing home staffing and quality. No bill number. Discussed long-term care, home health, hospice, and post-acute care. No bill number. Discussed Essential Caregivers Act. No bill number. Discussed 2026 Medicare Home Health Prospective Payment System (HH PPS). No bill number. Discussed family caregivers and Medicaid. No bill number. Discussed Acute Hospital Care at Home waiver.
S. 3439/H.R. 6735, Connecting Caregivers to Medicare Act of 2025. S. 1227/H.R. 2491, Alleviating Barriers for Caregivers Act of 2025. P.L. 119-21, One Big Beautiful Bill Act of 2025. S. 2466/H.R. 6210, the Senior Savings Protection Act of 2025. S. 1261/H.R. 4206, the CONNECT for Health Act of 2025. S. 639/HR 227, the Clergy Act of 2026. S.1105, the No UPCODE Act of 2025. S. 1816, the Improving Seniors Timely Access to Care Act of 2025. H.R. 6766/S. 3492. Essential Caregivers Act of 2025. H.R.3954. Improving Access to Medicare Coverage Act of 2025. No bill number. Discussed family caregiver exemption from Medicaid community engagement requirements. S. 2237/H.R. 4313, the Hospital Inpatient Services Modernization Act. No bill number. Discussed prior authorization and artificial intelligence in Medicare. No bill number. Discussed Medicare fraud. No bill number. Discussed Money Follows the person Rebalancing Demonstration Program and Medicaid home and community-based services (HCBS) spousal impoverishment protections. No bill number. Discussed Medicare Part B premiums. No bill number. Discussed support for family caregivers. No bill number. Discussed respite care. No bill number. Discussed Medicaid home and community-based services (HCBS), No bill number. Discussed Medicares support for family caregivers. No bill number. Discussed Medicare open enrollment. No bill number. Discussed timing for provider claims filings. No bill number. Discussed access to digital tools. No bill number. Nursing Home staffing standards, safety, and quality. No bill number. Home Health, Hospice and Long-term care.
S. 3439/H.R. 6735, Connecting Caregivers to Medicare Act of 2025. S. 1227/H.R. 2491, Alleviating Barriers for Caregivers Act of 2025. P.L. 119-21, One Big Beautiful Bill Act of 2025. S. 2466/H.R. 6210, the Senior Savings Protection Act of 2025. S. 1261/H.R. 4206, the CONNECT for Health Act of 2025. S. 639/HR 227, the Clergy Act of 2026. S.1105, the No UPCODE Act of 2025. S. 1816, the Improving Seniors Timely Access to Care Act of 2025. H.R. 6766/S. 3492. Essential Caregivers Act of 2025. H.R.3954. Improving Access to Medicare Coverage Act of 2025. No bill number. Discussed family caregiver exemption from Medicaid community engagement requirements. S. 2237/H.R. 4313, the Hospital Inpatient Services Modernization Act. No bill number. Discussed prior authorization and artificial intelligence in Medicare. No bill number. Discussed Medicare fraud. No bill number. Discussed Money Follows the person Rebalancing Demonstration Program and Medicaid home and community-based services (HCBS) spousal impoverishment protections. No bill number. Discussed Medicare Part B premiums. No bill number. Discussed support for family caregivers. No bill number. Discussed respite care. No bill number. Discussed Medicaid home and community-based services (HCBS), No bill number. Discussed Medicares support for family caregivers. No bill number. Discussed Medicare open enrollment. No bill number. Discussed timing for provider claims filings. No bill number. Discussed access to digital tools. No bill number. Nursing Home staffing standards, safety, and quality. No bill number. Home Health, Hospice and Long-term care.
S. 3439/H.R. 6735, Connecting Caregivers to Medicare Act of 2025. S. 1227/H.R. 2491, Alleviating Barriers for Caregivers Act of 2025. P.L. 119-21, One Big Beautiful Bill Act of 2025. S. 2466/H.R. 6210, the Senior Savings Protection Act of 2025. S. 1261/H.R. 4206, the CONNECT for Health Act of 2025. S. 639/HR 227, the Clergy Act of 2026. S.1105, the No UPCODE Act of 2025. S. 1816, the Improving Seniors Timely Access to Care Act of 2025. H.R. 6766/S. 3492. Essential Caregivers Act of 2025. H.R.3954. Improving Access to Medicare Coverage Act of 2025. No bill number. Discussed family caregiver exemption from Medicaid community engagement requirements. S. 2237/H.R. 4313, the Hospital Inpatient Services Modernization Act. No bill number. Discussed prior authorization and artificial intelligence in Medicare. No bill number. Discussed Medicare fraud. No bill number. Discussed Money Follows the person Rebalancing Demonstration Program and Medicaid home and community-based services (HCBS) spousal impoverishment protections. No bill number. Discussed Medicare Part B premiums. No bill number. Discussed support for family caregivers. No bill number. Discussed respite care. No bill number. Discussed Medicaid home and community-based services (HCBS), No bill number. Discussed Medicares support for family caregivers. No bill number. Discussed Medicare open enrollment. No bill number. Discussed timing for provider claims filings. No bill number. Discussed access to digital tools. No bill number. Nursing Home staffing standards, safety, and quality. No bill number. Home Health, Hospice and Long-term care.
H. Con. Res. 14/S. Con. Res. 7, the Budget Reconciliation Resolution S. 1096, the Preserving Access to Affordable Generics and Biosimilars Act. S. 1095, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act. S. 1040, the Drug Competition Enhancement Act. H.R. 9070/S. 1041, the Affordable Prescriptions for Patients Act. S. 1097, the Interagency Patent Coordination and Improvement Act of 2025. No bill number. Discussed pharmacy benefit managers. S. 527, Prescription Pricing for the People Act of 2025. S. 526, the Pharmacy Benefit Manager (PBM) Transparency Act of 2025. S. 229, the Drug-Price Transparency for Consumers (DTC) Act of 2025. No bill number. Discussed Medicare Part D. No bill number. Discussed cap on out-of-pocket prescription drug costs. No bill number. Discussed the Medicare Prescription Payment Plan. No bill number. Discussed the Medicare drug price negotiation program.
H. Con. Res. 14/S. Con. Res. 7, the Budget Reconciliation Resolution S. 1096, the Preserving Access to Affordable Generics and Biosimilars Act. S. 1095, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act. S. 1040, the Drug Competition Enhancement Act. H.R. 9070/S. 1041, the Affordable Prescriptions for Patients Act. S. 1097, the Interagency Patent Coordination and Improvement Act of 2025. No bill number. Discussed pharmacy benefit managers. S. 527, Prescription Pricing for the People Act of 2025. S. 526, the Pharmacy Benefit Manager (PBM) Transparency Act of 2025. S. 229, the Drug-Price Transparency for Consumers (DTC) Act of 2025. No bill number. Discussed Medicare Part D. No bill number. Discussed cap on out-of-pocket prescription drug costs. No bill number. Discussed the Medicare Prescription Payment Plan. No bill number. Discussed the Medicare drug price negotiation program.
H.R. 1, One Big Beautiful Bill Act. S. 1862/ H.R. 946, the Optimizing Research Progress Hope And New Cures (ORPHAN Cures) Act. S. 832, the Ensuring Pathways to Innovative Cures (EPIC) Act of 2025. H.R. 1492, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. No bill number. Discussed the Medicare drug price negotiation program. Discussed pharmacy benefit manager reforms. S. 229/ H.R. 3789, the Drug-Price Transparency for Consumers (DTC) Act of 2025. S. 1096, Preserving Access to Affordable Generics and Biosimilars Act. S. 1095, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act. S. 1097, the Interagency Patent Coordination and Improvement Act of 2025. S. 1040, Drug Competition Enhancement Act. S. 1041, Affordable Prescriptions for Patients Act.
H.R. 1, One Big Beautiful Bill Act. S. 1862/ H.R. 946, the Optimizing Research Progress Hope And New Cures (ORPHAN Cures) Act. S. 832, the Ensuring Pathways to Innovative Cures (EPIC) Act of 2025. H.R. 1492, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. No bill number. Discussed the Medicare drug price negotiation program. Discussed pharmacy benefit manager reforms. S. 229/ H.R. 3789, the Drug-Price Transparency for Consumers (DTC) Act of 2025. S. 1096, Preserving Access to Affordable Generics and Biosimilars Act. S. 1095, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act. S. 1097, the Interagency Patent Coordination and Improvement Act of 2025. S. 1040, Drug Competition Enhancement Act. S. 1041, Affordable Prescriptions for Patients Act.
H. Con. Res. 14/S. Con. Res. 7, the Budget Reconciliation Resolution S. 1096, the Preserving Access to Affordable Generics and Biosimilars Act. S. 1095, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act. S. 1040, the Drug Competition Enhancement Act. H.R. 9070/S. 1041, the Affordable Prescriptions for Patients Act. S. 1097, the Interagency Patent Coordination and Improvement Act of 2025. No bill number. Discussed pharmacy benefit managers. S. 527, Prescription Pricing for the People Act of 2025. S. 526, the Pharmacy Benefit Manager (PBM) Transparency Act of 2025. S. 229, the Drug-Price Transparency for Consumers (DTC) Act of 2025. No bill number. Discussed Medicare Part D. No bill number. Discussed cap on out-of-pocket prescription drug costs. No bill number. Discussed the Medicare Prescription Payment Plan. No bill number. Discussed the Medicare drug price negotiation program.
H. Con. Res. 14/S. Con. Res. 7, the Budget Reconciliation Resolution S. 1096, the Preserving Access to Affordable Generics and Biosimilars Act. S. 1095, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act. S. 1040, the Drug Competition Enhancement Act. H.R. 9070/S. 1041, the Affordable Prescriptions for Patients Act. S. 1097, the Interagency Patent Coordination and Improvement Act of 2025. No bill number. Discussed pharmacy benefit managers. S. 527, Prescription Pricing for the People Act of 2025. S. 526, the Pharmacy Benefit Manager (PBM) Transparency Act of 2025. S. 229, the Drug-Price Transparency for Consumers (DTC) Act of 2025. No bill number. Discussed Medicare Part D. No bill number. Discussed cap on out-of-pocket prescription drug costs. No bill number. Discussed the Medicare Prescription Payment Plan. No bill number. Discussed the Medicare drug price negotiation program.
H. Con. Res. 14/S. Con. Res. 7, the Budget Reconciliation Resolution S. 1096, the Preserving Access to Affordable Generics and Biosimilars Act. S. 1095, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act. S. 1040, the Drug Competition Enhancement Act. H.R. 9070/S. 1041, the Affordable Prescriptions for Patients Act. S. 1097, the Interagency Patent Coordination and Improvement Act of 2025. No bill number. Discussed pharmacy benefit managers. S. 527, Prescription Pricing for the People Act of 2025. S. 526, the Pharmacy Benefit Manager (PBM) Transparency Act of 2025. S. 229, the Drug-Price Transparency for Consumers (DTC) Act of 2025. No bill number. Discussed Medicare Part D. No bill number. Discussed cap on out-of-pocket prescription drug costs. No bill number. Discussed the Medicare Prescription Payment Plan. No bill number. Discussed the Medicare drug price negotiation program.
H.R. 1, One Big Beautiful Bill Act. S. 1862/ H.R. 946, the Optimizing Research Progress Hope And New Cures (ORPHAN Cures) Act. S. 832, the Ensuring Pathways to Innovative Cures (EPIC) Act of 2025. H.R. 1492, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. No bill number. Discussed the Medicare drug price negotiation program. Discussed pharmacy benefit manager reforms. S. 229/ H.R. 3789, the Drug-Price Transparency for Consumers (DTC) Act of 2025. S. 1096, Preserving Access to Affordable Generics and Biosimilars Act. S. 1095, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act. S. 1097, the Interagency Patent Coordination and Improvement Act of 2025. S. 1040, Drug Competition Enhancement Act. S. 1041, Affordable Prescriptions for Patients Act.
H. Con. Res. 14/S. Con. Res. 7, the Budget Reconciliation Resolution S. 1096, the Preserving Access to Affordable Generics and Biosimilars Act. S. 1095, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act. S. 1040, the Drug Competition Enhancement Act. H.R. 9070/S. 1041, the Affordable Prescriptions for Patients Act. S. 1097, the Interagency Patent Coordination and Improvement Act of 2025. No bill number. Discussed pharmacy benefit managers. S. 527, Prescription Pricing for the People Act of 2025. S. 526, the Pharmacy Benefit Manager (PBM) Transparency Act of 2025. S. 229, the Drug-Price Transparency for Consumers (DTC) Act of 2025. No bill number. Discussed Medicare Part D. No bill number. Discussed cap on out-of-pocket prescription drug costs. No bill number. Discussed the Medicare Prescription Payment Plan. No bill number. Discussed the Medicare drug price negotiation program.
H. Con. Res. 14/S. Con. Res. 7, the Budget Reconciliation Resolution S. 1096, the Preserving Access to Affordable Generics and Biosimilars Act. S. 1095, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act. S. 1040, the Drug Competition Enhancement Act. H.R. 9070/S. 1041, the Affordable Prescriptions for Patients Act. S. 1097, the Interagency Patent Coordination and Improvement Act of 2025. No bill number. Discussed pharmacy benefit managers. S. 527, Prescription Pricing for the People Act of 2025. S. 526, the Pharmacy Benefit Manager (PBM) Transparency Act of 2025. S. 229, the Drug-Price Transparency for Consumers (DTC) Act of 2025. No bill number. Discussed Medicare Part D. No bill number. Discussed cap on out-of-pocket prescription drug costs. No bill number. Discussed the Medicare Prescription Payment Plan. No bill number. Discussed the Medicare drug price negotiation program.
H.R. 1, One Big Beautiful Bill Act. S. 1862/ H.R. 946, the Optimizing Research Progress Hope And New Cures (ORPHAN Cures) Act. S. 832, the Ensuring Pathways to Innovative Cures (EPIC) Act of 2025. H.R. 1492, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. No bill number. Discussed the Medicare drug price negotiation program. Discussed pharmacy benefit manager reforms. S. 229/ H.R. 3789, the Drug-Price Transparency for Consumers (DTC) Act of 2025. S. 1096, Preserving Access to Affordable Generics and Biosimilars Act. S. 1095, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act. S. 1097, the Interagency Patent Coordination and Improvement Act of 2025. S. 1040, Drug Competition Enhancement Act. S. 1041, Affordable Prescriptions for Patients Act.
H. Con. Res. 14/S. Con. Res. 7, the Budget Reconciliation Resolution S. 1096, the Preserving Access to Affordable Generics and Biosimilars Act. S. 1095, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act. S. 1040, the Drug Competition Enhancement Act. H.R. 9070/S. 1041, the Affordable Prescriptions for Patients Act. S. 1097, the Interagency Patent Coordination and Improvement Act of 2025. No bill number. Discussed pharmacy benefit managers. S. 527, Prescription Pricing for the People Act of 2025. S. 526, the Pharmacy Benefit Manager (PBM) Transparency Act of 2025. S. 229, the Drug-Price Transparency for Consumers (DTC) Act of 2025. No bill number. Discussed Medicare Part D. No bill number. Discussed cap on out-of-pocket prescription drug costs. No bill number. Discussed the Medicare Prescription Payment Plan. No bill number. Discussed the Medicare drug price negotiation program.
H. Con. Res. 14/S. Con. Res. 7, the Budget Reconciliation Resolution S. 1096, the Preserving Access to Affordable Generics and Biosimilars Act. S. 1095, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act. S. 1040, the Drug Competition Enhancement Act. H.R. 9070/S. 1041, the Affordable Prescriptions for Patients Act. S. 1097, the Interagency Patent Coordination and Improvement Act of 2025. No bill number. Discussed pharmacy benefit managers. S. 527, Prescription Pricing for the People Act of 2025. S. 526, the Pharmacy Benefit Manager (PBM) Transparency Act of 2025. S. 229, the Drug-Price Transparency for Consumers (DTC) Act of 2025. No bill number. Discussed Medicare Part D. No bill number. Discussed cap on out-of-pocket prescription drug costs. No bill number. Discussed the Medicare Prescription Payment Plan. No bill number. Discussed the Medicare drug price negotiation program.
H. Con. Res. 14/S. Con. Res. 7, the Budget Reconciliation Resolution S. 1096, the Preserving Access to Affordable Generics and Biosimilars Act. S. 1095, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act. S. 1040, the Drug Competition Enhancement Act. H.R. 9070/S. 1041, the Affordable Prescriptions for Patients Act. S. 1097, the Interagency Patent Coordination and Improvement Act of 2025. No bill number. Discussed pharmacy benefit managers. S. 527, Prescription Pricing for the People Act of 2025. S. 526, the Pharmacy Benefit Manager (PBM) Transparency Act of 2025. S. 229, the Drug-Price Transparency for Consumers (DTC) Act of 2025. No bill number. Discussed Medicare Part D. No bill number. Discussed cap on out-of-pocket prescription drug costs. No bill number. Discussed the Medicare Prescription Payment Plan. No bill number. Discussed the Medicare drug price negotiation program.
H.R. 1, One Big Beautiful Bill Act. S. 1862/ H.R. 946, the Optimizing Research Progress Hope And New Cures (ORPHAN Cures) Act. S. 832, the Ensuring Pathways to Innovative Cures (EPIC) Act of 2025. H.R. 1492, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. No bill number. Discussed the Medicare drug price negotiation program. Discussed pharmacy benefit manager reforms. S. 229/ H.R. 3789, the Drug-Price Transparency for Consumers (DTC) Act of 2025. S. 1096, Preserving Access to Affordable Generics and Biosimilars Act. S. 1095, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act. S. 1097, the Interagency Patent Coordination and Improvement Act of 2025. S. 1040, Drug Competition Enhancement Act. S. 1041, Affordable Prescriptions for Patients Act.
H. Con. Res. 14/S. Con. Res. 7, the Budget Reconciliation Resolution S. 1096, the Preserving Access to Affordable Generics and Biosimilars Act. S. 1095, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act. S. 1040, the Drug Competition Enhancement Act. H.R. 9070/S. 1041, the Affordable Prescriptions for Patients Act. S. 1097, the Interagency Patent Coordination and Improvement Act of 2025. No bill number. Discussed pharmacy benefit managers. S. 527, Prescription Pricing for the People Act of 2025. S. 526, the Pharmacy Benefit Manager (PBM) Transparency Act of 2025. S. 229, the Drug-Price Transparency for Consumers (DTC) Act of 2025. No bill number. Discussed Medicare Part D. No bill number. Discussed cap on out-of-pocket prescription drug costs. No bill number. Discussed the Medicare Prescription Payment Plan. No bill number. Discussed the Medicare drug price negotiation program.
H. Con. Res. 14/S. Con. Res. 7, the Budget Reconciliation Resolution S. 1096, the Preserving Access to Affordable Generics and Biosimilars Act. S. 1095, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act. S. 1040, the Drug Competition Enhancement Act. H.R. 9070/S. 1041, the Affordable Prescriptions for Patients Act. S. 1097, the Interagency Patent Coordination and Improvement Act of 2025. No bill number. Discussed pharmacy benefit managers. S. 527, Prescription Pricing for the People Act of 2025. S. 526, the Pharmacy Benefit Manager (PBM) Transparency Act of 2025. S. 229, the Drug-Price Transparency for Consumers (DTC) Act of 2025. No bill number. Discussed Medicare Part D. No bill number. Discussed cap on out-of-pocket prescription drug costs. No bill number. Discussed the Medicare Prescription Payment Plan. No bill number. Discussed the Medicare drug price negotiation program.
H.R. 1, One Big Beautiful Bill Act. S. 1862/ H.R. 946, the Optimizing Research Progress Hope And New Cures (ORPHAN Cures) Act. S. 832, the Ensuring Pathways to Innovative Cures (EPIC) Act of 2025. H.R. 1492, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. No bill number. Discussed the Medicare drug price negotiation program. Discussed pharmacy benefit manager reforms. S. 229/ H.R. 3789, the Drug-Price Transparency for Consumers (DTC) Act of 2025. S. 1096, Preserving Access to Affordable Generics and Biosimilars Act. S. 1095, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act. S. 1097, the Interagency Patent Coordination and Improvement Act of 2025. S. 1040, Drug Competition Enhancement Act. S. 1041, Affordable Prescriptions for Patients Act.
S. 3439/H.R. 6735, Connecting Caregivers to Medicare Act of 2025. S. 1227/H.R. 2491, Alleviating Barriers for Caregivers Act of 2025. P.L. 119-21, One Big Beautiful Bill Act of 2025. S. 2466/H.R. 6210, the Senior Savings Protection Act of 2025. S. 1261/H.R. 4206, the CONNECT for Health Act of 2025. S. 639/HR 227, the Clergy Act of 2026. S.1105, the No UPCODE Act of 2025. S. 1816, the Improving Seniors Timely Access to Care Act of 2025. H.R. 6766/S. 3492. Essential Caregivers Act of 2025. H.R.3954. Improving Access to Medicare Coverage Act of 2025. No bill number. Discussed family caregiver exemption from Medicaid community engagement requirements. S. 2237/H.R. 4313, the Hospital Inpatient Services Modernization Act. No bill number. Discussed prior authorization and artificial intelligence in Medicare. No bill number. Discussed Medicare fraud. No bill number. Discussed Money Follows the person Rebalancing Demonstration Program and Medicaid home and community-based services (HCBS) spousal impoverishment protections. No bill number. Discussed Medicare Part B premiums. No bill number. Discussed support for family caregivers. No bill number. Discussed respite care. No bill number. Discussed Medicaid home and community-based services (HCBS), No bill number. Discussed Medicares support for family caregivers. No bill number. Discussed Medicare open enrollment. No bill number. Discussed timing for provider claims filings. No bill number. Discussed access to digital tools. No bill number. Nursing Home staffing standards, safety, and quality. No bill number. Home Health, Hospice and Long-term care.
H.R. 1, the One Big Beautiful Bill Act. No bill number. Discussed Medicaid health care services. No bill number. Discussed Medicaid expansion health care policies. No bill number. Discussed Medicaid, long-term care, and family caregivers. No bill number. Discussed Medicaid work requirements. No bill number. Discussed family caregiver exemption for Medicaid work requirements. No bill number. Discussed Medicaid retroactive coverage policies. No bill number. Discussed Medicaid FMAP policies. No bill number. Discussed nursing home staffing and quality. No bill number. Discussed long-term care, including home health, hospice, and post-acute care. No bill number. Discussed Essential Caregivers Act. No bill number. Discussed advance directives and provider accountability. No bill number. Discussed CMS Hospice Proposed Rule. H.R. 2082, the Well-Being Insurance for Seniors to be at Home (WISH) Act. S. 1105, the No Unreasonable Payments, Coding, Or Diagnoses for the Elderly (UPCODE) Act of 2025. S. 1816, the Improving Seniors Timely Access to Care Act of 2025. No bill number. Discussed long-term care. No bill number. Discussed Medicaid long-term care. H.R. 3079, Medicaid Empowerment Act of 2025. No bill number. Discussed elder abuse and elder justice. No bill number. Discussed 2026 Hospice Wage Index and Payment Rate Update. S. 1227/H.R. 2491, the Alleviating Barriers for Caregivers Act. No bill number. Discussed Medicare Advantage. No bill number. Discussed Medicaid and family caregivers. No bill number. Discussed digital health technologies in Medicare. S. 1261, the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2025. H.R. 1171, the Stopping Addiction and Falls for the Elderly (SAFE) Act. No bill number. Discussed falls prevention. No bill number. Discussed Medicare Advantage provider networks.
H.R. 1, the One Big Beautiful Bill Act of 2025. S. 1227/H.R. 2491, the Alleviating Barriers for Caregivers Act of 2025. S. 3766, the Connecting Caregivers to Medicare Act of 2025. H.R. 3665, the Medicare Economic Security Solutions Act of 2025. H.R. 4619, the Medicare Mental Health Inpatient Equity Act of 2025. S. 1996/H.R. 2757, the Medicare Audiology Access Improvement Act of 2025. S. 1105, the No Unreasonable Payments, Coding, or Diagnoses for the Elderly Act (No UPCODE Act of 2025). S. 1816, the Improving Seniors Timely Access to Care Act of 2025. S. 1261/H.R.4206, the CONNECT for Health Act of 2025. S. 2237/H.R. 4313, the Hospital Inpatient Services Modernization Act of 2025. H.R. 5228, the HCBS Worker Protection Act of 2025. H.R. 3954, the Improving Access to Medicare Coverage Act of 2025. No bill number. Discussed prior authorization in Medicare. No bill number. Discussed consumer protections and deceptive marketing in Medicare Advantage. No bill number. Discussed digital health technology and telehealth. No bill number. Discussed network adequacy and provider access issues in Medicare Advantage. No bill number. Discussed the proposed Medicare Physician Fee Schedule for calendar year 2026. No bill number. Discussed Long-term care ombudsman program. No bill number. Discussed the proposed Medicare Hospital Outpatient Prospective Payment System for calendar year 2026. No bill number. Discussed Medicaid work requirements. No bill number. Discussed Medicaid retroactive coverage. No bill number. Discussed Medicaid cost-sharing. No bill number. Discussed Medicaid redeterminations. No bill number. Discussed nursing home staffing and quality. No bill number. Discussed long-term care, home health, hospice, and post-acute care. No bill number. Discussed Essential Caregivers Act. No bill number. Discussed 2026 Medicare Home Health Prospective Payment System (HH PPS). No bill number. Discussed family caregivers and Medicaid. No bill number. Discussed Acute Hospital Care at Home waiver.
H.R. 1, the One Big Beautiful Bill Act of 2025. S. 1227/H.R. 2491, the Alleviating Barriers for Caregivers Act of 2025. S. 3766, the Connecting Caregivers to Medicare Act of 2025. H.R. 3665, the Medicare Economic Security Solutions Act of 2025. H.R. 4619, the Medicare Mental Health Inpatient Equity Act of 2025. S. 1996/H.R. 2757, the Medicare Audiology Access Improvement Act of 2025. S. 1105, the No Unreasonable Payments, Coding, or Diagnoses for the Elderly Act (No UPCODE Act of 2025). S. 1816, the Improving Seniors Timely Access to Care Act of 2025. S. 1261/H.R.4206, the CONNECT for Health Act of 2025. S. 2237/H.R. 4313, the Hospital Inpatient Services Modernization Act of 2025. H.R. 5228, the HCBS Worker Protection Act of 2025. H.R. 3954, the Improving Access to Medicare Coverage Act of 2025. No bill number. Discussed prior authorization in Medicare. No bill number. Discussed consumer protections and deceptive marketing in Medicare Advantage. No bill number. Discussed digital health technology and telehealth. No bill number. Discussed network adequacy and provider access issues in Medicare Advantage. No bill number. Discussed the proposed Medicare Physician Fee Schedule for calendar year 2026. No bill number. Discussed Long-term care ombudsman program. No bill number. Discussed the proposed Medicare Hospital Outpatient Prospective Payment System for calendar year 2026. No bill number. Discussed Medicaid work requirements. No bill number. Discussed Medicaid retroactive coverage. No bill number. Discussed Medicaid cost-sharing. No bill number. Discussed Medicaid redeterminations. No bill number. Discussed nursing home staffing and quality. No bill number. Discussed long-term care, home health, hospice, and post-acute care. No bill number. Discussed Essential Caregivers Act. No bill number. Discussed 2026 Medicare Home Health Prospective Payment System (HH PPS). No bill number. Discussed family caregivers and Medicaid. No bill number. Discussed Acute Hospital Care at Home waiver.
S. 3439/H.R. 6735, Connecting Caregivers to Medicare Act of 2025. S. 1227/H.R. 2491, Alleviating Barriers for Caregivers Act of 2025. P.L. 119-21, One Big Beautiful Bill Act of 2025. S. 2466/H.R. 6210, the Senior Savings Protection Act of 2025. S. 1261/H.R. 4206, the CONNECT for Health Act of 2025. S. 639/HR 227, the Clergy Act of 2026. S.1105, the No UPCODE Act of 2025. S. 1816, the Improving Seniors Timely Access to Care Act of 2025. H.R. 6766/S. 3492. Essential Caregivers Act of 2025. H.R.3954. Improving Access to Medicare Coverage Act of 2025. No bill number. Discussed family caregiver exemption from Medicaid community engagement requirements. S. 2237/H.R. 4313, the Hospital Inpatient Services Modernization Act. No bill number. Discussed prior authorization and artificial intelligence in Medicare. No bill number. Discussed Medicare fraud. No bill number. Discussed Money Follows the person Rebalancing Demonstration Program and Medicaid home and community-based services (HCBS) spousal impoverishment protections. No bill number. Discussed Medicare Part B premiums. No bill number. Discussed support for family caregivers. No bill number. Discussed respite care. No bill number. Discussed Medicaid home and community-based services (HCBS), No bill number. Discussed Medicares support for family caregivers. No bill number. Discussed Medicare open enrollment. No bill number. Discussed timing for provider claims filings. No bill number. Discussed access to digital tools. No bill number. Nursing Home staffing standards, safety, and quality. No bill number. Home Health, Hospice and Long-term care.
H.R. 1, the One Big Beautiful Bill Act. No bill number. Discussed Medicaid health care services. No bill number. Discussed Medicaid expansion health care policies. No bill number. Discussed Medicaid, long-term care, and family caregivers. No bill number. Discussed Medicaid work requirements. No bill number. Discussed family caregiver exemption for Medicaid work requirements. No bill number. Discussed Medicaid retroactive coverage policies. No bill number. Discussed Medicaid FMAP policies. No bill number. Discussed nursing home staffing and quality. No bill number. Discussed long-term care, including home health, hospice, and post-acute care. No bill number. Discussed Essential Caregivers Act. No bill number. Discussed advance directives and provider accountability. No bill number. Discussed CMS Hospice Proposed Rule. H.R. 2082, the Well-Being Insurance for Seniors to be at Home (WISH) Act. S. 1105, the No Unreasonable Payments, Coding, Or Diagnoses for the Elderly (UPCODE) Act of 2025. S. 1816, the Improving Seniors Timely Access to Care Act of 2025. No bill number. Discussed long-term care. No bill number. Discussed Medicaid long-term care. H.R. 3079, Medicaid Empowerment Act of 2025. No bill number. Discussed elder abuse and elder justice. No bill number. Discussed 2026 Hospice Wage Index and Payment Rate Update. S. 1227/H.R. 2491, the Alleviating Barriers for Caregivers Act. No bill number. Discussed Medicare Advantage. No bill number. Discussed Medicaid and family caregivers. No bill number. Discussed digital health technologies in Medicare. S. 1261, the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2025. H.R. 1171, the Stopping Addiction and Falls for the Elderly (SAFE) Act. No bill number. Discussed falls prevention. No bill number. Discussed Medicare Advantage provider networks.
S. 3439/H.R. 6735, Connecting Caregivers to Medicare Act of 2025. S. 1227/H.R. 2491, Alleviating Barriers for Caregivers Act of 2025. P.L. 119-21, One Big Beautiful Bill Act of 2025. S. 2466/H.R. 6210, the Senior Savings Protection Act of 2025. S. 1261/H.R. 4206, the CONNECT for Health Act of 2025. S. 639/HR 227, the Clergy Act of 2026. S.1105, the No UPCODE Act of 2025. S. 1816, the Improving Seniors Timely Access to Care Act of 2025. H.R. 6766/S. 3492. Essential Caregivers Act of 2025. H.R.3954. Improving Access to Medicare Coverage Act of 2025. No bill number. Discussed family caregiver exemption from Medicaid community engagement requirements. S. 2237/H.R. 4313, the Hospital Inpatient Services Modernization Act. No bill number. Discussed prior authorization and artificial intelligence in Medicare. No bill number. Discussed Medicare fraud. No bill number. Discussed Money Follows the person Rebalancing Demonstration Program and Medicaid home and community-based services (HCBS) spousal impoverishment protections. No bill number. Discussed Medicare Part B premiums. No bill number. Discussed support for family caregivers. No bill number. Discussed respite care. No bill number. Discussed Medicaid home and community-based services (HCBS), No bill number. Discussed Medicares support for family caregivers. No bill number. Discussed Medicare open enrollment. No bill number. Discussed timing for provider claims filings. No bill number. Discussed access to digital tools. No bill number. Nursing Home staffing standards, safety, and quality. No bill number. Home Health, Hospice and Long-term care.
H.R. 1, the One Big Beautiful Bill Act of 2025. S. 1227/H.R. 2491, the Alleviating Barriers for Caregivers Act of 2025. S. 3766, the Connecting Caregivers to Medicare Act of 2025. H.R. 3665, the Medicare Economic Security Solutions Act of 2025. H.R. 4619, the Medicare Mental Health Inpatient Equity Act of 2025. S. 1996/H.R. 2757, the Medicare Audiology Access Improvement Act of 2025. S. 1105, the No Unreasonable Payments, Coding, or Diagnoses for the Elderly Act (No UPCODE Act of 2025). S. 1816, the Improving Seniors Timely Access to Care Act of 2025. S. 1261/H.R.4206, the CONNECT for Health Act of 2025. S. 2237/H.R. 4313, the Hospital Inpatient Services Modernization Act of 2025. H.R. 5228, the HCBS Worker Protection Act of 2025. H.R. 3954, the Improving Access to Medicare Coverage Act of 2025. No bill number. Discussed prior authorization in Medicare. No bill number. Discussed consumer protections and deceptive marketing in Medicare Advantage. No bill number. Discussed digital health technology and telehealth. No bill number. Discussed network adequacy and provider access issues in Medicare Advantage. No bill number. Discussed the proposed Medicare Physician Fee Schedule for calendar year 2026. No bill number. Discussed Long-term care ombudsman program. No bill number. Discussed the proposed Medicare Hospital Outpatient Prospective Payment System for calendar year 2026. No bill number. Discussed Medicaid work requirements. No bill number. Discussed Medicaid retroactive coverage. No bill number. Discussed Medicaid cost-sharing. No bill number. Discussed Medicaid redeterminations. No bill number. Discussed nursing home staffing and quality. No bill number. Discussed long-term care, home health, hospice, and post-acute care. No bill number. Discussed Essential Caregivers Act. No bill number. Discussed 2026 Medicare Home Health Prospective Payment System (HH PPS). No bill number. Discussed family caregivers and Medicaid. No bill number. Discussed Acute Hospital Care at Home waiver.
H.R. 1, the One Big Beautiful Bill Act. No bill number. Discussed Medicaid health care services. No bill number. Discussed Medicaid expansion health care policies. No bill number. Discussed Medicaid, long-term care, and family caregivers. No bill number. Discussed Medicaid work requirements. No bill number. Discussed family caregiver exemption for Medicaid work requirements. No bill number. Discussed Medicaid retroactive coverage policies. No bill number. Discussed Medicaid FMAP policies. No bill number. Discussed nursing home staffing and quality. No bill number. Discussed long-term care, including home health, hospice, and post-acute care. No bill number. Discussed Essential Caregivers Act. No bill number. Discussed advance directives and provider accountability. No bill number. Discussed CMS Hospice Proposed Rule. H.R. 2082, the Well-Being Insurance for Seniors to be at Home (WISH) Act. S. 1105, the No Unreasonable Payments, Coding, Or Diagnoses for the Elderly (UPCODE) Act of 2025. S. 1816, the Improving Seniors Timely Access to Care Act of 2025. No bill number. Discussed long-term care. No bill number. Discussed Medicaid long-term care. H.R. 3079, Medicaid Empowerment Act of 2025. No bill number. Discussed elder abuse and elder justice. No bill number. Discussed 2026 Hospice Wage Index and Payment Rate Update. S. 1227/H.R. 2491, the Alleviating Barriers for Caregivers Act. No bill number. Discussed Medicare Advantage. No bill number. Discussed Medicaid and family caregivers. No bill number. Discussed digital health technologies in Medicare. S. 1261, the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2025. H.R. 1171, the Stopping Addiction and Falls for the Elderly (SAFE) Act. No bill number. Discussed falls prevention. No bill number. Discussed Medicare Advantage provider networks.
H.R. 1, the One Big Beautiful Bill Act of 2025. No bill number. Discussed drug supply chain and Executive Order on strategic reserve of active pharmaceutical ingredients. S. 2620, the Reforming Evergreening and Manipulation that Extends Drug Years (REMEDY) Act of 2025. S. 1784/H.R. 4191, the Mapping America's Pharmaceutical Supply (MAPS) Act of 2025. S.832/H.R. 1492, the Ensuring Pathways to Innovative Cures (EPIC) Act of 2025. No bill number. Discussed the Medicare drug price negotiation program. No bill number. Discussed pharmacy benefit manager reforms. No bill number. Discussed Most Favored Nation drug pricing proposals.
S. 3439/H.R. 6735, Connecting Caregivers to Medicare Act of 2025. S. 1227/H.R. 2491, Alleviating Barriers for Caregivers Act of 2025. P.L. 119-21, One Big Beautiful Bill Act of 2025. S. 2466/H.R. 6210, the Senior Savings Protection Act of 2025. S. 1261/H.R. 4206, the CONNECT for Health Act of 2025. S. 639/HR 227, the Clergy Act of 2026. S.1105, the No UPCODE Act of 2025. S. 1816, the Improving Seniors Timely Access to Care Act of 2025. H.R. 6766/S. 3492. Essential Caregivers Act of 2025. H.R.3954. Improving Access to Medicare Coverage Act of 2025. No bill number. Discussed family caregiver exemption from Medicaid community engagement requirements. S. 2237/H.R. 4313, the Hospital Inpatient Services Modernization Act. No bill number. Discussed prior authorization and artificial intelligence in Medicare. No bill number. Discussed Medicare fraud. No bill number. Discussed Money Follows the person Rebalancing Demonstration Program and Medicaid home and community-based services (HCBS) spousal impoverishment protections. No bill number. Discussed Medicare Part B premiums. No bill number. Discussed support for family caregivers. No bill number. Discussed respite care. No bill number. Discussed Medicaid home and community-based services (HCBS), No bill number. Discussed Medicares support for family caregivers. No bill number. Discussed Medicare open enrollment. No bill number. Discussed timing for provider claims filings. No bill number. Discussed access to digital tools. No bill number. Nursing Home staffing standards, safety, and quality. No bill number. Home Health, Hospice and Long-term care.
H.R. 1, the One Big Beautiful Bill Act. No bill number. Discussed Medicaid health care services. No bill number. Discussed Medicaid expansion health care policies. No bill number. Discussed Medicaid, long-term care, and family caregivers. No bill number. Discussed Medicaid work requirements. No bill number. Discussed family caregiver exemption for Medicaid work requirements. No bill number. Discussed Medicaid retroactive coverage policies. No bill number. Discussed Medicaid FMAP policies. No bill number. Discussed nursing home staffing and quality. No bill number. Discussed long-term care, including home health, hospice, and post-acute care. No bill number. Discussed Essential Caregivers Act. No bill number. Discussed advance directives and provider accountability. No bill number. Discussed CMS Hospice Proposed Rule. H.R. 2082, the Well-Being Insurance for Seniors to be at Home (WISH) Act. S. 1105, the No Unreasonable Payments, Coding, Or Diagnoses for the Elderly (UPCODE) Act of 2025. S. 1816, the Improving Seniors Timely Access to Care Act of 2025. No bill number. Discussed long-term care. No bill number. Discussed Medicaid long-term care. H.R. 3079, Medicaid Empowerment Act of 2025. No bill number. Discussed elder abuse and elder justice. No bill number. Discussed 2026 Hospice Wage Index and Payment Rate Update. S. 1227/H.R. 2491, the Alleviating Barriers for Caregivers Act. No bill number. Discussed Medicare Advantage. No bill number. Discussed Medicaid and family caregivers. No bill number. Discussed digital health technologies in Medicare. S. 1261, the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2025. H.R. 1171, the Stopping Addiction and Falls for the Elderly (SAFE) Act. No bill number. Discussed falls prevention. No bill number. Discussed Medicare Advantage provider networks.
H.R. 1, the One Big Beautiful Bill Act of 2025. S. 1227/H.R. 2491, the Alleviating Barriers for Caregivers Act of 2025. S. 3766, the Connecting Caregivers to Medicare Act of 2025. H.R. 3665, the Medicare Economic Security Solutions Act of 2025. H.R. 4619, the Medicare Mental Health Inpatient Equity Act of 2025. S. 1996/H.R. 2757, the Medicare Audiology Access Improvement Act of 2025. S. 1105, the No Unreasonable Payments, Coding, or Diagnoses for the Elderly Act (No UPCODE Act of 2025). S. 1816, the Improving Seniors Timely Access to Care Act of 2025. S. 1261/H.R.4206, the CONNECT for Health Act of 2025. S. 2237/H.R. 4313, the Hospital Inpatient Services Modernization Act of 2025. H.R. 5228, the HCBS Worker Protection Act of 2025. H.R. 3954, the Improving Access to Medicare Coverage Act of 2025. No bill number. Discussed prior authorization in Medicare. No bill number. Discussed consumer protections and deceptive marketing in Medicare Advantage. No bill number. Discussed digital health technology and telehealth. No bill number. Discussed network adequacy and provider access issues in Medicare Advantage. No bill number. Discussed the proposed Medicare Physician Fee Schedule for calendar year 2026. No bill number. Discussed Long-term care ombudsman program. No bill number. Discussed the proposed Medicare Hospital Outpatient Prospective Payment System for calendar year 2026. No bill number. Discussed Medicaid work requirements. No bill number. Discussed Medicaid retroactive coverage. No bill number. Discussed Medicaid cost-sharing. No bill number. Discussed Medicaid redeterminations. No bill number. Discussed nursing home staffing and quality. No bill number. Discussed long-term care, home health, hospice, and post-acute care. No bill number. Discussed Essential Caregivers Act. No bill number. Discussed 2026 Medicare Home Health Prospective Payment System (HH PPS). No bill number. Discussed family caregivers and Medicaid. No bill number. Discussed Acute Hospital Care at Home waiver.
H.R. 1, One Big Beautiful Bill Act. S. 1862/ H.R. 946, the Optimizing Research Progress Hope And New Cures (ORPHAN Cures) Act. S. 832, the Ensuring Pathways to Innovative Cures (EPIC) Act of 2025. H.R. 1492, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. No bill number. Discussed the Medicare drug price negotiation program. Discussed pharmacy benefit manager reforms. S. 229/ H.R. 3789, the Drug-Price Transparency for Consumers (DTC) Act of 2025. S. 1096, Preserving Access to Affordable Generics and Biosimilars Act. S. 1095, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act. S. 1097, the Interagency Patent Coordination and Improvement Act of 2025. S. 1040, Drug Competition Enhancement Act. S. 1041, Affordable Prescriptions for Patients Act.
H.R. 1, the One Big Beautiful Bill Act of 2025. S. 1227/H.R. 2491, the Alleviating Barriers for Caregivers Act of 2025. S. 3766, the Connecting Caregivers to Medicare Act of 2025. H.R. 3665, the Medicare Economic Security Solutions Act of 2025. H.R. 4619, the Medicare Mental Health Inpatient Equity Act of 2025. S. 1996/H.R. 2757, the Medicare Audiology Access Improvement Act of 2025. S. 1105, the No Unreasonable Payments, Coding, or Diagnoses for the Elderly Act (No UPCODE Act of 2025). S. 1816, the Improving Seniors Timely Access to Care Act of 2025. S. 1261/H.R.4206, the CONNECT for Health Act of 2025. S. 2237/H.R. 4313, the Hospital Inpatient Services Modernization Act of 2025. H.R. 5228, the HCBS Worker Protection Act of 2025. H.R. 3954, the Improving Access to Medicare Coverage Act of 2025. No bill number. Discussed prior authorization in Medicare. No bill number. Discussed consumer protections and deceptive marketing in Medicare Advantage. No bill number. Discussed digital health technology and telehealth. No bill number. Discussed network adequacy and provider access issues in Medicare Advantage. No bill number. Discussed the proposed Medicare Physician Fee Schedule for calendar year 2026. No bill number. Discussed Long-term care ombudsman program. No bill number. Discussed the proposed Medicare Hospital Outpatient Prospective Payment System for calendar year 2026. No bill number. Discussed Medicaid work requirements. No bill number. Discussed Medicaid retroactive coverage. No bill number. Discussed Medicaid cost-sharing. No bill number. Discussed Medicaid redeterminations. No bill number. Discussed nursing home staffing and quality. No bill number. Discussed long-term care, home health, hospice, and post-acute care. No bill number. Discussed Essential Caregivers Act. No bill number. Discussed 2026 Medicare Home Health Prospective Payment System (HH PPS). No bill number. Discussed family caregivers and Medicaid. No bill number. Discussed Acute Hospital Care at Home waiver.
S. 3439/H.R. 6735, Connecting Caregivers to Medicare Act of 2025. S. 1227/H.R. 2491, Alleviating Barriers for Caregivers Act of 2025. P.L. 119-21, One Big Beautiful Bill Act of 2025. S. 2466/H.R. 6210, the Senior Savings Protection Act of 2025. S. 1261/H.R. 4206, the CONNECT for Health Act of 2025. S. 639/HR 227, the Clergy Act of 2026. S.1105, the No UPCODE Act of 2025. S. 1816, the Improving Seniors Timely Access to Care Act of 2025. H.R. 6766/S. 3492. Essential Caregivers Act of 2025. H.R.3954. Improving Access to Medicare Coverage Act of 2025. No bill number. Discussed family caregiver exemption from Medicaid community engagement requirements. S. 2237/H.R. 4313, the Hospital Inpatient Services Modernization Act. No bill number. Discussed prior authorization and artificial intelligence in Medicare. No bill number. Discussed Medicare fraud. No bill number. Discussed Money Follows the person Rebalancing Demonstration Program and Medicaid home and community-based services (HCBS) spousal impoverishment protections. No bill number. Discussed Medicare Part B premiums. No bill number. Discussed support for family caregivers. No bill number. Discussed respite care. No bill number. Discussed Medicaid home and community-based services (HCBS), No bill number. Discussed Medicares support for family caregivers. No bill number. Discussed Medicare open enrollment. No bill number. Discussed timing for provider claims filings. No bill number. Discussed access to digital tools. No bill number. Nursing Home staffing standards, safety, and quality. No bill number. Home Health, Hospice and Long-term care.
H.R. 1, the One Big Beautiful Bill Act of 2025. S. 1227/H.R. 2491, the Alleviating Barriers for Caregivers Act of 2025. S. 3766, the Connecting Caregivers to Medicare Act of 2025. H.R. 3665, the Medicare Economic Security Solutions Act of 2025. H.R. 4619, the Medicare Mental Health Inpatient Equity Act of 2025. S. 1996/H.R. 2757, the Medicare Audiology Access Improvement Act of 2025. S. 1105, the No Unreasonable Payments, Coding, or Diagnoses for the Elderly Act (No UPCODE Act of 2025). S. 1816, the Improving Seniors Timely Access to Care Act of 2025. S. 1261/H.R.4206, the CONNECT for Health Act of 2025. S. 2237/H.R. 4313, the Hospital Inpatient Services Modernization Act of 2025. H.R. 5228, the HCBS Worker Protection Act of 2025. H.R. 3954, the Improving Access to Medicare Coverage Act of 2025. No bill number. Discussed prior authorization in Medicare. No bill number. Discussed consumer protections and deceptive marketing in Medicare Advantage. No bill number. Discussed digital health technology and telehealth. No bill number. Discussed network adequacy and provider access issues in Medicare Advantage. No bill number. Discussed the proposed Medicare Physician Fee Schedule for calendar year 2026. No bill number. Discussed Long-term care ombudsman program. No bill number. Discussed the proposed Medicare Hospital Outpatient Prospective Payment System for calendar year 2026. No bill number. Discussed Medicaid work requirements. No bill number. Discussed Medicaid retroactive coverage. No bill number. Discussed Medicaid cost-sharing. No bill number. Discussed Medicaid redeterminations. No bill number. Discussed nursing home staffing and quality. No bill number. Discussed long-term care, home health, hospice, and post-acute care. No bill number. Discussed Essential Caregivers Act. No bill number. Discussed 2026 Medicare Home Health Prospective Payment System (HH PPS). No bill number. Discussed family caregivers and Medicaid. No bill number. Discussed Acute Hospital Care at Home waiver.
H. Con. Res. 14/S. Con. Res. 7, the Budget Reconciliation Resolution S. 1096, the Preserving Access to Affordable Generics and Biosimilars Act. S. 1095, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act. S. 1040, the Drug Competition Enhancement Act. H.R. 9070/S. 1041, the Affordable Prescriptions for Patients Act. S. 1097, the Interagency Patent Coordination and Improvement Act of 2025. No bill number. Discussed pharmacy benefit managers. S. 527, Prescription Pricing for the People Act of 2025. S. 526, the Pharmacy Benefit Manager (PBM) Transparency Act of 2025. S. 229, the Drug-Price Transparency for Consumers (DTC) Act of 2025. No bill number. Discussed Medicare Part D. No bill number. Discussed cap on out-of-pocket prescription drug costs. No bill number. Discussed the Medicare Prescription Payment Plan. No bill number. Discussed the Medicare drug price negotiation program.
H.R. 1, One Big Beautiful Bill Act. S. 1862/ H.R. 946, the Optimizing Research Progress Hope And New Cures (ORPHAN Cures) Act. S. 832, the Ensuring Pathways to Innovative Cures (EPIC) Act of 2025. H.R. 1492, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. No bill number. Discussed the Medicare drug price negotiation program. Discussed pharmacy benefit manager reforms. S. 229/ H.R. 3789, the Drug-Price Transparency for Consumers (DTC) Act of 2025. S. 1096, Preserving Access to Affordable Generics and Biosimilars Act. S. 1095, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act. S. 1097, the Interagency Patent Coordination and Improvement Act of 2025. S. 1040, Drug Competition Enhancement Act. S. 1041, Affordable Prescriptions for Patients Act.
H. Con. Res. 14/S. Con. Res. 7, the Budget Reconciliation Resolution S. 1096, the Preserving Access to Affordable Generics and Biosimilars Act. S. 1095, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act. S. 1040, the Drug Competition Enhancement Act. H.R. 9070/S. 1041, the Affordable Prescriptions for Patients Act. S. 1097, the Interagency Patent Coordination and Improvement Act of 2025. No bill number. Discussed pharmacy benefit managers. S. 527, Prescription Pricing for the People Act of 2025. S. 526, the Pharmacy Benefit Manager (PBM) Transparency Act of 2025. S. 229, the Drug-Price Transparency for Consumers (DTC) Act of 2025. No bill number. Discussed Medicare Part D. No bill number. Discussed cap on out-of-pocket prescription drug costs. No bill number. Discussed the Medicare Prescription Payment Plan. No bill number. Discussed the Medicare drug price negotiation program.
S. 3439/H.R. 6735, Connecting Caregivers to Medicare Act. S. 1227/H.R. 2491, Alleviating Barriers for Caregivers Act. P.L. 119-21, the One Big Beautiful Bill Act. H.R. 6766/S. 3492, the Essential Caregivers Act. H.R. 7966/S. 4118, Hospice Care Accountability, Reform, and Enforcement (Hospice CARE) Act. H.R. 7618, Stopping Addiction and Falls for the Elderly (SAFE) Act. S. 2237/H.R. 4313, Hospital Inpatient Services Modernization Act. H.R. 8100, Safe Staffing Saves Lives Act. S. 3886, Nurses Belong in Nursing Homes Act. H.R. 7966/S. 4118, Hospice Care Accountability, Reform, and Enforcement (Hospice CARE) Act. S. 3886, Nurses Belong in Nursing Homes Act. No bill number. Discussed Medicare payment models. No bill number. Discussed Medicare waste, fraud, and abuse. No bill number. Discussed health technology, data security, enrollee accounts, and access. No bill number. Discussed Medicaid and waste, fraud, and abuse. No bill number. Discussed Medicaid community engagement requirements and Data Strategy for Family Caregiver Verification. No bill number. Discussed nursing home staffing standards, safety, and quality. No bill number. Discussed nursing home transparency and ownership requirements. No bill number. Discussed home health, hospice, and long-term care. No bill number. Discussed Medicare Advantage. No bill number. Discussed the Medicare Prescription Drug Benefit Program. No bill number. Discussed the Medicare Cost Plan Program. No bill number. Discussed Medicare Advantage Capitation Rates. No bill number. Discussed Medicare Part C and Part D payment policies. No bill number. Discussed Medicare Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH). No bill number. Discussed AI tools for Medicare Experience modernization. No bill number. Discussed Medicare Advantage provider networks. No bill number. Discussed fraud in Medicare and Medicaid. No bill number. Discussed long-term services and supports. No bill number. Discussed home and community-based services. No bill number. Discussed the Money Follows the Person Rebalancing Demonstration Program. No bill number. Discussed Medicaid home and community-based services (HCBS) spousal impoverishment protections. No bill number. Discussed the direct care workforce. No bill number. Discussed family caregiver exemption from Medicaid community engagement requirements. No bill number. Discussed falls prevention. No bill number. Discussed age-friendly communities. No bill number. Discussed health at home. No bill number. Discussed the National Strategy to Support Family Caregivers. No bill number. Discussed the Older Americans Act reauthorization. No bill number. Discussed Medicaid HCBS waivers. No bill number. Discussed the health care workforce.
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Federal Bureau of Investigation (FBI), Federal Communications Commission (FCC), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Highway Traffic Safety Administration (NHTSA), Natl Telecommunications & Information Administration (NTIA), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), White House Office
S. 3439/H.R. 6735, Connecting Caregivers to Medicare Act of 2025. S. 1227/H.R. 2491, Alleviating Barriers for Caregivers Act of 2025. P.L. 119-21, One Big Beautiful Bill Act of 2025. S. 2466/H.R. 6210, the Senior Savings Protection Act of 2025. S. 1261/H.R. 4206, the CONNECT for Health Act of 2025. S. 639/HR 227, the Clergy Act of 2026. S.1105, the No UPCODE Act of 2025. S. 1816, the Improving Seniors Timely Access to Care Act of 2025. H.R. 6766/S. 3492. Essential Caregivers Act of 2025. H.R.3954. Improving Access to Medicare Coverage Act of 2025. No bill number. Discussed family caregiver exemption from Medicaid community engagement requirements. S. 2237/H.R. 4313, the Hospital Inpatient Services Modernization Act. No bill number. Discussed prior authorization and artificial intelligence in Medicare. No bill number. Discussed Medicare fraud. No bill number. Discussed Money Follows the person Rebalancing Demonstration Program and Medicaid home and community-based services (HCBS) spousal impoverishment protections. No bill number. Discussed Medicare Part B premiums. No bill number. Discussed support for family caregivers. No bill number. Discussed respite care. No bill number. Discussed Medicaid home and community-based services (HCBS), No bill number. Discussed Medicares support for family caregivers. No bill number. Discussed Medicare open enrollment. No bill number. Discussed timing for provider claims filings. No bill number. Discussed access to digital tools. No bill number. Nursing Home staffing standards, safety, and quality. No bill number. Home Health, Hospice and Long-term care.
S.3345, the PBM Price Transparency and Accountability Act of 2025. S.832/H.R. 1492, the Ensuring Pathways to Innovative Cures (EPIC) Act of 2025. No bill number. Discussed the Medicare drug price negotiation program. No bill number. Discussed pharmacy benefit manager reforms. No bill number. Discussed GLOBE, GUARD, and GENEROUS drug pricing models. No bill number. Discussed Most-favored nation prescription drugs.
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Commodity Futures Trading Commission (CFTC), Federal Bureau of Investigation (FBI), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Highway Traffic Safety Administration (NHTSA), Natl Telecommunications & Information Administration (NTIA), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), White House Office
H.R. 1, the One Big Beautiful Bill Act of 2025. S. 1227/H.R. 2491, the Alleviating Barriers for Caregivers Act of 2025. S. 3766, the Connecting Caregivers to Medicare Act of 2025. H.R. 3665, the Medicare Economic Security Solutions Act of 2025. H.R. 4619, the Medicare Mental Health Inpatient Equity Act of 2025. S. 1996/H.R. 2757, the Medicare Audiology Access Improvement Act of 2025. S. 1105, the No Unreasonable Payments, Coding, or Diagnoses for the Elderly Act (No UPCODE Act of 2025). S. 1816, the Improving Seniors Timely Access to Care Act of 2025. S. 1261/H.R.4206, the CONNECT for Health Act of 2025. S. 2237/H.R. 4313, the Hospital Inpatient Services Modernization Act of 2025. H.R. 5228, the HCBS Worker Protection Act of 2025. H.R. 3954, the Improving Access to Medicare Coverage Act of 2025. No bill number. Discussed prior authorization in Medicare. No bill number. Discussed consumer protections and deceptive marketing in Medicare Advantage. No bill number. Discussed digital health technology and telehealth. No bill number. Discussed network adequacy and provider access issues in Medicare Advantage. No bill number. Discussed the proposed Medicare Physician Fee Schedule for calendar year 2026. No bill number. Discussed Long-term care ombudsman program. No bill number. Discussed the proposed Medicare Hospital Outpatient Prospective Payment System for calendar year 2026. No bill number. Discussed Medicaid work requirements. No bill number. Discussed Medicaid retroactive coverage. No bill number. Discussed Medicaid cost-sharing. No bill number. Discussed Medicaid redeterminations. No bill number. Discussed nursing home staffing and quality. No bill number. Discussed long-term care, home health, hospice, and post-acute care. No bill number. Discussed Essential Caregivers Act. No bill number. Discussed 2026 Medicare Home Health Prospective Payment System (HH PPS). No bill number. Discussed family caregivers and Medicaid. No bill number. Discussed Acute Hospital Care at Home waiver.
H.R. 1, the One Big Beautiful Bill Act of 2025. No bill number. Discussed drug supply chain and Executive Order on strategic reserve of active pharmaceutical ingredients. S. 2620, the Reforming Evergreening and Manipulation that Extends Drug Years (REMEDY) Act of 2025. S. 1784/H.R. 4191, the Mapping America's Pharmaceutical Supply (MAPS) Act of 2025. S.832/H.R. 1492, the Ensuring Pathways to Innovative Cures (EPIC) Act of 2025. No bill number. Discussed the Medicare drug price negotiation program. No bill number. Discussed pharmacy benefit manager reforms. No bill number. Discussed Most Favored Nation drug pricing proposals.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Consumer Financial Protection Bureau (CFPB), Federal Bureau of Investigation (FBI), Federal Communications Commission (FCC), Federal Emergency Management Agency (FEMA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Telecommunications & Information Administration (NTIA), Office of the Vice President of the United States, SENATE, Social Security Administration (SSA), White House Office
H. Con. Res. 14/S. Con. Res. 7, the Budget Reconciliation Resolution. H.R. 2491, the Alleviating Barriers for Caregivers Act. No bill number. Discussed the Connecting Caregivers to Medicare Act. H.R. 1171, the Stopping Addiction and Falls for the Elderly (SAFE) Act. H.R. 1317/S. 575, the Improving Care and Access to Nurses (I CAN) Act of 2025. H.R. 10445, Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025 No bill number. Discussed Medicare physician reimbursement reform. No bill number. Discussed Medicare telehealth access. No bill number. Discussed Medicare Advantage. No bill number. Discussed access to home and community-based services, long-term services and supports, and post-acute care. No bill number. Discussed nursing home staffing and quality. No bill number. Discussed falls prevention. No bill number. Discussed Essential Caregivers Act No bill number, discussed Medicaid self-direction programs and related data No bill number. Discussed the Care for Military Kids Act No bill number. Discussed the Ensuring Access to Medicaid Buy-in Programs Act. No bill number. Discussed hospice and advance directives. No bill number. Discussed scope of practice and bed rails in nursing homes. No bill number. Discussed Medicaid, long-term care, and family caregivers.
H. Con. Res. 14/S. Con. Res. 7, the Budget Reconciliation Resolution S. 1096, the Preserving Access to Affordable Generics and Biosimilars Act. S. 1095, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act. S. 1040, the Drug Competition Enhancement Act. H.R. 9070/S. 1041, the Affordable Prescriptions for Patients Act. S. 1097, the Interagency Patent Coordination and Improvement Act of 2025. No bill number. Discussed pharmacy benefit managers. S. 527, Prescription Pricing for the People Act of 2025. S. 526, the Pharmacy Benefit Manager (PBM) Transparency Act of 2025. S. 229, the Drug-Price Transparency for Consumers (DTC) Act of 2025. No bill number. Discussed Medicare Part D. No bill number. Discussed cap on out-of-pocket prescription drug costs. No bill number. Discussed the Medicare Prescription Payment Plan. No bill number. Discussed the Medicare drug price negotiation program.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commodity Futures Trading Commission (CFTC), Consumer Financial Protection Bureau (CFPB), Federal Bureau of Investigation (FBI), Federal Communications Commission (FCC), Federal Trade Commission (FTC), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Telecommunications & Information Administration (NTIA), Office of the Vice President of the United States, SENATE, Social Security Administration (SSA), Treasury, Dept of, White House Office
H.R. 1, the One Big Beautiful Bill Act. No bill number. Discussed Medicaid health care services. No bill number. Discussed Medicaid expansion health care policies. No bill number. Discussed Medicaid, long-term care, and family caregivers. No bill number. Discussed Medicaid work requirements. No bill number. Discussed family caregiver exemption for Medicaid work requirements. No bill number. Discussed Medicaid retroactive coverage policies. No bill number. Discussed Medicaid FMAP policies. No bill number. Discussed nursing home staffing and quality. No bill number. Discussed long-term care, including home health, hospice, and post-acute care. No bill number. Discussed Essential Caregivers Act. No bill number. Discussed advance directives and provider accountability. No bill number. Discussed CMS Hospice Proposed Rule. H.R. 2082, the Well-Being Insurance for Seniors to be at Home (WISH) Act. S. 1105, the No Unreasonable Payments, Coding, Or Diagnoses for the Elderly (UPCODE) Act of 2025. S. 1816, the Improving Seniors Timely Access to Care Act of 2025. No bill number. Discussed long-term care. No bill number. Discussed Medicaid long-term care. H.R. 3079, Medicaid Empowerment Act of 2025. No bill number. Discussed elder abuse and elder justice. No bill number. Discussed 2026 Hospice Wage Index and Payment Rate Update. S. 1227/H.R. 2491, the Alleviating Barriers for Caregivers Act. No bill number. Discussed Medicare Advantage. No bill number. Discussed Medicaid and family caregivers. No bill number. Discussed digital health technologies in Medicare. S. 1261, the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2025. H.R. 1171, the Stopping Addiction and Falls for the Elderly (SAFE) Act. No bill number. Discussed falls prevention. No bill number. Discussed Medicare Advantage provider networks.
H.R. 1, One Big Beautiful Bill Act. S. 1862/ H.R. 946, the Optimizing Research Progress Hope And New Cures (ORPHAN Cures) Act. S. 832, the Ensuring Pathways to Innovative Cures (EPIC) Act of 2025. H.R. 1492, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. No bill number. Discussed the Medicare drug price negotiation program. Discussed pharmacy benefit manager reforms. S. 229/ H.R. 3789, the Drug-Price Transparency for Consumers (DTC) Act of 2025. S. 1096, Preserving Access to Affordable Generics and Biosimilars Act. S. 1095, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act. S. 1097, the Interagency Patent Coordination and Improvement Act of 2025. S. 1040, Drug Competition Enhancement Act. S. 1041, Affordable Prescriptions for Patients Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commodity Futures Trading Commission (CFTC), Consumer Financial Protection Bureau (CFPB), Federal Communications Commission (FCC), Federal Emergency Management Agency (FEMA), Federal Trade Commission (FTC), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Telecommunications & Information Administration (NTIA), Office of the Vice President of the United States, SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, White House Office
H. Con. Res. 14/S. Con. Res. 7, the Budget Reconciliation Resolution. H.R. 2491, the Alleviating Barriers for Caregivers Act. No bill number. Discussed the Connecting Caregivers to Medicare Act. H.R. 1171, the Stopping Addiction and Falls for the Elderly (SAFE) Act. H.R. 1317/S. 575, the Improving Care and Access to Nurses (I CAN) Act of 2025. H.R. 10445, Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025 No bill number. Discussed Medicare physician reimbursement reform. No bill number. Discussed Medicare telehealth access. No bill number. Discussed Medicare Advantage. No bill number. Discussed access to home and community-based services, long-term services and supports, and post-acute care. No bill number. Discussed nursing home staffing and quality. No bill number. Discussed falls prevention. No bill number. Discussed Essential Caregivers Act No bill number, discussed Medicaid self-direction programs and related data No bill number. Discussed the Care for Military Kids Act No bill number. Discussed the Ensuring Access to Medicaid Buy-in Programs Act. No bill number. Discussed hospice and advance directives. No bill number. Discussed scope of practice and bed rails in nursing homes. No bill number. Discussed Medicaid, long-term care, and family caregivers.
S. 142, the Preserve Access to Affordable Generics and Biosimilars Act. S. 148, the Stop STALLING act. S. 150, the Affordable Prescriptions for Patients Act. H.R. 9070, the Affordable Prescriptions for Patients Act. S. 3131/H.R. 5539, the ORPHAN Cures Act. No bill number. Discussed prescription drug provisions of the Inflation Reduction Act. No bill number. Discussed pharmacy benefit manager reforms. No bill number. Discussed biologics, biosimilars, and interchangeability. No bill number. Discussed out-of-pocket caps for generic prescription drugs. No bill number. Discussed Medicare part D open enrollment. No bill number. Discussed prescription drug pricing reforms. No bill number. Discussed Medicare Two Dollar Drug List Model.
S. 3109/H.R. 8018, the Alleviating Barriers for Caregivers Act. S. 3766/H.R. 7274, the Connecting Caregivers to Medicare Act. No bill number. Discussed fraud and means testing for federal benefits. No bill number. Discussed Medicare coverage of telehealth services. No bill number. Discussed Medicare coverage of dental services. No bill number. Discussed SHIPs and Medicare low-income beneficiary outreach and enrollment activities. No bill number. Discussed Medicare primary care workforce access and shortages. No bill number. Discussed Medicaid managed care. No bill number. Discussed Medicaid program proposals. No bill number. Discussed Medicare Advantage network adequacy. H.R.10437, To amend title XVIII of the Social Security Act to provide for the guaranteed issue of Medigap policies to all Medigap-eligible Medicare beneficiaries and Medicare Advantage enrollees, and for other purposes. No bill number. Discussed care at home. H.R. 8108, the Care for Military Kids Act. No bill number. Discussed Medicare Physician Fee Schedule final rule and Caregiver Training Services. H.R. 8331/S. 4280, the Essential Caregivers Act. H.R. 3227/H.R. 8244, the Ensuring Seniors Access to Quality Care Act. HR 7513/S.3410, the Protecting Americas Seniors Access to Care Act. H.R. 468/H.R. 9067, the Building Americas Health Care Workforce Act. S. 5023, the Stand Strong Falls Prevention Act. H.R. 7618, the Stopping Addiction and Falls for the Elderly (SAFE) Act. No bill number. Discussed Nursing Home Staffing Standard.
S. 476, the Maintaining Investments in New Innovation Act. S. 3131/ H.R. 5539, the ORPHAN Cures Act. H.R. 5547, the Maintaining Investments in New Innovation Act. No bill number. Discussed implementation of prescription drug provisions of Inflation Reduction Act. S. 150, Affordable Prescriptions for Patients Act of 2023. H.R. 6986, To address patent thickets. H.R. 9070, the Affordable Prescriptions for Patients Act. H.R. 1717, the Interagency Patent Coordination and Improvement Act of 2023. H.R. 5429, the Medication Affordability and Patent Integrity Act. S. 2780, the Medication Affordability and Patent Integrity Act. S. 4878, the Reforming Evergreening and Manipulation that Extends Drug Years (REMEDY) Act. No bill number. Discussed the Medicare Drug Price Negotiation Program Draft Guidance. No bill number. Discussed Medicare Prescription Payment Plan. No bill number. Discussed out-of-pocket caps for prescription drugs. No bill number. Discussed pharmacy benefit manager reforms. No bill number. Discussed Medicare negotiated drug prices. No bill number. Discussed the low-income subsidy Extra Help program. No bill number. Discussed Medicare Part D open enrollment. S. 2973, the Modernizing and Ensuring PBM Accountability Act. S. 142, the Preserve Access to Affordable Generics and Biosimilars Act. S. 4845, the Prescription Drug Affordability and Access Act. S.3311, the American Made Pharmaceuticals Act of 2023.
No bill number. Discussed medically necessary dental coverage and oral health care in Medicare. No bill number. Discussed Medicare coverage for telehealth services. No bill number. Discussed workforce training, physician reimbursement, and Medicare provider access. No bill number. Discussed Improving Seniors Timely Access to Care Act of 2024. H.R. 2407, the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act. No bill number. Discussed Medicaid estate recovery. No bill number. Discussed Medicare Advantage data. H.R. 3549/ S. 1703, the PACE Part D Choice Act of 2023. No bill number. Discussed family caregivers and Medicare and Medicaid policy. No bill number. Discussed Medicare FY25 Skilled Nursing Facility Payment Proposed Rule. No bill number. Discussed Medicare FY25 Hospital Inpatient Payment Proposed Rule. No bill number. Discussed hospitals and a buffer of essential medicines. No bill number. Discussed Medicaid unwinding. H.R. 8114, To prohibit the Secretary of Health and Human Services from finalizing a rule proposed by the Centers for Medicare & Medicaid Services to place certain limitations on Medicaid payments for home or community-based services. No bill number. Discussed Care Executive Order. H.R. 8018, the Alleviating Barriers for Caregivers Act. S. 3109, Alleviating Barriers for Caregivers Act. S. 3766/H.R. 7274, Connecting Caregivers to Medicare Act. No bill number. Discussed Acute Hospital Care at Home waiver and family caregivers. No bill number. Discussed family caregivers, direct care workers, care at home, and in other settings. S. 4120/H.R. 7994, the Long-Term Care Workforce Support Act. H.R. 8094, to amend Title XIX of the Social Security Act to modify certain asset recovery rules. H.R. 7573, the Stop Unfair Medicaid Recoveries Act. No bill number. Discussed the Coordinating Care for Veterans and Wounded Warriors Act. No bill number. Discussed nursing home staffing standards. No bill number. Discussed Medicare home health and hospice benefits. No bill number. Discussed health care coverage expansion. H.R. 8331/S. 4280, the Essential Caregivers Act. H.R. 7442, Philippine Medicare Portability Study Act. H.R. 3227, the Ensuring Seniors Access to Quality Care Act. H.R. 8244, Ensuring Seniors Access to Quality Care Act. H.R.468, the Building Americas Health Care Workforce Act. HR 7513/S.3410, the Protecting Americas Seniors Access to Care Act. H.J.Res.139, Providing for Congressional disapproval of the rule submitted by the Centers for Medicare & Medicaid Services relating to "Medicare and Medicaid Programs: Minimum Staffing Standards for Long-Term Care Facilities and Medicaid Institutional Payment Transparency Reporting. S.J.Res.91, A joint resolution providing for congressional disapproval of the rule submitted by the Centers for Medicare & Medicaid Services relating to "Medicare and Medicaid Programs; Minimum Staffing Standards for Long-Term Care Facilities and Medicaid Institutional Payment Transparency Reporting" S.4137, the Improving Access to Medicare Coverage Act of 2024.
S. 3766/H.R. 7274, the Connecting Family Caregivers to Medicare Act. S. 3109, the Alleviating Barriers for Caregivers Act. S. 3410/HR 5796, the Protecting Rural Seniors Access to Care Act. H.R. 7513, the Protecting Americas Seniors Access to Care Act. No bill number. Discussed Medicare low-income outreach and enrollment programs. No bill number. Discussed medically necessary dental coverage in Medicare. No bill number. Discussed Medicare Advantage and Medicare Prescription Drug Benefit Programs for contract year 2025. No bill number. Discussed Medicare capitation rates, and Part C and Part A payment policies for contract year 2025. No bill number. Discussed the Medicare Prescription Payment Plan (MPPP) program. No bill number. Discussed nursing home staffing rule. No bill number. Discussed long-term care workforce issues. No bill number. Discussed proposed rule on observation status appeals. No bill number. Discussed coverage of Medicaid, Medicare, and dual eligibles. No bill number. Discussed primary care. No bill number. Discussed Appeal Rights for Certain Changes in Patient Status. No bill number. Discussed family caregivers and Hospital-at-Home programs. No bill number. Discussed Medicare hospice benefit and respite care. No bill number. Discussed family caregivers and Medicare. No bill number. Discussed family caregivers and Medicaid self-direction programs. No bill number. Discussed state Long-Term Services and Supports Scorecard. No bill number. Discussed Veterans Administration care and Medicare. No bill number. Discussed paid direct care workforce. No bill number. Discussed access to physicians in Medicare. No bill number. Discussed observation stays in Medicare. No bill number. Discussed GUIDE Model.
S. 838, the Improving Access to Mental Health Act of 2023. H.R. 1638, the Improving Access to Mental Health Act of 2023. S. 1378/H.R. 5819, the Connecting Our Medical Providers with Links to Expand Tailored and Effective (COMPLETE) Care Act of 2023. No bill number. Discussed Medicare beneficiary outreach and enrollment activities and programmatic funding. No bill number. Discussed Medicare telehealth coverage. H.R. 6490, the Medicare Economic Security Solutions Act. No bill number. Discussed Medicare Advantage prior authorization. H.R. 5518, the Right to Medicare Act. No bill number. Discussed Medicaid and state flexibility for non-MAGI populations. No bill number. Discussed Medicare and Medicare Advantage. No bill number. Discussed nursing home staffing. No bill number. Discussed Medicare dental services. No bill number. Discussed veterans respite. No bill number. Discussed connecting caregivers to Medicare. S. 3109, the Alleviating Barriers for Caregivers Act. No bill number. Discussed reducing red tape for family caregivers in Medicare. No bill number. Discussed nursing home staffing standards. No bill number. Discussed paid direct care workforce. No bill number. Discussed Medicaid access rule (HCBS). No bill number. Discussed Medicare Skilled Nursing Facility Proposed Payment rule. No bill number. Discussed Fairness in Nursing Home Arbitration Act. No bill number. Discussed Acute Care Hospital at Home waiver. No bill number. Discussed 2024 Medicare Physician Fee Schedule. No bill number. Discussed Medicaid personal care services. No bill number. Discussed Medicaid 1115 waiver. No bill number. Discussed Medicare policy to support family caregivers.
H.R. 5378, the Lower Cost, More Transparency Act. S. 2117, the Provider Training in Palliative Care Act. H.R. 5518, the Right to Medicare Act. No bill number. Discussed implementation of proposed rule for P.L. 110-343, the Mental Health Parity and Addiction Equity Act.
No bill number. Discussed medication overdoses. S.1250, the Drug Price Transparency for Consumers Act of 2023. No bill number. Discussed Medicare drug price negotiation. No bill number. Discussed Medicare Prescription Payment Plan (MPPP) program. H.R. 4134, the Updated Drug Labeling for Patient Safety Act. S.2886, Patient Safety and Generic Labeling Improvement Act. H.R. 5378, the Lower Costs, More Transparency Act. S. 1967, the Patients Before Middleman (PBM) Act. S.2973, the Modernizing and Ensuring PBM Accountability Act. S.127, the Pharmacy Benefit Manager (PBM) Transparency Act of 2023. S. 79, the Interagency Patent Coordination and Improvement Act of 2023. S. 113, the Prescription Pricing for the People Act of 2023. S. 142, the Preserve Access to Affordable Generics and Biosimilars Act of 2023. S. 148, the Stop STALLING Act. S. 150, the Affordable Prescriptions for Patients Act of 2023. S. 2780, the Medication Affordability and Patent Integrity Act. S. 1339, the Pharmacy Benefit Manager Reform Act.
No bill number. Discussed implementation of P.L. 117-169 The Inflation Reduction Act of 2022. H.R.4189, the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2023 No bill number. Discussed Medicare Hospital Inpatient Prospective Payment System Proposed Rule. H.R. 2829, the Chronic Care Management Improvement Act of 2023. No bill number. Discussed oral health access in Medicare. No bill number. Discussed prior authorization process for Medicare Advantage. No bill number. Discussed telehealth access in Medicare. No bill number. Discussed disclosure of nursing home ownership and additional disclosable parties' information. No bill number. Discussed CMS collection and reporting of Medicaid long-term services and supports (LTSS) expenditure data. No bill number. Discussed family caregivers and the Hospital-at-Home programs under the Acute Hospital Care at Home waiver. No bill number. Discussed Fiscal Year 2024 Medicare hospice payment proposed rule. S. 2112, the Search Engine Examine Care Compare Act. No bill number. Discussed Fiscal Year 2024 Medicare skilled nursing facility payment proposed rule. No bill number. Discussed minimum federal nursing home staffing standards for nursing homes participating in Medicare and Medicaid. No bill number. Discussed Oregon 1115 waiver application. No bill number. Discussed Medicare Shared Savings Program, Accountable Care Organizations, and support for family caregivers. No bill number. Discussed data from Medicare post-acute care assessment instruments, Medicare beneficiaries, and family caregivers. H.R. 2853, the Expanding Care in the Home Act. No bill number. Discussed nursing home state survey agency surveyor report. No bill number. Discussed the Essential Caregivers Act. No bill number. Discussed evictions, assisted living facilities, and Medicaid Home and Community-Based Settings rule. No bill number. Discussed reducing red tape for family caregivers. No bill number. Discussed 1-800-MEDICARE, patient personal health information, and family caregivers. No bill number. Discussed the Compassionate Care Act. No bill number. Discussed home and community-based services. No bill number. Discussed the Improving Access to Medicare Coverage Act of 2021. S. 2133, the Medically Tailored Home-Delivered Meals Demonstration Act.
H.R. 824, the Telehealth Benefit Expansion for Workers Act of 2023. H.R. 2713/S. 2418, the Improving Care and Access to Nurses Act. S. 1687, the Beneficiary Enrollment Notification and Eligibility Simplification 2.0 Act. No bill number. Discussed Medicare financial stability and solvency. No bill number. Discussed family caregivers and 1-800-MEDICARE. No bill number. Discussed reducing red tape for family caregivers in Medicare, Medicaid, Social Security and CHIP. No bill number. Discussed access to Medicaid services, including home and community-based services. No bill number. Discussed Medicare home health payment proposed rule. H.R. 5138, the Improving Access to Medicare Coverage Act. No bill number. Discussed Civil Money Penalty Reinvestment Program. No bill number. Discussed 2024 Medicare physician fee schedule proposed rule and family caregivers. No bill number. Discussed 2024 Medicare hospital outpatient prospective payment system proposed rule and family caregivers. No bill number. Discussed minimum nursing home staffing standards and proposed rule. No bill number. Discussed 21st Century Long-Term Care Caucus. No bill number. Discussed GUIDE Model. No bill number. Discussed shortage of nursing home state surveyors and related funding. No bill number. Discussed Medicare home health. H.R. 5518, the Right to Medicare Act. H.R. 5378, the Lower Costs, More Transparency Act. No bill number. Discussed Medicaid Managed Care programs.
No bill number. Discussed implementation of P.L. 117-169 The Inflation Reduction Act of 2022. H.R.4189, the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2023 No bill number. Discussed Medicare Hospital Inpatient Prospective Payment System Proposed Rule. H.R. 2829, the Chronic Care Management Improvement Act of 2023. No bill number. Discussed oral health access in Medicare. No bill number. Discussed prior authorization process for Medicare Advantage. No bill number. Discussed telehealth access in Medicare. No bill number. Discussed disclosure of nursing home ownership and additional disclosable parties' information. No bill number. Discussed CMS collection and reporting of Medicaid long-term services and supports (LTSS) expenditure data. No bill number. Discussed family caregivers and the Hospital-at-Home programs under the Acute Hospital Care at Home waiver. No bill number. Discussed Fiscal Year 2024 Medicare hospice payment proposed rule. S. 2112, the Search Engine Examine Care Compare Act. No bill number. Discussed Fiscal Year 2024 Medicare skilled nursing facility payment proposed rule. No bill number. Discussed minimum federal nursing home staffing standards for nursing homes participating in Medicare and Medicaid. No bill number. Discussed Oregon 1115 waiver application. No bill number. Discussed Medicare Shared Savings Program, Accountable Care Organizations, and support for family caregivers. No bill number. Discussed data from Medicare post-acute care assessment instruments, Medicare beneficiaries, and family caregivers. H.R. 2853, the Expanding Care in the Home Act. No bill number. Discussed nursing home state survey agency surveyor report. No bill number. Discussed the Essential Caregivers Act. No bill number. Discussed evictions, assisted living facilities, and Medicaid Home and Community-Based Settings rule. No bill number. Discussed reducing red tape for family caregivers. No bill number. Discussed 1-800-MEDICARE, patient personal health information, and family caregivers. No bill number. Discussed the Compassionate Care Act. No bill number. Discussed home and community-based services. No bill number. Discussed the Improving Access to Medicare Coverage Act of 2021. S. 2133, the Medically Tailored Home-Delivered Meals Demonstration Act.
S.79, Interagency Patent Coordination and Improvement Act of 2023. S.113, Prescription Pricing for the People Act of 2023. S.142, Preserve Access to Affordable Generics and Biosimilars Act of 2023. S.148, Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act or the Stop (STALLING) Act. S.150, Affordable Prescriptions for Patients Act of 2023. S.935, the Fair Accountability and Innovative Research (FAIR) Drug Pricing Act of 2023. No bill number. Discussed Medicare prescription drug inflation rebate program. No bill number. Discussed proposed Advance Notice of Methodological Changes for Calendar Year (CY) 2024 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies. No bill number. Discussed proposed Contract Year 2024 Policy and Technical Changes to the Medicare Advantage (MA) and Medicare Prescription Drug Benefit Program (Part D). H.R.485, Protecting Health Care for All Patients Act of 2023. No bill number. Discussed Drug-Price Transparency for Consumers (DTC) Act of 2023. No bill number. Discussed Biosimilar Red Tape Elimination Act. No bill number. Discussed Protecting Consumer Access to Generic Drugs Act. No bill number. Discussed federal prescription drug pricing. No bill number. Discussed insulin prices. No bill number. Discussed out of pocket cost smoothing in Part D. No bill number. Discussed prescription drug access and prices.
H.R. 2617, Consolidated Appropriations Act, 2023 No bill number. Discussed Medicare Advantage beneficiary issues. No bill number. Discussed National Family Caregiving Strategy. No bill number. Discussed older adult needs in CDC reorganization. No bill number. Discussed COVID-19 vaccines, tests, and treatments. No bill number. Discussed promoting efficiency and equity in CMS programs. No bill number. Discussed streamlining eligibility and enrollment processes in CMS programs. No bill number. Discussed non-discrimination provisions in ACA and CMS health coverage programs. No bill number. Discussed employer-provided benefit plans and the Medicare Secondary Payer statute. H.R.8295/S. 4659 Labor, Health & Human Services Appropriations Act, FY 2023. H.R. 253, Adult Day Center Enhancement Act. No bill number. Discussed data on COVID-19, nursing home residents and staff, and low up-to-date COVID-19 vaccination rates. H.R. 6302, Protecting the Health of Americas Older Adults Act.
H.R. 2617, Consolidated Appropriations Act, 2023. No bill number. Discussed mental and behavioral health coverage in Medicare. No bill number. Discussed telehealth coverage in Medicare. No bill number. Discussed Medicare Physician Fee Schedule and medically necessary dental coverage. No bill number. Discussed family caregivers and Hospital at Home Programs. No bill number. Discussed Medicare coverage of at-home COVID-19 diagnostic tests. No bill number. Discussed Medicaid funding for Puerto Rico and the U.S. Territories. No bill number. Discussed access to COVID-19 vaccines, tests, and treatments. No bill number. Discussed efficiency and equity in CMS programs. No bill number. Discussed eligibility and enrollment processes in CMS programs. No bill number. Discussed Medicaid quality measures. No bill number. Discussed non-discrimination provisions in ACA and CMS health coverage programs. No bill number. Discussed relationship between employer-provided benefit plans and the Medicare Secondary Payer statute. No bill number. Discussed allowing Medicare Part D enrollees a one-time plan switch. H.R.8295/S. 4659 Labor, Health & Human Services Appropriations Act, FY 2023. No bill number. Discussed nursing home debt collection. H.R. 7053/S. 3792, Hospital Inpatient Services Modernization Act and family caregivers P.L. 115-119. RAISE Family Caregivers Act. No bill number. Discussed Medicaid home and community-based services settings rule. No bill number. Discussed family caregivers in Medicare. H.R. 3733, Essential Caregivers Act of 2021. No bill number. Discussed COVID-19, nursing home residents and staff, and low up-to-date COVID-19 vaccination rates. No bill number. Discussed Tennessees TennCare III Section 1115 Demonstration Waiver Amendment 3 request. No bill number. Discussed the Money Follows the Person Rebalancing Demonstration Program and financial protections for the spouses of individuals receiving Medicaid home and community-based services. No bill number. Discussed Elder Justice Act program reauthorization, modernization, and funding.
P.L. 117-169, Inflation Reduction Act. S.4430, the Interagency Patent Coordination and Improvement Act of 2022. No bill number. Discussed allowing one time change in Medicare Part D plans. No bill number. Discussed cancer drug launch prices.
HR 3321/S 1670, Credit for Caring Act. HR 6823/S 3854, Elizabeth Dole Home Care Act. Public Law 115-119 the RAISE Family Caregivers Act. No bill number. Discussed rural telehealth. No bill number. Discussed Medicare Advantage oversight. P.L. 117-169, Inflation Reduction Act. No bill number. Discussed mental and behavioral health coverage. No bill number. Discussed coverage of ESRD in private plans in relation to Medicare Secondary Payer Act. H.R.6302, Protecting the Health of Americas Older Adults Act. H.R.8994, Supporting Our First Responders Act . H.R.4040, Advancing Telehealth Beyond COVID-19 Act of 2022. No bill number. Discussed HHS Initiative to Strengthen primary health care. No bill number. Discussed COVID-19 vaccines and oral anti-viral medication. H.R. 8295 Labor, Health & Human Services Appropriations Act, FY 2023 S.4862, Supporting our Seniors Act. No bill number. Discussed disability policies, telehealth, and assistive technologies. No bill number. Discussed nursing homes, COVID-19, residents, and staff issues.
No bill number. Discussed Medicare solvency. No bill number. Discussed oversight of Medicare Advantage plans and promoting access to services. No bill number. Discussed Medicare Part B enrollment process. No bill number. Discussed the Medicare Hospital Inpatient Prospective Payment System. H.R.5376 - Build Back Better Act. H.R. 8295 Labor, Health & Human Services Appropriations Act, FY 2023. No bill number. Discussed Money Follows the Person Rebalancing Demonstration Program. No bill number. Discussed Medicaid access. No bill number. Discussed New Jerseys FamilyCare Comprehensive Demonstration 1115 Waiver Renewal Application. S. 3792/H.R. 7053 - Hospital Inpatient Services Modernization Act. Discussed Hospital at Home programs, and family caregivers. No bill number. Discussed Medicare and family caregiver supportive services pilot concept and CMMI strategy refresh. No bill number. Discussed nursing home COVID-19 boosters and vaccinations. No bill number. Discussed CMS Medicaid access request for information and provided related technical assistance. No bill number. Discussed Medicaid home and community-based services and reconciliation. No bill number. Discussed nursing home reforms on staffing, transparency and accountability. No bill number. Discussed National Academies of Sciences, Engineering, and Medicine nursing home report. No bill number. Discussed federal oversight of state survey agencies regarding nursing home surveys. No bill number. Discussed the Medicare skilled nursing facility proposed payment rule for Fiscal Year 2023. No bill number. Discussed issues affecting dual eligibles. No bill number. Discussed Medicare coverage of at-home COVID-19 tests.
H.R. 4502, the CMS State Certification & Survey Programs and LTC inspection. H.R.3076, the Postal Service Reform Act of 2021. No bill number. Discussed Medicare coverage of at-home COVID tests. No bill number. Discussed Medicare coverage of Aduhelm and impact on Medicare Part B. No bill number. Discussed Medicare and antipsychotic drug use in nursing homes. H.R.6698, the Stop Unfair Medicaid Recoveries Act of 2022. No bill number. Discussed Medicaid estate recovery. H.R. 5376, the Build Back Better Act. No bill number. Discussed Medicare Advantage and Medicare Part D proposed rule and dual eligibles. No bill number. Discussed family caregivers and Medicare. No bill number. Discussed CMS COVID-19 nursing home visitation. No bill number. Discussed Hospital at Home programs and family caregivers. No bill number. Discussed COVID-19 vaccinations and boosters in nursing homes. No bill number. Discussed HCBS settings rule. No bill number. Discussed AARP Nursing Home Dashboard. No bill number. Discussed federal surveys of nursing homes. No bill number. Discussed Medicaid home care and workforce issue. Discussed home care, supporting family caregivers, and the paid direct care workforce. H.R. 3650/S. 2048, the Improving Access to Medicare Coverage Act. No bill number. Discussed observation stays and issues related to the three-day inpatient stay requirement for Medicare coverage of skilled nursing facility care. No bill number. Discussed Administrations proposed nursing home reforms. H.R. 598, Quality Care for Nursing Home Residents and Workers During COVID-19 and Beyond Act P.L. 117-2. American Rescue Plan Act. No bill number. Discussed mental and behavioral health care. No bill number. Discussed Medicare financing. No bill number. Discussed Medicare dental coverage. No bill number. Discussed innovation center payment models.
H.R. 5376 Build Back Better Act. H.R. 4356, Agriculture, Rural Development Appropriations Act, FY 2022. H.R. 5260, Reduced Costs and Continued Cures Act. No bill number. Discussed prescription drug prices and Medicare. No bill number. Discussed comparative effectiveness review.
H.R. 5376, the Build Back Better Act. H.R. 3733, Essential Caregivers Act. H.R. 3321/S. 1670 - Credit for Caring Act No bill number. Discussed visitation protocols, mental health needs, dementia, and short-term delirium in hospitals. S. 2890, Provider Training in Palliative Care Act. No bill number. Discussed advanced illness/end-of-life. No bill number. Discussed Covid-19, nursing home and long-term care facility residents and staff, visitation, vaccination, boosters. No bill number. Discussed crisis standards of care. No bill number. Discussed long-term services and supports workforce roundtable. No bill number. Comment letter to the Centers for Medicare & Medicaid Services on the interim final rule with comment on COVID-19 health care worker vaccination requirements for certain Medicare and/or Medicaid certified providers and suppliers. P.L. 117-2. American Rescue Plan Act. H.R. 4502, Labor, Health & Human Services Appropriations Act, FY 2022. S.2307, the COVID-19 and Pandemic Response Centers of Excellence Act of 2021. No bill number. Discussed the Supplemental Nutrition Assistance Program. H.R. 5724/S. 3064, White House Conference on Food, Nutrition, Hunger, and Health Act. S. 19, FEED Act. S. 2210/H.R. 4131, Better Care Better Jobs Act. S. 3431, the Revitalizing the Aging Network Act. No bill number. Aging Innovation Act. No bill number. Discussed United States Preventive Services Task Force report to Congress. Discussed draft insulin legislation.
H.R. 3321/S. 1670 - Credit for Caring Act H.R. 3733, Essential Caregivers Act. No bill number. Discussed COVID-19 booster shots and long-term care facilities. S. 2890, Provider Training in Palliative Care Act. No bill number. Discussed nursing home COVID-19 resident and staff vaccination rates displayed on Care Compare. No bill number. Discussed Medicare nursing home COVID-19 vaccine interim final rule with comment No bill number. Discussed nursing home issues, including COVID-19 nursing home vaccinations, the waiver and guidance relating to certified nurse aide training, and visitation. No bill number. Discussed the Department of Health and Human Services current COVID-19 declaration (Fourth Amended Declaration) and the accompanying January 8, 2021 Advisory Opinion by the Office of General Counsel. No bill number. Discussed permanent expansion of the ACA expanded tax credits. No bill number. Discussed paid and medical leave. H.R. 4502, Labor, Health & Human Services Appropriations Act, FY 2022
H.R. 5376 Build Back Better Act. No bill number. Discussed prescription drugs prices and costs and Medicare. H.R. 4356, Agriculture, Rural Development Appropriations Act, FY 2022. S. 1428, the Preserve Access to Affordable Generics and Biosimilars Act. S. 1287, the REFUND Act.
H.R. 2114, Essential Caregivers Act. H.R. 3321/S. 1670 - Credit for Caring Act. No bill number. Discussed nursing homes and COVID-19 vaccines. No bill number. Discussed COVID-19, nursing home ownership, vaccines, and technology. H.R. 1319, the American Rescue Plan Act of 2021. FY 2022 Labor, Health & Human Services Appropriations Act. No bill number. Discussed draft caregiving legislation. No bill number. Discussed draft insulin legislation.
No bill number. Discussed prescription drugs and Medicare. No bill number - FY 2022 Agriculture, Rural Development & FDA Appropriations.
Filing targets: Administration for Children & Families (ACF), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Consumer Financial Protection Bureau (CFPB), Corporation for Natl & Community Service, Defense, Dept of (DOD), Equal Employment Opportunity Commission (EEOC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Natl Transportation Safety Board (NTSB), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of the Comptroller of the Currency (OCC), Pension Benefit Guaranty Corporation (PBGC), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
P.L. 117,2, American Rescue Plan Act of 2021 No bill number-Discussed SNAP online pilot program No bill number - Discussed vaccine coverage, development, approval, funding distribution and prioritization No bill number - Discussed drug pricing reforms, including price negotiation, out-of-pocket cap, and inflation-based rebates No bill number - Credit for Caring Act No bill number. Discussed nursing homes and vaccines S. 57/H.R. 596, Advancing Connectivity during the Coronavirus to Ensure Support for Seniors Act (ACCESS Act). H.R. 598, Quality Care for Nursing Home Residents and Workers During COVID-19 and Beyond Act H.R. 727, Facilitating Virtual Visitation for Nursing Home Residents Act S. 782, Nursing Home Reform Modernization Act No bill number - Discussed nursing home visitation No bill number - Discussed Affordable Care Act, Medicare, health equity, health care, and long-term care No bill number - Discussed home and community-based services, H.R. 1230 - Discussed Protecting Older Workers Against Discrimination Act No bill number - Discussed women and retirement security No bill number - COVID-19 Nursing Home Protection Act No bill number - Discussed enhanced FMAP for Medicaid home and community-based services No bill number - Essential Caregivers Act No bill number - Adult Day Center Enhancement Act No bill number - Discussed the health care and long-term care workforce that cares for older adults
H.R. 133, Consolidated Appropriations Act. H.R 3, the Elijah E. Cummings Lower Drug Costs Now Act. No bill number. Discussed vaccine development, coverage, approval, distribution and prioritization. S. 2543, the Prescription Drug Pricing Reduction Act. H.R. 7288, the Taxpayer Research and Coronavirus Knowledge (TRACK) Act. No bill number. Discussed mail-order prescription drugs. H.R. 19/S. 3129, Lower Cost More Cures Act
H.R. 133, Consolidated Appropriations At, 2021. H.R. 6201, Families First Coronavirus Response Act. S. 2543, the Prescription Drug Pricing Reduction Act. H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act. S. 3548/H.R. 748, CARES Act. H.R. 6074, Coronavirus Preparedness Response Supplemental Appropriations Act. H.R. 19/S. 3129, Lower Cost More Cures Act. H.R. 5821 HOSPICE Act. No bill number. Discussed vaccine development, approval, distribution and prioritization. No bill number. Discussed vaccine coverage. No bill number. Discussed Nursing Home Dashboard and COVID-19 nursing home priorities . S. 4866, Nursing Home Reform Modernization Act. No bill number. Discussed COVID-19, nursing homes and the VA. No bill number. Discussed various issues for nursing home residents related to COVID-19, including PPE, testing, visitation, equipment, surveys, family notification and accountability for use of Provider Relief Funds. H.R. 925/H.R 6800, Heroes Act. S. 3768/H.R. 6972, Nursing Home COVID-19 Protection and Prevention Act S. 4182, Emergency Support for Nursing Homes and Elder Justice Reform Act of 2020. No bill number. Discussed the US Postal Service, health and wellness, caregiving, COVID-19 and nursing homes, social isolation, and the aging network. S. 3517/H.R. 6487, Advancing Connectivity during the Coronavirus to Ensure Support for Seniors Act (ACCESS Act). No bill number. Comment letter on Medicare and Medicaid Programs, Clinical Laboratory Improvement Amendments (CLIA), and Patient Protection and Affordable Care Act; Additional Policy and Regulatory Revisions in Response to the COVID- 19 Public Health Emergency. No bill number. Comment letter on CMS COVID-19 interim final rule. No bill number. Discussed COVID-19 vaccines and vaccinations in nursing homes and other long-term care settings. H.R. 2730/S. 1443, Credit for Caring Act. No bill number. Discussed senior suicides in response to COVID-19. No bill number. Discussed COVID-19 vaccines, 50 percent rule, and federal Pharmacy Partnership for Long-Term Care Program. H.R. 8874, Nurses CARE Act. H.R. 7714, Amend IRS Code of 1986 to Reduce the Floor on Deductions for Medical Expense.
S. 2543, the Prescription Drug Pricing Reduction Act. H.R. 7288, the Taxpayer Research and Coronavirus Knowledge (TRACK) Act. No bill number. Discussed COVID-19 vaccine development, approval, and distribution. No bill number. Discussed mail-order prescription drugs. H.R. 19/S. 3129, Lower Cost More Cures Act. H.R. 3, Elijah E. Cummings Lower Cost Drugs Now Act.
S. 4182, Emergency Support for Nursing Homes and Elder Justice Reform Act of 2020. S. 4184/H.R. 7463, Assisted Living Facility Coronavirus Reporting Act. H.R. 6698, Quality Care for Nursing Home Residents and Workers During COVID-19 Act of 2020. H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions Act (Heroes Act). HR 925, Updated Health and Economic Recovery Omnibus Emergency Solutions Act (Updated HEROES); No bill number. Discussed funding for nursing homes, home and community-based services, and other institutional care in next COVID-19 package. S. 3768/H.R. 6972, Nursing Home COVID-19 Protection and Prevention Act. No bill number. Discussed May 8 COVID-19 interim final rule. No bill number. Discussed VA and nursing homes addressing COVID-19 and the collection of demographic data in possible COVID-19 package. H.R. 6972, Nursing Home COVID-19 Protection and Prevention Act. S. 3517/H.R. 6487, Advancing Connectivity during the Coronavirus to Ensure Support for Seniors Act (ACCESS Act). No bill number. Discussed immunity related to COVID-19 for nursing homes and other long-term care facilities. H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021. No bill number. Submitted statement regarding nursing homes and COVID-19 to the Coronavirus Commission on Safety and Quality in Nursing Homes. No bill number. Discussed dual eligible and Medicaid. S 4318, American Workers, Families, and Employers Assistance Act (HEALS). S. 4320, Coronavirus Response Additional Supplemental Appropriations Act of 2020. No bill number. Discussed resources for Medicaid HCBS in COVID legislation. No bill number. Discussed Community Immunity During COVID-19 Act. No bill number. Discussed and provided technical assistance on draft nursing home and COVID-19 provisions/amendments. No bill number. Discussed first person account related to long-term care facilities and COVID-19. No bill number. Provided technical assistance on family caregiver tax credit. S. 1443, Credit for Caring Act. Discussed the bill and a possible COVID package. No bill number. Discussed family caregiving with RAISE Family Caregiving Advisory Council. No bill number. Discussed RAISE Family Caregiving Advisory Council report. No bill number. Discussed care transitions for Community Living staff. P.L. 116-136, CARES Act. H.R. 8114, Emergency Support for Nursing Homes and Elder Justice Reform Act of 2020. S. 4555/H.R. 8079, Elder Justice Reauthorization Act of 2020. No bill number. Nursing Home Transparency and Oversight Act. No bill number. Discussed nursing home point-of-care testing and nursing home and long-term care facility testing. No bill number. Discussed logistics for virtual aging conference. No bill number. Discussed nursing homes, COVID package, testing, health extenders, continuing resolution, home care providers, and long-term services and supports. No bill number. Discussed Fiscal 2021 Medicare home health payment proposed rule. H.R. 2073/S. 110, legislation to permanently extend the medical expense deduction at 7.5% of income. No bill number. Discussed health care affordability for Americans age 50-64. H.R. 7714, Legislation to amend IRS Code of 1986 to Reduce the Floor on Deductions for Medical Expense. H.R. 6201, Families First Coronavirus Response Act. H.R. 6074, Coronavirus Preparedness Response Supplemental Appropriations Act, 2020. S. 2543, Prescription Drug Pricing Reduction Act (Grassley-Wyden). H.R. 19/S. 3129, Lower Cost More Cures Act. H.R. 3, Elijah E. Cummings Lower Cost Drugs Now Act.
H.R. 3, Elijah E. Cummings Lower Cost Drugs Now Act. S. 2543, the Prescription Drug Pricing Reduction Act. H.R. 2296/S.1391 - The FAIR Drug Pricing Act. S. 474/H.R. 2069, the SPIKE Act. H.R. 1425, the Patient Protection and Affordable Care Enhancement Act. H.R. 7288, the Taxpayer Research and Coronavirus Knowledge (TRACK) Act. S. 2543, Prescription Drug Pricing Reduction Act (Grassley-Wyden). H.R. 19/S. 3129, Lower Cost More Cures Act.
No bill number. Participated in CMS HCBS and Nursing Home Diversification Strategies brainstorming session. H.R.7254. Infection Control Training and Support Act of 2020. No bill number. Discussed nursing homes seizing residents economic impact payments. No bill number. Discussed and provided technical assistance on draft legislation related to State Veterans Homes and COVID-19. No bill number. Discussed nursing home COVID-19 issues, AARP priorities, and COVID-19 nursing home briefing with House staff and provided contact information for possible witnesses. No bill number. Discussed AARP priorities to protect nursing home and other long-term care facilities in response to COVID-19. H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions Act H.R. 6074, Preparedness and Response Supplemental H.R. 6201, Families First Coronavirus Response Act H.R. 748, Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 266, Paycheck Protection Program and Health Care Enhancement Act. No bill number. Discussed telehealth and waiver extensions granted for COVID-19. H.R.6698/S. 3644, Quality Care for Nursing Home Residents and Workers During COVID-19 Act of 2020. No bill number. Discussed long-term care facility issues and COVID-19. S. 3768/H.R. 6972, Nursing Home COVID-19 Protection and Prevention Act. No bill number. Discussed and shared letter to FCC urging them to take sustained action to expand the affordability and availability of communication services to address COVID-19. S. 3544, Coronavirus Relief for Seniors and People with Disabilities Act of 2020. H.R. 6379, Take Responsibility for Workers and Families Act. S. 1443, H.R. 2730, Discussed Credit for Caring Act. No bill number. Discussed use of civil money penalties to purchase technology for virtual visitation. No bill number. Submitted comments on the proposed rule regarding the Medicare Program; Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities (SNFs); and Updates to the Value-Based Purchasing Program for FY2021. Discussed implementation of the Patient Driven Payment Model (PDPM). No bill number. Written statement submitted for House hearing on Health Care Inequality: Confronting Racial and Ethnic Disparities in COVID-19 and the Health Care System, in addition to action needed to ensure health and safety in long-term care facilities, the collection and reporting of demographic data, and testing and contact tracing. No bill number. Submitted written statement for House hearing on The Disproportionate Impact of COVID-19 on Communities of Color. No bill number. Sent letter to Senate Judiciary Committee and discussed opposition to immunity related to COVID-19 for nursing homes, assisted living facilities, and other long-term care facilities. S. 3517/H.R. 6487, Advancing Connectivity during the Coronavirus to Ensure Support for Seniors Act (ACCESS Act). H.R. 6666, the COVID-19 Testing, Reaching, And Contacting Everyone (TRACE) Act. H.R. 1425, the Patient Protection and Affordable Care Enhancement Act. H.R. 2073/S.110, Permanent extension of the 7.5% income threshold for the medical expense deduction. S. 3057, Modernization of the Older Americans Act Amendments S. 2543, Prescription Drug Pricing Reduction Act (Grassley-Wyden). H.R. 19/S. 3129, Lower Cost More Cures Act. H.R. 3, Elijah E. Cummings Lower Cost Drugs Now Act.
H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act. H.R. 6201, Families First Coronavirus Response Act; H.R. 748, Coronavirus Aid, Relief, and Economic Security (CARES) Act - Discussed Medicare enrollment national open enrollment period, medical expense deduction, cost-sharing protections for commercial/private health insurance holders, telehealth access, nursing homes, virtual visitation, home and community-based services, Older Americans Act programs, Medicare home health care, and family caregiving, no-cost COVID-19 testing, equitable relief payments, retirement savings tax relief, suspensions of foreclosures and evictions, expanded unemployment benefits, paid sick and family leave, affordable broadband, and government operations, among other issues. H.R. 3, Elijah E. Cummings Lower Cost Drugs Now Act. S. 2543, the Prescription Drug Pricing Reduction Act. S.64/H.R. 2375 - the Preserve Access to Generics and Biosimilars Act. H.R. 1499 - the Preserving Consumer Access to Generics Act. H.R. 2113 - the Prescription STAR Act. H.R. 2296/S.1391 - The FAIR Drug Pricing Act. S.1416 - the Affordable Prescriptions for Patients Act. S.1437, the Drug-price Transparency in Communications (DTC) Act. S.551, the REFUND Act. S.1209, the REMEDY Act. S. 474/H.R. 2069, the SPIKE Act. H.R. 19/S. 3129, Lower Cost More Cures Act.
H.R. 1158/H.R. 1865 - The Consolidated Appropriations Act/Further Consolidated Appropriations Act. H.R. 3055/S.2584 Commerce, Justice, Science, Agriculture, Rural Development, FDA, Interior Environment, Military Construction, VA,Transportation, Housing and Urban Development Appropriations Act, FY 2020. S. 340/H.R. 965 - CREATES Act. H.R. 1499 Preserving Consumer Access to Generic Drugs Act. S.64/H.R. 2375 - the Preserve Access to Generics and Biosimilars Act. H.R. 2113 - the Prescription STAR Act. H.R. 2296/S.1391 - The FAIR Drug Pricing Act. S.1416 - the Affordable Prescriptions for Patients Act. S.1437, the Drug-price Transparency in Communications (DTC) Act. S.551, the REFUND Act. S.1209, the REMEDY Act. S. 474/H.R. 2069, the SPIKE Act. Discussed Part D price negotiation and out-of-pocket cap with House and Senate. Discussed proposed Anti-Kickback rule. Discussed importation. Discussed international reference pricing. Discussed H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act of 2019 and H.R. 1682, the Improving Access to Medicare Coverage Act. No bill number and H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act of 2019, discussed prescription drug legislation with House staff. S.2543 the Prescription Drug Pricing Reduction Act (Grassley-Wyden bill). No bill number. Provided feedback on long-term care pharmacy bill.
H.R. 3055/S.2584 Commerce, Justice, Science, Agriculture, Rural Development, FDA, Interior Environment, Military Construction, VA,Transportation, Housing and Urban Development Appropriations Act, FY 2020. Discussed H.R. 3, the Lower Drug Costs Now Act of 2019 and S. 2543, Prescription Drug Pricing Reduction Act and lowering prescription drug prices. H.R. 3164 Agriculture-Rural Development Appropriations bill, FY 2020- lobbied to protect funding for FDA drug processing funding and user fees. Discussed Medicare Part D issues including part D price negotiation and Part D out-of-pocket cap. S. 340/H.R. 965 - CREATES Act. H.R. 1499 Preserving Consumer Access to Generic Drugs Act. S.64/H.R. 2375 - the Preserve Access to Generics and Biosimilars Act. H.R. 2113 - the Prescription STAR Act. H.R. 2296/S.1391 - The FAIR Drug Pricing Act. S.1416 - the Affordable Prescriptions for Patients Act. S.1437, the Drug-price Transparency in Communications (DTC) Act. S.551, the REFUND Act. S.1209, the REMEDY Act. S. 474/H.R. 2069, the SPIKE Act. H.R. 3 - The Lower Drug Costs Now Act. S. 2543- the Prescription Drug Pricing Reduction Act. Lobbied Senate in support. Discussed proposed Anti-Kickback rule. Discussed Rx importation. Discussed international reference pricing for Rx.
H.R. 3164 Agriculture-Rural Development Appropriations bill, FY 2020- lobbied to protect funding for FDA drug processing funding and user fees. Discussed Medicare Part D. S. 340/H.R. 965 - CREATES Act. H.R. 1499 Preserving Consumer Access to Generic Drugs Act. S.64/H.R. 2375 - the Preserve Access to Generics and Biosimilars Act. H.R. 2113 - the Prescription STAR Act. H.R. 2296/S.1391 - The FAIR Drug Pricing Act. S.1416 - the Affordable Prescriptions for Patients Act. S.1437, the Drug-price Transparency in Communications (DTC) Act. S.551, the REFUND Act. S.1209, the REMEDY Act. S. 474/H.R. 2069, the SPIKE Act. S. 1169, a bill to amend the Federal Food, Drug, and Cosmetic Act with respect to citizen petitions. Discussed Part D price negotiation. Discussed Part D out-of-pocket cap. Discussed proposed Anti-Kickback rule. Discussed Rx importation. Discussed international reference pricing for Rx. No bill number - shared invitation regarding prescription drug price briefing No bill number - discussed lowering prices for prescription drugs.
H.R. 2740 Labor-HHS Appropriations bill, FY 2020 - Lobbied in support of increased funding for CMS' state survey and certification program and opposition to hostile policy riders re ACA, and various related medical care research and supportive services. Discussed issue related to the Supplemental Nutrition Assistance Program. P.L. 114-42, NOTICE Act and no bill number, Improving Access to Medicare Coverage Act - discussed transparency/surprise medical billing, including observation issues and related prior legislation, in response to Senate request for information. S.340/H.R. 965 - the CREATES Act. S.64/H.R. 2375 - the Preserve Access to Generics and Biosimilars Act. H.R. 1499 - the Preserving Consumer Access to Generics Act. Endorsed H.R. 986, H.R. 987, and H.R. 1010, aimed at protecting the core consumer provisions of the ACA, including the prohibition on insurers engaging in an age tax and preexisting condition discrimination. S.1531- STOP Act. Discussed support for restoration and extension of the medical expense deduction. S.110/HR. 2073 Medical Expenses Permanency Legislation. S.617 Tax Extenders & Disaster Relief Act. H.R.2730/S. 1443 Credit for Caring Act. Medical Expense Deductions (included in H.R. 1628 and Better Care Reconciliation Act drafts) S.1209 REMEDY ACT. H.R.1373, Protecting Seniors from Poverty Act. H.R.2150/S. 296, Home Health Care Planning Improvement Act. H.R.1682/S.753 Improving Access to Medicare Coverage Act. H.R.1342/S.548 Empower Act. Better Care Reconciliation Act draft.
H.R. 21, Consolidated Appropriations Act. FY 2019, H.R. 648, 2nd Consolidated Appropriations Act. FY 2019, H.J.R. 31 Continuing Appropriations for Homeland Security. FY 2019, H.J.R. 143, H.R. 695, Short-term Continuing Appropriations Act Resolution. FY 2019, Labor-HHS Appropriations bill. FY 2020 (no bill numbers) - lobbied in support of increased funding for CMS' state survey and certification program and opposition to hostile policy riders re ACA, and various related medical care research and supportive services. Discussed issue related to the Supplemental Nutrition Assistance Program. P.L. 114-42, NOTICE Act and no bill number, Improving Access to Medicare Coverage Act - discussed transparency/surprise medical billing, including observation issues and related prior legislation, in response to Senate request for information. S.340/H.R. 965 - the CREATES Act. S.64 - the Preserve Access to Generics and Biosimilars Act. H.R. 1499 - the Preserving Consumer Access to Generics Act. Endorsed of H.R. 986, H.R. 987, and H.R. 1010, aimed at protecting the core consumer provisions of the ACA, including the prohibition on insurers engaging in an age tax and preexisting condition discrimination. Discussed support for the medical expense deduction.
H.R. 2212/ S. 974, CREATES Act - Discussed support of bill. H.R. 2439/S.1131, FAIR Drug Pricing Act - Discussed support of bill. S. 124, The Preserve Access to Affordable Generics Act - Discussed support of bill. Part D Deal in Bipartisan Budget Act, met with House and Senate offices to reiterate our support for the deal; sent multiple letters to House and Senate leadership; discussed support for the deal with House and Senate staff. Discussed the Presidents Prescription Drug Blueprint and RFI. S. 2553, Know the Lowest Price Act - supported passage of legislation. S.2554, Patient Right to Know Act - supported passage of legislation. Discussed possible ways to improve Medicare Part D. Discussed Rx Price Watch Reports and the impact of high drug costs. Discussed drug pricing reforms AARP supports, including secretarial negotiation, importation, reducing exclusivity for biologics, and ending pay-for-delay deals. Discussed Rx issues with HHS.
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Equal Employment Opportunity Commission (EEOC), Federal Highway Administration (FHA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Highway Traffic Safety Administration (NHTSA), SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, White House Office
Discussed efforts to include harmful prescription drug policies in NAFTA with House and Senate staff. H.R. 2212/ S. 974, CREATES Act - Discussed support of bill. H.R. 2439/S.1131, FAIR Drug Pricing Act - Discussed support of bill. S. 124, The Preserve Access to Affordable Generics Act - Discussed support of bill. Part D Deal in Bipartisan Budget Act, Met with House offices to reiterate our support for the deal; sent multiple letters to House and Senate leadership; discussed support for the deal with House and Senate staff. Discussed the Presidents Prescription Drug Blueprint and RFI. S. 1091, the Supporting Grandparents Raising Grandkids Act - Advocated for passage of bill. S. 2553, Know the Lowest Price Act - Endorsed legislation. S.2554, Patient Right to Know Act - Endorsed legislation. Discussed opioid abuse legislation to address opioid abuse and misuse. Discussed possible ways to improve Medicare Part D. Discussed Rx Price Watch Reports and the impact of high drug costs. Discussed drug pricing reforms AARP supports, including secretarial negotiation, importation, reducing exclusivity for biologics, and ending pay-for-delay deals. Discussed family caregiving, opioids, and Supporting Grandparents Raising Grandchildren Act (P.L. 115-196, S. 1091/H.R. 3105).
Filing targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Federal Highway Administration (FHA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Labor, Dept of (DOL), Natl Highway Traffic Safety Administration (NHTSA), SENATE, Securities & Exchange Commission (SEC), Treasury, Dept of, White House Office
Sent a letter to USTR regarding prescription drugs concerns in NAFTA negotiations. Sent letter supporting the inclusion of H.R. 3032, the Mental Health Access Improvement Act, in larger opioids bill, H.R. 5531, the Opioid Emergency Response Act. Participated in stakeholder calls organized by the White House and HHS on the Presidents Prescription Drug Blueprint. H.R. 2212/ S. 974, CREATES Act - Discussed support of bill. H.R. 2439/S.1131, FAIR Drug Pricing Act - Discussed support of bill. S. 124, The Preserve Access to Affordable Generics Act - Discussed support of bill. Part D Deal in Bipartisan Budget Act - Met with House offices to reiterate our support for the deal; sent a letter to House and Senate leadership; discussed support for the deal with Senate staff. Discussed the Presidents Prescription Drug Blueprint and RFI. S. 1091, the Supporting Grandparents Raising Grandkids Act - Advocated for passage of bill. S. 2553, Know the Lowest Price Act - Sent letter of endorsement. S.2554, Patient Right to Know Act - Sent letter of endorsement. Discussed Committee activities on opioid abuse legislation to address opioid abuse and misuse. Discussed possible ways to improve Medicare Part D. Discussed Rx Price Watch Reports and the impact of high drug costs. Discussed drug pricing reforms AARP supporting, including secretarial negotiation, importation, reducing exclusivity for biologics, and ending pay-for-delay deals. Discussed family caregiving, opioids, and Supporting Grandparents Raising Grandchildren Act (P.L. 115-196, S. 1091/H.R. 3105).
Discussed upcoming administrative action on drug costs and PBMs with Senate staff. Discussed changes to the Cody Miller PMI Act with Senate staff. H.R. 1625, Consolidated Appropriations Act for FY 2018, (P.L. 115-141), H.R.3354, Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Education, State and Foreign Operations, Transportation, Housing and Urban Development, Defense, Military Construction and Veterans Affairs, Legislative Branch, and Energy and Water Development Appropriations Act, 2018, H.J.R. 123, Further Continuing Appropriations Act, 2018, H.J. Res. 99 (P.L. 115-30), H.R. 244, Consolidated Appropriations Act 2017 (P.L. 115-31) and (H.R. 3358 & S. 1771) Agriculture-Rural Development & Related Agencies bill for FY 2018 - Lobbied in support of increased funding for FDA drug processing funding and user fees.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Consumer Financial Protection Bureau (CFPB), Equal Employment Opportunity Commission (EEOC), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Labor, Dept of (DOL), Natl Highway Traffic Safety Administration (NHTSA), Office of Management & Budget (OMB), SENATE, Securities & Exchange Commission (SEC), Veterans Affairs, Dept of (VA)
Discussed upcoming administrative action on drug costs and PBMs with Senate staff. Discussed changes to the Cody Miller PMI Act with Senate staff. H.R. 1625, Consolidated Appropriations Act for FY 2018, (P.L. 115-141), H.R.3354, Interior and Environment, Agriculture and Rural Development, Commerce, Justice, Science, Financial Services and General Government, Homeland Security, Labor, Health and Human Services, Education, State and Foreign Operations, Transportation, Housing and Urban Development, Defense, Military Construction and Veterans Affairs, Legislative Branch, and Energy and Water Development Appropriations Act, 2018, H.J.R. 123, Further Continuing Appropriations Act, 2018, H.J. Res. 99 (P.L. 115-30), H.R. 244, Consolidated Appropriations Act 2017 (P.L. 115-31) and (H.R. 3358 & S. 1771) Agriculture-Rural Development & Related Agencies bill for FY 2018 - Lobbied in support of increased funding for FDA drug processing funding and user fees.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Consumer Financial Protection Bureau (CFPB), Equal Employment Opportunity Commission (EEOC), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Labor, Dept of (DOL), Natl Highway Traffic Safety Administration (NHTSA), Office of Management & Budget (OMB), SENATE, Securities & Exchange Commission (SEC), Veterans Affairs, Dept of (VA)
Provided comments to CMS on value-based pricing arrangements for prescription drugs. S. 974/H.R. 2212, CREATES Act - Discussed support of bill. H.R. 2051, FAST Generics Act - Discussed support of bill. S.1131/H.R. 2439, FAIR Drug Pricing Act - Discussed support of bill. S. 124, Preserve Access to Affordable Generics Act - Discussed support of bill. Advocated for biosimilar drugs to be added to the Medicare Part D Coverage Gap Discount Program. Cody Miller PMI Act - Participated in meetings with the sponsoring office to discuss updates to the bill text and re-introduction in the 115th Congress. Submitted a letter outlining the reforms we support to lower prescription drugs costs to the House Energy and Commerce Committee and the Senate HELP Committee when they held hearings on the drug supply chain. Discussed possible ways to improve Medicare Part D. Discussed Rx Price Watch Reports and the impact of high drug costs. Discussed drug pricing reforms AARP supports, including secretarial negotiation, importation, reducing exclusivity for biologics, and ending pay-for-delay deals. H.R. 3354, Omnibus Appropriations Act, 2018, H.R. 1370, H.J.R. 123, Further Continuing Appropriations Act, 2018, H.J. Res. 99 (P.L. 115-30), H.R. 244, Consolidated Appropriations Act 2017 (P.L. 115-31) and (H.R. 3358 & S. 1771) Agriculture-Rural Development & Related Agencies bill for FY 2018 - Lobbied in support of increased funding for FDA drug processing funding and user fees.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Consumer Financial Protection Bureau (CFPB), Equal Employment Opportunity Commission (EEOC), Federal Communications Commission (FCC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Highway Traffic Safety Administration (NHTSA), SENATE, Securities & Exchange Commission (SEC), Veterans Affairs, Dept of (VA)
H.R. 1628, Better Care Reconciliation Act (Senate)/ American Health Care Act(House) - Discussed priorities for older adults in health care reform legislation including Medicare, private health insurance/age tax, Medicaid, and prescription drugs. S. 974, CREATES Act - Discussed support of bill. H.R. 2051, FAST Generics Act - Endorsed bill. Cody Miller PMI Act - Participated in a meeting with the sponsoring office to discuss updated bill text and re-introduction in the 115th Congress. (no bill number) Discussed possible ways to improve Medicare Part D. Discussed new Rx Price Watch reports and the impact of high drug costs. Discussed drug pricing reforms AARP supports, including secretarial negotiation, importation, reducing exclusivity for biologics, and ending pay-for-delay. H.J. Res. 99 (P.L. 115-30), H.R. 244, Consolidated Appropriations Act 2017 (P.L. 115-31) and (H.R. 3358 & S. 1771) Agriculture-Rural Development & Related Agencies bill for FY 2108 - Lobbied in support of increased funding for FDA drug processing funding and user fees.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Consumer Financial Protection Bureau (CFPB), Equal Employment Opportunity Commission (EEOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Veterans Affairs, Dept of (VA)
H.R. 1628, American Health Care Act (H.R. 1628) and Better Care Reconciliation Act (H.R. 1628) - Discussed opposition to the bill because of provisions regarding the age tax, changes to Medicaid, pre-existing conditions, and Medicare. Shared data on the impact of the legislation, including state data. Discussed priorities for older adults in health care reform legislation including Medicare, private health insurance/age tax, Medicaid, and prescription drugs. H.J. Res. 99 (P.L. 115-30), H.R.244, Consolidated Appropriations Act 2017 (P.L. 115-31) and (no bill numbers) Agriculture-Rural Development & Related Agencies bill for FY 2108 - lobbied in support of increased funding for FDA drug processing funding and user fees. S. 974, the Creates Act - Endorsed bill. H.R. 2051, FAST Generics Act - Endorsed bill. S. 1131, H.R. 2439, Fair Drug Pricing Act - Endorsed bill. S. 124, H.R. 1776, Preserve Access to Affordable Generics Act - Endorsed bill. Discussed with the Hill and Administration our support for other drug proposals including secretarial negotiation, safe importation and other administrative options to address drug prices.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Equal Employment Opportunity Commission (EEOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Office of Management & Budget (OMB), Pension Benefit Guaranty Corporation (PBGC), SENATE, Social Security Administration (SSA), Transportation, Dept of (DOT), Veterans Affairs, Dept of (VA), White House Office
H.R.1628, American Health Care Act of 2017 - Lobbied in opposition to the bill. Discussed support for medical expense deduction. H.R. 708, State Age Rating Flexibility Act of 2017 - Discussed opposition to bill. Sent letter to House Energy and Commerce Committee. H.R. 1121, Pre-Existing Conditions Protection Act of 2017 - Discussed bill. H.R. 708/H.R.1628 - Provided information on the age tax and its impact on older adults. Discussed priorities for older adults in health care reform legislation including Medicare, private health insurance/age tax, Medicaid, and prescription drugs. S. 191, Patient Freedom Act of 2017 - Discussed bill. Discussed health care reform generally. H.R. 2028 (Public Law 114-254) - Further Continuing and Security Assistance Appropriations Act, 2017 - Lobbied in support of increased funding for CMS' state survey and certification program and opposition to hostile policy riders re Patient Protection and Affordable Care Act. H.R. 1313, Preserving Employee Wellness Programs Act - Opposed bill. Discussed health care tax provisions - Sent letter to House and Senate committee leadership addressing preservation of tax exempt status of employer sponsored insurance coverage, maintenance of tax subsidies for lower- and moderate-income Americans to purchase health insurance coverage in health care marketplaces, the creation of a new, non-refundable tax credit for working family caregivers, and the retention of the medical expense itemized deduction.
H.R. 749, Lower Drug Costs through Competition Act - Discussed importation, price negotiation, and other prescription drug legislation. Responded to inquiry regarding pharmaceutical benefit managers (PBMs). S. 469, Affordable and Safe Prescription Drug Importation Act - Discussed bill. Discussed CREATES Act (no bill number) and pay-for-delay legislation. Discussed priorities for older adults in health care reform legislation including Medicare, private health insurance/age tax, Medicaid, and prescription drugs. H.R. 2028 (Public Law 114-254) - Further Continuing and Security Assistance Appropriations Act, 2017 - Lobbied in support of increased CSFP and FDA drug processing funding and user fees.
H.R.1628, American Health Care Act of 2017 - Lobbied in opposition to the bill. Discussed support for medical expense deduction. H.R. 708, State Age Rating Flexibility Act of 2017 - Discussed opposition to bill. Sent letter to House Energy and Commerce Committee. H.R. 1121, Pre-Existing Conditions Protection Act of 2017 - Discussed bill. H.R. 708/H.R.1628 - Provided information on the age tax and its impact on older adults. Discussed priorities for older adults in health care reform legislation including Medicare, private health insurance/age tax, Medicaid, and prescription drugs. S. 191, Patient Freedom Act of 2017 - Discussed bill. Discussed health care reform generally. H.R. 2028 (Public Law 114-254) - Further Continuing and Security Assistance Appropriations Act, 2017 - Lobbied in support of increased funding for CMS' state survey and certification program and opposition to hostile policy riders re Patient Protection and Affordable Care Act. H.R. 1313, Preserving Employee Wellness Programs Act - Opposed bill. Discussed health care tax provisions - Sent letter to House and Senate committee leadership addressing preservation of tax exempt status of employer sponsored insurance coverage, maintenance of tax subsidies for lower- and moderate-income Americans to purchase health insurance coverage in health care marketplaces, the creation of a new, non-refundable tax credit for working family caregivers, and the retention of the medical expense itemized deduction.
Pub.Law 111-148 & 111-152 - Discussed implementation of health care law that would reform the health care system to provide affordable quality health care, reduce drug costs and expand access to long-term services and supports. Discussed how to implement Medicaid provisions of Affordable Care Act. (PL. 111-148)S. 374, Medicare Mental Health Inpatient Equity Act - Lobbied in support of this legislation to eliminate the 190-day lifetime limit on Medicare coverage for in-patient psychiatric hospital services (112th). Discussed improving access to care for underserved population. (no bill) Discussed importance of maintaining low income subsididies and supports in Medicare. (no bill) Discussed the importance of coordinating services for those who qualify for both Medicare and Medicaid in order to ensure that beneficiaries receive all needed benefits but there is no duplication. (no bill) Discussed whether, and under what circumstances, managed care could effectively be used to provide benefits to dual eligible beneficiaries. (no bill) Discussed additional methods for fighting fraud and waste in Health Care. (no bill) Discussed Medigap and need for guaranteed issue for all populations and need to increase medical loss ratio. Discussed durable medical equipment bidding. (no bill) Lobbied for legislation to provide Medicare beneficiaries with additional opportunities to enroll in Medicare Part B.(no bill) Lobbied against the use of the Social Security account number on Government-issued identification cards issued in connection with Medicare, Medicaid, and SCHIP benefits and for other purposes. (no bill) Discussed support to curb waste and fraud from the Medicare and Medicaid programs. (no bill) H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2012 - Discussed the legislation as it pertained to SGR. Discussed Medicare Reform. (no bill) H.R. 2305/S. 1123, PRIME ACT (Preventing and Reducing Improper Medicare Expenditures) - Discussed support for bill and urged cosponsorship. Discussed the Medicare Part D prescription drug benefit program and changes needed to further lower prescription drug costs. (no bill) H.R. 1588/S. 740, Medicare Drug Savings Act - Discussed the Medicare Drug Savings Act to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. Discussed potential improvements to the Medicare Savings Programs for low-income befeficiaries. (no bill) Discussed proposals that would establish per-capita caps under Medicaid as well as other Medicaid financing proposals including block grants and changes to the current FMAP structure. (no bill) H.R. 1717 - Discussed Medicare DMEPOS Market Pricing Program Act. Discussed the Medicare Part D prescription drug benefit program and changes needed to further lower prescription drug costs and related agency proposed rule changes. (no bill) H.R.3830/S.1900 - Discussed pending U.S. trade agreement negotiations and trade promotional or "fast track" authority legislation and their potential impact on Medicare and Medicaid prescription drug programs. S. 2461 - Discussed Children's Health Insurance Program (CHIP) extension and CHIP Extension Act of 2014. Discussed Part D Payment for Drugs for Beneficiaries Enrolled in Hospice - Final 2014 CMS Guidance. H.R.5294, Health Equity & Accountability Act of 2014 - Addresses health care disparities; no endorsement due to budget impact. Medicare Advantage- Answered questions from some Hill offices. (no bill) Medicare Supplemental Insurance - Stated opposition to the elimination of first dollar coverage. (no bill) Discussed LTSS issues, including financing. (no bill)Discussed Medicare Graduate Nursing Education pilot design. (no bill) Discussed Prescription Drug Affordability. (no bill) Discussed Prescription Drug Shortages. (no bill) H.R. 3342, Affordable Medicines Utilization Act of 2011 - Lobbied to encourage state Medicaid programs to use safe, effective generic medications. H.R. 2576 - Discussion to amend the Internal Revenue Code of 1986 to modify the calculation of modified adjusted gross income for purposes of determining eligibility for certain healthcare-related programs. Discussed opposition to caps on dual eligibles; discussed managed care and dual eligibles. (no bill) Discussed with CMS demonstration programs for dual eligibles and process related to the demonstrations, as well as other work of the Medicare-Medicaid Coordination Office, discussed consumer choice and continuity of care in Medicaid managed long-term services and supports programs, discussed focus groups on dual eligibles. Discussed Hospital & Critical Access Hospitals Conditions of Participation proposed regulations; requested that advanced practice registered nurses and physicians assistants be allowed the full scope of services in hospital admitting and visiting privileges. (no bill) Discussed Hospital Outpatient Therapeutic Services Final Rule underscoring that advanced practice registered nurses and physicians should be allowed to supervise such outpatient service clinics without physician oversight as long as in line with state scope of practice laws. (no bill) Discussed health disparities. (no bill) Discussed Medicaid reform, Medicare/Medicaid "dual eligibles" integration efforts and financial alignment demonstrations; and other CMS demonstration initiatives. (no bill) S. 3586, Recruiting Individuals to Drive Elders (RIDE) Act - Discussed Medicaid non-emergency transportation bill (112th). Discussed proposals that would establish per-capita caps under Medicaid as well as other Medicaid financing proposals including block grants and changes to the current FMAP structure. (no bill) Discussed extension of funding originally provided under the Medicare Improvement for Patients and Providers Act (P.L. 110-275) to State Health Insurance Assistance Programs (SHIPs), Aging and Disability Resource Centers (ADRICs), and Area Agencies on Aging (AAAs) for Medicare outreach and enrollment counseling. (no bill) Discussed the prevention of cuts to beneficiaries in the Medicare program. (no bill) Discussed the prevention of an increase in the age of eligibility in the Medicare program. (no bill) Discussed the patch to the Sustainable Growth Rate (SGR) in the Medicare program. (no bill) Discussed concerns of block granting Medicaid. (no bill) Discussed the Kansas managed long-term services and supports waiver proposals and related implementation issues. (no bill). H.R.928/S.408, the Medicare Drug Savings Act - Discussed requirement for drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. Discussed Health Disparities. (no bill) Discussed medicare demonstration project replacing standard medicare cards with Smart Card technology. (no bill) H.R. 574 - The Medicare Physician Payment Innovation Act of 2013. Discussed Medicaid expansion and estate recovery. (no bill) S. 2491, Discussed Medicare Protection Act. Discussed concern about CMS guidance on prescription drugs for medicare beneficiaries receiving hospice and coordination between hospice providers and medicare Part D sponsors. (no bill) Discussed long-term services and supports in Hill briefings. (no bill) H.R. 1173 - Discussed advance care planning, CMS payment for advance care planning, advanced illness, and Personalize Your Care Act.H.R. 1179/S.569, Improving Access to Medicare Act - Discussed support of Improving Access to Medicare Coverage Act and urged cosponsorship and advancement of the bill. Discussed CMS information regarding healthcare marketplaces. H.R. 2305/S.1123, Preventing and Reducing Improper Medicare and Medicaid Expenditures Act. Bill reduces waste, fraud, and abuse in Medicare and Medicaid programs. Discussed Competitive bidding of durable medical equipment, prosthetics, orthotics, and supplies. (no bill) Discussed repeal of Affordable Care Act provision making prescriptions necessary for over-the-counter drugs purchased with flexible spending accounts. (no bill) Discussed Medicare supplemental coverage. (no bill) Discussed the Medicare Part D prescription drug benefit program and changes needed to further lower prescription drug cost. (no bill) Discussed potential improvements to the Medicare Savings Programs for low-income beneficiaries. (no bill) H.R. 83, Consolidated and Further Continuing Appropriations, 2015 - Lobbied to protect vital health and social services programs from enhanced reductions from the prior year baseline, and to prevent repeal of certain financial and health care-related regulation.(no bill) Discussed potential improvements to the Medicare Savings Programs for low-income beneficiares. (no bill) Discussed pending U.S. trade agreement negotiations, including trade promotional or 'fast track' authority, and their potential impact on Medicare and Medicaid prescription drug programs. (no bill) Discussed fraud, Medicare home healthcare, ways to find savings in Medicare without harming Medicare beneficiaries (care coordination, prescription drugs, waste, fraud and abuse). Discussed You've Earned A Say, ways to find savings in medicare without harming medicare beneficiaries (care coordination, prescription drugs, waste, fraud and abuse). PL.111-148 - Discussed implementation of provision to require reporting of nursing home staffing data based on payroll data and executive actions related to nursing homes, IMPACT Act, PL 113-185).. Discussed the draft legislation on Medicare fraud and abuse. Protecting the Integrity of Medicare Act. (no bill) Discussed the Medicare Part D prescription drug benefit program and changes needed to further lower prescription drug costs and related agency proposed rule changes. (no bill) H.R. 1588/S.740 - Discussed the Medicare Drug Savings Act to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. H.R. 3830/S. 1900 - Discussed pending U.S. trade agreement negotiations and trade promotional or "fast track" authority legislation and their potential impact on Medicare and Medicaid prescription drug programs. S. 2461 - Discussed Children's Health Insurance Program (CHIP) Extension Act of 2014. Discussed Part D Payment for Drugs for Beneficiaries Enrolled in Hospice-Final 2014 CMS Guidance. Discussed the Protecting Integrity of Medicare Act. (no bill) H.R.5435, Home Infusion Site of Care Act - Sent letter of endorsement H.R. 5958 - Discussed the ACO Improvement Act. H.J. Res. 124, Continuing Appropriations Resolution - Lobbied to protect funding levels for CMS program management under Continuing Resolution. H.R. 1179/S. 569 - Discussed observation impace on Medicare beneficiaries, counting time in observation toward Medicare's three-day inpatient hospital stay requirement for Medicare skilled nursing facility coverage, and the Improving Access to Medicare Coverage Act (CMS & MedPAC). PL. 113-295 - Responded to inquiry about Medicare offsets on Achieving a Better Life Expense Act.Discussed Medicare Advantage. (no bill) Discussed H.R. 3616, Protecting Seniors from Healthcare Fraud Act. Discussed observation care and "two-midnight rule". (no bill) H.R. 1070, the Removing Barriers to Colorectal Cancer Screening Act - Discussed and sent letter of endorsement to bill. Discussed the Medicare Part D prescription drug benefit program and changes needed to further lower prescription drug costs and related agency proposed rule changes. (no bill) H.R. 1588/S.740, Medicaid Drug Savings Act - Discussed the requirement for drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. Discussed potential improvements to the Medicare Savings Programs for low-income beneficiaries. (no bill) Discussed pending U.S. Trade agreement negotiations, including trade promotional or "fast track" authority, and their potential impact on Medicare and Medicaid prescription drug programs. (no bill) H.R. 2810/S.1871/H.R. 4015/S.2110 - Discussed SGR repeal and health care extender provisions, including the Qualified Individual low-income Medicare beneficiary assistance program. H.R. 4418, The Expanding Availability of Medicare Data Act - Sent letter of endorsement. Discussed Medicare data and billing transparency. (no bill) Discussed socio-economic risk adjustment. (no bill) S. 2240 - Discussed Medicare Choices Empowerment and Protection Act. H.R. 3024 - Discussed the Medicare Common Access Card Act. Discussed Medicare expansion. (no bill) Discussed Medicaid Labs Spousal Impoverishment provisions (PL. 111-198). Discussed transparency in healthcare. (no bill) Discussed Medicaid managed care regulations. (CMS, no bill) PL.111-148 - Discussed long-term services and supports broadly and Older Americans Act. Submitted comments on Medicare Physician fee schedule final rule and advance care planning (CMS - 1612-FC). Discussed Medicare enrollment and notification of eligibility. (no bill) Discussed Medicare in-office ancillary services exception. (no bill)
S.452, Medicare Diabetes Prevention Act - Discussed bill with Senate. Discussed draft language on senior mental health with Senate HELP Committee staff. (no bill) Discussed Medicare Reform (no bill) Discussed Age Rating in the ACA and rate shock. (no bill)Labor, HHS Appropriations bill, 2015-Lobbied on preserving funding for the ACA; defended meaningful use of the ACA. (no bill) Discussed need to increase health information technology quality measurements and access to qualified systems. (no bill) H.R. 1099, To repeal the Prevention and Public Health Fund - Lobbied against the repeal of the Prevention and Public Health Trust Fund, an important component in state and community efforts to prevent illness and promote health. Discussed Pre-existing Condition Insurance Program. (no bill) Discussed Accountable Care Organization and Medical Shared savings. (no bill) Discussed Rate Review. (no bill) Discussed Internal Appeals and External Review Process. (no bill) Discussed Medicare reimbursement issues. Lobbied in support of Medicare physician payment reform. Discussed legislation to make prescription drugs more affordable to older Americans. S. 1416/H.R. 2645 (112th Congress), Medigap Medical Loss Ratio Improvement Act of 2011. Discussed coverage for screening depression and screening and counseling for alcohol misuse. (no bill) Discussed consumer operated and oriented plan programs. (no bill) Discussed standards related to risk adjustment, reinsurance, and risk mitigation as they relate to exchanges. (no bill) H.R.2077, MLR Repeal Act of 2011 - Expressed opposition to the elimination of provision in the Affordable Care Act (P.L. 111-148)Discussed opposition to draft legislation regarding the elimination of grandfathered status. (no bill) Discussed association health plans with DOL, HHS and DOT. (no bill) Discussed quality and care coordination with HHS. (no bill) Discussed Essential Health Benefits with HHS. (no bill) Discussed employer affordability safe harbor. (no bill) Discussed health insurance exchanges - eligibility, enrollment, premium tax credits. (no bill) Discussed Basic Health Plans. (no bill) Discussed Medigap reform. (no bill) Discussed Pre-existing Condition Insurance Program. (no bill) Discussed role of grandfathered plans. (no bill) Discussed reauthorization of the Older Americans Act and other amendments to the OAA. (no bill) Discussed dual eligibles. (no bill) Discussed S.1119, Positive Aging Act of 2013. H.R. 2641, Farm Program bill-Discussed the severed nutrition programs from Farm Bill. S. 562, Seniors Mental Health Access Improvement Act - Discussed the bill for eventual endorsement. Discussed need to suport family caregivers and long-term services and supports. (no bill) Discussed repeal of medical device tax. (no bill) Discussed proposed regulation relating to Medicaid expansion coverage and minimum essential coverage. (no bill) Discussed Affordable Care Act Medicaid expansion issues, including AARP comments on state 1115 waiver proposals to use premium assistance authority to expand Medicaid. (no bill) Discussed Medicare-Medicaid integration efforts and financial alignment demonstrations, other CMS demonstration initiatives. (no bill) H.R.3850/S. 1562, Discussed Older Americans Act reauthorization legislation. H.R.3662, the Mental Health Access Improvement Act - Sent letter of endorsement. H.R.4879, the Research for All Act - Sent letter of endorsement. S.2348, the Removing Barriers to Colorectal Cancer Screening Act - Sent letter of endorsement. Discussed legislation to address health disparities. (no bill) H.R.5294 - Discussed Health Equity & Accountability Act of 2014; no endorsement due to budget implications. H.J. Res. 124, Continuing Appropriations Resolution, 2015 - Lobbied to protect various healthcare programs serving seniors from disproportionate reduction under Continuing Resolution.Discussed FTC participation in state scope of practice issues. Also sent follow-up items for their review. (no bill) Discussed Social Security programs. (no bill) Lobbied against cuts to the health care prevention fund. (no bill) Discussed deficit reduction issues dealing with Medicare and Medicaid including concerns over increasing Medicare's age of eligibility, chained CPI, and cuts to Medicaid. (no bill) Discussed Affordable Care Medicaid expansion issues. Centers for Medicare and Medicaid Services, Center for Medicaid and CHIP Services. Discussed Medicaid reform, Medicare-Medicaid integration efforts and financial alignment demonstrations, other CMS demonstration initiatives. (no bill) Discussed Medicaid expansion implementation, as included in the ACA (P.L. 111-140). Discussed Medicaid including concerns over cuts to Medicaid flexibility and Medicaid structural reforms to. (no bill) Discussed implementation of the Affordable Care Act, its provisions and H.R. 95 to repeal the Patient Protection and Affordable Care Act. Labor, Health and Human Services Appropriations Act, 2015 - Lobbied to protect employment, health and human services and energy assistance programs for seniors, disabled and low income assistance. (no bill) Discussed Affordable Care Act Medicaid expansion issues, including questions related to the use of premium assistance authority to expand Medicaid. (no bill) H.R. 1263, Excellence in Mental Health Act - Discussed the bill for eventual endorsement. Discussed Affordable Care Act Medicaid expansion issues, including AARP comments on state 1115 waiver proposals to use premium assistance authority to expand Medicaid, Centers for Medicare and Medicaid Services, Center for Medicaid and CHIP Services. Discussed perspectives on proposed ideas for legislation to address health disparities with HHS and CMS officials. Discussed H.R. 3717, the Helping Families in Mental Health Crisis Act. Discussed Affordable Care Act Medicaid expansion issues, including AARP comments on state 1115 waiver proposals to use premium assistance authority to expand Medicaid. Centers for Medicare and Medicaid Services, Center for Medicaid and CHIP Services. Discussed Medicare-Medicaid integration efforts and financial alignment demonstrations, other CMS demonstration initiatives. (no bill) Discussed the Convention on the Rights of Persons with Disabilities. (no bill) H.R. 2835/S. 1647, Restoring Access to Medication Act of 2013 - Urged co-sponsorship of these bills. Discussed hospital readmissions. (no bill) Discussed Affordable Care Act Medicaid expansion issues, including AARP comments on state 1115 waiver proposals to use premium assistance authority to expand Medicaid. Discussed Medicare-Medicaid integration efforts and financial alignment demonstrations, other CMS demonstration initiatives. (no bill) H. R. 3850 - Discussed Older Americans Act reauthorization legislation. H.R. 5183, Better Care Act - Discussed legislation with staff regarding the bill. H.R. 5232, Notice of Observation Treatment & Implication for Care Eligibility (Notice Act) - Discussed legislation with staff.
Pub.Law 111-148 & 111-152 - Discussed implementation of health care law that would reform the health care system to provide affordable quality health care, reduce drug costs and expand access to long-term services and supports. Discussed how to implement Medicaid provisions of Affordable Care Act. (PL. 111-148)S. 374, Medicare Mental Health Inpatient Equity Act - Lobbied in support of this legislation to eliminate the 190-day lifetime limit on Medicare coverage for in-patient psychiatric hospital services (112th). Discussed improving access to care for underserved population. (no bill) Discussed importance of maintaining low income subsididies and supports in Medicare. (no bill) Discussed the importance of coordinating services for those who qualify for both Medicare and Medicaid in order to ensure that beneficiaries receive all needed benefits but there is no duplication. (no bill) Discussed whether, and under what circumstances, managed care could effectively be used to provide benefits to dual eligible beneficiaries. (no bill) Discussed additional methods for fighting fraud and waste in Health Care. (no bill) Discussed Medigap and need for guaranteed issue for all populations and need to increase medical loss ratio. Discussed durable medical equipment bidding. (no bill) Lobbied for legislation to provide Medicare beneficiaries with additional opportunities to enroll in Medicare Part B.(no bill) Lobbied against the use of the Social Security account number on Government-issued identification cards issued in connection with Medicare, Medicaid, and SCHIP benefits and for other purposes. (no bill) Discussed support to curb waste and fraud from the Medicare and Medicaid programs. (no bill) H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2012 - Discussed the legislation as it pertained to SGR. Discussed Medicare Reform. (no bill) H.R. 2305/S. 1123, PRIME ACT (Preventing and Reducing Improper Medicare Expenditures) - Discussed support for bill and urged cosponsorship. Discussed the Medicare Part D prescription drug benefit program and changes needed to further lower prescription drug costs. (no bill) H.R. 1588/S. 740, Medicare Drug Savings Act - Discussed the Medicare Drug Savings Act to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. Discussed potential improvements to the Medicare Savings Programs for low-income befeficiaries. (no bill) Discussed proposals that would establish per-capita caps under Medicaid as well as other Medicaid financing proposals including block grants and changes to the current FMAP structure. (no bill) H.R. 1717 - Discussed Medicare DMEPOS Market Pricing Program Act. Discussed implementation of regulations regarding minimum wage and overtime for home care workers and consumer-directed care. (no bill) Discussed the Medicare Part D prescription drug benefit program and changes needed to further lower prescription drug costs and related agency proposed rule changes. (no bill) H. R. 1588/S.740 - Discussed the Medicare Drug Savings Act to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. H.R.3830/S.1900 - Discussed pending U.S. trade agreement negotiations and trade promotional or "fast track" authority legislation and their potential impact on Medicare and Medicaid prescription drug programs. S. 2461 - Discussed Children's Health Insurance Program (CHIP) extension and CHIP Extension Act of 2014. Discussed Part D Payment for Drugs for Beneficiaries Enrolled in Hospice - Final 2014 CMS Guidance.Discussed Medicare Graduate Nursing Education pilot design. (no bill) Discussed Prescription Drug Affordability. (no bill) Discussed Prescription Drug Shortages. (no bill) H.R. 3342, Affordable Medicines Utilization Act of 2011 - Lobbied to encourage state Medicaid programs to use safe, effective generic medications. H.R. 2576 - Discussion to amend the Internal Revenue Code of 1986 to modify the calculation of modified adjusted gross income for purposes of determining eligibility for certain healthcare-related programs. Discussed opposition to caps on dual eligibles; discussed managed care and dual eligibles. (no bill) Discussed with CMS demonstration programs for dual eligibles and process related to the demonstrations, as well as other work of the Medicare-Medicaid Coordination Office, discussed consumer choice and continuity of care in Medicaid managed long-term services and supports programs, discussed focus groups on dual eligibles. Discussed Hospital & Critical Access Hospitals Conditions of Participation proposed regulations; requested that advanced practice registered nurses and physicians assistants be allowed the full scope of services in hospital admitting and visiting privileges. (no bill) Discussed Hospital Outpatient Therapeutic Services Final Rule underscoring that advanced practice registered nurses and physicians should be allowed to supervise such outpatient service clinics without physician oversight as long as in line with state scope of practice laws. (no bill) Discussed health disparities. (no bill) Discussed Medicaid reform, Medicare/Medicaid "dual eligibles" integration efforts and financial alignment demonstrations; and other CMS demonstration initiatives. (no bill) S. 3586, Recruiting Individuals to Drive Elders (RIDE) Act - Discussed Medicaid non-emergency transportation bill (112th). Discussed proposals that would establish per-capita caps under Medicaid as well as other Medicaid financing proposals including block grants and changes to the current FMAP structure. (no bill) Discussed extension of funding originally provided under the Medicare Improvement for Patients and Providers Act (P.L. 110-275) to State Health Insurance Assistance Programs (SHIPs), Aging and Disability Resource Centers (ADRICs), and Area Agencies on Aging (AAAs) for Medicare outreach and enrollment counseling. (no bill) Discussed the prevention of cuts to beneficiaries in the Medicare program. (no bill) Discussed the prevention of an increase in the age of eligibility in the Medicare program. (no bill) Discussed the patch to the Sustainable Growth Rate (SGR) in the Medicare program. (no bill) Discussed concerns of block granting Medicaid. (no bill) Discussed the Kansas managed long-term services and supports waiver proposals and related implementation issues. (no bill). H.R.928/S.408, the Medicare Drug Savings Act - Discussed requirement for drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. Discussed Health Disparities. (no bill) Discussed medicare demonstration project replacing standard medicare cards with Smart Card technology. (no bill) H.R. 574 - The Medicare Physician Payment Innovation Act of 2013. H.R. 1173 - Discussed Personalize Your Care Act. Discussed Medicaid expansion and estate recovery. (no bill) Discussed Medicaid and asset transfers. (no bill) Discussed the Improving Medicare Post-Acute Care Transformation Act of 2014 and provided feedback on the draft bill. (no bill number at the time, but later bill number was H.R. 4944/S. 2553) S. 2491, Discussed Medicare Protection Act. Submitted comment letter on FYIS Medicare Skilled Nursing Facility payment rule. (no bill) Discussed concern about CMS guidance on prescription drugs for medicare beneficiaries receiving hospice and coordination between hospice providers and medicare Part D sponsors. (no bill)H.R. 1179/S.569, Improving Access to Medicare Act - Discussed support of Improving Access to Medicare Coverage Act and urged cosponsorship and advancement of the bill. Discussed comments regarding Medicare and You handbook. (no bill) Discussed CMS information regarding healthcare marketplaces. H.R. 2305/S.1123, Preventing and Reducing Improper Medicare and Medicaid Expenditures Act. Bill reduces waste, fraud, and abuse in Medicare and Medicaid programs. Discussed Competitive bidding of durable medical equipment, prosthetics, orthotics, and supplies. (no bill) Discussed repeal of Affordable Care Act provision making prescriptions necessary for over-the-counter drugs purchased with flexible spending accounts. (no bill) Discussed Medicare supplemental coverage. (no bill) Discussed the Medicare Part D prescription drug benefit program and changes needed to further lower prescription drug cost. (no bill) Discussed potential improvements to the Medicare Savings Programs for low-income beneficiaries. (no bill) Discussed Recruiting Individuals to Drive Our Elders Act (RIDE) would increase state flexibility by giving states the option to receive federal assistance to reimburse their volunteer drivers for no-load miles. (no bill) Labor, Health and Human Services Appropriations Act, 2014 - Lobbied to protect vital health and social services programs from enhanced reductions from the prior year baseline, and to prevent repeal of certain financial and health care-related regulation.(no bill) Discussed potential improvements to the Medicare Savings Programs for low-income beneficiares. (no bill) Discussed pending U.S. trade agreement negotiations, including trade promotional or 'fast track' authority, and their potential impact on Medicare and Medicaid prescription drug programs. (no bill) Discussed fraud, Medicare home healthcare, ways to find savings in Medicare without harming Medicare beneficiaries (care coordination, prescription drugs, waste, fraud and abuse). Discussed You've Earned A Say, ways to find savings in medicare without harming medicare beneficiaries (care coordination, prescription drugs, waste, fraud and abuse). PL.111-148 - Discussed implementation of provision to require reporting of nursing home staffing data based on payroll data.Discussed Medicare Advantage. (no bill) Discussed H.R. 3616, Protecting Seniors from Healthcare Fraud Act. Discussed observation care and "two-midnight rule". (no bill) H.R. 1070, the Removing Barriers to Colorectal Cancer Screening Act - Discussed and sent letter of endorsement to bill. Discussed the Medicare Part D prescription drug benefit program and changes needed to further lower prescription drug costs and related agency proposed rule changes. (no bill) H.R. 1588/S.740, Medicaid Drug Savings Act - Discussed the requirement for drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. Discussed potential improvements to the Medicare Savings Programs for low-income beneficiaries. (no bill) Discussed pending U.S. Trade agreement negotiations, including trade promotional or "fast track" authority, and their potential impact on Medicare and Medicaid prescription drug programs. (no bill) H.R. 2810/S.1871/H.R. 4015/S.2110 - Discussed SGR repeal and health care extender provisions, including the Qualified Individual low-income Medicare beneficiary assistance program. H.R. 4418, The Expanding Availability of Medicare Data Act - Sent letter of endorsement. Discussed Medicare data and billing transparency. (no bill) Discussed socio-economic risk adjustment. (no bill) Discussed nursing home staffing data in meeting with CMS. (no bill) Discussed advanced care planning, Welcome to Medicare visit, and Medicare wellness visits. Discussed language access in managed long-term services and supports in meeting with the HHS Office for Civil Rights. S. 2240, Discussed Medicare Choices Empowerment and Protection Act. S. 1439, Discussed support for Care Planning Act. Discussed LTSS Scorecard and reserving a room/logistics for Hill briefing on the LTSS Scorecard. (no bill). Discussed managed LTSS and language access. (no bill) H.R. 3024, Discussed the Medicare Common Access Card Act. H.R. 9673, Discussed the Bundling and Coordinating Post Acute Care (BACPAC) Act and shared views on post-acute care return. Discussed Medicare expansion. (no bill) H.R. 1179/S. 569, Improving Access to Medicare Coverage Act - Submitted written statement for the record for the current hospital ---in the Medicare program hearings. Shared draft witness questions with some subcommittee members and committee staff. Discussed Medicaid Labs Spousal Impoverishment provisions (PL. 111-198). S. 2361, Discussed Stop Schemes and cons against Medicare and seniors. Invited Hill staff to attend the LTSS Scorecard briefing. (no bill) Participated in a roundtable discussion on long-term services and supports. (no bill) Discussed Welcome to Medicare Visit and advance care planning. (no bill) Discussed transparency in healthcare. (no bill) Discussed New York State Community first choice option and workforce issues. (no bill)
Discussed importance of potential savings both to consumers and to the federal government of granting Secretarial Negotiating Authority to Secretary of HHS on Medicare Part D. (no bill)Discussed legislative intent with respect to biologic drugs and the exclusivity period; and discussed importance of potential savings to the health care system generally. (no bill) Discussed need for greater consumer safety protections both in OTC and prescription drugs. (no bill) Discussed need for doctors to get unbiased information on prescription pharmaceuticals through programs like academic detailing. (no bill) Discussed possible savings and better health care outcomes that could result from Medication Therapy Management. (no bill) Pub. Law 111-148 and 111-152 - Discussed implementation of health care legislation to reform the health care system to provide quality healthcare, expand access to long-term services and supports, and reduced prescription drug costs. Discussed greater affordability of generic versions of both generic and biologic drugs. S. 319, Pharmaceutical Market Access and Drug Safety Act of 2011 - Discussed legislation that establishes a framework for the safe, legal importation of lower-priced prescription drugs from abroad. S. 1206, Medicare Drug Savings Act of 2011 - Discussed rebates in Medicare Part D as a cost savings measure in Medicare that does not harm beneficiaries. H. R. 3342, Affordable Medicines Utilization Act of 2011 - Lobbied on legislation to encourage state Medicaid programs to use safe, effective generic medications. S. 27, Preserve Access to Affordable Generics Act of 2011- Lobbied for this legislation preventing abuses in patent settlements between generic and brand name prescription drug companies. S. 1886/H.R. 3468 of 2011- Discussed counterfeit drug penalty enhancement. Discussed prescription drug safety, drug shortage, and medical device safety, and related user fee legislation. S. 2193 of 2012, the Ensuring Safe Medical Devices for Patients Act - Discussed legislation to include devices in the post-market risk identification and analysis system for prescription drugs and to expedite the implementation of the unique device identification system for medical devices. Discussed draft legislation to address the issue of whether generic drug manufacturers have a duty to include new warnings about potentially serious side effects on their labels as they become known by giving generic drug makers the same ability to update their labeling as manufacturers of brand name drugs. (no bill) S.3187, Food and Drug Administration safety and Innovation Act - FDA user fee agreement legislation focusing on the review process for prescription drugs and medical devices, prescription drug safety, drug shortages, medical device safety and access to generic drugs. S.3212, Cody Miller Initiative for Safer Prescriptions Act - To require the Secretary of Health and Human Services to promulgate regulations regarding the authorship, content, format, and dissemination of Patient Medication information. Discussed pay-for-delay agreements as tactic by drug manufacturers to block lower cost drugs from entering the market, and the Fair and Immediate Release of Generics Drugs Act that would address the underlying issue of "parked exclusivities" in the Hatch-Waxman Act (S.1882). Discussed the issue of biosimilar drug naming and how biosimilars should use a common International Non-proprietary name as reference originator biologic products. (no bill) S. 504, the Fair and Immediate Release of Generic Drugs Act/S.214, the Preserve Access to Affordable Generics Act - Discussed the Patient Safety and Generic Labeling Improvement Act. (no bill)Discussed Unique Device Identification (UDI) issues including proposed rules and implementation. (no bill) Discussed oversight of laboratory genetic testing. (no bill) Discussed AARP's concerns with prescription drug costs. (no bill) S.117, Medicare Prescription Drug Price Negotiation Act - Discussed bill that allows medicare to negotiate medicare prescription drug prices with drug companies. S.504/S.214, The Fair and Immediate Release of Generics Drugs Act/Preserve Access to Affordable Generics Act - Discussed legislation to address pay-for-delay agreements used by drug manufacturers to block lower cost drugs from entering the market. Discussed the exclusivity period for biologic drugs. (no bill) Discussed the Patient Safety and Generic Labeling Improvement Act. (no bill) Discussed biologic drug issues including implementation of the new approval pathway for biosimilar drugs. (no bill) Discussed the importance of potential savings to both consumers and the federal government of granting Secretarial negotiating authority to the HHS Secretary under Medicare Part D. (no bill) S. 504, the Fair and Immediate Release of Generics Drugs Act/S. 214, the Preserve Access to Affordable Generics - Discussed legislation to address pay-for-delay agreements used by drug manufacturers to block lower cost drugs from entering the market. Discussed the exclusivity period ofr biologic drugs. (no bill) Discussed the Food and Drug Administration proposed rule to enable generic drug makers to independently update their drug labeling. (no bill) Discussed biologic drug issues including implementation of the new approval pathway for biosimilar drugs. (no bill) S. 1720/S.2049/S.866, - Discussed patent reform legislation and related provisions
Pub.Law 111-148 & 111-152 - Discussed implementation of health care law that would reform the health care system to provide affordable quality health care, reduce drug costs and expand access to long-term services and supports. Discussed how to implement Medicaid provisions of Affordable Care Act. (PL. 111-148)S. 374, Medicare Mental Health Inpatient Equity Act - Lobbied in support of this legislation to eliminate the 190-day lifetime limit on Medicare coverage for in-patient psychiatric hospital services (112th). Discussed improving access to care for underserved population. (no bill) Discussed importance of maintaining low income subsididies and supports in Medicare. (no bill) Discussed the importance of coordinating services for those who qualify for both Medicare and Medicaid in order to ensure that beneficiaries receive all needed benefits but there is no duplication. (no bill) Discussed whether, and under what circumstances, managed care could effectively be used to provide benefits to dual eligible beneficiaries. (no bill) Discussed additional methods for fighting fraud and waste in Health Care. (no bill) Discussed Medigap and need for guaranteed issue for all populations and need to increase medical loss ratio. Discussed durable medical equipment bidding. (no bill) Lobbied for legislation to provide Medicare beneficiaries with additional opportunities to enroll in Medicare Part B.(no bill) Lobbied against the use of the Social Security account number on Government-issued identification cards issued in connection with Medicare, Medicaid, and SCHIP benefits and for other purposes. (no bill) Discussed support to curb waste and fraud from the Medicare and Medicaid programs. (no bill) H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2012 - Discussed the legislation as it pertained to SGR. Discussed family caregiving, long-term care, Older Americans Act, private LTC insurance. (no bill) Discussed Medicaid long-term services and supports. (no bill) Discussed Medicare Reform. (no bill) H.R. 2305/S. 1123, PRIME ACT (Preventing and Reducing Improper Medicare Expenditures) - Discussed support for bill and urged cosponsorship. Discussed the Medicare Part D prescription drug benefit program and changes needed to further lower prescription drug costs. (no bill) H.R. 1588/S. 740, Medicare Drug Savings Act - Discussed the Medicare Drug Savings Act to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. Discussed potential improvements to the Medicare Savings Programs for low-income befeficiaries. (no bill) Discussed proposals that would establish per-capita caps under Medicaid as well as other Medicaid financing proposals including block grants and changes to the current FMAP structure. (no bill) S. 1439 - Discussed and endorsed the Care Planning Act of 2013. Discussed status of regulations regarding disclosure of nursing home ownership. (no bill) Discussed regulations defining whether a home and community-based setting in medicaid and state data on ome and community-based services spending. (no bill) Discussed family caregiver assessment in proposed regulations and shared a report on the topics. (no bill) Discussed measures for re-balancing in medicaid managed LTSS waivers and dual demonstration programs in sign on letter to CMS. (no bill) H.R. 1717 - Discussed Medicare DMEPOS Market Pricing Program Act. H.R. 3531 - Discussed Creating Access to Rehabilitation for Every Senior (CARES) Act.Discussed Medicare Graduate Nursing Education pilot design. (no bill) Discussed Prescription Drug Affordability. (no bill) Discussed Prescription Drug Shortages. (no bill) H.R. 3342, Affordable Medicines Utilization Act of 2011 - Lobbied to encourage state Medicaid programs to use safe, effective generic medications. H.R. 2576 - Discussion to amend the Internal Revenue Code of 1986 to modify the calculation of modified adjusted gross income for purposes of determining eligibility for certain healthcare-related programs. Discussed opposition to caps on dual eligibles; discussed managed care and dual eligibles. (no bill) Discussed with CMS demonstration programs for dual eligibles and process related to the demonstrations, as well as other work of the Medicare-Medicaid Coordination Office, discussed consumer choice and continuity of care in Medicaid managed long-term services and supports programs, discussed focus groups on dual eligibles. Discussed Medicaid managed care and long-term services and supports broadly. Discussed Hospital & Critical Access Hospitals Conditions of Participation proposed regulations; requested that advanced practice registered nurses and physicians assistants be allowed the full scope of services in hospital admitting and visiting privileges. (no bill) Discussed Hospital Outpatient Therapeutic Services Final Rule underscoring that advanced practice registered nurses and physicians should be allowed to supervise such outpatient service clinics without physician oversight as long as in line with state scope of practice laws. (no bill) Discussed health disparities. (no bill) Discussed Medicaid reform, Medicare/Medicaid "dual eligibles" integration efforts and financial alignment demonstrations; and other CMS demonstration initiatives. (no bill) Discussed the AARP Initiative called "You've Earned a Say". (no bill) S. 3586, Recruiting Individuals to Drive Elders (RIDE) Act - Discussed Medicaid non-emergency transportation bill (112th). Discussed proposals that would establish per-capita caps under Medicaid as well as other Medicaid financing proposals including block grants and changes to the current FMAP structure. (no bill) Discussed extension of funding originally provided under the Medicare Improvement for Patients and Providers Act (P.L. 110-275) to State Health Insurance Assistance Programs (SHIPs), Aging and Disability Resource Centers (ADRICs), and Area Agencies on Aging (AAAs) for Medicare outreach and enrollment counseling. (no bill) Discussed the prevention of cuts to beneficiaries in the Medicare program. (no bill) Discussed the prevention of an increase in the age of eligibility in the Medicare program. (no bill) Discussed the patch to the Sustainable Growth Rate (SGR) in the Medicare program. (no bill) Discussed concerns of block granting Medicaid. (no bill) Discussed the Kansas and Florida managed long-term services and supports waiver proposals and related implementation issues. (no bill). H.R.928/S.408, the Medicare Drug Savings Act - Discussed requirement for drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. Discussed Health Disparities. (no bill) Discussed medicare demonstration project replacing standard medicare cards with Smart Card technology. (no bill) H.R. 574 - The Medicare Physician Payment Innovation Act of 2013.H.R. 1179/S.569, Improving Access to Medicare Act - Discussed support of Improving Access to Medicare Coverage Act and urged cosponsorship and advancement of the bill. Discussed comments regarding Medicare and You handbook. (no bill) Discussed CMS information regarding healthcare marketplaces. H. R. 933, Consolidated and Further Continuing Appropriations Act, 2013 - Lobbied to protect vital health and social services programs from enhanced reductions from the prior year baseline, and to prevent repeal of certain financial and health care-related regulation. S. Con. Res. 8, Concurrent Resolution on the Budget, 2014 - Lobbied to prevent inclusion of Medicare, Medicaid and Social Security benefit cuts and to protect vital health, social services, housing and transportation programs from enhanced reductions from the prior year baseline, and to prevent repeal of certain financial and health care-related regulation. H.Con. Res. 25, Concurrent Resolution on the Budget, 2014 - Lobbied to prevent inclusion of Medicare, Medicaid and Social Security benefit cuts and to protect vital health, social services, housing and transportation programs from enhanced reductions from the prior year baseline, and to prevent repeal of certain financial and health care-related regulation.Lobbied on expected "QM" safe harbor amendment. (The amendment was not offered) H.R. 2305/S.1123, Preventing and Reducing Improper Medicare and Medicaid Expenditures Act. Bill reduces waste, fraud, and abuse in Medicare and Medicaid programs. Discussed Competitive bidding of durable medical equipment, prosthetics, orthotics, and supplies. (no bill) Discussed repeal of Affordable Care Act provision making prescriptions necessary for over-the-counter drugs purchased with flexible spending accounts. (no bill) Discussed Medicare supplemental coverage. (no bill) Discussed the Medicare Part D prescription drug benefit program and changes needed to further lower prescription drug cost. (no bill) Discussed potential improvements to the Medicare Savings Programs for low-income beneficiaries. (no bill) Discussed Recruiting Individuals to Drive Our Elders Act (RIDE) would increase state flexibility by giving states the option to receive federal assistance to reimburse their volunteer drivers for no-load miles. (no bill) Discussed the Medicare Adult Day Services Act. (no bill) Discussed the Commission on Long-Term Care and Senate Aging Committee hearing and long-term care generally. H.J.R. 59/H.R. 2775, Continuing Appropriations Resolution, 2014 - Lobbied to prevent inclusion of Medicare, Medicaid and Social Security benefit cuts and to protect vital health, social services, housing and transportation programs from enhanced reductions from the prior year baseline, and to prevent repeal of certain financial and health care-related regulation. S. 1284, Labor, Health and Human Services Appropriations Act, 2014 - Lobbied to protect vital health and social services programs from enhanced reductions from the prior year baseline, and to prevent repeal of certain financial and health care-related regulation. Discussed potential improvements to the Medicare Savings Programs for low-income beneficiares. (no bill) Discussed pending U.S. trade agreement negotiations, including trade promotional or 'fast track' authority, and their potential impact on Medicare and Medicaid prescription drug programs. (no bill) H.R. 2810/S. 1871 - Discussed SGR repeal and health care extender provisions, including the Qualified Individual low-income Medicare beneficiary assistance program. Discussed fraud, Medicare home healthcare, ways to find savings in Medicare without harming Medicare beneficiaries (care coordination, prescription drugs, waste, fraud and abuse). Discussed new report on observation services that included policy recommendations. Discussed you've earned a say, ways to find savings in medicare without harming medicare beneficiaries (care coordination, prescriotion drugs, waste, fraud and abuse).Discussed and shared invitation for a Hill briefing on innovation and progress in long-term services and supports. (no bill) Submitted and shared written testimony for the record for the Senate Aging Committee hearing on the future of Long-Term Care Policy and Continuing the Conversation. (no bill) Discussed Medicare Advantage. H.R. 3616, Protecting Seniors from Medicare Act- Sent letters endorsing bill. H.R. 2810, The SGR Repeal and Medicare Beneficiary Improvement Act - Sent letters endorsing bill. Discussed observation care and "two-midnight rule".
Discussed legislative intent with respect to Biologic drugs and exclusivity period.(no bill) Discussed importance of potential savings both to consumers and to the federal government of granting Secretarial Negotiating Authority to Secretary of HHS on Medicare Part D. (no bill)Discussed legislative intent with respect to biologic drugs and the exclusivity period; and discussed importance of potential savings to the health care system generally. (no bill) Discussed need for greater consumer safety protections both in OTC and prescription drugs. (no bill) Discussed need to end industry tactics like Pay for Delay which inappropriately extends patents with effect of keeping prices high for consumers and government. (no bill) Discussed need for doctors to get unbiased information on prescription pharmaceuticals through programs like academic detailing. (no bill) Discussed possible savings and better health care outcomes that could result from Medication Therapy Management. (no bill) Pub. Law 111-148 and 111-152 - Discussed implementation of health care legislation to reform the health care system to provide quality healthcare, expand access to long-term services and supports, and reduced prescription drug costs. Discussed greater affordability of generic versions of both generic and biologic drugs. S. 319, Pharmaceutical Market Access and Drug Safety Act of 2011 - Discussed legislation that establishes a framework for the safe, legal importation of lower-priced prescription drugs from abroad. S. 1206, Medicare Drug Savings Act of 2011 - Discussed rebates in Medicare Part D as a cost savings measure in Medicare that does not harm beneficiaries. H. R. 3342, Affordable Medicines Utilization Act of 2011 - Lobbied on legislation to encourage state Medicaid programs to use safe, effective generic medications. S. 27, Preserve Access to Affordable Generics Act of 2011- Lobbied for this legislation preventing abuses in patent settlements between generic and brand name prescription drug companies. S. 1886/H.R. 3468 of 2011- Discussed counterfeit drug penalty enhancement. Discussed prescription drug safety, drug shortage, and medical device safety, and related user fee legislation. S. 2193 of 2012, the Ensuring Safe Medical Devices for Patients Act - Discussed legislation to include devices in the post-market risk identification and analysis system for prescription drugs and to expedite the implementation of the unique device identification system for medical devices. Discussed draft legislation to address the issue of whether generic drug manufacturers have a duty to include new warnings about potentially serious side effects on their labels as they become known by giving generic drug makers the same ability to update their labeling as manufacturers of brand name drugs. (no bill) S.3187, Food and Drug Administration safety and Innovation Act - FDA user fee agreement legislation focusing on the review process for prescription drugs and medical devices, prescription drug safety, drug shortages, medical device safety and access to generic drugs. S.3212, Cody Miller Initiative for Safer Prescriptions Act - To require the Secretary of Health and Human Services to promulgate regulations regarding the authorship, content, format, and dissemination of Patient Medication information. Discussed the importance of potential savings to both consumers and the federal government of granting Secretarial negotiating authority to the HHS Secretary under Medicare Part D. (no bill) Discussed pay-for-delay agreements as tactic by drug manufacturers to block lower cost drugs from entering the market, and the Fair and Immediate Release of Generics Drugs Act that would address the underlying issue of "parked exclusivities" in the Hatch-Waxman Act (S.1882). Discussed the issue of biosimilar drug naming and how biosimilars should use a common International Non-proprietary name as reference originator biologic products. (no bill) S. 504, the Fair and Immediate Release of Generic Drugs Act/S.214, the Preserve Access to Affordable Generics Act - Discussed legislation to address pay-for-delay agreements used by drug manufacturers to block lower cost drugs from entering the market. Discussed the Patient Safety and Generic Labeling Improvement Act. (no bill)Discussed Unique Device Identification (UDI) issues including proposed rules and implementation. (no bill) Discussed oversight of laboratory genetic testing. (no bill) Discussed AARP's concerns with prescription drug costs. (no bill) S.117, Medicare Prescription Drug Price Negotiation Act - Discussed bill that allows medicare to negotiate medicare prescription drug prices with drug companies. Discussed the importance of potential savings to both consumers and the federal government of granting Secretarial negotiating authority to the HHS Secretary under Medicare Part D. (no bill) S.504/S.214, The Fair and Immediate Release of Generics Drugs Act/Preserve Access to Affordable Generics Act - Discussed legislation to address pay-for-delay agreements used by drug manufacturers to block lower cost drugs from entering the market. Discussed the exclusivity period for biologic drugs. (no bill) Discussed the Patient Safety and Generic Labeling Improvement Act. (no bill) Discussed biologic drug issues including implementation of the new approval pathway for biosimilar drugs. (no bill)
S.452, Medicare Diabetes Prevention Act - Discussed bill with Senate. Discussed draft language on senior mental health with Senate HELP Committee staff. (no bill) Discussed Medicare Reform (no bill) Discussed Age Rating in the ACA and rate shock. (no bill)Lobbied on preserving funding for the ACA; defended meaningful use of the ACA. (no bill) Discussed need to increase health information technology quality measurements and access to qualified systems. (no bill) H.R. 1099, To repeal the Prevention and Public Health Fund - Lobbied against the repeal of the Prevention and Public Health Trust Fund, is an important component in state and community efforts to prevent illness and promote health. Discussed Pre-existing Condition Insurance Program. (no bill) Discussed Accountable Care Organization and Medical Shared savings. (no bill) Discussed Rate Review. (no bill) Discussed Internal Appeals and External Review Process. (no bill) Discussed Medicare reimbursement issues. Lobbied in support of Medicare physician payment reform. Discussed legislation to make prescription drugs more affordable to older Americans. S. 1416/H.R. 2645 (112th Congress), Medigap Medical Loss Ratio Improvement Act of 2011. Discussed coverage for screening depression and screening and counseling for alcohol misuse. (no bill) Discussed consumer operated and oriented plan programs. (no bill) Discussed standards related to risk adjustment, reinsurance, and risk mitigation as they relate to exchanges. (no bill) H.R.2077, MLR Repeal Act of 2011 - Expressed opposition to the elimination of provision in the Affordable Care Act (P.L. 111-148)Discussed opposition to draft legislation regarding the elimination of grandfathered status. (no bill) Discussed association health plans with DOL, HHS and DOT. (no bill) Discussed quality and care coordination with HHS. (no bill) Discussed Essential Health Benefits with HHS. (no bill) Discussed employer affordability safe harbor. (no bill) Discussed health insurance exchanges - eligibility, enrollment, premium tax credits. (no bill) Discussed Basic Health Plans. (no bill) Discussed Medigap reform. (no bill) Discussed Pre-existing Condition Insurance Program. (no bill) Discussed role of grandfathered plans. (no bill) Discussed reauthorization of the Older Americans Act and other amendments to the OAA. (no bill) Discussed dual eligibles. (no bill)Discussed inviting FTC to participate in a webinar on how they are and can be engaged on state scope of practice issues. Also sent follow-up items for their review. (no bill) Discussed Medicare and Social Security programs. (no bill) Lobbied against cuts to the health care prevention fund. (no bill) Discussed deficit reduction issues dealing with Medicare and Medicaid including concerns over increasing Medicare's age of eligibility, chained CPI, payroll tax holiday extension, and cuts to Medicaid. (no bill) Discussed Affordable Care Medicaid expansion issues. Centers for Medicare and Medicaid Services, Center for Medicaid and CHIP Services. Discussed Medicaid reform, Medicare-Medicaid integration efforts and financial alignment demonstrations, other CMS demonstration initiatives. (no bill) Discussed Medicaid expansion implementation, as included in the ACA (P.L. 111-140). Discussed Medicaid including concerns over cuts to Medicaid. (no bill) Discussed Medicare-Medicaid integration efforts and financial alignment demonstrations and other CMS demonstration initiatives. (no bill) H.R. 8/PL 112-240 of 2012, American Taxpayer Relief Act - Discussed the establishment of the Commission on Long-Term Care and process related to the Commission. Discussed Senate amendment 99 to H.R. 933, the Consolidated and Further Continuing Appropriations Act (PL 113-6). Also made changes to Commission on Long-Term Care. Discussed implementation of the Affordable Care Act, its provisions and H.R. 95 to repeal the Patient Protection and Affordable Care Act. H. R. 933, Consolidated and Further Continuing Appropriations Act, 2013 - Lobbied to protect vital health and social services programs from enhanced reductions from the prior year baseline, and to prevent repeal of certain financial and health care-related regulation. S. Con. Res. 8/ H.Con. Res. 25, Concurrent Resolution on the Budget, 2014 - Lobbied to prevent inclusion of Medicare, Medicaid and Social Security benefit cuts and to protect vital health, social services, housing and transportation programs from enhanced reductions from the prior year baseline, and to prevent repeal of certain financial and health care-related regulation. H.R. 1549, Helping Sick Americans Now Act - Discussed cuts to the health care prevention fund. The Labor, Health and Human Services Appropriations Act, 2014 - Lobbied to protect employment, health and human services and energy assistance programs for seniors, disabled and low income assistance. (no bill) Discussed Affordable Care Act Medicaid expansion issues, including questions related to the use of premium assistance authority to expand Medicaid. (no bill) Discussed Medicare-Medicaid integration efforts and financial alignment demonstrations, other CMS demonstration initiatives. (no bill)
Provided information on the need for nursing education capacity and the retention of newer and older nurses in the workplace. (no bill) Discussed barriers to care that can result from language differences between providers and patients and/or lack of translation services. (no bill) Lobbied on preserving funding for the ACA; defended meaningful use of the ACA. (no bill) Discussed need to increase health information technology quality measurements and access to qualified systems. (no bill) S. 1019, Hearing Aid Assistance Tax Credit Act - Discussed Hearing Aid Assistance Tax Credit Act which would provide a $500 credit to people of all ages. H.R. 217, To repeal the Prevention and Public Health Fund - Lobbied against the repeal of the Prevention and Public Health Trust Fund. This fund is an important component in state and community efforts to prevent illness and promote health. Discussed Pre-existing Condition Insurance Program. (no bill) Discussed Accountable Care Organization and Medical Shared savings. (no bill) Discussed Rate Review. (no bill) Discussed Internal Appeals and External Review Process. (no bill) Discussed Medicare reimbursement issues. Lobbied in support of Medicare physician payment reform. Discussed legislation to make prescription drugs more affordable to older Americans. S. 1416/H.R. 2645, Medigap Medical Loss Ratio Improvement Act. Discussed Internal Claims, Appeals and external Review Process. (no bill) Discussed HIPAA Privacy Rule Accounting under HITECH Act. (no bill) Discussed coverage for screening depression and screening and counseling for alcohol misuse. (no bill) Discussed consumer operated and oriented plan programs. (no bill) Discussed standards related to risk adjustment, reinsurance, and risk mitigation as they relate to exchanges. (no bill) H.R.2077, MLR Repeal Act of 2011 - Expressed opposition to the elimination of provision in the Affordable Care Act (P.L. 111-148)Discussed opposition to draft legislation regarding the elimination of grandfathered status. (no bill) Discussed association health plans with DOL, HHS and DOT. (no bill) Discussed quality and care coordination with HHS. (no bill) Discussed Essential Health Benefits with HHS. (no bill) Discussed employer affordability safe harbor. (no bill) Discussed health insurance exchanges - eligibility, enrollment, premium tax credits. (no bill) Discussed Basic Health Plans. (no bill) Discussed Medigap reform. (no bill) Discussed Pre-existing Condition Insurance Program. (no bill) Discussed role of grandfathered plans. (no bill) Discussed reauthorization of the Older Americans Act and other amendments to the OAA. (no bill) Discussed dual eligibles. (no bill) S.3295, the Labor-HHS Appropriations bill for FY 2013 - Lobbied to protect/increase funding for the Social Security Administration, Older Americans Act nutrition, family caregiver & supportive services programs, low income home energy assistance (LIHEAP), and to protect funding for program authorized under the Affordable Care Act, including CMS State Health insurance exchanges, state survey & demonstrations and preventive Care Act, including CMS State Health insurance exchanges, state survey and demonstrations and preventive health. H.R. 8, the American Taxpayer Relief Act of 2012 - Lobbied against inclusion of Social Security, Medicare and Medicaid legislation affecting benefit levels or service delivery in any end-of-the-session budget deal, and urged congress to not reduce spending levels below current services levels for various non-security discretionary programs, including Health Care (including Rx, medical research and premium support), Social Security (administrative expenses), Older Americans Act Supportive Service, Nutrition and Caregiver programs, Low Income Home Energy Assistance, Weatherization, Elderly Housing and Transit/Transportation, Legal and Taxpayer Assistance, Consumer and Worker Protections and Postal Services. Discussed Hospital & Critical Access Hospitals Conditions of Participation proposed regulations; requested that advanced practice registered nurses and physicians assistants be allowed the full scope of services in hospital admitting and visiting privileges. (no bill) Discussed Hospital Outpatient Therapeutic Services Final Rule underscoring that advanced practice registered nurses and physicians should be allowed to supervise such outpatient service clinics without physician oversight as long as in line with state scope of practice laws. (no bill) Discussed Medicare GNE demonstration design problems. Discussed inviting FTC to participate in a webinar on how they are and can be engaged on state scope of practice issues. Also sent follow-up items for their review. (no bill) Discussed Medicare and Social Security programs. (no bill) Lobbied against cuts to the health care prevention fund. (no bill) Discussed fiscal cliff issues dealing with Medicare and Medicaid including concerns over increasing Medicare's age of eligibility, chained CPI, payroll tax holiday extension, and cuts to Medicaid. (no bill) Discussed Affordable Care Medicaid expansion issues. Centers for Medicare and Medicaid Services, Center for Medicaid and CHIP Services. Discussed Medicaid reform, Medicare-Medicaid integration efforts and financial alignment demonstrations, other CMS demonstration initiatives. (no bill) Discussed Medicaid expansion implementation, as included in the ACA (P.L. 111-140).
Provided information on the need for nursing education capacity and the retention of newer and older nurses in the workplace. (no bill) Discussed barriers to care that can result from language differences between providers and patients and/or lack of translation services. (no bill) Lobbied on preserving fund for the ACA; defended meaningful use of the ACA. (no bill) Discussed need to increase health information technology quality measurements and access to qualified systems. (no bill) S. 1019, Hearing Aid Assistance Tax Credit Act - Discussed Hearing Aid Assistance Tax Credit Act which would provide a $500 credit to people of all ages. H.R. 217, To repeal the Prevention and Public Health Fund - Lobbied against the repeal of the Prevention and Public Health Trust Fund. This fund is an important component in state and community efforts to prevent illness and promote health. Discussed Pre-existing Condition Insurance Program. (no bill) Discussed Accountable Care Organization and Medical Shared savings. (no bill) Discussed Rate Review. (no bill) Discussed Internal Appeals and External Review Process. (no bill) Discussed Medicare reimbursement issues. Lobbied in support of Medicare physician payment reform. Discussed legislation to make prescription drugs more affordable to older Americans. S. 1416/H.R. 2645, Medigap Medical Loss Ratio Improvement Act - Lobbied for bill introduction and helped with crafting. Discussed Internal Claims, Appeals and external Review Process. (no bill) Discussed HIPAA Privacy Rule Accounting under HITECH Act. (no bill) Discussed coverage for screening depression and screening and counseling for alcohol misuse. (no bill) Discussed consumer operated and oriented plan programs. (no bill) Discussed standards related to risk adjustment, reinsurance, and risk mitigation as they relate to exchanges. (no bill) H.R.2077, MLR Repeal Act of 2011 - Expressed opposition to the elimination of provision in the Affordable Care Act (P.L. 111-148)Discussed opposition to draft legislation regarding the elimination of grandfathered status. (no bill) Discussed association health plans with DOL, HHS and DOT. (no bill) Discussed quality and care coordination with HHS. (no bill) Discussed Essential Health Benefits with HHS. (no bill) Discussed employer affordability safe harbor. (no bill) Discussed health insurance exchanges - eligibility, enrollment, premium tax credits. (no bill) Discussed Basic Health Plans. (no bill) Discussed Medigap reform. (no bill) Discussed Pre-existing Condition Insurance Program. (no bill) Discussed role of grandfathered plans. (no bill) Discussed reauthorization of the Older Americans Act and other amendments to the OAA. (no bill) Discussed dual eligibles with Medpac. (no bill) S.3295, the Labor-HHS Appropriations bill for FY 2013 - Lobbied to protect/increase funding for the Social Security Administration, Older Americans Act nutrition, family caregiver & supportive services programs, low income home energy assistance (LIHEAP), and to protect funding for program authorized under the Affordable Care Act, including CMS State Health insurance exchanges, state survey & demonstrations and preventive Care Act, including CMS State Health insurance exchanges, state survey and demonstrations and preventive health. Discussed Hospital & Critical Access Hospitals Conditions of Participation proposed regulations; requested that advanced practice registered nurses and physicians assistants be allowed the full scope of services in hospital admitting and visiting privileges. (no bill) Discussed Hospital Outpatient Therapeutic Services Final Rule underscoring that advanced practice registered nurses and physicians should be allowed to supervise such outpatient service clinics without physician oversight as long as in line with state scope of practice laws. (no bill) Discussed Medicare GNE demonstration design problems. Discussed inviting FTC to participate in a webinar on how they are and can be engaged on state scope of practice issues. Also sent follow-up items for their review. (no bill) Discussed Medicare and Social Security programs. (no bill) Lobbied against cuts to the health care prevention fund. (no bill)
Discussed legislative intent with respect to Biologic drugs and exclusivity period.(no bill) Discussed importance of potential savings both to consumers and to the federal government of granting Secretarial Negotiating Authority to Secretary of HHS on Medicare Part D. (no bill) Discussed legislative intent with respect to biologic drugs and the exclusivity period; and discussed importance of potential savings to the health care system generally. (no bill) Discussed need for greater consumer safety protections both in OTC and prescription drugs. (no bill) Discussed need to end industry tactics like Pay for Delay which inappropriately extends patents with effect of keeping prices high for consumers and government. (no bill) Discussed need for doctors to get unbiased information on prescription pharmaceuticals through programs like academic detailing. (no bill) Discussed possible savings and better health care outcomes that could result from Medication Therapy Management. (no bill) Pub. Law 111-148 and 111-152 - Discussed implementation of health care legislation to reform the health care system to provide quality healthcare, expand access to long-term services and supports, and reduced prescription drug costs. Discussed greater affordability of generic versions of both generic and biologic drugs. S. 319, Pharmaceutical Market Access and Drug Safety Act of 2011 - Discussed legislation that establishes a framework for the safe, legal importation of lower-priced prescription drugs from abroad. S. 1206, Medicare Drug Savings Act of 2011 - Discussed rebates in Medicare Part D as a cost savings measure in Medicare that does not harm beneficiaries. H. R. 3342, Affordable Medicines Utilization Act of 2011 - Lobbied on legislation to encourage state Medicaid programs to use safe, effective generic medications. S. 27, Preserve Access to Affordable Generics Act - Lobbied for this legislation preventing abuses in patent settlements between generic and brand name prescription drug companies. S. 1886/H.R. 3468, Discussed counterfeit drug penalty enhancement. Discussed prescription drug safety, drug shortage, and medical device safety, and related user fee legislation. S. 2193, the Ensuring Safe Medical Devices for Patients Act - Discussed legislation to include devices in the post-market risk identification and analysis system for prescription drugs and to expedite the implementation of the unique device identification system for medical devices. Discussed draft legislation to address the issue of whether generic drug manufacturers have a duty to include new warnings about potentially serious side effects on their labels as they become known. The bill would accomplish this by giving generic drug makers the same ability to update their labeling as currently exists for manufacturers of brand name drugs. (no bill) S.3187, Food and Drug Administration safety and Innovation Act - FDA user fee agreement legislation focusing on the review process for prescription drugs and medical devices, prescription drug safety, drug shortages, medical device safety and access to generic drugs. S. 1882, Fair and Immediate Release of Generic Drugs Act or the FAIR Generics Act - Discussed pay-for-delay amendment to the FDA user fee agreement legislation based the stand-alone bill. S.3212, Cody Miller Initiative for Safer Prescriptions Act - To require the Secretary of Health and Human Services to promulgate regulations regarding the authorship, content, format, and dissemination of Patient Medication information.
Provided information on the need for nursing education capacity and the retention of newer and older nurses in the workplace (no bill). Pub.Law 111-148 & 111-152 - Discussed implementation of health care law that would reform the health care system to provide affordable quality health care, reduce drug costs and expand access to long-term services and supports. Discussed transitional care demonstration program. Discussed how to implement Medicaid provisions of Affordable Care Act. (PL. 111-148) Lobbied in support of draft legislation that would grant individuals whose COBRA has expired the same Medicare Part B enrollment rights as those who have group coverage. (no bill) S. 374, Medicare Mental Health Inpatient Equity Act - Lobbied in support of this legislation to eliminate the 190-day lifetime limit on Medicare coverage for in-patient psychiatric hospital services. Consolidated Appropriations Act, FY 2012, H.R. 2055, H.R. 3671, H.R. 2017, Consolidated and Further Appropriations Continuing Appropriations Act, H.R. 2112, Continuing Resolution, FY 2012, H.R. 2608 and H.J. Res. 79, 94 and 95 - Lobbied for funding for agencies and programs within jurisdiction of the Labor-HHS Appropriations bill (H.R. 3055/S. 1599), including Social Security Administration operations, Older Americans Act nutrition, health care delivery reform, CLASS, LIHEAP, Older Americans Act caregiver programs, high risk pool subsidies to states and Medicaid. Discussed improving access to care for underserved population. (no bill) Discussed importance of maintaining low income subsididies and supports in Medicare. (no bill) Discussed the importance of coordinating services for those who qualify for both Medicare and Medicaid in order to ensure that beneficiaries receive all needed benefits but there is no duplication. (no bill) Discussed whether, and under what circumstances, managed care could effectively be used to provide benefits to dual eligible beneficiaries. (no bill) Discussed implementation of Anti-Fraud Measures of Affordable Care Act (PL. 111-148), including coordination between HHS, DOJ and state Attorneys General. Discussed additional methods for fighting fraud and waste in Health Care. (no bill) Discussed Medigap and need for guaranteed issue for all populations and need to increase medical loss ratio. Discussed medicare physician payment issues. (no bill) Discussed durable medical equipment bidding. (no bill) H.R. 1654, Medicare Enrollment Protection Act - Lobbied for legislation to provide Medicare beneficiaries with additional opportunities to enroll in Medicare Part B. H.R. 978, To amend Title II of the Social Security Act - Lobbied against the use of the Social Security account number on Government-issued identification cards issued in connection with Medicare, Medicaid, and SCHIP benefits and for other purposes. S. 1206/H.R. 2190, The Medicare Drug Savings Act of 2011 - Discussed legislation to require prescription drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. S. 1251, Medicare and Medicaid Fighting Fraud and Abuse to Save Taxpayers' Dollars Act - Discussed support to curb waste and fraud from the Medicare and Medicaid programs. S. 1275, The Medicare and Medicaid FAST Act - Lobbied on legislation to prevent fraud and abuse within the federal health programs. S. 1206/H.R. 2190, The Medicare Drug Savings Act - Discussed legislation that would establish Medicaid drug rebates for the duals. Medicare physician reimbursement issues. (no bill) H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2012 - Discussed the legislation as it pertained to SGR. Discussed Medicare Graduate Nursing Education pilot design. (no bill) Discussed Medicare Physician Payment Reform. (no bill) Discussed Prescription Drug Affordability. (no bill) Discussed Prescription Drug Shortages. (no bill) H.R. 3342, Affordable Medicines Utilization Act of 2011 - Lobbied to encourage state Medicaid programs to use safe, effective generic medications. H.R. 2576 - Discussion to amend the Internal Revenue Code of 1986 to modify the calculation of modified adjusted gross income for purposes of determining eligibility for certain healthcare-related programs. Discussed opposition to caps on dual eligibles; discussed managed care and dual eligibles. (no bill) Discussed Senior Navigation and Planning Act. (no bill) Discussed with CMS demonstration programs for dual eligibles and process related to the demonstrations, as well as other work of the Medicare-Medicaid Coordination Office, discussed opposition to Florida medicaid waivers (including letter), discussed home and community setting issue in Medicaid, discussed focus groups on dual eligibles; discussed implementation of some Medicaid HCBS provisions. Discussed Medicaid managed care and long-term services and supports broadly, discussed CLASS Program. Discussed Fair Labor Standards Act and companionship exemption. Discussed Hospital & Critical Access Hospitals Conditions of Participation proposed regulations; requested that advanced practice registered nurses and physicians assistants be allowed the full scope of services in hospital admitting and visiting privileges. (no bill) Discussed Hospital Outpatient Therapeutic Services Final Rule underscoring that advanced practice registered nurses and physicians should be allowed to supervise such outpatient service clinics without physician oversight as long as in line with state scope of practice laws. (no bill) Discussed inviting FTC to participate in a webinar on how they are and can be engaged on state scope of practice issues. Also sent follow-up items for their review. (no bill) Discussed Medicaid reform, Medicare-Medicaid "dual eligible" integration efforts and financial alignment demonstrations, other CMS demonstration initiatives. (no bill) Discussed "Medicare Better Health Rewards Program Act of 2012". (no bill) Discussed You've Earned A Say. (no bill) Discussed health disparities. (no bill)
Consolidated Appropriations Act, FY 2012, H.R. 2055, H.R. 3671, H.R. 2017, Consolidated and Further Appropriations Continuing Appropriations Act, H.R. 2112, Continuing Resolution, FY 2012, H.R. 2608 and H.J. Res.79, 94 and 95 - Lobbied for funding for agencies and programs within jurisdiction of the Agriculture Appropriations bill ( H.R. 2112, S. 1573), including funding for the FDA Office of Generic Drugs. Discussed legislative intent with respect to Biologic drugs and exclusivity period.(no bill) Discussed importance of potential savings both to consumers and to the federal government of granting Secretarial Negotiating Authority to Secretary of HHS on Medicare Part D. (no bill) Discussed need for greater consumer safety protections both in OTC and prescription drugs. (no bill) Discussed need to end industry tactics like Pay for Delay which inappropriately extends patents with effect of keeping prices high for consumers and government. (no bill) Discussed need for doctors to get unbiased information on prescription pharmaceuticals through programs like academic detailing. (no bill) Discussed possible savings and better health care outcomes that could result from Medication Therapy Management. (no bill) Pub. Law 111-148 and 111-152 - Discussed implementation of health care legislation to reform the health care system to provide quality healthcare, expand access to long-term services and supports, and reduced prescription drug costs. Discussed greater affordability of generic versions of both generic and biologic drugs. S. 319, Pharmaceutical Market Access and Drug Safety Act of 2011 - Discussed legislation that establishes a framework for the safe, legal importation of lower-priced prescription drugs from abroad. S. 1206, Medicare Drug Savings Act of 2011 - Discussed rebates in Medicare Part D as a cost savings measure in Medicare that does not harm beneficiaries. H. R. 3342, Affordable Medicines Utilization Act of 2011 - Lobbied on legislation to encourage state Medicaid programs to use safe, effective generic medications. S. 27, Preserve Access to Affordable Generics Act - Lobbied for this legislation preventing abuses in patent settlements between generic and brand name prescription drug companies. Discussed counterfeit drug penalty enhancement (S. 1886/H.R.3468).
Provided information on the need for nursing education capacity and the retention of newer and older nurses in the workplace. (no bill) Discussed barriers to care that can result from language differences between providers and patients and/or lack of translation services. (no bill) H.J.Res 44, H.R. 1599, H.J. Res.79, H.R. 2068, H.R. 2017Labor-Health & Human Services, Education and Related Agencies Appropriations bill for FY2012 - Lobbied for funding for LIHEAP. Sent letters to House and Senate LHHS Subcommittees on funding for SSA Administration, Older Americans Act nutrition, health care delivery reform, CLASS, LIHEAP, Older Americans Act caregiver programs and Medicaid. Pub. Law 111-148 & 111-152 - Discussed implementation of health disparities data collection provisions of the Affordable Care Act. Pub. Law 111-148 & 111-152 - Discussed implementation of health care legislation that would reform the health care system to provide affordable quality health care and expand access to long term care services. Lobbied in support of comparative effectiveness research. (no bill) Discussed need to increase health information technology quality measurements and access to qualified systems. (no bill) S. 1019, Hearing Aid Assistance Tax Credit Act - Discussed Hearing Aid Assistance Tax Credit Act which would provide a $500 credit to people of all ages. H.R. 217, To repeal the Prevention and Public Health Fund - Lobbied against the repeal the Prevention and Public Health Trust Fund. This fund is an important component in state and community efforts to prevent illness and promote health. Discussed Pre-existing Condition Insurance Program. (no bill) Discussed Accountable Care Organization and Medical Shared savings. (no bill) Discussed Rate Review. (no bill) Discussed Internal Appeals and External Review Process. (no bill) Discussed Medicare reimbursement issues. Lobbied in support of Medicare physician payment reform. Discussed legislation to make prescription drugs more affordable to older Americans. S. 159, The Confidence in Long-Term Care Insurance Act - Discussed the Long-Term Insurance Act which improves the consumer protections of LTC insurance policies and make more and better information available to consumers to help them make informed decisions about such policies. H.R. 63, The Long-Term Care Insurance Reform Act - Discussed the Long Term Care Insurance Act which improves the consumer protections of LTC insurance policies and make more and better information available to consumers to help them make informed decisions about such policies. S. 1416/H.R. 2645, Medigap Medical Loss Ratio Improvement Act - Lobbied for bill introduction and helped with crafting. Discussed Internal Claims, Appeals and external Review Process. (no bill) Discussed HIPAA Privacy Rule Accounting under HITECH Act. (no bill) Discussed coverage for screening depression and screening and counseling for alcohol misuse. (no bill) Discussed consumer operated and oriented plan programs. (no bill) Discussed standards related to risk adjustment, reinsurance, and risk mitigation as they relate to exchanges. (no bill) H.R.2077, MLR Repeal Act of 2011 - Expressed opposition to the elimination of provision in the Affordable Care Act (P.L. 111-148)Discussed opposition to draft legislation regarding the elimination of grandfathered status. (no bill) Discussed association health plans with DOL, HHS and DOT. (no bill) Discussed quality and care coordination with HHS. (no bill)
Provided information on the need for nursing education capacity and the retention of newer and older nurses in the workplace (no bill). Pub.Law 111-148 & 111-152 - Discussed implementation of health care law that would reform the health care system to provide affordable quality health care, reduce drug costs and expand access to long-term services and supports. Discussed transitional care demonstration program. Discussed how to implement Medicaid provisions of Affordable Care Act. (PL. 111-148) Lobbied in support of draft legislation that would grant individuals whose COBRA has expired the same Medicare Part B enrollment rights as those who have group coverage. (no bill) S. 374, Medicare Mental Health Inpatient Equity Act - Lobbied in support of this legislation to eliminate the 190-day lifetime limit on Medicare coverage for in-patient psychiatric hospital services. S. 1599 (no House bill), H.J. Res. 79, H.R. 2068, H.R. 2017, H.J.Res. 44, Labor-Health & Human Services, Education and Related Agencies appropriations bill for FY 2012 - Lobbied for funding for LIHEAP. Lobbied for funding for Medicaid, SSA, Older Americans Act supportive service, nutrition and family caregiver programs, LIHEAP, CLASS, and helath care delivery reform and Affordable Care Act implementation. Discussed improving access to care for underserved population. (no bill) Discussed importance of maintaining low income subsididies and supports in Medicare. (no bill) Discussed the importance of coordinating services for those who qualify for both Medicare and Medicaid in order to ensure that beneficiaries receive all needed benefits but there is no duplication. (no bill) Discussed whether, and under what circumstances, managed care could effectively be used to provide benefits to dual eligible beneficiaries. (no bill) Discussed implementation of Anti-Fraud Measures of Affordable Care Act (PL. 111-148), including coordination between HHS, DOJ and state Attorneys General. Discussed additional methods for fighting fraud and waste in Health Care. (no bill) Discussed Medigap and need for guaranteed issue for all populations and need to increase medical loss ratio. H.R. 978 - Lobbied in support of legislation to preclude the use of Social Security numbers on government issued identification cards. Discussed medicare physician payment issues. (no bill) Discussed durable medical equipment bidding. (no bill) H.R. 1654, Medicare Enrollment Protection Act - Lobbied for legislation to provide Medicare beneficiaries with additional opportunities to enroll in Medicare Part B. H.R. 978, To amend Title II of the Social Security Act - Lobbied against the use of the Social Security account number on Government-issued identification cards issued in connection with Medicare, Medicaid, and SCHIP benefits and for other purposes. H.R. 1683, State Flexibility Act - Lobbied against H.R. 1683, a bill that would eliminate the Medicaid Maintenance of Effort (MOE) requirement included as a part of the Affordable Care Act. S. 1206/H.R. 2190, The Medicare Drug Savings Act of 2011 - Discussed legislation to require prescription drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. S. 1251, Medicare and Medicaid Fighting Fraud and Abuse to Save Taxpayers' Dollars Act - Discussed support to curb waste and fraud from the Medicare and Medicaid programs. S. 1275, The Medicare and Medicaid FAST Act - Lobbied on legislation to prevent fraud and abuse within the federal health programs. S. 1206/H.R. 2190, The Medicare Drug Savings Act - Discussed legislation that would establish Medicaid drug rebates for the duals. Medicare physician reimbursement issues. (no bill) S. 365, Budget Control Act - Lobbied Congress against cuts to Medicare and Medicaid in the debt ceiling debate. Discussed Medicare Graduate Nursing Education pilot design. (no bill)
Provided information on the need for nursing education capacity and the retention of newer and older nurses in the workplace (no bill). Pub.Law 111-148 & 111-152 - Discussed implementation of health care law that would reform the health care system to provide affordable quality health care, reduce drug costs and expand access to long-term services and supports. Discussed transitional care demonstration program. Discussed opposition to Medicaid cuts. (no bill) Discussed how to implement Medicaid provisions of Affordable Care Act. (PL. 111-148) Lobbied in support of draft legislation that would grant individuals whose COBRA has expired the same Medicare Part B enrollment rights as those who have group coverage. (no bill) S. 374, Medicare Mental Health Inpatient Equity Act - Lobbied in support of this legislation to eliminate the 190-day lifetime limit on Medicare coverage for in-patient psychiatric hospital services. H.J.Res. 44, Labor-Health & Human Services, Education and Related Agencies appropriations bill for FY 2012 - Lobbied for funding for LIHEAP. Lobbied for funding for Medicaid. Discussed improving access to care for underserved population. (no bill) Discussed importance of maintaining low income subsididies and supports in Medicare. (no bill) Discussed the importance of coordinating services for those who qualify for both Medicare and Medicaid in order to ensure that beneficiaries receive all needed benefits but there is no duplication. (no bill) Discussed whether, and under what circumstances, managed care could effectively be used to provide benefits to dual eligible beneficiaries. (no bill) Discussed implementation of Anti-Fraud Measures of Affordable Care Act (PL. 111-148), including coordination between HHS, DOJ and state Attorneys General. Discussed additional methods for fighting fraud and waste in Health Care. (no bill) Discussed Medigap and need for guaranteed issue for all populations and need to increase medical loss ratio. H.R. 978 - Lobbied in support of legislation to preclude the use of Social Security numbers on government issued identification cards. Discussed medicare physician payment issues. (no bill) Discussed durable medical equipment bidding. (no bill) H.R. 1654, Medicare Enrollment Protection Act - Lobbied for legislation to provide Medicare beneficiaries with additional opportunities to enroll in Medicare Part B. H.R. 978, To amend Title II of the Social Security Act - Lobbied against the use of the Social Security account number on Government-issued identification cards issued in connection with Medicare, Medicaid, and SCHIP benefits and for other purposes. H.R. 2267/S. 227, The Home Health Care Planning Improvement Act - Discussed the Home Health Care Planning Improvement Act that recognizes and authorizes nurse practitioners, clinical nurse specialists, certified nurse-midwives and physician assistants as eligible health care professionals who can order home health services under Medicare. S. 818/H.R. 1543, Improving Access to Medicare Coverage Act - Endorsed legislation to count a period of observation status in a hospital exceeding 24 hours toward satisfying the 3-day in-patient hospital requirement for coverage of skilled nursing facility serivices under medicare. H.R. 1683, State Flexibility Act - Lobbied against H.R. 1683, a bill that would eliminate the Medicaid Maintenance of Effort (MOE) requirement included as a part of the Affordable Care Act. S. 1206/H.R. 2190, The Medicare Drug Savings Act of 2011 - Discussed legislation to require prescription drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. S. 1251, Medicare and Medicaid Fighting Fraud and Abuse to Save Taxpayers' Dollars Act - Discussed support to curb waste and fraud from the Medicare and Medicaid programs.
Provided information on the need for nursing education capacity and the retention of newer and older nurses in the workplace (no bill). S.1256 Home and Community Balanced Incentives Act - Discussed implementation of certain enacted provisions. Pub.Law 111-148 & 111-152 - Discussed implementation of health care law that would reform the health care system to provide affordable quality health care, reduce drug costs and expand access to long-term services and supports. S. 227, Home Health Planning Improvement Act of 2011 - Lobbied for Nurse Practitioners, Clinical Nurse Specialists, and Physician Assistants being able to order Medicare funded home health care. Improving Access to Medicare Coverage Act - Discussed draft legislation to count a period of observation status in a hospital exceeding 24 hours toward satisfying the 3-day inpatient hospital requirement for coverage of skilled nursing facility services under Medicare.(no bill) Discussed transitional care demonstration program. Discussed how to preserve Medicaid services despite budgetary pressures at both state and federal levels. (no bill) Discussed how to implement Medicaid provisions of Affordable Care Act. Lobbied in support of draft legislation that would grant individuals whose COBRA has expired the same Medicare Part B enrollment rights as those who have group coverage. (no bill) S. 374, Medicare Mental Health Inpatient Equity Act - Lobbied in support of legislation to eliminate the 190-day lifetime limit on in-patient psychiatric hospital services. H.J.Res. 44, H.J. Res. 48, Continuing Appropriations Amendments, FY 2011 - Lobbied for funding for various federal programs serving Older Americans, most notably SSA Administrative expenses, LIHEAP, aging services, HECM reverse mortgage subsidy and Section 202, Housing for the Elderly. Discussed improving access to care for underserved population. (no bill) Discussed importance of maintaining low income subsididies and supports in Medicare. (no bill) Discussed the importance of coordinating services for those who qualify for both Medicare and Medicaid in order to ensure that beneficiaries receive all needed benefits but there is no duplication. (no bill) Discussed whether, and under what circumstances, managed care could effectively be used to provide benefits to dual eligible beneficiaries. (no bill) Discussed implementation of Anti-Fraud Measures of Affordable Care Act, including coordination between HHS, DOJ and state Attorneys General. Discussed additional methods for fighting fraud and waste in Health Care. (no bill) Discussed Medigap and need for guaranteed issue for all populations and need to increase medical loss ratio. H.R. 978 - Lobbied in support of legislation to preclude the use of Social Security numbers on government issued identification cards. Discussed medicare physician payment issues. (no bill) Discussed durable medical equipment bidding. (no bill)
S.525/H.R.1298/S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009 - Discussed legislation which would create a system of safe importation of prescription drugs from abroad. S.726/H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act - Discussed legislation which would create a pathway for the approval of safe, effective biosimilar and generic biologic drugs. H.R.1706, Protecting Consumer Access to Generic Drugs Act of 2009 - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes. S. 369, Preserve Access to Affordable Generics Act - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market,and for other purposes. S.515/H.R.1260/S.610, Patent Reform Act of 2009 - Discussed legislation that would amend federal patent law to rewrite provisions concerning the conditions for patentability. Specifically, AARP weighed in on the inequitable conduct provisions of the legislation. S. 301, Physician Payments Sunshine Act of 2009 - Discussed legislation that would provide for disclosure of gifts given by pharmaceutical and device manufacturers to physicians. S.1315, Federal Food, Drug and Cosmetic Act Amendment/H.R.3777 Drug Price Competition Act - Lobbied to expand the definition of "first applicant" under such Act to allow a generic drug manufacturer that is currently considered an applicant subsequent to a brand-name manufacturer's 180-day exclusivity period to qualify as a first applicant for purposes of filing an abbreviated application for a new drug. Requires such applicant ot submit a substantially complete application that contains and lawfully maintains a certification for such drug. H.R. 3590, Patient Protection and Affordable Care Act - Lobbied in support of and implementation of health care legislation to reform the health care system to provide quality health care and expand access to long-term services and supports. H.R. 4872, Health Care and Education Reconciliation Act - Lobbied in support of and implementation of health care law which makes improvements, such as closing the Part D coverage gap, in the Patient Protection and Affordable Care Act. S. 3606, Agriculture, Rural Development, FDA and related agencies Appropriations Act, FY 2011 - Lobbied for increased funding for the FDA Office of Generic Drugs to reduction of application backlog. H.R. 3081, H.R. 3082, H.J.Res. 105, H.J.Res.101, Continuing Resolution, FY 2011 - Lobbied for funding for FDA Office of Generic Drugs and nutrition assistance. S.3690, the Drug Safety and Accountability Act of 2010 - Requires drug manufacturers to implement quality management plans and document the manufacturing supply chain to ensure the quality and safety of drugs. The bill also would expand FDA authority to recall unsafe drugs, uncluding over the counter drugs, and offers protection to whistle blowers. H.R.5809,would amend the Controlled Substances Act to provide for the take back and safe disposal of controlled substances. The bill provides for an educational effort about proper drug disposal, an EPA report on the same and a GAO report on the effectiveness of disposal programs.
S.525/H.R.1298/S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009 - Discussed legislation which would create a system of safe importation of prescription drugs from abroad. S.726/H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act - Discussed legislation which would create a pathway for the approval of safe, effective biosimilar and generic biologic drugs. H.R.1706, Protecting Consumer Access to Generic Drugs Act of 2009 - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes. S. 369, Preserve Access to Affordable Generics Act - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market,and for other purposes. S.515/H.R.1260/S.610, Patent Reform Act of 2009 - Discussed legislation that would amend federal patent law to rewrite provisions concerning the conditions for patentability. Specifically, AARP weighed in on the inequitable conduct provisions of the legislation. S. 301, Physician Payments Sunshine Act of 2009 - Discussed legislation that would provide for disclosure of gifts given by pharmaceutical and device manufacturers to physicians. S.1315, Federal Food, Drug and Cosmetic Act Amendment/H.R.3777 Drug Price Competition Act - Lobbied to expand the definition of "first applicant" under such Act to allow a generic drug manufacturer that is currently considered an applicant subsequent to a brand-name manufacturer's 180-day exclusivity period to qualify as a first applicant for purposes of filing an abbreviated application for a new drug. Requires such applicant ot submit a substantially complete application that contains and lawfully maintains a certification for such drug. H.R. 3590, Patient Protection and Affordable Care Act - Lobbied in support of and implementation of health care legislation to reform the health care system to provide quality health care and expand access to long-term services and supports. H.R. 4872, Health Care and Education Reconciliation Act - Lobbied in support of and implementation of health care law which makes improvements, such as closing the Part D coverage gap, in the Patient Protection and Affordable Care Act. S. 3606, Agriculture, Rural Development, FDA and related agencies Appropriations Act, FY 2011 - Lobbied for increased funding for the FDA Office of Generic Drugs to reduction of application backlog. H.R. 3081, H.R. 3082, H.J.Res. 105, H.J.Res.101, Continuing Resolution, FY 2011 - Lobbied for funding for FDA Office of Generic Drugs and nutrition assistance. S.3690, the Drug Safety and Accountability Act of 2010 - Requires drug manufacturers to implement quality management plans and document the manufacturing supply chain to ensure the quality and safety of drugs. The bill also would expand FDA authority to recall unsafe drugs, uncluding over the counter drugs, and offers protection to whistle blowers. H.R.5809,would amend the Controlled Substances Act to provide for the take back and safe disposal of controlled substances. The bill provides for an educational effort about proper drug disposal, an EPA report on the same and a GAO report on the effectiveness of disposal programs.
S.525/H.R.1298/S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009 - Discussed legislation which would create a system of safe importation of prescription drugs from abroad. S.726/H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act - Discussed legislation which would create a pathway for the approval of safe, effective biosimilar and generic biologic drugs. H.R.1706, Protecting Consumer Access to Generic Drugs Act of 2009 - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes. S. 369, Preserve Access to Affordable Generics Act - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market,and for other purposes. S.515/H.R.1260/S.610, Patent Reform Act of 2009 - Discussed legislation that would amend federal patent law to rewrite provisions concerning the conditions for patentability. Specifically, AARP weighed in on the inequitable conduct provisions of the legislation. S. 301, Physician Payments Sunshine Act of 2009 - Discussed legislation that would provide for disclosure of gifts given by pharmaceutical and device manufacturers to physicians. S.1315, Federal Food, Drug and Cosmetic Act Amendment/H.R.3777 Drug Price Competition Act - Lobbied to expand the definition of "first applicant" under such Act to allow a generic drug manufacturer that is currently considered an applicant subsequent to a brand-name manufacturer's 180-day exclusivity period to qualify as a first applicant for purposes of filing an abbreviated application for a new drug. Requires such applicant ot submit a substantially complete application that contains and lawfully maintains a certification for such drug. H.R. 3590, Patient Protection and Affordable Care Act - Lobbied in support of and implementation of health care legislation to reform the health care system to provide quality health care and expand access to long-term services and supports. H.R. 4872, Health Care and Education Reconciliation Act - Lobbied in support of and implementation of health care law which makes improvements, such as closing the Part D coverage gap, in the Patient Protection and Affordable Care Act. S. 3606, Agriculture, Rural Development, FDA and related agencies Appropriations Act, FY 2011 - Lobbied for increased funding for the FDA Office of Generic Drugs to reduction of application backlog. H.R. 3081, Continuing Resolution, FY 2011 - Lobbied for funding for FDA Office of Generic Drugs and nutrition assistance.
S.525/H.R.1298/S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009 - Discussed legislation which would create a system of safe importation of prescription drugs from abroad. S.726/H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act - Discussed legislation which would create a pathway for the approval of safe, effective biosimilar and generic biologic drugs. H.R.1706, Protecting Consumer Access to Generic Drugs Act of 2009 - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes. S. 369, Preserve Access to Affordable Generics Act - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market,and for other purposes. S.515/H.R.1260/S.610, Patent Reform Act of 2009 - Discussed legislation that would amend federal patent law to rewrite provisions concerning the conditions for patentability. Specifically, AARP weighed in on the inequitable conduct provisions of the legislation. S. 301, Physician Payments Sunshine Act of 2009 - Discussed legislation that would provide for disclosure of gifts given by pharmaceutical and device manufacturers to physicians. S.1315, Federal Food, Drug and Cosmetic Act Amendment/H.R.3777 Drug Price Competition Act - Lobbied to expand the definition of "first applicant" under such Act to allow a generic drug manufacturer that is currently considered an applicant subsequent to a brand-name manufacturer's 180-day exclusivity period to qualify as a first applicant for purposes of filing an abbreviated application for a new drug. Requires such applicant ot submit a substantially complete application that contains and lawfully maintains a certification for such drug. H.R. 3590, Patient Protection and Affordable Care Act - Lobbied in support of and implementation of health care legislation to reform the health care system to provide quality health care and expand access to long-term services and supports. H.R. 4872, Health Care and Education Reconciliation Act - Lobbied in support of and implementation of health care law which makes improvements, such as closing the Part D coverage gap, in the Patient Protection and Affordable Care Act.
S.525/H.R.1298/S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009 - Discussed legislation which would create a system of safe importation of prescription drugs from abroad. S.726/H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act - Discussed legislation which would create a pathway for the approval of safe, effective biosimilar and generic biologic drugs. H.R.1706, Protecting Consumer Access to Generic Drugs Act of 2009 - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes. S. 369, Preserve Access to Affordable Generics Act - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market,and for other purposes. S.515/H.R.1260/S.610, Patent Reform Act of 2009 - Discussed legislation that would amend federal patent law to rewrite provisions concerning the conditions for patentability. Specifically, AARP weighed in on the inequitable conduct provisions of the legislation. S. 301, Physician Payments Sunshine Act of 2009 - Discussed legislation that would provide for disclosure of gifts given by pharmaceutical and device manufacturers to physicians. S.1315, Federal Food, Drug and Cosmetic Act Amendment/H.R.3777 Drug Price Competition Act - Lobbied to expand the definition of "first applicant" under such Act to allow a generic drug manufacturer that is currently considered an applicant subsequent to a brand-name manufacturer's 180-day exclusivity period to qualify as a first applicant for purposes of filing an abbreviated application for a new drug. Requires such applicant ot submit a substantially complete application that contains and lawfully maintains a certification for such drug. H.R. 3590, Patient Protection and Affordable Care Act - Lobbied in support of and implementation of health care legislation to reform the health care system to provide quality health care and expand access to long-term services and supports. H.R. 4872, Health Care and Education Reconciliation Act - Lobbied in support of and implementation of health care law which makes improvements, such as closing the Part D coverage gap, in the Patient Protection and Affordable Care Act.
S.525/H.R.1298/S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009 - Discussed legislation which would create a system of safe importation of prescription drugs from abroad. S.726/H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act - Discussed legislation which would create a pathway for the approval of safe, effective biosimilar and generic biologic drugs. H.R.1706, Protecting Consumer Access to Generic Drugs Act of 2009 - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes. S. 369, Preserve Access to Affordable Generics Act - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market,and for other purposes. S.515/H.R.1260/S.610, Patent Reform Act of 2009 - Discussed legislation that would amend federal patent law to rewrite provisions concerning the conditions for patentability. Specifically, AARP weighed in on the inequitable conduct provisions of the legislation. S. 301, Physician Payments Sunshine Act of 2009 - Discussed legislation that would provide for disclosure of gifts given by pharmaceutical and device manufacturers to physicians. S.1315, Federal Food, Drug and Cosmetic Act Amendment/H.R.3777 Drug Price Competition Act - Lobbied to expand the definition of "first applicant" under such Act to allow a generic drug manufacturer that is currently considered an applicant subsequent to a brand-name manufacturer's 180-day exclusivity period to qualify as a first applicant for purposes of filing an abbreviated application for a new drug. Requires such applicant ot submit a substantially complete application that contains and lawfully maintains a certification for such drug. H.R. 3200 America's Affordable Health Choices Act/S. 1679, Americas Health Choices Act/S.1796, America's Healthy Future Act - Discussed need for affordable quality healthcare, delivery system reform, ending age discrimination in the health ending rating by health condition or any proxy, insurance industry, closing the doughnut hole, creating a pathway for generic biologics, allowing and funding states to provide home and community based services, creating a transitional benefit or other transitional care proposals in medicare and expanding the asset limit to qualify for low-income programs in medicare. H.R. 3590, Patient Protection and Affordable Care Act - Lobbied in support of health care legislation to reform the health care system to provide quality health care and expand access to long-term services and supports. H.R. 4872, Health Care and Education Reconciliation Act - Lobbied in support of health care legislation which makes improvements, such as closing the Part D coverage gap, in the Patient Protection and Affordable Care Act.
S.525/H.R.1298/S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009 - Discussed legislation which would create a system of safe importation of prescription drugs from abroad. S.726/H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act - Discussed legislation which would create a pathway for the approval of safe, effective biosimilar and generic biologic drugs. H.R.1706, Protecting Consumer Access to Generic Drugs Act of 2009 - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes. S. 369, Preserve Access to Affordable Generics Act - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market,and for other purposes. S.515/H.R.1260/S.610, Patent Reform Act of 2009 - Discussed legislation that would amend federal patent law to rewrite provisions concerning the conditions for patentability. Specifically, AARP weighed in on the inequitable conduct provisions of the legislation. S. 301, Physician Payments Sunshine Act of 2009 - Discussed legislation that would provide for disclosure of gifts given by pharmaceutical and device manufacturers to physicians. S.1315, Federal Food, Drug and Cosmetic Act Amendment/H.R.3777 Drug Price Competition Act - Lobbied to expand the definition of "first applicant" under such Act to allow a generic drug manufacturer that is currently considered an applicant subsequent to a brand-name manufacturer's 180-day exclusivity period to qualify as a first applicant for purposes of filing an abbreviated application for a new drug. Requires such applicant ot submit a substantially complete application that contains and lawfully maintains a certification for such drug. H.R. 3200 America's Affordable Health Choices Act/S. 1679, Americas Health Choices Act/S.1796, America's Healthy Future Act - Discussed need for affordable quality healthcare, delivery system reform, ending age discrimination in the health ending rating by health condition or any proxy, insurance industry, closing the doughnut hole, creating a pathway for generic biologics, allowing and funding states to provide home and community based services, creating a transitional benefit or other transitional care proposals in medicare and expanding the asset limit to qualify for low-income programs in medicare. H.R. 3590, Patient Protection and Affordable Care Act - Lobbied in support of health care legislation to reform the health care system to provide quality health care and expand access to long-term services and supports. H.R. 4872, Health Care and Education Reconciliation Act - Lobbied in support of health care legislation which makes improvements, such as closing the Part D coverage gap, in the Patient Protection and Affordable Care Act.
S.525/H.R.1298/S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009 - Discussed legislation which would create a system of safe importation of prescription drugs from abroad. S.726/H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act - Discussed legislation which would create a pathway for the approval of safe, effective biosimilar and generic biologic drugs. H.R.1706, Protecting Consumer Access to Generic Drugs Act of 2009 - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes. S. 369, Preserve Access to Affordable Generics Act - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market,and for other purposes. S.515/H.R.1260/S.610, Patent Reform Act of 2009 - Discussed legislation that would amend federal patent law to rewrite provisions concerning the conditions for patentability. Specifically, AARP weighed in on the inequitable conduct provisions of the legislation. S. 301, Physician Payments Sunshine Act of 2009 - Discussed legislation that would provide for disclosure of gifts given by pharmaceutical and device manufacturers to physicians. H.R.2997 Agriculture, Rural Development, FDA and related agencies Appropriations bill for FY2010-Lobbied in support of funding for the Commodity Supplemental Food Program and FDA Office of Generic Drugs. FDA research on bioequivalency of generic epilepsy drugs, rural housing assistance and repair (no bill). S.1315, Federal Food, Drug and Cosmetic Act Amendment/H.R.3777 Drug Price Competition Act - Lobbied to expand the definition of "first applicant" under such Act to allow a generic drug manufacturer that is currently considered an applicant subsequent to a brand-name manufacturer's 180-day exclusivity period to qualify as a first applicant for purposes of filing an abbreviated application for a new drug. Requires such applicant ot submit a substantially complete application that contains and lawfully maintains a certification for such drug. H.R. 3200 America's Affordable Health Choices Act/S. 1679, Americas Health Choices Act, America's Healthy Future Act (no Senate bill)- Discussed need for affordable quality healthcare, delivery system reform, ending age discrimination in the health ending rating by health condition or any proxy, insurance industry, closing the doughnut hole, creating a pathway for generic biologics, allowing and funding states to provide home and community based services, creating a transitional benefit or other transitional care proposals in medicare and expanding the asset limit to qualify for low-income programs in medicare.
S.525/H.R.1298/S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009 - Discussed legislation which would create a system of safe importation of prescription drugs from abroad. S.726/H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act - Discussed legislation which would create a pathway for the approval of safe, effective biosimilar and generic biologic drugs. H.R.1706, Protecting Consumer Access to Generic Drugs Act of 2009 - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes. S. 369, Preserve Access to Affordable Generics Act - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market,and for other purposes. S.515/H.R.1260/S.610, Patent Reform Act of 2009 - Discussed legislation that would amend federal patent law to rewrite provisions concerning the conditions for patentability. Specifically, AARP weighed in on the inequitable conduct provisions of the legislation. S. 301, Physician Payments Sunshine Act of 2009 - Discussed legislation that would provide for disclosure of gifts given by pharmaceutical and device manufacturers to physicians. H.R.2997 Agriculture, Rural Development, FDA and related agencies Appropriations bill for FY2010-Lobbied in support of funding for the Commodity Supplemental Food Program and FDA Office of Generic Drugs. FDA research on bioequivalency of generic epilepsy drugs, rural housing assistance and repair (no bill). S.1315, Federal Food, Drug and Cosmetic Act Amendment/H.R.3777 Drug Price Competition Act - Lobbied to expand the definition of "first applicant" under such Act to allow a generic drug manufacturer that is currently considered an applicant subsequent to a brand-name manufacturer's 180-day exclusivity period to qualify as a first applicant for purposes of filing an abbreviated application for a new drug. Requires such applicant ot submit a substantially complete application that contains and lawfully maintains a certification for such drug. H.R. 3200 America's Affordable Health Choices Act/S. 1679, Americas Health Choices Act, America's Healthy Future Act (no Senate bill)- Discussed need for affordable quality healthcare, delivery system reform, ending age discrimination in the health ending rating by health condition or any proxy, insurance industry, closing the doughnut hole, creating a pathway for generic biologics, allowing and funding states to provide home and community based services, creating a transitional benefit or other transitional care proposals in medicare and expanding the asset limit to qualify for low-income programs in medicare.
S.540/H.R.1346, Medical Device Safety Act - Legislation would make clear congressional intent that state tort claims are not preempted by the FFDCA. S.512, Fairness in Nursing Home Arbitration Act - Bill to prevent pre-dispute arbitration agreements with LTC facility and residents. H.R.1237, Fairness in Nursing Home Arbitration Act - Urged co-sponsorship of bill to prevent pre-dispute arbitration clauses in LTC facility contracts and submitted written testimony in support of this legislation. Shared related information on arbitration.
S.330/H.R.684, Medicare Prescription Drug Savings and Choice Act of 2009 - Discussed legislation which would create a government-operated Medicare prescription drug plan. Provided information on the need for nursing education capacity and the retention of newer and older nurses in the workplace (no bill). S.683/H.R.1670, Community Choice Act - Engaged in discussions about the bill, possible changes to advance bill in health reform and it's provisions to balance Medicaid. Discussed chronic care issues and caregiver assessment in Medicaid. Discussed ways to provide better care coordination to dual eligibles and possible legislation (no bill). S.245/H.R. 468/S.434/H.R.468 Retooling the Health Care Workforce for an Aging America Act and possible amendment, the Empowered at Home Act and the Independence at Home Act - Discussed long-term care and chronic care legislation that AARP endorsed and shared endorsement letters. Discussed co-sponsors of Medicaid HCBS legislation. S.631/H.R.2223, Patient Safety and Abuse Prevention Act - Support for legislation and amendment on criminal background checks for employees of long-term care providers and specific bill provisions. S. 697/H.R.1721, Class Act - Discussed this bill and versions marked up in committee. Endorsed provisions in HELP and E&C Committee healthcare reform bills. S.1131/H.R.2560 Independence at Home Act - Endorsed and discussed AARP's support for this Medicare care coordination bill; and House Committee amendment and urged co-sponsorship. Discussed healthcare coverage for the 50-64 year old population age rating and closing the doughnut hole. S.1133/H.R. 2580, Empowering Medicare Patient Choices Act - To promote patient decision aids to help people make informed, evidence-based decisions about health care treatment options. H.R. 2773/S 1295, Medicare Transitional Care Act of 2009 - To reduce unnecessary hospital readmissions, improving quality for Medicare beneficiaries, and reducing wasteful spending in Medicare; endorsed committee amendment; worked to incorporate bill and its elements into health reform legislation. S. 960, Medicare Early Access Act of 2009 - To let Americans aged 55-64 who are otherwise without access to grup or public coverage buy into Medicare. H.R. 2700, Prescription Coverage Now Act of 2009 - To assist low-invome individuals in obtaining subsidized prescription drug coverage under the Medicare prescription drug program by expediting the application and qualification process and by revising the resource standards used to determine eligibility for such subsidies, and for other purposes. S. 1185, Medicare Financial Stability for Beneficiaries Act of 2009 - To ensure that low-income beneficiaries have improved access to health care under the Medicare and Medicaid programs. H.R. 2716, Medicare Savings Program Improvement Act of 2009 - To provide financial stability for older Americans and people with disabilities through improvements in the Medicare Savings Program. Advocated for modernizing Medicare funding so that nursing education funds are directed to advanced nurse practice programs to help produce more highly-skilled nurses to care for the Medicare population (no bill). H.R. 3293, Labor, HHS, Education and related agencies Appropriations bill for FY2010-Lobbied for funding for SSA, Older Americans Act programs, Lifespan Respite Care Act, Nursing Education/Workforce Development, National Corporation for Community Service (Kennedy Serve America Act), among other items (no bill numbers). S.750 Caring for an Aging america Act - Lobbied in support of legislation and discussed possible floor amendment.. S.1257/H.R.2852 Project 2020:Building the Promise of Home and Community Based Services Act - Lobbied in support of legislation. Discussed ideas to improve medicare for medicare beneficiaries. (no bill) Discussed Medicare physician payment issues and SGR. Responded to staff inquiry about AARP position on Medicare fraud bill; referred staff to appropriate AARP staff. Discussed idea of an annual physical for Medicare beneficiaries (no bill). S.1009 Medicare Care Transitions Program Act - Discussed provisions of Medicare Care Transitions Program Act. S.975 Seniors and Taxpayers Obligation and Protection Act - Lobbied in support of legislation. Discussed care coordination for dual eligibles and policy ideas to address this (no bill). Discussed proposals to address LTC and HCBS in the context of health care reform. (no bill) S.1150 Advance Planning and Compassionate Care Act - Endorsed advance care planning legislation. S.1263 Senior Navigation and Planning Act legislation - discussed legislation. S.1256 Home and Community Balanced Incentives Act - Discussed inclusion of this legislation in health reform legislation and urged cosponsors, advocated for amendment in committee. H.R. 3631, Medicare Premium Fairness Act - Lobbied to pass legislation to allow premiums for Medicare Part B to remain at 2009 levels for all beneficiaries. H.R. 3200 America's Affordable Health Choices Act/S. 1679, Americas Health Choices Act, America's Healthy Future Act (no Senate bill)- Discussed need for affordable quality healthcare, delivery system reform, ending age discrimination in the health insurance industry, closing the doughnut hole, creating a pathway for generic biologics, allowing and funding states to provide home and community based services, creating a transitional benefit in medicare and expanding the asset limit to qualify for low-income programs in medicare.
S.540/H.R.1346, Medical Device Safety Act - Legislation would make clear congressional intent that state tort claims are not preempted by the FFDCA. S.512, Fairness in Nursing Home Arbitration Act - Bill to prevent pre-dispute arbitration agreements with LTC facility and residents. H.R.1237, Fairness in Nursing Home Arbitration Act - Urged co-sponsorship of bill to prevent pre-dispute arbitration clauses in LTC facility contracts and submitted written testimony in support of this legislation. Shared related information on arbitration.
Discussed AARP criteria for a federal role in the regulation of insurance.(no bill) H.R. 3200 America's Affordable Health Choices Act/S. 1679, Americas Health Choices Act, America's Healthy Future Act (no Senate bill)- Discussed need for affordable quality healthcare, delivery system reform, ending age discrimination in the health insurance industry, closing the doughnut hole, creating a pathway for generic biologics, allowing and funding states to provide home and community based services, creating a transitional benefit in medicare and expanding the asset limit to qualify for low-income programs in medicare.
S.330/H.R.684, Medicare Prescription Drug Savings and Choice Act of 2009 - Discussed legislation which would create a government-operated Medicare prescription drug plan. Provided information on the need for nursing education capacity and the retention of newer and older nurses in the workplace (no bill). S.683/H.R.1670, Community Choice Act - Engaged in discussions about the bill and it's provisions to balance Medicaid. Discussed ideas to balance state long-term care systems including enhanced FMAP provisions for Medicaid (no bill). Discussed chronic care issues and caregiver assessment in Medicaid. Provided feedback on Medicare Realigning CARE Act (?) chronic care coordinating HCBS and provided feedback on draft proposals (no bill). Discussed challenges to replication of the PACE program. Discussed lessons learned from PACE that could be applicable to dual eligible SNPs (no bill). Discussed ways to provide better care coordination to dual eligibles and possible legislation. S.647/H.R.7128, Nursing Home Transparency and Quality of Care Improvement Act - Discussed reintroduction of the Nursing Home Transparency and Improvement Act in the House and discussed feedback on the bill's provisions. Also discussed provisions of S.647 Nursing Home Quality of Care and Transparency and Improvement Act (S.647). S.245/H.R. 468/S.434/H.R.468 Retooling the Health Care Workforce for an Aging America Act, the Empowered at Home Act and the Independence at Home Act - Discussed long-term care and chronic care legislation that AARP endorsed and shared endorsement letters. Discussed co-sponsors of Medicaid HCBS legislation. S.631/H.R.2223, Patient Safety and Abuse Prevention Act - Endorsed legislation on criminal background checks for employees of long-term care providers and specific bill provisions. Discussed system delivery reform in health care reform and logistics for testimony. Submitted delivery system reform testimony and comments to Finance Committee. Discussed health care reform substance and process in Finance and HELP Committees (no bill). Discussed Budget Committee letter on health care reform, shared AARP's position on the budget and health care reform. (no bill) S. 697/H.R.1721, Class Act - Discussed this bill, (next steps, scoring, actual analysis, testimony, markup and AARP position, S.1131/H.R.2560 Independence at Home Act - Discussed AARP's support for Medicare care coordination bill; a Hill briefing, bill reintroduction, and urged co-sponsorship. Discussed healthcare coverage for the 50-64 year old population and scheduled meetings for volunteers to share their coverage stories (no bill). S.1133/H.R. 2580, Empowering Medicare Patient Choices Act - To promote patient decision aids to help people make informed, evidence-based decisions about health care treatment options. H.R. 2773/S 1295, Medicare Transitional Care Act of 2009 - To reduce unnecessary hospital readmissions, improving quality for Medicare beneficiaries, and reducing wasteful spending in Medicare. S. 960, Medicare Early Access Act of 2009 - To let Americans aged 55-64 who are otherwise without access to grup or public coverage buy into Medicare. H.R. 2700, Prescription Coverage Now Act of 2009 - To assist low-invome individuals in obtaining subsidized prescription drug coverage under the Medicare prescription drug program by expediting the application and qualification process and by revising the resource standards used to determine eligibility for such subsidies, and for other purposes. S. 1185, Medicare Financial Stability for Beneficiaries Act of 2009 - To ensure that low-income beneficiaries have improved access to health care under the Medicare and Medicaid programs. H.R. 2716, Medicare Savings Program Improvement Act of 2009 - To provide financial stability for older Americans and people with disabilities through improvements in the Medicare Savings Program. Advocated for modernizing Medicare funding so that nursing education funds are directed to advanced nurse practice programs to help produce more highly-skilled nurses to care for the Medicare population. Labor, HHS, Education and related agencies Appropriations bill for FY2010-Lobbied for funding for SSA, Older Americans Act programs, Lifespan Respite Care Act, Nursing Education/Workforce Development, National Corporation for Community Service (Kennedy Serve America Act), among other items (no bill numbers). S.1004 Re-Aligning CARE Act - Discussed feedback on draft Re-aligning CARE Act and urged Sen. Lincoln to sponsor a bill to establish a transitional care benefit in Medicare. Discussed AARP proposal for a Medicare transitional care benefit (no bill number). Set up meeting with MedPAC staff to discuss Medicare transitional care benefit; meeting subsequently held. S.750 Caring for an Aging america Act - Lobbied in support of legislation. Discussed concerns over HHA regulation which would make it more difficult for state surveyors to share information about their surveys of nursing homes. (no bill) S.1257/H.R.2852 Project 2020:Building the Promise of Home and Community Based Services Act - Lobbied in support of legislation. Discussed ideas to improve medicare for medicare beneficiaries. (no bill) S.975 Seniors and Taxpayers Obligation and Protection Act - Lobbied in support of legislation. Inquired regarding use of Medicaid stimulus funds for an enhanced match in the Money Follows the Person Demonstration Program. Set up meetings to discuss AARP Health Care Reform priorities. Discussed Medicare physician payment issues and SGR. Inquired about information regarding a Medicare waiver and five New England states. Responded to staff inquiry about AARP position on Medicare fraud bill; referred staff to appropriate AARP staff. Discussed idea of an annual physical for Medicare beneficiaries. S.1009 Medicare Care Transitions Program Act - Discussed provisions of Medicare Care Transitions Program Act. Discussed care coordination for dual eligibles and policy ideas to address this. Provided information to help educate family caregivers about benefits under Medicare and Medicaid. (no bill) Discussed proposals to address LTC and HCBS in the context of health care reform. (no bill) S.1150 Advance Planning and Compassionate Care Act - Discussed concerns on draft advance care planning legislation. S.1263 Senior Navigation and Planning Act - Discussed legislation. S.1256 Home and Community Balanced Incentives Act - Discussed inclusion of this legislation in health reform legislation.
H. Con. Res. 14/S. Con. Res. 7, the Budget Reconciliation Resolution S. 1096, the Preserving Access to Affordable Generics and Biosimilars Act. S. 1095, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act. S. 1040, the Drug Competition Enhancement Act. H.R. 9070/S. 1041, the Affordable Prescriptions for Patients Act. S. 1097, the Interagency Patent Coordination and Improvement Act of 2025. No bill number. Discussed pharmacy benefit managers. S. 527, Prescription Pricing for the People Act of 2025. S. 526, the Pharmacy Benefit Manager (PBM) Transparency Act of 2025. S. 229, the Drug-Price Transparency for Consumers (DTC) Act of 2025. No bill number. Discussed Medicare Part D. No bill number. Discussed cap on out-of-pocket prescription drug costs. No bill number. Discussed the Medicare Prescription Payment Plan. No bill number. Discussed the Medicare drug price negotiation program.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commodity Futures Trading Commission (CFTC), Consumer Financial Protection Bureau (CFPB), Federal Bureau of Investigation (FBI), Federal Communications Commission (FCC), Federal Trade Commission (FTC), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Telecommunications & Information Administration (NTIA), Office of the Vice President of the United States, SENATE, Social Security Administration (SSA), Treasury, Dept of, White House Office
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Consumer Financial Protection Bureau (CFPB), Equal Employment Opportunity Commission (EEOC), Federal Communications Commission (FCC), Federal Trade Commission (FTC), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Telecommunications & Information Administration (NTIA), SENATE, Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
S. 3109/H.R. 8018, the Alleviating Barriers for Caregivers Act. S. 3766/H.R. 7274, the Connecting Caregivers to Medicare Act. No bill number. Discussed funding for SHIP low-income outreach and enrollment programs. No bill number. Discussed Medicare Advantage and health savings accounts. H.R.7623/S.3697, the Telehealth Modernization Act. S. 5070/H.R. 8107, the Ensuring Access to Medicaid Buy-In Programs Act. No bill number. Discussed Medicare Physician Fee Schedule for calendar year 2025. No bill number. Discussed Medicare Hospital Outpatient Prospective Payment System for calendar year 2025. No bill number. Discussed Fiscal Year 2025 Home Health Prospective Payment System Rate Update. No bill number. Discussed Medicare open enrollment. H.R. 8702/S.4532, the Improving Seniors Timely Access to Care Act of 2024. H.R. 8331/S. 4280, the Essential Caregivers Act. H.J.Res.139, Providing for Congressional disapproval of the rule submitted by the Centers for Medicare & Medicaid Services relating to "Medicare and Medicaid Programs: Minimum Staffing Standards for Long-Term Care Facilities and Medicaid Institutional Payment Transparency Reporting. S.J.Res.91, A joint resolution providing for Congressional disapproval of the rule submitted by the Centers for Medicare & Medicaid Services relating to "Medicare and Medicaid Programs; Minimum Staffing Standards for Long-Term Care Facilities and Medicaid Institutional Payment Transparency Reporting" H.R. 8244, the Ensuring Seniors Access to Quality Care Act. S.1749/H.R. 3227, the Ensuring Seniors Access to Quality Care Act. S.3410/H.R. 7513, the Protecting Americas Seniors Access to Care Act. H.R. 468, the Building Americas Health Care Workforce Act. H.R. 9067, the Building Americas Health Care Workforce Act. S. 5023, the Stand Strong Falls Prevention Act. S.1190, the Direct Support Worker Training Reimbursement Act of 2023. S.1196, the Mollie Baldwin Upskilling of Personal and Home Care Aides Act of 2023. S.1192, the CADSAW Act of 2023. No bill number. Discussed Medicaid home and community-based services and presumptive eligibility and self-directed services. No bill number. Discussed Caregiver Training Services. No bill number. Discussed GUIDE Model. No bill number. Discussed Medicare, Medicaid, and family caregivers. No bill number. Discussed Medicaid access final rule. H.R. 8108, the Care for Military Kids Act. H. R. 8106, to increase transparency and expand coverage options for home and community-based services under a Medicaid waiver. No bill number. Discussed long-term care. H.R. 9803, the Hospice Care Act.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commodity Futures Trading Commission (CFTC), Consumer Financial Protection Bureau (CFPB), Equal Employment Opportunity Commission (EEOC), Federal Communications Commission (FCC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Labor, Dept of (DOL), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, Veterans Affairs, Dept of (VA), Vice President of the U.S., White House Office
No bill number. Discussed out-of-pocket caps for prescription drugs. No bill number. Discussed pharmacy benefit manager reforms. H.R. 4818, the Treat and Reduce Obesity Act. No bill number. Discussed medication safety at home. No bill number. Discussed Medicare drug price negotiation program. No bill number. Discussed Medicare Prescription Payment Plan. S.79, the Interagency Patent Coordination and Improvement Act of 2023. S.142, the Preserve Access to Affordable Generics and Biosimilars Act of 2023. S.148, the Stop STALLING Act. S.150, the Affordable Prescriptions for Patients Act of 2023. S.113, the Prescription Pricing for the People Act of 2023. H.R. 5539/ S. 3131, Optimizing Research Progress Hope and New Cures Act. H.R. 5547/ S. 476, Maintaining Investments in New Innovation Act. H.R. 3549/ S. 1703, the PACE Part D Choice Act of 2023. No bill number. Discussed generic prescription drug shortages. S.2220/ H.R. 4370, the PREVAIL Act. No bill number. Discussed US Patent and Trade Office proposed rule. H.R. 8848, Affordable and Safe Prescription Drug Importation Act of 2024.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commodity Futures Trading Commission (CFTC), Consumer Financial Protection Bureau (CFPB), Equal Employment Opportunity Commission (EEOC), Federal Communications Commission (FCC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Telecommunications & Information Administration (NTIA), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Treasury, Dept of, White House Office
No bill number. Discussed the Medicare Prescription Payment Plan program. H.R. 5385, the Medicare PBM Accountability Act. H.R. 5372, Expanding Seniors Access to Lower Cost Medicines Act of 2023. H.R. 2880, Protecting Patients Against PBM Abuses Act. H.R. 5539, the Optimizing Research Progress Hope and New (ORPHAN) Cures Act. H.R. 5547, the Maintaining Investments in New Innovation (MINI) Act. S. 79, the Interagency Patent Coordination and Improvement Act of 2023. S. 150, the Affordable Prescriptions for Patients Act of 2023. S. 113, the Prescription Pricing for the People Act of 2023. S. 142, the Preserve Access to Affordable Generics and Biosimilars Act. S. 148, the Stop STALLING Act. No bill number. Discussed the Reducing Drug Prices for Seniors Act. No bill number. Discussed the Inflation Reduction Act.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commodity Futures Trading Commission (CFTC), Consumer Financial Protection Bureau (CFPB), Equal Employment Opportunity Commission (EEOC), Federal Communications Commission (FCC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Telecommunications & Information Administration (NTIA), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, White House Office
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Commodity Futures Trading Commission (CFTC), Consumer Financial Protection Bureau (CFPB), Equal Employment Opportunity Commission (EEOC), Federal Communications Commission (FCC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
H.R. 824, the Telehealth Benefit Expansion for Workers Act of 2023. H.R. 2713/S. 2418, the Improving Care and Access to Nurses Act. S. 1687, the Beneficiary Enrollment Notification and Eligibility Simplification 2.0 Act. No bill number. Discussed Medicare financial stability and solvency. No bill number. Discussed family caregivers and 1-800-MEDICARE. No bill number. Discussed reducing red tape for family caregivers in Medicare, Medicaid, Social Security and CHIP. No bill number. Discussed access to Medicaid services, including home and community-based services. No bill number. Discussed Medicare home health payment proposed rule. H.R. 5138, the Improving Access to Medicare Coverage Act. No bill number. Discussed Civil Money Penalty Reinvestment Program. No bill number. Discussed 2024 Medicare physician fee schedule proposed rule and family caregivers. No bill number. Discussed 2024 Medicare hospital outpatient prospective payment system proposed rule and family caregivers. No bill number. Discussed minimum nursing home staffing standards and proposed rule. No bill number. Discussed 21st Century Long-Term Care Caucus. No bill number. Discussed GUIDE Model. No bill number. Discussed shortage of nursing home state surveyors and related funding. No bill number. Discussed Medicare home health. H.R. 5518, the Right to Medicare Act. H.R. 5378, the Lower Costs, More Transparency Act. No bill number. Discussed Medicaid Managed Care programs.
Filing targets: Bureau of the Census, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Consumer Financial Protection Bureau (CFPB), Equal Employment Opportunity Commission (EEOC), Federal Communications Commission (FCC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Legal Services Corporation, Natl Institutes of Health (NIH), Natl Telecommunications & Information Administration (NTIA), Office of Management & Budget (OMB), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
No bill number. Discussed implementation of P.L. 117-169 The Inflation Reduction Act of 2022. S. 1250, the Drug-Price Transparency for Consumers (DTC) Act of 2023. No bill number. Discussed Medicare Drug Price Negotiation Program guidance. S. 127, the Pharmacy Benefit Manager Transparency Act of 2023. No bill number. Discussed consumer-directed savings provisions for pharmacy benefit manager legislation. No bill number. Discussed prescription drug value assessment and potential impacts for older adults and people with disabilities.
No bill number. Discussed implementation of P.L. 117-169 The Inflation Reduction Act of 2022. S. 2112, the Search Engines Examine (SEE) Care Compare Act. No bill number. AI and health care benefit decisions. H.R. 824, the Telehealth Benefit Expansion for Workers Act of 2023. H.R. 2868. Association Health Plans Act. H.R.2411/S.1150. National Nursing Workforce Center Act of 2023. No bill number. Discussed Labor, Health & Human Services Appropriations, FY 2024. No bill number. Discussed cancer screening in LGBTQ+ older adults. No bill number. Discussed the Compassionate Care Act. No bill number. Discussed tax credit for recruitment and retention of direct care workers, nurses, and public safety officers. S. 2117, the Provider Training in Palliative Care Act. S. 1298, Supporting our Direct Care Workforce and Family Caregivers Act. No bill number. Discussed the health care workforce.
Filing targets: Administration for Children & Families (ACF), Bureau of the Census, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Consumer Financial Protection Bureau (CFPB), Equal Employment Opportunity Commission (EEOC), Federal Communications Commission (FCC), Federal Deposit Insurance Corporation (FDIC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Legal Services Corporation, Natl Institutes of Health (NIH), Natl Telecommunications & Information Administration (NTIA), Office of Management & Budget (OMB), Office of the Comptroller of the Currency (OCC), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
No bill number. Discussed medication overdoses. S.1250, the Drug Price Transparency for Consumers Act of 2023. No bill number. Discussed Medicare drug price negotiation. No bill number. Discussed Medicare Prescription Payment Plan (MPPP) program. H.R. 4134, the Updated Drug Labeling for Patient Safety Act. S.2886, Patient Safety and Generic Labeling Improvement Act. H.R. 5378, the Lower Costs, More Transparency Act. S. 1967, the Patients Before Middleman (PBM) Act. S.2973, the Modernizing and Ensuring PBM Accountability Act. S.127, the Pharmacy Benefit Manager (PBM) Transparency Act of 2023. S. 79, the Interagency Patent Coordination and Improvement Act of 2023. S. 113, the Prescription Pricing for the People Act of 2023. S. 142, the Preserve Access to Affordable Generics and Biosimilars Act of 2023. S. 148, the Stop STALLING Act. S. 150, the Affordable Prescriptions for Patients Act of 2023. S. 2780, the Medication Affordability and Patent Integrity Act. S. 1339, the Pharmacy Benefit Manager Reform Act.
H.R. 5378, the Lower Cost, More Transparency Act. S. 2117, the Provider Training in Palliative Care Act. H.R. 5518, the Right to Medicare Act. No bill number. Discussed implementation of proposed rule for P.L. 110-343, the Mental Health Parity and Addiction Equity Act.
Filing targets: Bureau of the Census, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Consumer Financial Protection Bureau (CFPB), Equal Employment Opportunity Commission (EEOC), Federal Communications Commission (FCC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Legal Services Corporation, Natl Institutes of Health (NIH), Natl Telecommunications & Information Administration (NTIA), Office of Management & Budget (OMB), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
No bill number. Discussed implementation of P.L. 117-169 The Inflation Reduction Act of 2022. S. 1250, the Drug-Price Transparency for Consumers (DTC) Act of 2023. No bill number. Discussed Medicare Drug Price Negotiation Program guidance. S. 127, the Pharmacy Benefit Manager Transparency Act of 2023. No bill number. Discussed consumer-directed savings provisions for pharmacy benefit manager legislation. No bill number. Discussed prescription drug value assessment and potential impacts for older adults and people with disabilities.
No bill number. Discussed implementation of P.L. 117-169 The Inflation Reduction Act of 2022. S. 2112, the Search Engines Examine (SEE) Care Compare Act. No bill number. AI and health care benefit decisions. H.R. 824, the Telehealth Benefit Expansion for Workers Act of 2023. H.R. 2868. Association Health Plans Act. H.R.2411/S.1150. National Nursing Workforce Center Act of 2023. No bill number. Discussed Labor, Health & Human Services Appropriations, FY 2024. No bill number. Discussed cancer screening in LGBTQ+ older adults. No bill number. Discussed the Compassionate Care Act. No bill number. Discussed tax credit for recruitment and retention of direct care workers, nurses, and public safety officers. S. 2117, the Provider Training in Palliative Care Act. S. 1298, Supporting our Direct Care Workforce and Family Caregivers Act. No bill number. Discussed the health care workforce.
Filing targets: Administration for Children & Families (ACF), Bureau of the Census, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Consumer Financial Protection Bureau (CFPB), Equal Employment Opportunity Commission (EEOC), Federal Communications Commission (FCC), Federal Deposit Insurance Corporation (FDIC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Legal Services Corporation, Natl Institutes of Health (NIH), Natl Telecommunications & Information Administration (NTIA), Office of Management & Budget (OMB), Office of the Comptroller of the Currency (OCC), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
No bill number. Discussed equitable funding for community health care, nursing home safety, and health and nutrition for Puerto Rico and other Territories. No bill number. Discussed over-the-counter hearing aid regulations. No bill number. Discussed Medicare and Medicare Advantage. No bill number. Discussed individual market commercial health insurance. No bill number. Discussed health care workforce training and shortages. No bill number. Discussed the Affordable Care Act Proposed Notice of Benefit and Payment Parameters for 2024. H.R. 382, the Pandemic is Over Act. S.818, Maximizing Opioid Recovery Emergency (MORE) Savings Act. No bill number. Discussed home and community-based services, health care workforce, family caregiving, direct care workforce, and nurses. No bill number. Discussed prescription drug policy, health care transparency, competition, and affordability. No bill number. Discussed rare diseases.
No bill number. Discussed health care provider workforce. No bill number. Discussed Medicare coverage of telehealth. No bill number. Discussed Medicare spending and the debt ceiling. No bill number. Discussed Medicare coverage of dental services. No bill number. Discussed Medicare Advantage coverage of telehealth. No bill number. Discussed Medicare Advantage prior authorization system. No bill number. Discussed Medicare prescription drug inflation rebate program. No bill number. Discussed proposed Advance Notice of Methodological Changes for Calendar Year (CY) 2024 for Medicare Advantage (MA) Capitation Rates and Part C and Part D Payment Policies. No bill number. Discussed proposed Contract Year 2024 Policy and Technical Changes to the Medicare Advantage (MA) and Medicare Prescription Drug Benefit Program (Part D). No bill number. Discussed dual eligible enrollees. No bill number. Discussed CMS State Survey & Certification funding. No bill number. Discussed federal minimum nursing home staffing standards. No bill number. Discussed family caregivers, home care, and the paid direct care workforce. No bill number. Discussed New Mexico Centennial Care five-year Medicaid 1115 Demonstration Waiver renewal request. No bill number. Discussed nursing home COVID-19 vaccination rates, treatments, and other related issues. S.100/H.R. 547, Better Care Better Jobs Act. No bill number. Discussed HCBS settings rule. S.762/H.R. 1493, Home and Community-Based Services Access Act. No bill number. Discussed chronic care and family caregiving. No bill number. Discussed Oregon 1115 waiver.
Filing targets: Agriculture, Dept of (USDA), Bureau of the Census, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Consumer Financial Protection Bureau (CFPB), Consumer Product Safety Commission (CPSC), Equal Employment Opportunity Commission (EEOC), Federal Communications Commission (FCC), Federal Deposit Insurance Corporation (FDIC), Federal Emergency Management Agency (FEMA), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Legal Services Corporation, Natl Telecommunications & Information Administration (NTIA), Office of Management & Budget (OMB), Office of the Comptroller of the Currency (OCC), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
S. 4953, Protecting Drug Innovation Act. H.R.7529, Plain Prescription Prices Act. No bill number. Discussed access to COVID-19 vaccines, tests, and treatments. No bill number. Discussed allowing Medicare Part D enrollees a one-time plan switch. No bill number. Discussed new payment and delivery models to lower drug costs and promote access to innovative drug therapies. H.R. 8239/S. 4661 Agriculture, Rural Development & FDA Appropriations, FY 2023. No bill number. Discussed drug price transparency.
Filing targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Consumer Financial Protection Bureau (CFPB), Equal Employment Opportunity Commission (EEOC), Federal Communications Commission (FCC), Federal Deposit Insurance Corporation (FDIC), Federal Emergency Management Agency (FEMA), Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Telecommunications & Information Administration (NTIA), Office of Management & Budget (OMB), Office of the Comptroller of the Currency (OCC), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
P.L. 117-169, Inflation Reduction Act. No bill number. Discussed mental and behavioral health coverage in Medicare. No bill number. Discussed Physician Fee Schedule and Other Medicare Part B Issues, such as dental coverage. H.R.8487, Improving Seniors Timely Access to Care Act of 2022. No bill number. Discussed allowing one time change in Medicare Part D plans. No bill number. Discussed coverage of ESRD in private plans in relation to Medicare Secondary Payer Act. No bill number. Discussed Medicares role in addressing extreme heat and disaster resilience. H.R.4040, Advancing Telehealth Beyond COVID-19 Act of 2022. H.R. 8295, Labor, Health & Human Services Appropriations Act, FY 2023; H.R.6833, Continuing Appropriations, FY 2023 No bill number. Discussed Medicaid access. No bill number. Discussed Medicare Pilot on Family Caregiver Supportive Services. S. 3792/H.R. 7053, Hospital Inpatient Services Modernization Act. No bill number. Discussed family caregivers and Hospital at Home Programs. H.R. 3650/S. 2048, Improving Access to Medicare Coverage Act. No bill number. Discussed observation stays, three-day inpatient stay requirement for Medicare coverage of skilled nursing facility care, and COVID-19 public health emergency waiver. No bill number. Discussed family caregiving, consumer and family caregiver experience of care surveys, family caregiver assessments. No bill number. Discussed Medicare Advantage Value-Based Insurance Design and Hospice Value-Based Insurance Design carve out. No bill number. Discussed nursing home issues. No bill number. Discussed disability policies and Medicaid No bill number. Discussed Medicaid streamlining proposed rule. No bill number. Discussed Medicare Home Health Prospective Payment System Rate Update and Other Home Health Issues. S. 4873/H.R. 8840, Improving Access to Advance Care Planning Act. No bill number. Discussed state 1115 waiver. No bill number. Discussed HCBS settings rule. No bill number. Discussed nursing home staffing. No bill number. Discussed nursing home debt collection and family caregiving.
Filing targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Consumer Financial Protection Bureau (CFPB), Equal Employment Opportunity Commission (EEOC), Federal Communications Commission (FCC), Federal Deposit Insurance Corporation (FDIC), Federal Emergency Management Agency (FEMA), Federal Highway Administration (FHA), Federal Reserve System, Federal Trade Commission (FTC), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Telecommunications & Information Administration (NTIA), Office of Management & Budget (OMB), Office of the Comptroller of the Currency (OCC), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Substance Abuse & Mental Health Services Administration (SAMHSA), Transportation, Dept of (DOT), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
No bill number. Discussed extension of COVID-19 public health emergency. No bill number. Discussed the extension of the ARPA ACA subsidies. No bill number. Discussed RX reform in a potential reconciliation bill. H.R. 8295 Labor, Health & Human Services Appropriations Act, FY 2023. No bill number. Discussed nursing home COVID-19 boosters and vaccinations.
H.R.5376 - Build Back Better Act. No bill number. Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN) Act. S.3700 - Affordable Insulin Now Act. H.R.7667 - Food and Drug Amendments of 2022 (User Fee bill).
Filing targets: Administration for Children & Families (ACF), Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Consumer Financial Protection Bureau (CFPB), Equal Employment Opportunity Commission (EEOC), Federal Communications Commission (FCC), Federal Emergency Management Agency (FEMA), Federal Reserve System, Federal Trade Commission (FTC), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Council on Disability, Natl Telecommunications & Information Administration (NTIA), Office of Management & Budget (OMB), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Substance Abuse & Mental Health Services Administration (SAMHSA), Transportation, Dept of (DOT), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
H.R. 5376 the Build Back Better Act. Discussed Affordable Care Act subsidy extension, state reinsurance funding, and Medicaid expansion via ACA subsidies. No bill number. Discussed medical debt. No bill number. Discussed COVID-19 supplemental funding. No bill number. Discussed COVID protections for seniors. No bill number. Discussed COVID-19 vaccinations and boosters in nursing homes. No bill number. Discussed inappropriate use of antipsychotic drugs in nursing homes. No bill number. Discussed CMS COVID-19 nursing home visitation guidance. No bill number. Discussed AARP Nursing Home Dashboard. H.R. 598, Quality Care for Nursing Home Residents and Workers During COVID-19 and Beyond Act S. 2890, Provider Training in Palliative Care Act. S. 3799, PREVENT Pandemics Act. H.R. 4502, the FY 2022 Labor, Health & Human Services Appropriations Act. No bill number. Discussed investing in Medicaid home and community-based services and the paid workforce.
No bill number. Discussed prescription drug legislation and policies to lower prescription drug prices. H.R.5376, the Build Back Better Act. S.3700/H.R.6833, the Affordable Insulin Now Act. No bill number. Discussed disclosure of prescription drug prices in television ads. No bill number. Discussed inappropriate use of antipsychotic drugs in nursing homes. H.R. 4356, the FY 2022 Agriculture, Rural Development & FDA Appropriations.
Filing targets: Administration for Children & Families (ACF), Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Consumer Financial Protection Bureau (CFPB), Equal Employment Opportunity Commission (EEOC), Federal Communications Commission (FCC), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Council on Disability, Natl Telecommunications & Information Administration (NTIA), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Substance Abuse & Mental Health Services Administration (SAMHSA), Transportation, Dept of (DOT), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
Filing targets: Administration for Children & Families (ACF), Agency for Healthcare Research & Quality (AHRQ), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Consumer Financial Protection Bureau (CFPB), Corporation for Natl & Community Service, Defense, Dept of (DOD), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Council on Disability, Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
Filing targets: Administration for Children & Families (ACF), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Consumer Financial Protection Bureau (CFPB), Corporation for Natl & Community Service, Defense, Dept of (DOD), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
Public L.117-2, American Rescue Plan Act of 2021 No bill number - Discussed vaccine coverage, development, approval, funding, distribution and prioritization No bill number - Discussed vaccine coverage No bill number - Discussed drug pricing reforms, including price negotiation, out-of-pocket cap, and inflation-based rebates
Filing targets: Administration for Children & Families (ACF), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Consumer Financial Protection Bureau (CFPB), Corporation for Natl & Community Service, Defense, Dept of (DOD), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Indian Health Service, Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Natl Transportation Safety Board (NTSB), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of the Comptroller of the Currency (OCC), Pension Benefit Guaranty Corporation (PBGC), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
Filing targets: Administration for Children & Families (ACF), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Consumer Financial Protection Bureau (CFPB), Corporation for Natl & Community Service, Defense, Dept of (DOD), Federal Communications Commission (FCC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Indian Health Service, Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Natl Transportation Safety Board (NTSB), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of the Comptroller of the Currency (OCC), Pension Benefit Guaranty Corporation (PBGC), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
Filing targets: Administration for Children & Families (ACF), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Consumer Financial Protection Bureau (CFPB), Corporation for Natl & Community Service, Federal Communications Commission (FCC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Indian Health Service, Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of the Comptroller of the Currency (OCC), Pension Benefit Guaranty Corporation (PBGC), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
Filing targets: Administration for Children & Families (ACF), Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Consumer Financial Protection Bureau (CFPB), Corporation for Natl & Community Service, Federal Communications Commission (FCC), Federal Deposit Insurance Corporation (FDIC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Indian Health Service, Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of the Comptroller of the Currency (OCC), Pension Benefit Guaranty Corporation (PBGC), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act. H.R. 6201, Families First Coronavirus Response Act; H.R. 748, Coronavirus Aid, Relief, and Economic Security (CARES) Act - Discussed Medicare enrollment national open enrollment period, medical expense deduction, cost-sharing protections for commercial/private health insurance holders, telehealth access, nursing homes, virtual visitation, home and community-based services, Older Americans Act programs, Medicare home health care, and family caregiving, no-cost COVID-19 testing, equitable relief payments, retirement savings tax relief, suspensions of foreclosures and evictions, expanded unemployment benefits, paid sick and family leave, affordable broadband, and government operations, among other issues. S. 3517, Discussed Advancing Connectivity during the Coronavirus to Ensure Support for Seniors Act (ACCESS Act). S. 753/H.R. 1682, Improving Access to Medicare Coverage Act, discussed bill and Coronavirus legislation (no bill number). S. 296/H.R.2150, Home Health Care Planning Improvement Act, discussed bill and Coronavirus legislation. No bill number. CMS nursing home Coronavirus guidance. No bill number. Discussed nursing home virtual visitation. S. 3548/H.R. 748, P.L. 116-136, CARES Act Lobbied regarding nursing homes, virtual visitation, home and community-based services, Older Americans Act programs, Medicare home health care, and family caregiving. H.R. 6379, Take Responsibility for Workers and Families Act. Discussed virtual visitation provisions of bill and Medicaid HCBS grants. H.R. 6305, To assist older Americans and people with disabilities affected by COVID-19. S. 3544, Coronavirus Relief for Seniors and People with Disabilities Act. S. 1443, H.R. 2730, Discussed Credit for Caring Act, and inclusion of bill in Coronavirus legislation. No bill. Discussed Coronavirus disease 2019 and appropriations supplemental. S.64/H.R. 2375 - the Preserve Access to Generics and Biosimilars Act. H.R. 1499 - the Preserving Consumer Access to Generics Act. Discussed telehealth, interoperability, and data sharing with Department of Health and Human Services. H.R. 19/S. 3129, Lower Cost More Cures Act. S. 2543, the Prescription Drug Pricing Reduction Act. H.R. 2073/S. 110, Permanent Extension of the Medical Expense Deduction. H.R. 3, Elijah E. Cummings Lower Cost Drugs Now Act. S. 3057, Modernization of the Older Americans Act Amendments.
Filing targets: Administration for Children & Families (ACF), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Consumer Financial Protection Bureau (CFPB), Corporation for Natl & Community Service, Federal Deposit Insurance Corporation (FDIC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Indian Health Service, Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of the Comptroller of the Currency (OCC), Pension Benefit Guaranty Corporation (PBGC), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
H.R. 1158/H.R. 1865 - The Consolidated Appropriations Act/Further Consolidated Appropriations Act. H.R. 2740 Labor-HHS Appropriations bill, FY 2020 - Lobbied in support of increased funding for CMS' state survey and certification program and opposition to hostile policy riders re ACA, and various related medical care research and supportive services. S.340/H.R. 965 - the CREATES Act. S.64/H.R. 2375 - The Preserve Access to Generics and Biosimilars Act. H.R. 1499 - The Preserving Consumer Access to Generics Act. H.R. 3 - The Lower Drug Costs Now Act. H.R. 2073/S.110 - Lobbied in support of a permanent extension of the 7.5% income threshold for the medical expense deduction. H.R. 1865/H.R. 1158 - Lobbied in support of 2 year extension of 7.5% income threshold for the medical expense deduction in the final FY 2020 Consolidated Appropriations Act. H.R. 19/S.3129 - The Lower Costs, More Cures Act H.R. 1682/S.753 - The Improving Access to Medicare Coverage Act H.R. 1342/S. 548 - The Empower Act S. 1921, Provider Training in Palliative Care Act. S. 1399, Title VIII Nursing Workforce Reauthorization Act. P.L. 115-119, RAISE Family Caregivers Act - Discussed family caregiving in Cures 2.0.
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Pension Benefit Guaranty Corporation (PBGC), SENATE, Securities & Exchange Commission (SEC), Transportation, Dept of (DOT), Treasury, Dept of, White House Office
H.R. 2740 Labor-HHS Appropriations bill, FY 2020 - Lobbied in support of increased funding for CMS' state survey and certification program and opposition to hostile policy riders re ACA, and various related medical care research and supportive services. S.340/H.R. 965 - the CREATES Act. S.64/H.R. 2375 - the Preserve Access to Generics and Biosimilars Act. H.R. 1499 - the Preserving Consumer Access to Generics Act. H.R. 3 - The Lower Drug Costs Now Act. S. 2543 - the Prescription Drug Pricing Reduction Act. S. 1921, Discussed the Provider Training in Palliative Care Act. S. 299, Discussed the Geriatrics Workforce Improvement Act. No bill number - Discussed Medicare Advantage program. H.R. 1682/S.753 Improving Access to Medicare Coverage Act. H.R. 1342/S.548 Empower Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE, Securities & Exchange Commission (SEC), Transportation, Dept of (DOT), Treasury, Dept of, White House Office
Filing targets: Centers For Medicare and Medicaid Services (CMS), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, Securities & Exchange Commission (SEC), Transportation, Dept of (DOT), Treasury, Dept of, White House Office
H.R. 21, Consolidated Appropriations Act FY 2019, H.R. 648, 2nd Consolidated Appropriations Act FY 2019, H.J.R. 31 Continuing Appropriations for Homeland Security FY 2019, H.J.R. 143, H.R. 695, Short-term Continuing Appropriations Act Resolution FY 2019, Agriculture-Rural Development Appropriations bill (no bill numbers) - lobbied to protect funding for FDA drug processing funding and user fees.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Securities & Exchange Commission (SEC), Transportation, Dept of (DOT)
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Consumer Financial Protection Bureau (CFPB), Federal Communications Commission (FCC), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Natl Highway Traffic Safety Administration (NHTSA), Office of Management & Budget (OMB), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office
H.R. 749, Lower Drug Costs through Competition Act - Discussed importation, price negotiation, and other prescription drug legislation. Responded to inquiry regarding pharmaceutical benefit managers (PBMs). S. 469, Affordable and Safe Prescription Drug Importation Act - Discussed bill. Discussed CREATES Act (no bill number) and pay-for-delay legislation. Discussed priorities for older adults in health care reform legislation including Medicare, private health insurance/age tax, Medicaid, and prescription drugs. H.R. 2028 (Public Law 114-254) - Further Continuing and Security Assistance Appropriations Act, 2017 - Lobbied in support of increased CSFP and FDA drug processing funding and user fees.
S.9, Over-the-Counter Hearing Aid Act of 2016 - Sent endorsement letter. Discussed potential repeal of the Affordable Care Act (P.L.111-148, P.L.111-152). Discussed MACRA implementation. Discussed changes to the Medicare benefit design, such as: copays, premiums, and deductibles. Discussed health care quality and measurement. Discussed AARP opposition to Medicaid block grants and per capita caps. H.R. 1017/S. 479, Removing Barriers to Colorectal Cancer Screening Act - Sent a letter of endorsement. Discussed concerns with/opposition to potential changes to Medicaid (includes letter to House Energy and Commerce Oversight and Investigations Subcommittee). Discussed Medicaid home and community-based services. Discussed Medicare code relating to family caregivers. H.R. 1421/S.568, Improving Access to Medicare Coverage Act - Discussed reintroduction of and our support for bill. Responded to question regarding H.R. 181 (regarding annuities for community spouse of an institutionalized spouse and Medicaid spousal impoverishment provisions) and Prioritizing the Most Vulnerable Over Lottery Winners Act of 2017 (H.R. 829). Discussed possible repeal of final federal regulations regarding conditions of participation for long-term care facilities and our comments on the proposed rule. Responded to inquiry regarding nursing home abuses. Responded to inquiry regarding the Supplemental Security Income (SSI) Restoration Act (no bill number). H.R. 1628, American Health Care Act - Discussed health care reform and opposition to the bill including because of age tax and changes to Medicaid. Discussed priorities for older adults in health care reform legislation including Medicare, private health insurance/age tax, Medicaid, and prescription drugs. S. 191, Patient Freedom Act of 2017 - Discussed bill. Discussed health care reform generally. H.R. 2028 (Public Law 114-254) - Further Continuing and Security Assistance Appropriations Act, 2017 - Lobbied in support of increased funding for CMS' state survey and certification program and opposition to hostile policy riders re Patient Protection and Affordable Care Act. Discussed possible Medicaid hearing questions.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Equal Employment Opportunity Commission (EEOC), Federal Transit Administration (FTA), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, Social Security Administration (SSA), Transportation, Dept of (DOT)
S.9, Over-the-Counter Hearing Aid Act of 2016 - Sent endorsement letter. Discussed potential repeal of the Affordable Care Act (P.L.111-148, P.L.111-152). Discussed MACRA implementation. Discussed changes to the Medicare benefit design, such as: copays, premiums, and deductibles. Discussed health care quality and measurement. Discussed AARP opposition to Medicaid block grants and per capita caps. H.R. 1017/S. 479, Removing Barriers to Colorectal Cancer Screening Act - Sent a letter of endorsement. Discussed concerns with/opposition to potential changes to Medicaid (includes letter to House Energy and Commerce Oversight and Investigations Subcommittee). Discussed Medicaid home and community-based services. Discussed Medicare code relating to family caregivers. H.R. 1421/S.568, Improving Access to Medicare Coverage Act - Discussed reintroduction of and our support for bill. Responded to question regarding H.R. 181 (regarding annuities for community spouse of an institutionalized spouse and Medicaid spousal impoverishment provisions) and Prioritizing the Most Vulnerable Over Lottery Winners Act of 2017 (H.R. 829). Discussed possible repeal of final federal regulations regarding conditions of participation for long-term care facilities and our comments on the proposed rule. Responded to inquiry regarding nursing home abuses. Responded to inquiry regarding the Supplemental Security Income (SSI) Restoration Act (no bill number). H.R. 1628, American Health Care Act - Discussed health care reform and opposition to the bill including because of age tax and changes to Medicaid. Discussed priorities for older adults in health care reform legislation including Medicare, private health insurance/age tax, Medicaid, and prescription drugs. S. 191, Patient Freedom Act of 2017 - Discussed bill. Discussed health care reform generally. H.R. 2028 (Public Law 114-254) - Further Continuing and Security Assistance Appropriations Act, 2017 - Lobbied in support of increased funding for CMS' state survey and certification program and opposition to hostile policy riders re Patient Protection and Affordable Care Act. Discussed possible Medicaid hearing questions.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Equal Employment Opportunity Commission (EEOC), Federal Transit Administration (FTA), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, Social Security Administration (SSA), Transportation, Dept of (DOT)
S.452, Medicare Diabetes Prevention Act - Discussed bill with Senate. Discussed draft language on senior mental health with Senate HELP Committee staff. (no bill) Discussed Medicare Reform (no bill) Discussed Age Rating in the ACA and rate shock. (no bill)Labor, HHS Appropriations bill, 2015-Lobbied on preserving funding for the ACA; defended meaningful use of the ACA. (no bill) Discussed need to increase health information technology quality measurements and access to qualified systems. (no bill) H.R. 1099, To repeal the Prevention and Public Health Fund - Lobbied against the repeal of the Prevention and Public Health Trust Fund, an important component in state and community efforts to prevent illness and promote health. Discussed Pre-existing Condition Insurance Program. (no bill) Discussed Accountable Care Organization and Medical Shared savings. (no bill) Discussed Rate Review. (no bill) Discussed Internal Appeals and External Review Process. (no bill) Discussed Medicare reimbursement issues. Lobbied in support of Medicare physician payment reform. Discussed legislation to make prescription drugs more affordable to older Americans. S. 1416/H.R. 2645 (112th Congress), Medigap Medical Loss Ratio Improvement Act of 2011. Discussed coverage for screening depression and screening and counseling for alcohol misuse. (no bill) Discussed consumer operated and oriented plan programs. (no bill) Discussed standards related to risk adjustment, reinsurance, and risk mitigation as they relate to exchanges. (no bill) H.R.2077, MLR Repeal Act of 2011 - Expressed opposition to the elimination of provision in the Affordable Care Act (P.L. 111-148)Discussed opposition to draft legislation regarding the elimination of grandfathered status. (no bill) Discussed association health plans with DOL, HHS and DOT. (no bill) Discussed quality and care coordination with HHS. (no bill) Discussed Essential Health Benefits with HHS. (no bill) Discussed employer affordability safe harbor. (no bill) Discussed health insurance exchanges - eligibility, enrollment, premium tax credits. (no bill) Discussed Basic Health Plans. (no bill) Discussed Medigap reform. (no bill) Discussed Pre-existing Condition Insurance Program. (no bill) Discussed role of grandfathered plans. (no bill) Discussed reauthorization of the Older Americans Act and other amendments to the OAA. (no bill) Discussed dual eligibles. (no bill) Discussed S.1119, Positive Aging Act of 2013. H.R. 2641, Farm Program bill-Discussed the severed nutrition programs from Farm Bill. S. 562, Seniors Mental Health Access Improvement Act - Discussed the bill for eventual endorsement. Discussed need to suport family caregivers and long-term services and supports. (no bill) Discussed repeal of medical device tax. (no bill) Discussed proposed regulation relating to Medicaid expansion coverage and minimum essential coverage. (no bill) Discussed Affordable Care Act Medicaid expansion issues, including AARP comments on state 1115 waiver proposals to use premium assistance authority to expand Medicaid. (no bill) Discussed Medicare-Medicaid integration efforts and financial alignment demonstrations, other CMS demonstration initiatives. (no bill) H.R.3850/S. 1562, Discussed Older Americans Act reauthorization legislation. H.R.3662, the Mental Health Access Improvement Act - Sent letter of endorsement. H.R.4879, the Research for All Act - Sent letter of endorsement. S.2348, the Removing Barriers to Colorectal Cancer Screening Act - Sent letter of endorsement. Discussed legislation to address health disparities. (no bill) H.R.5294 - Discussed Health Equity & Accountability Act of 2014; no endorsement due to budget implications. H.R. 83, Consolidated and Further Continuing Appropriations, 2015 - Lobbied to protect various healthcare programs serving seniors from disproportionate reduction.Discussed FTC participation in state scope of practice issues. Also sent follow-up items for their review. (no bill) Discussed Social Security programs. (no bill) Lobbied against cuts to the health care prevention fund. (no bill) Discussed deficit reduction issues dealing with Medicare and Medicaid including concerns over increasing Medicare's age of eligibility, chained CPI, and cuts to Medicaid. (no bill) Discussed Affordable Care Medicaid expansion issues. Centers for Medicare and Medicaid Services, Center for Medicaid and CHIP Services. Discussed Medicaid reform, Medicare-Medicaid integration efforts and financial alignment demonstrations, other CMS demonstration initiatives. (no bill) Discussed Medicaid expansion implementation, as included in the ACA (P.L. 111-140). Discussed Medicaid including concerns over cuts to Medicaid flexibility and Medicaid structural reforms to. (no bill) Discussed implementation of the Affordable Care Act, its provisions and H.R. 95 to repeal the Patient Protection and Affordable Care Act. Labor, Health and Human Services Appropriations Act, 2015 - Lobbied to protect employment, health and human services and energy assistance programs for seniors, disabled and low income assistance. (no bill) Discussed Affordable Care Act Medicaid expansion issues, including questions related to the use of premium assistance authority to expand Medicaid. (no bill) H.R. 1263, Excellence in Mental Health Act - Discussed the bill for eventual endorsement. Discussed Affordable Care Act Medicaid expansion issues, including AARP comments on state 1115 waiver proposals to use premium assistance authority to expand Medicaid, Centers for Medicare and Medicaid Services, Center for Medicaid and CHIP Services. Discussed perspectives on proposed ideas for legislation to address health disparities with HHS and CMS officials. Discussed H.R. 3717, the Helping Families in Mental Health Crisis Act. Discussed Affordable Care Act Medicaid expansion issues, including AARP comments on state 1115 waiver proposals to use premium assistance authority to expand Medicaid. Centers for Medicare and Medicaid Services, Center for Medicaid and CHIP Services. Discussed Medicare-Medicaid integration efforts and financial alignment demonstrations, other CMS demonstration initiatives. (no bill) Discussed the Convention on the Rights of Persons with Disabilities. (no bill) H.R. 2835/S. 1647, Restoring Access to Medication Act of 2013 - Urged co-sponsorship of these bills. Discussed hospital readmissions. (no bill) Discussed Affordable Care Act Medicaid expansion issues, including AARP comments on state 1115 waiver proposals to use premium assistance authority to expand Medicaid. Discussed Medicare-Medicaid integration efforts and financial alignment demonstrations, other CMS demonstration initiatives. (no bill) H. R. 3850 - Discussed Older Americans Act reauthorization legislation. H.R. 5183, Better Care Act - Discussed legislation with staff regarding the bill. H.R. 5232, Notice of Observation Treatment & Implication for Care Eligibility (Notice Act) - Discussed legislation with staff. Discussed oral health and older adulsts. (no bill)
Discussed importance of potential savings both to consumers and to the federal government of granting Secretarial Negotiating Authority to Secretary of HHS on Medicare Part D. (no bill)Discussed legislative intent with respect to biologic drugs and the exclusivity period; and discussed importance of potential savings to the health care system generally. (no bill) Discussed need for greater consumer safety protections both in OTC and prescription drugs. (no bill) Discussed need for doctors to get unbiased information on prescription pharmaceuticals through programs like academic detailing. (no bill) Discussed possible savings and better health care outcomes that could result from Medication Therapy Management. (no bill) Pub. Law 111-148 and 111-152 - Discussed implementation of health care legislation to reform the health care system to provide quality healthcare, expand access to long-term services and supports, and reduced prescription drug costs. Discussed greater affordability of generic versions of both generic and biologic drugs. S. 319, Pharmaceutical Market Access and Drug Safety Act of 2011 - Discussed legislation that establishes a framework for the safe, legal importation of lower-priced prescription drugs from abroad. S. 1206, Medicare Drug Savings Act of 2011 - Discussed rebates in Medicare Part D as a cost savings measure in Medicare that does not harm beneficiaries. H. R. 3342, Affordable Medicines Utilization Act of 2011 - Lobbied on legislation to encourage state Medicaid programs to use safe, effective generic medications. S. 27, Preserve Access to Affordable Generics Act of 2011- Lobbied for this legislation preventing abuses in patent settlements between generic and brand name prescription drug companies. S. 1886/H.R. 3468 of 2011- Discussed counterfeit drug penalty enhancement. Discussed prescription drug safety, drug shortage, and medical device safety, and related user fee legislation. S. 2193 of 2012, the Ensuring Safe Medical Devices for Patients Act - Discussed legislation to include devices in the post-market risk identification and analysis system for prescription drugs and to expedite the implementation of the unique device identification system for medical devices. Discussed draft legislation to address the issue of whether generic drug manufacturers have a duty to include new warnings about potentially serious side effects on their labels as they become known by giving generic drug makers the same ability to update their labeling as manufacturers of brand name drugs. (no bill) S.3187, Food and Drug Administration safety and Innovation Act - FDA user fee agreement legislation focusing on the review process for prescription drugs and medical devices, prescription drug safety, drug shortages, medical device safety and access to generic drugs. S.3212, Cody Miller Initiative for Safer Prescriptions Act - To require the Secretary of Health and Human Services to promulgate regulations regarding the authorship, content, format, and dissemination of Patient Medication information. Discussed pay-for-delay agreements as tactic by drug manufacturers to block lower cost drugs from entering the market, and the Fair and Immediate Release of Generics Drugs Act that would address the underlying issue of "parked exclusivities" in the Hatch-Waxman Act (S.1882). Discussed the issue of biosimilar drug naming and how biosimilars should use a common International Non-proprietary name as reference originator biologic products. (no bill) S. 504, the Fair and Immediate Release of Generic Drugs Act/S.214, the Preserve Access to Affordable Generics Act - Discussed the Patient Safety and Generic Labeling Improvement Act. (no bill) H.R. 83, Consolidated and Further Continuing Appropriations, 2015 - Lobbied to protect and enhance funding levels for FDA to enable it to effectively manage it's food safety and medical product programs. H.J. Res. 124, Continuing Appropriations Resolutions, 2015 - Lobbied to protect senior housing and nutrition programs, and FDA programs from disproportionate reduction under the bill.Discussed Unique Device Identification (UDI) issues including proposed rules and implementation. (no bill) Discussed oversight of laboratory genetic testing. (no bill) Discussed AARP's concerns with prescription drug costs. (no bill) S.117, Medicare Prescription Drug Price Negotiation Act - Discussed bill that allows medicare to negotiate medicare prescription drug prices with drug companies. Discussed the exclusivity period for biologic drugs. (no bill) Discussed the Patient Safety and Generic Labeling Improvement Act. (no bill) Discussed biologic drug issues including implementation of the new approval pathway for biosimilar drugs. (no bill) Discussed the importance of potential savings to both consumers and the federal government of granting Secretarial negotiating authority to the HHS Secretary under Medicare Part D. (no bill) S. 504, the Fair and Immediate Release of Generics Drugs Act/S. 214, the Preserve Access to Affordable Generics - Discussed legislation to address pay-for-delay agreements used by drug manufacturers to block lower cost drugs from entering the market. Discussed the exclusivity period ofr biologic drugs. (no bill) Discussed the Food and Drug Administration proposed rule to enable generic drug makers to independently update their drug labeling. (no bill) Discussed biologic drug issues including implementation of the new approval pathway for biosimilar drugs. (no bill) S. 1720/S.2049/S.866, - Discussed patent reform legislation and related provisions. Discussed the importance of potential savings to both consumers and the federal government of granting Secretarial negotiating authority to the HHS Secretary under Medicare Part D. (no bill) Discussed legislation to address pay-for-delay agreements used by drug manufacturers to block lower cost drugs from entering the market (the Fair and Immediate Release of Generic Drugs Act (S. 504) and (the Preserve Access to Affordable Generics Act) (S.214). Discussed the Food and Drug Administration proposed rule to enable generic drug makers to independently update their drug labeling. (no bill) Discussed other prescription drug issues and potential legislation on drug importation and "least costly alternative" payment for Part B durgs. (no bill) S.504/S.214 - Discussed legislation to address pay-for-delay agreements used by drug manufacturers to block lower cost drugs from entering the market (the Fair and Immediate Release of Generics Drugs Act) and the Preserve Access to Affordable Generics Act. Discussed the Food and Drug Administration proposed rule to enable generic drug makers to independently update their drug labeling. (no bill) Discussed biologic drug issues including implementation of the new approval pathway for biosimilar drugs. (no bill) S.1720/S.2040/S.866 - Discussed patent reform legislation and related provisions. Discussed other prescription drug issues and potential legislation on drug importation and "least costly alternative" payment for Part B drugs. (no bill) Discussed the need to data transparency on prescription drug research and development costs and drug prices, and enhanced data reporting on coverage determinations, exception, and redeterminations under Part D appeals process. (no bill) Discussed the House Energy and Commerce Committee 21st Century Cures Initiative focused on drug and medical device innovation issues. (no bill)
Filing targets: Administration on Aging, Agriculture, Dept of (USDA), Bureau of the Census, Centers For Medicare and Medicaid Services (CMS), Commodity Futures Trading Commission (CFTC), Congressional Budget Office (CBO), Energy, Dept of, Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Federal Communications Commission (FCC), Federal Highway Administration (FHA), Federal Reserve System, Federal Trade Commission (FTC), Federal Transit Administration (FTA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Highway Traffic Safety Administration (NHTSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of the Comptroller of the Currency (OCC), Pension Benefit Guaranty Corporation (PBGC), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
Discussed importance of potential savings both to consumers and to the federal government of granting Secretarial Negotiating Authority to Secretary of HHS on Medicare Part D. (no bill)Discussed legislative intent with respect to biologic drugs and the exclusivity period; and discussed importance of potential savings to the health care system generally. (no bill) Discussed need for greater consumer safety protections both in OTC and prescription drugs. (no bill) Discussed need for doctors to get unbiased information on prescription pharmaceuticals through programs like academic detailing. (no bill) Discussed possible savings and better health care outcomes that could result from Medication Therapy Management. (no bill) Pub. Law 111-148 and 111-152 - Discussed implementation of health care legislation to reform the health care system to provide quality healthcare, expand access to long-term services and supports, and reduced prescription drug costs. Discussed greater affordability of generic versions of both generic and biologic drugs. S. 319, Pharmaceutical Market Access and Drug Safety Act of 2011 - Discussed legislation that establishes a framework for the safe, legal importation of lower-priced prescription drugs from abroad. S. 1206, Medicare Drug Savings Act of 2011 - Discussed rebates in Medicare Part D as a cost savings measure in Medicare that does not harm beneficiaries. H. R. 3342, Affordable Medicines Utilization Act of 2011 - Lobbied on legislation to encourage state Medicaid programs to use safe, effective generic medications. S. 27, Preserve Access to Affordable Generics Act of 2011- Lobbied for this legislation preventing abuses in patent settlements between generic and brand name prescription drug companies. S. 1886/H.R. 3468 of 2011- Discussed counterfeit drug penalty enhancement. Discussed prescription drug safety, drug shortage, and medical device safety, and related user fee legislation. S. 2193 of 2012, the Ensuring Safe Medical Devices for Patients Act - Discussed legislation to include devices in the post-market risk identification and analysis system for prescription drugs and to expedite the implementation of the unique device identification system for medical devices. Discussed draft legislation to address the issue of whether generic drug manufacturers have a duty to include new warnings about potentially serious side effects on their labels as they become known by giving generic drug makers the same ability to update their labeling as manufacturers of brand name drugs. (no bill) S.3187, Food and Drug Administration safety and Innovation Act - FDA user fee agreement legislation focusing on the review process for prescription drugs and medical devices, prescription drug safety, drug shortages, medical device safety and access to generic drugs. S.3212, Cody Miller Initiative for Safer Prescriptions Act - To require the Secretary of Health and Human Services to promulgate regulations regarding the authorship, content, format, and dissemination of Patient Medication information. Discussed pay-for-delay agreements as tactic by drug manufacturers to block lower cost drugs from entering the market, and the Fair and Immediate Release of Generics Drugs Act that would address the underlying issue of "parked exclusivities" in the Hatch-Waxman Act (S.1882). Discussed the issue of biosimilar drug naming and how biosimilars should use a common International Non-proprietary name as reference originator biologic products. (no bill) S. 504, the Fair and Immediate Release of Generic Drugs Act/S.214, the Preserve Access to Affordable Generics Act - Discussed the Patient Safety and Generic Labeling Improvement Act. (no bill) H.R. 4800/S. 2389, Agriculture Appropriations bill, 2015 - Lobbied to protect and enhance funding levels for FDA to enable it to effectively manage it's food safety and medical product programs. H.J. Res. 124, Continuing Appropriations Resolutions, 2015 - Lobbied to protect senior housing and nutrition programs, and FDA programs from disproportionate reduction under the bill.Discussed Unique Device Identification (UDI) issues including proposed rules and implementation. (no bill) Discussed oversight of laboratory genetic testing. (no bill) Discussed AARP's concerns with prescription drug costs. (no bill) S.117, Medicare Prescription Drug Price Negotiation Act - Discussed bill that allows medicare to negotiate medicare prescription drug prices with drug companies. S.504/S.214, The Fair and Immediate Release of Generics Drugs Act/Preserve Access to Affordable Generics Act - Discussed legislation to address pay-for-delay agreements used by drug manufacturers to block lower cost drugs from entering the market. Discussed the exclusivity period for biologic drugs. (no bill) Discussed the Patient Safety and Generic Labeling Improvement Act. (no bill) Discussed biologic drug issues including implementation of the new approval pathway for biosimilar drugs. (no bill) Discussed the importance of potential savings to both consumers and the federal government of granting Secretarial negotiating authority to the HHS Secretary under Medicare Part D. (no bill) S. 504, the Fair and Immediate Release of Generics Drugs Act/S. 214, the Preserve Access to Affordable Generics - Discussed legislation to address pay-for-delay agreements used by drug manufacturers to block lower cost drugs from entering the market. Discussed the exclusivity period ofr biologic drugs. (no bill) Discussed the Food and Drug Administration proposed rule to enable generic drug makers to independently update their drug labeling. (no bill) Discussed biologic drug issues including implementation of the new approval pathway for biosimilar drugs. (no bill) S. 1720/S.2049/S.866, - Discussed patent reform legislation and related provisions. Discussed the importance of potential savings to both consumers and the federal government of granting Secretarial negotiating authority to the HHS Secretary under Medicare Part D. (no bill) Discussed legislation to address pay-for-delay agreements used by drug manufacturers to block lower cost drugs from entering the market (the Fair and Immediate Release of Generic Drugs Act (S. 504) and (the Preserve Access to Affordable Generics Act) (S.214). Discussed the exclusivity period for biologic drugs. (no bill) Discussed the Food and Drug Administration proposed rule to enable generic drug makers to independently update their drug labeling. (no bill) Discussed biologic drug issues including implementation of the new approval pathway for biosimilar drugs. (no bill) S. 1720/S. 2049/S.866 - Discussed patent reform legislation and related provisions. Discussed other prescription drug issues and potential legislation on drug importation and "least costly alternative" payment for Part B durgs. (no bill) Discussed the importance of potential savings to both consumers and the federal government of granting Secretarial negotiating authority to the HHS Secretary under Medicare Part D. (no bill) S.504/S.214 - Discussed legislation to address pay-for-delay agreements used by drug manufacturers to block lower cost drugs from entering the market (the Fair and Immediate Release of Generics Drugs Act) and the Preserve Access to Affordable Generics Act. Discussed the exclusivity period for biologic drugs. (no bill) Discussed the Food and Drug Administration proposed rule to enable generic drug makers to independently update their drug labeling. (no bill) Discussed biologic drug issues including implementation of the new approval pathway for biosimilar drugs. (no bill) S.1720/S.2040/S.866 - Discussed patent reform legislation and related provisions. Discussed other prescription drug issues and potential legislation on drug importation and "least costly alternative" payment for Part B drugs. (no bill) Discussed the need to data transparency on prescription drug research and development costs and drug prices, and enhanced data reporting on coverage determinations, exception, and redeterminations under Part D appeals process. (no bill) Discussed the House Energy and Commerce Committee 21st Century Cures Initiative focused on drug and medical device innovation issues. (no bill)
Pub.Law 111-148 & 111-152 - Discussed implementation of health care law that would reform the health care system to provide affordable quality health care, reduce drug costs and expand access to long-term services and supports. Discussed how to implement Medicaid provisions of Affordable Care Act. (PL. 111-148)S. 374, Medicare Mental Health Inpatient Equity Act - Lobbied in support of this legislation to eliminate the 190-day lifetime limit on Medicare coverage for in-patient psychiatric hospital services (112th). Discussed improving access to care for underserved population. (no bill) Discussed importance of maintaining low income subsididies and supports in Medicare. (no bill) Discussed the importance of coordinating services for those who qualify for both Medicare and Medicaid in order to ensure that beneficiaries receive all needed benefits but there is no duplication. (no bill) Discussed whether, and under what circumstances, managed care could effectively be used to provide benefits to dual eligible beneficiaries. (no bill) Discussed additional methods for fighting fraud and waste in Health Care. (no bill) Discussed Medigap and need for guaranteed issue for all populations and need to increase medical loss ratio. Discussed durable medical equipment bidding. (no bill) Lobbied for legislation to provide Medicare beneficiaries with additional opportunities to enroll in Medicare Part B.(no bill) Lobbied against the use of the Social Security account number on Government-issued identification cards issued in connection with Medicare, Medicaid, and SCHIP benefits and for other purposes. (no bill) Discussed support to curb waste and fraud from the Medicare and Medicaid programs. (no bill) H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2012 - Discussed the legislation as it pertained to SGR. Discussed Medicare Reform. (no bill) H.R. 2305/S. 1123, PRIME ACT (Preventing and Reducing Improper Medicare Expenditures) - Discussed support for bill and urged cosponsorship. Discussed the Medicare Part D prescription drug benefit program and changes needed to further lower prescription drug costs. (no bill) H.R. 1588/S. 740, Medicare Drug Savings Act - Discussed the Medicare Drug Savings Act to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. Discussed potential improvements to the Medicare Savings Programs for low-income befeficiaries. (no bill) Discussed proposals that would establish per-capita caps under Medicaid as well as other Medicaid financing proposals including block grants and changes to the current FMAP structure. (no bill) H.R. 1717 - Discussed Medicare DMEPOS Market Pricing Program Act. Discussed implementation of regulations regarding minimum wage and overtime for home care workers and consumer-directed care. (no bill) Discussed the Medicare Part D prescription drug benefit program and changes needed to further lower prescription drug costs and related agency proposed rule changes. (no bill) H. R. 1588/S.740 - Discussed the Medicare Drug Savings Act to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. H.R.3830/S.1900 - Discussed pending U.S. trade agreement negotiations and trade promotional or "fast track" authority legislation and their potential impact on Medicare and Medicaid prescription drug programs. S. 2461 - Discussed Children's Health Insurance Program (CHIP) extension and CHIP Extension Act of 2014. Discussed Part D Payment for Drugs for Beneficiaries Enrolled in Hospice - Final 2014 CMS Guidance. H.R.5294, Health Equity & Accountability Act of 2014 - Addresses health care disparities; no endorsement due to budget impact. Medicare Advantage- Answered questions from some Hill offices. (no bill) Medicare Supplemental Insurance - Stated opposition to the elimination of first dollar coverage. (no bill)Discussed Medicare Graduate Nursing Education pilot design. (no bill) Discussed Prescription Drug Affordability. (no bill) Discussed Prescription Drug Shortages. (no bill) H.R. 3342, Affordable Medicines Utilization Act of 2011 - Lobbied to encourage state Medicaid programs to use safe, effective generic medications. H.R. 2576 - Discussion to amend the Internal Revenue Code of 1986 to modify the calculation of modified adjusted gross income for purposes of determining eligibility for certain healthcare-related programs. Discussed opposition to caps on dual eligibles; discussed managed care and dual eligibles. (no bill) Discussed with CMS demonstration programs for dual eligibles and process related to the demonstrations, as well as other work of the Medicare-Medicaid Coordination Office, discussed consumer choice and continuity of care in Medicaid managed long-term services and supports programs, discussed focus groups on dual eligibles. Discussed Hospital & Critical Access Hospitals Conditions of Participation proposed regulations; requested that advanced practice registered nurses and physicians assistants be allowed the full scope of services in hospital admitting and visiting privileges. (no bill) Discussed Hospital Outpatient Therapeutic Services Final Rule underscoring that advanced practice registered nurses and physicians should be allowed to supervise such outpatient service clinics without physician oversight as long as in line with state scope of practice laws. (no bill) Discussed health disparities. (no bill) Discussed Medicaid reform, Medicare/Medicaid "dual eligibles" integration efforts and financial alignment demonstrations; and other CMS demonstration initiatives. (no bill) S. 3586, Recruiting Individuals to Drive Elders (RIDE) Act - Discussed Medicaid non-emergency transportation bill (112th). Discussed proposals that would establish per-capita caps under Medicaid as well as other Medicaid financing proposals including block grants and changes to the current FMAP structure. (no bill) Discussed extension of funding originally provided under the Medicare Improvement for Patients and Providers Act (P.L. 110-275) to State Health Insurance Assistance Programs (SHIPs), Aging and Disability Resource Centers (ADRICs), and Area Agencies on Aging (AAAs) for Medicare outreach and enrollment counseling. (no bill) Discussed the prevention of cuts to beneficiaries in the Medicare program. (no bill) Discussed the prevention of an increase in the age of eligibility in the Medicare program. (no bill) Discussed the patch to the Sustainable Growth Rate (SGR) in the Medicare program. (no bill) Discussed concerns of block granting Medicaid. (no bill) Discussed the Kansas managed long-term services and supports waiver proposals and related implementation issues. (no bill). H.R.928/S.408, the Medicare Drug Savings Act - Discussed requirement for drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. Discussed Health Disparities. (no bill) Discussed medicare demonstration project replacing standard medicare cards with Smart Card technology. (no bill) H.R. 574 - The Medicare Physician Payment Innovation Act of 2013. Discussed Medicaid expansion and estate recovery. (no bill) Discussed Medicaid and asset transfers. (no bill) H.R.4994/S. 2553, Improving Medicare Post-Acute Care Transformation Act of 2014 - Discussed the bill and AARP support for the bill. Shared our letter of support. S. 2491, Discussed Medicare Protection Act. Discussed concern about CMS guidance on prescription drugs for medicare beneficiaries receiving hospice and coordination between hospice providers and medicare Part D sponsors. (no bill) H.R. 1179/S.569 - Submitted statement for the record for Senate Aging Committee hearing on Observation Improving Access to Medicare Coverage Act and Notice of Observation Treatment and Implication for Care Eligibility Act (H.R. 5232). Discussed aging in place, HCBS, family caregiving. (no bill)H.R. 1179/S.569, Improving Access to Medicare Act - Discussed support of Improving Access to Medicare Coverage Act and urged cosponsorship and advancement of the bill. Discussed CMS information regarding healthcare marketplaces. H.R. 2305/S.1123, Preventing and Reducing Improper Medicare and Medicaid Expenditures Act. Bill reduces waste, fraud, and abuse in Medicare and Medicaid programs. Discussed Competitive bidding of durable medical equipment, prosthetics, orthotics, and supplies. (no bill) Discussed repeal of Affordable Care Act provision making prescriptions necessary for over-the-counter drugs purchased with flexible spending accounts. (no bill) Discussed Medicare supplemental coverage. (no bill) Discussed the Medicare Part D prescription drug benefit program and changes needed to further lower prescription drug cost. (no bill) Discussed potential improvements to the Medicare Savings Programs for low-income beneficiaries. (no bill) Discussed Recruiting Individuals to Drive Our Elders Act (RIDE) would increase state flexibility by giving states the option to receive federal assistance to reimburse their volunteer drivers for no-load miles. (no bill) Labor, Health and Human Services Appropriations Act, 2015 - Lobbied to protect vital health and social services programs from enhanced reductions from the prior year baseline, and to prevent repeal of certain financial and health care-related regulation.(no bill) Discussed potential improvements to the Medicare Savings Programs for low-income beneficiares. (no bill) Discussed pending U.S. trade agreement negotiations, including trade promotional or 'fast track' authority, and their potential impact on Medicare and Medicaid prescription drug programs. (no bill) Discussed fraud, Medicare home healthcare, ways to find savings in Medicare without harming Medicare beneficiaries (care coordination, prescription drugs, waste, fraud and abuse). Discussed You've Earned A Say, ways to find savings in medicare without harming medicare beneficiaries (care coordination, prescription drugs, waste, fraud and abuse). PL.111-148 - Discussed implementation of provision to require reporting of nursing home staffing data based on payroll data. Discussed the draft legislation on Medicare fraud and abuse. Protecting the Integrity of Medicare Act. (no bill) Discussed the Medicare Part D prescription drug benefit program and changes needed to further lower prescription drug costs and related agency proposed rule changes. (no bill) H.R. 1588/S.740 - Discussed the Medicare Drug Savings Act to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. H.R. 3830/S. 1900 - Discussed pending U.S. trade agreement negotiations and trade promotional or "fast track" authority legislation and their potential impact on Medicare and Medicaid prescription drug programs. S. 2461 - Discussed Children's Health Insurance Program (CHIP) Extension Act of 2014. Discussed Part D Payment for Drugs for Beneficiaries Enrolled in Hospice-Final 2014 CMS Guidance. Discussed the Protecting Integrity of Medicare Act. (no bill) H.R.5435, Home Infusion Site of Care Act - Sent letter of endorsement H.R. 5958 - Discussed the ACO Improvement Act. H.R. 5232 - Discussed and sent letter on the Notice of Observation Treatment and Implication for Care Eligibility Act. Met with Centers for Medicare and medicaid services to discuss three-day stay requirement for medicare skilled nursing coverage. H.J. Res. 124, Continuing Appropriations Resolution - Lobbied to protect funding levels for CMS program management under Continuing Resolution. Discussed coordination with hospice providers and Medicare Part D plans guidance for Medicare beneficiaries receiving hospice. (no bill) H.R. 1179/S. 569 - Discussed observation impace on Medicare beneficiaries, counting time in observation toward Medicare's three-day inpatient hospital stay requirement for Medicare skilled nursing facility coverage, and the Improving Access to Medicare Coverage Act (CMS & MedPAC). Discussed caucus for military/veteran family caregivers and support for family caregivers. (no bill) Discussed draft working paper on impact of observation on Medicare beneficiary out of pocket. (no bill)Discussed District of Columbia EPD Medicaid HCBS waiver. (no bill) H.R. 5232 - Discussed legislation and shared letter of support for the Notice of Observation Treatment and Implication for Care Eligibility (NOTICE) Act of 2014. Discussed Medicare Advantage. (no bill) Discussed H.R. 3616, Protecting Seniors from Healthcare Fraud Act. Discussed observation care and "two-midnight rule". (no bill) H.R. 1070, the Removing Barriers to Colorectal Cancer Screening Act - Discussed and sent letter of endorsement to bill. Discussed the Medicare Part D prescription drug benefit program and changes needed to further lower prescription drug costs and related agency proposed rule changes. (no bill) H.R. 1588/S.740, Medicaid Drug Savings Act - Discussed the requirement for drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. Discussed potential improvements to the Medicare Savings Programs for low-income beneficiaries. (no bill) Discussed pending U.S. Trade agreement negotiations, including trade promotional or "fast track" authority, and their potential impact on Medicare and Medicaid prescription drug programs. (no bill) H.R. 2810/S.1871/H.R. 4015/S.2110 - Discussed SGR repeal and health care extender provisions, including the Qualified Individual low-income Medicare beneficiary assistance program. H.R. 4418, The Expanding Availability of Medicare Data Act - Sent letter of endorsement. Discussed Medicare data and billing transparency. (no bill) Discussed socio-economic risk adjustment. (no bill) S. 2240 - Discussed Medicare Choices Empowerment and Protection Act. H.R. 3024 - Discussed the Medicare Common Access Card Act. H.R. 4673-Discussed the Bundling and Coordinating Post Acute Care (BACPAC) Act and shared views on post-acute care return. Discussed Medicare expansion. (no bill) Discussed Medicaid Labs Spousal Impoverishment provisions (PL. 111-198). S. 2361, Discussed Stop Schemes and cons against Medicare and seniors. Discussed transparency in healthcare. (no bill) Discussed LTSS Hill briefing series. (no bill) Met with CMS on observation status. (no bill) Submitted comment letter to CMS on the FY2015 Medicare Hospice proposed regulation. Shared comment letter with some Hill staff. H.R. 4994/S.2553 - Shared letter of support for Improving Medicare Post-Acute Care Transformation Act and discussed the status of the bill. Discussed long-term survey and supports Hill briefings. (no bill) Submitted comment letter to CMS on the FY 2015 Medicare Home Health proposed regulation. Shared draft working paper on impact of observation on Medicare beneficiary out of pocket cost. (no bill) Responded to inquiry on observation. (no bill)
Filing targets: Administration on Aging, Agriculture, Dept of (USDA), Bureau of the Census, Centers For Medicare and Medicaid Services (CMS), Commodity Futures Trading Commission (CFTC), Congressional Budget Office (CBO), Energy, Dept of, Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Federal Communications Commission (FCC), Federal Highway Administration (FHA), Federal Reserve System, Federal Trade Commission (FTC), Federal Transit Administration (FTA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Highway Traffic Safety Administration (NHTSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of the Comptroller of the Currency (OCC), Pension Benefit Guaranty Corporation (PBGC), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
Discussed importance of potential savings both to consumers and to the federal government of granting Secretarial Negotiating Authority to Secretary of HHS on Medicare Part D. (no bill)Discussed legislative intent with respect to biologic drugs and the exclusivity period; and discussed importance of potential savings to the health care system generally. (no bill) Discussed need for greater consumer safety protections both in OTC and prescription drugs. (no bill) Discussed need for doctors to get unbiased information on prescription pharmaceuticals through programs like academic detailing. (no bill) Discussed possible savings and better health care outcomes that could result from Medication Therapy Management. (no bill) Pub. Law 111-148 and 111-152 - Discussed implementation of health care legislation to reform the health care system to provide quality healthcare, expand access to long-term services and supports, and reduced prescription drug costs. Discussed greater affordability of generic versions of both generic and biologic drugs. S. 319, Pharmaceutical Market Access and Drug Safety Act of 2011 - Discussed legislation that establishes a framework for the safe, legal importation of lower-priced prescription drugs from abroad. S. 1206, Medicare Drug Savings Act of 2011 - Discussed rebates in Medicare Part D as a cost savings measure in Medicare that does not harm beneficiaries. H. R. 3342, Affordable Medicines Utilization Act of 2011 - Lobbied on legislation to encourage state Medicaid programs to use safe, effective generic medications. S. 27, Preserve Access to Affordable Generics Act of 2011- Lobbied for this legislation preventing abuses in patent settlements between generic and brand name prescription drug companies. S. 1886/H.R. 3468 of 2011- Discussed counterfeit drug penalty enhancement. Discussed prescription drug safety, drug shortage, and medical device safety, and related user fee legislation. S. 2193 of 2012, the Ensuring Safe Medical Devices for Patients Act - Discussed legislation to include devices in the post-market risk identification and analysis system for prescription drugs and to expedite the implementation of the unique device identification system for medical devices. Discussed draft legislation to address the issue of whether generic drug manufacturers have a duty to include new warnings about potentially serious side effects on their labels as they become known by giving generic drug makers the same ability to update their labeling as manufacturers of brand name drugs. (no bill) S.3187, Food and Drug Administration safety and Innovation Act - FDA user fee agreement legislation focusing on the review process for prescription drugs and medical devices, prescription drug safety, drug shortages, medical device safety and access to generic drugs. S.3212, Cody Miller Initiative for Safer Prescriptions Act - To require the Secretary of Health and Human Services to promulgate regulations regarding the authorship, content, format, and dissemination of Patient Medication information. Discussed pay-for-delay agreements as tactic by drug manufacturers to block lower cost drugs from entering the market, and the Fair and Immediate Release of Generics Drugs Act that would address the underlying issue of "parked exclusivities" in the Hatch-Waxman Act (S.1882). Discussed the issue of biosimilar drug naming and how biosimilars should use a common International Non-proprietary name as reference originator biologic products. (no bill) S. 504, the Fair and Immediate Release of Generic Drugs Act/S.214, the Preserve Access to Affordable Generics Act - Discussed the Patient Safety and Generic Labeling Improvement Act. (no bill) H.R. 4800/S. 2389, Agriculture Appropriations bill, 2015 - Lobbied to protect and enhance funding levels for FDA to enable it to effectively manage it's food safety and medical product programs.Discussed Unique Device Identification (UDI) issues including proposed rules and implementation. (no bill) Discussed oversight of laboratory genetic testing. (no bill) Discussed AARP's concerns with prescription drug costs. (no bill) S.117, Medicare Prescription Drug Price Negotiation Act - Discussed bill that allows medicare to negotiate medicare prescription drug prices with drug companies. S.504/S.214, The Fair and Immediate Release of Generics Drugs Act/Preserve Access to Affordable Generics Act - Discussed legislation to address pay-for-delay agreements used by drug manufacturers to block lower cost drugs from entering the market. Discussed the exclusivity period for biologic drugs. (no bill) Discussed the Patient Safety and Generic Labeling Improvement Act. (no bill) Discussed biologic drug issues including implementation of the new approval pathway for biosimilar drugs. (no bill) Discussed the importance of potential savings to both consumers and the federal government of granting Secretarial negotiating authority to the HHS Secretary under Medicare Part D. (no bill) S. 504, the Fair and Immediate Release of Generics Drugs Act/S. 214, the Preserve Access to Affordable Generics - Discussed legislation to address pay-for-delay agreements used by drug manufacturers to block lower cost drugs from entering the market. Discussed the exclusivity period ofr biologic drugs. (no bill) Discussed the Food and Drug Administration proposed rule to enable generic drug makers to independently update their drug labeling. (no bill) Discussed biologic drug issues including implementation of the new approval pathway for biosimilar drugs. (no bill) S. 1720/S.2049/S.866, - Discussed patent reform legislation and related provisions. Discussed the importance of potential savings to both consumers and the federal government of granting Secretarial negotiating authority to the HHS Secretary under Medicare Part D. (no bill) Discussed legislation to address pay-for-delay agreements used by drug manufacturers to block lower cost drugs from entering the market (the Fair and Immediate Release of Generic Drugs Act (S. 504) and (the Preserve Access to Affordable Generics Act) (S.214). Discussed the exclusivity period for biologic drugs. (no bill) Discussed the Food and Drug Administration proposed rule to enable generic drug makers to independently update their drug labeling. (no bill) Discussed biologic drug issues including implementation of the new approval pathway for biosimilar drugs. (no bill) S. 1720/S. 2049/S.866 - Discussed patent reform legislation and related provisions. Discussed other prescription drug issues and potential legislation on drug importation and "least costly alternative" payment for Part B durgs. (no bill)
S.452, Medicare Diabetes Prevention Act - Discussed bill with Senate. Discussed draft language on senior mental health with Senate HELP Committee staff. (no bill) Discussed Medicare Reform (no bill) Discussed Age Rating in the ACA and rate shock. (no bill)Labor, HHS Appropriations bill, 2015-Lobbied on preserving funding for the ACA; defended meaningful use of the ACA. (no bill) Discussed need to increase health information technology quality measurements and access to qualified systems. (no bill) H.R. 1099, To repeal the Prevention and Public Health Fund - Lobbied against the repeal of the Prevention and Public Health Trust Fund, an important component in state and community efforts to prevent illness and promote health. Discussed Pre-existing Condition Insurance Program. (no bill) Discussed Accountable Care Organization and Medical Shared savings. (no bill) Discussed Rate Review. (no bill) Discussed Internal Appeals and External Review Process. (no bill) Discussed Medicare reimbursement issues. Lobbied in support of Medicare physician payment reform. Discussed legislation to make prescription drugs more affordable to older Americans. S. 1416/H.R. 2645 (112th Congress), Medigap Medical Loss Ratio Improvement Act of 2011. Discussed coverage for screening depression and screening and counseling for alcohol misuse. (no bill) Discussed consumer operated and oriented plan programs. (no bill) Discussed standards related to risk adjustment, reinsurance, and risk mitigation as they relate to exchanges. (no bill) H.R.2077, MLR Repeal Act of 2011 - Expressed opposition to the elimination of provision in the Affordable Care Act (P.L. 111-148)Discussed opposition to draft legislation regarding the elimination of grandfathered status. (no bill) Discussed association health plans with DOL, HHS and DOT. (no bill) Discussed quality and care coordination with HHS. (no bill) Discussed Essential Health Benefits with HHS. (no bill) Discussed employer affordability safe harbor. (no bill) Discussed health insurance exchanges - eligibility, enrollment, premium tax credits. (no bill) Discussed Basic Health Plans. (no bill) Discussed Medigap reform. (no bill) Discussed Pre-existing Condition Insurance Program. (no bill) Discussed role of grandfathered plans. (no bill) Discussed reauthorization of the Older Americans Act and other amendments to the OAA. (no bill) Discussed dual eligibles. (no bill) Discussed S.1119, Positive Aging Act of 2013. H.R. 2641, Farm Program bill-Discussed the severed nutrition programs from Farm Bill. S. 562, Seniors Mental Health Access Improvement Act - Discussed the bill for eventual endorsement. Discussed Care Corps. (no bill) Discussed need to suport family caregivers and long-term services and supports. (no bill) Discussed repeal of medical device tax. (no bill) Discussed proposed regulation relating to Medicaid expansion coverage and minimum essential coverage. (no bill) Discussed Affordable Care Act Medicaid expansion issues, including AARP comments on state 1115 waiver proposals to use premium assistance authority to expand Medicaid. (no bill) Discussed Medicare-Medicaid integration efforts and financial alignment demonstrations, other CMS demonstration initiatives. (no bill) H.R.3850/S. 1562, Discussed Older Americans Act reauthorization legislation.Discussed FTC participation in state scope of practice issues. Also sent follow-up items for their review. (no bill) Discussed Social Security programs. (no bill) Lobbied against cuts to the health care prevention fund. (no bill) Discussed deficit reduction issues dealing with Medicare and Medicaid including concerns over increasing Medicare's age of eligibility, chained CPI, and cuts to Medicaid. (no bill) Discussed Affordable Care Medicaid expansion issues. Centers for Medicare and Medicaid Services, Center for Medicaid and CHIP Services. Discussed Medicaid reform, Medicare-Medicaid integration efforts and financial alignment demonstrations, other CMS demonstration initiatives. (no bill) Discussed Medicaid expansion implementation, as included in the ACA (P.L. 111-140). Discussed Medicaid including concerns over cuts to Medicaid flexibility and Medicaid structural reforms to. (no bill) Discussed implementation of the Affordable Care Act, its provisions and H.R. 95 to repeal the Patient Protection and Affordable Care Act. S. Con. Res. 8/ H.Con. Res. 25, Concurrent Resolution on the Budget, 2014 - Lobbied to prevent inclusion of Medicare, Medicaid and Social Security benefit cuts and to protect vital health, social services, housing and transportation programs from enhanced reductions from the prior year baseline, and to prevent repeal of certain financial and health care-related regulation. H.R. 1549, Helping Sick Americans Now Act - Discussed cuts to the health care prevention fund. The Labor, Health and Human Services Appropriations Act, 2015 - Lobbied to protect employment, health and human services and energy assistance programs for seniors, disabled and low income assistance. (no bill) Discussed Affordable Care Act Medicaid expansion issues, including questions related to the use of premium assistance authority to expand Medicaid. (no bill) H.R. 1263, Excellence in Mental Health Act - Discussed the bill for eventual endorsement. Discussed Affordable Care Act Medicaid expansion issues, including AARP comments on state 1115 waiver proposals to use premium assistance authority to expand Medicaid, Centers for Medicare and Medicaid Services, Center for Medicaid and CHIP Services. Discussed perspectives on proposed ideas for legislation to address health disparities with HHS and CMS officials. Discussed H.R. 3717, the Helping Families in Mental Health Crisis Act. Discussed Affordable Care Act Medicaid expansion issues, including AARP comments on state 1115 waiver proposals to use premium assistance authority to expand Medicaid. Centers for Medicare and Medicaid Services, Center for Medicaid and CHIP Services. Discussed Medicare-Medicaid integration efforts and financial alignment demonstrations, other CMS demonstration initiatives. (no bill) Discussed National Alzheimer's Project Act 111-375. Discussed the Convention on the Rights of Persons with Disabilities. (no bill) Discussed family caregiving, doctors and health professionals engaging family caregivers of older adults with multiple chronic conditions, family caregiver assessment, shared relevant information. (no bill) H.R. 2835/S. 1647, Restoring Access to Medication Act of 2013 - Urged co-sponsorship of these bills. Submitted statement for the record to the Advisory Counsel on Alzheimer's Disease, Research, Care & Services for their April meeting. Discussed hospital readmissions. (no bill)
Filing targets: Administration on Aging, Agriculture, Dept of (USDA), Bureau of the Census, Centers For Medicare and Medicaid Services (CMS), Commodity Futures Trading Commission (CFTC), Energy, Dept of, Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Federal Communications Commission (FCC), Federal Highway Administration (FHA), Federal Reserve System, Federal Trade Commission (FTC), Federal Transit Administration (FTA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Highway Traffic Safety Administration (NHTSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of the Comptroller of the Currency (OCC), Pension Benefit Guaranty Corporation (PBGC), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
S.452, Medicare Diabetes Prevention Act - Discussed bill with Senate. Discussed draft language on senior mental health with Senate HELP Committee staff. (no bill) Discussed Medicare Reform (no bill) Discussed Age Rating in the ACA and rate shock. (no bill)Lobbied on preserving funding for the ACA; defended meaningful use of the ACA. (no bill) Discussed need to increase health information technology quality measurements and access to qualified systems. (no bill) H.R. 1099, To repeal the Prevention and Public Health Fund - Lobbied against the repeal of the Prevention and Public Health Trust Fund, an important component in state and community efforts to prevent illness and promote health. Discussed Pre-existing Condition Insurance Program. (no bill) Discussed Accountable Care Organization and Medical Shared savings. (no bill) Discussed Rate Review. (no bill) Discussed Internal Appeals and External Review Process. (no bill) Discussed Medicare reimbursement issues. Lobbied in support of Medicare physician payment reform. Discussed legislation to make prescription drugs more affordable to older Americans. S. 1416/H.R. 2645 (112th Congress), Medigap Medical Loss Ratio Improvement Act of 2011. Discussed coverage for screening depression and screening and counseling for alcohol misuse. (no bill) Discussed consumer operated and oriented plan programs. (no bill) Discussed standards related to risk adjustment, reinsurance, and risk mitigation as they relate to exchanges. (no bill) H.R.2077, MLR Repeal Act of 2011 - Expressed opposition to the elimination of provision in the Affordable Care Act (P.L. 111-148)Discussed opposition to draft legislation regarding the elimination of grandfathered status. (no bill) Discussed association health plans with DOL, HHS and DOT. (no bill) Discussed quality and care coordination with HHS. (no bill) Discussed Essential Health Benefits with HHS. (no bill) Discussed employer affordability safe harbor. (no bill) Discussed health insurance exchanges - eligibility, enrollment, premium tax credits. (no bill) Discussed Basic Health Plans. (no bill) Discussed Medigap reform. (no bill) Discussed Pre-existing Condition Insurance Program. (no bill) Discussed role of grandfathered plans. (no bill) Discussed reauthorization of the Older Americans Act and other amendments to the OAA. (no bill) Discussed dual eligibles. (no bill) Discussed S.1119, Positive Aging Act of 2013. H.R. 2641, Farm Program bill-Discussed the severed nutrition programs from Farm Bill. S. 562, Seniors Mental Health Access Improvement Act - Discussed the bill for eventual endorsement. Discussed Care Corps. (no bill) Discussed need to suport family caregivers and long-term services and supports. (no bill) Discussed repeal of medical device tax. (no bill) Discussed proposed regulation relating to Medicaid expansion coverage and minimum essential coverage. (no bill)Discussed FTC participation in state scope of practice issues. Also sent follow-up items for their review. (no bill) Discussed Social Security programs. (no bill) Lobbied against cuts to the health care prevention fund. (no bill) Discussed deficit reduction issues dealing with Medicare and Medicaid including concerns over increasing Medicare's age of eligibility, chained CPI, and cuts to Medicaid. (no bill) Discussed Affordable Care Medicaid expansion issues. Centers for Medicare and Medicaid Services, Center for Medicaid and CHIP Services. Discussed Medicaid reform, Medicare-Medicaid integration efforts and financial alignment demonstrations, other CMS demonstration initiatives. (no bill) Discussed Medicaid expansion implementation, as included in the ACA (P.L. 111-140). Discussed Medicaid including concerns over cuts to Medicaid flexibility and Medicaid structural reforms to. (no bill) Discussed implementation of the Affordable Care Act, its provisions and H.R. 95 to repeal the Patient Protection and Affordable Care Act. H. R. 933, Consolidated and Further Continuing Appropriations Act, 2013 - Lobbied to protect vital health and social services programs from enhanced reductions from the prior year baseline, and to prevent repeal of certain financial and health care-related regulation. S. Con. Res. 8/ H.Con. Res. 25, Concurrent Resolution on the Budget, 2014 - Lobbied to prevent inclusion of Medicare, Medicaid and Social Security benefit cuts and to protect vital health, social services, housing and transportation programs from enhanced reductions from the prior year baseline, and to prevent repeal of certain financial and health care-related regulation. H.R. 1549, Helping Sick Americans Now Act - Discussed cuts to the health care prevention fund. S. 1284, The Labor, Health and Human Services Appropriations Act, 2014 - Lobbied to protect employment, health and human services and energy assistance programs for seniors, disabled and low income assistance. Discussed Affordable Care Act Medicaid expansion issues, including questions related to the use of premium assistance authority to expand Medicaid. (no bill) H.R. 1263, Excellence in Mental Health Act - Discussed the bill for eventual endorsement. Discussed Affordable Care Act Medicaid expansion issues, including AARP comments on state 1115 waiver proposals to use premium assistance authority to expand Medicaid, Centers for Medicare and Medicaid Services, Center for Medicaid and CHIP Services. Discussed perspectives on proposed ideas for legislation to address health disparities with HHS and CMS officials. H.R 3547/H.J.R. 59/H.R. 2775/H.J.R. 106, Consolidated Appropriations Act, 2014 - Lobbied to protect employment, health and human services and energy assistance programs for seniors, disabled and low income assistance. Discussed H.R. 3717, the Helping Families in Mental Health Crisis Act. Discussed Affordable Care Act Medicaid expansion issues, including AARP comments on state 1115 waiver proposals to use premium assistance authority to expand Medicaid. Centers for Medicare and Medicaid Services, Center for Medicaid and CHIP Services. Discussed Medicare-Medicaid integration efforts and financial alignment demonstrations, other CMS demonstration initiatives. (no bill) Discussed National Alzheimer's Project Act 111-375.
Pub.Law 111-148 & 111-152 - Discussed implementation of health care law that would reform the health care system to provide affordable quality health care, reduce drug costs and expand access to long-term services and supports. Discussed how to implement Medicaid provisions of Affordable Care Act. (PL. 111-148)S. 374, Medicare Mental Health Inpatient Equity Act - Lobbied in support of this legislation to eliminate the 190-day lifetime limit on Medicare coverage for in-patient psychiatric hospital services (112th). Discussed improving access to care for underserved population. (no bill) Discussed importance of maintaining low income subsididies and supports in Medicare. (no bill) Discussed the importance of coordinating services for those who qualify for both Medicare and Medicaid in order to ensure that beneficiaries receive all needed benefits but there is no duplication. (no bill) Discussed whether, and under what circumstances, managed care could effectively be used to provide benefits to dual eligible beneficiaries. (no bill) Discussed additional methods for fighting fraud and waste in Health Care. (no bill) Discussed Medigap and need for guaranteed issue for all populations and need to increase medical loss ratio. Discussed durable medical equipment bidding. (no bill) Lobbied for legislation to provide Medicare beneficiaries with additional opportunities to enroll in Medicare Part B.(no bill) Lobbied against the use of the Social Security account number on Government-issued identification cards issued in connection with Medicare, Medicaid, and SCHIP benefits and for other purposes. (no bill) Discussed support to curb waste and fraud from the Medicare and Medicaid programs. (no bill) H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2012 - Discussed the legislation as it pertained to SGR. Discussed Medicaid long-term services and supports. (no bill) Discussed Medicare Reform. (no bill) H.R. 2305/S. 1123, PRIME ACT (Preventing and Reducing Improper Medicare Expenditures) - Discussed support for bill and urged cosponsorship. Discussed the Medicare Part D prescription drug benefit program and changes needed to further lower prescription drug costs. (no bill) H.R. 1588/S. 740, Medicare Drug Savings Act - Discussed the Medicare Drug Savings Act to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. Discussed potential improvements to the Medicare Savings Programs for low-income befeficiaries. (no bill) Discussed proposals that would establish per-capita caps under Medicaid as well as other Medicaid financing proposals including block grants and changes to the current FMAP structure. (no bill) Discussed measures for re-balancing in medicaid managed LTSS waivers and dual demonstration programs in sign on letter to CMS. (no bill) H.R. 1717 - Discussed Medicare DMEPOS Market Pricing Program Act. H.R. 3531 - Discussed Creating Access to Rehabilitation for Every Senior (CARES) Act. Discussed implementation of regulations regarding minimum wage and overtime for home care workers and consumer-directed care.Discussed Medicare Graduate Nursing Education pilot design. (no bill) Discussed Prescription Drug Affordability. (no bill) Discussed Prescription Drug Shortages. (no bill) H.R. 3342, Affordable Medicines Utilization Act of 2011 - Lobbied to encourage state Medicaid programs to use safe, effective generic medications. H.R. 2576 - Discussion to amend the Internal Revenue Code of 1986 to modify the calculation of modified adjusted gross income for purposes of determining eligibility for certain healthcare-related programs. Discussed opposition to caps on dual eligibles; discussed managed care and dual eligibles. (no bill) Discussed with CMS demonstration programs for dual eligibles and process related to the demonstrations, as well as other work of the Medicare-Medicaid Coordination Office, discussed consumer choice and continuity of care in Medicaid managed long-term services and supports programs, discussed focus groups on dual eligibles. Discussed Medicaid managed care and long-term services and supports broadly. Discussed Hospital & Critical Access Hospitals Conditions of Participation proposed regulations; requested that advanced practice registered nurses and physicians assistants be allowed the full scope of services in hospital admitting and visiting privileges. (no bill) Discussed Hospital Outpatient Therapeutic Services Final Rule underscoring that advanced practice registered nurses and physicians should be allowed to supervise such outpatient service clinics without physician oversight as long as in line with state scope of practice laws. (no bill) Discussed health disparities. (no bill) Discussed Medicaid reform, Medicare/Medicaid "dual eligibles" integration efforts and financial alignment demonstrations; and other CMS demonstration initiatives. (no bill) Discussed the AARP Initiative called "You've Earned a Say". (no bill) S. 3586, Recruiting Individuals to Drive Elders (RIDE) Act - Discussed Medicaid non-emergency transportation bill (112th). Discussed proposals that would establish per-capita caps under Medicaid as well as other Medicaid financing proposals including block grants and changes to the current FMAP structure. (no bill) Discussed extension of funding originally provided under the Medicare Improvement for Patients and Providers Act (P.L. 110-275) to State Health Insurance Assistance Programs (SHIPs), Aging and Disability Resource Centers (ADRICs), and Area Agencies on Aging (AAAs) for Medicare outreach and enrollment counseling. (no bill) Discussed the prevention of cuts to beneficiaries in the Medicare program. (no bill) Discussed the prevention of an increase in the age of eligibility in the Medicare program. (no bill) Discussed the patch to the Sustainable Growth Rate (SGR) in the Medicare program. (no bill) Discussed concerns of block granting Medicaid. (no bill) Discussed the Kansas managed long-term services and supports waiver proposals and related implementation issues. (no bill). H.R.928/S.408, the Medicare Drug Savings Act - Discussed requirement for drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. Discussed Health Disparities. (no bill) Discussed medicare demonstration project replacing standard medicare cards with Smart Card technology. (no bill) H.R. 574 - The Medicare Physician Payment Innovation Act of 2013. H.R. 1173 - Discussed Personalize Your Care Act. Discussed observation issues. (no bill) Discussed rebalancing measures in Medicaid managed LTSS in 1115 waivers and duals demonstration programs. (no bill) Discussed proposed regulation relating to Medicaid expansion coverage and minimum essential coverage. (no bill) Discussed Medicaid expansion and estate recovery. (no bill) Discussed Medicaid and asset transfers. (no bill) Discussed draft legislation regarding Dual Eligible Special Need Plans (D-SNP) - Strengthing Healthcare Options for Vulnerable Populations Act. (no bill) Discussed post-acute care reform. (no bill)H.R. 1179/S.569, Improving Access to Medicare Act - Discussed support of Improving Access to Medicare Coverage Act and urged cosponsorship and advancement of the bill. Participated on press call on the bill. Discussed comments regarding Medicare and You handbook. (no bill) Discussed CMS information regarding healthcare marketplaces. H. R. 933, Consolidated and Further Continuing Appropriations Act, 2013 - Lobbied to protect vital health and social services programs from enhanced reductions from the prior year baseline, and to prevent repeal of certain financial and health care-related regulation. S. Con. Res. 8, Concurrent Resolution on the Budget, 2014 - Lobbied to prevent inclusion of Medicare, Medicaid and Social Security benefit cuts and to protect vital health, social services, housing and transportation programs from enhanced reductions from the prior year baseline, and to prevent repeal of certain financial and health care-related regulation. H.Con. Res. 25, Concurrent Resolution on the Budget, 2014 - Lobbied to prevent inclusion of Medicare, Medicaid and Social Security benefit cuts and to protect vital health, social services, housing and transportation programs from enhanced reductions from the prior year baseline, and to prevent repeal of certain financial and health care-related regulation.Lobbied on expected "QM" safe harbor amendment. (The amendment was not offered) H.R. 2305/S.1123, Preventing and Reducing Improper Medicare and Medicaid Expenditures Act. Bill reduces waste, fraud, and abuse in Medicare and Medicaid programs. Discussed Competitive bidding of durable medical equipment, prosthetics, orthotics, and supplies. (no bill) Discussed repeal of Affordable Care Act provision making prescriptions necessary for over-the-counter drugs purchased with flexible spending accounts. (no bill) Discussed Medicare supplemental coverage. (no bill) Discussed the Medicare Part D prescription drug benefit program and changes needed to further lower prescription drug cost. (no bill) Discussed potential improvements to the Medicare Savings Programs for low-income beneficiaries. (no bill) Discussed Recruiting Individuals to Drive Our Elders Act (RIDE) would increase state flexibility by giving states the option to receive federal assistance to reimburse their volunteer drivers for no-load miles. (no bill) H.R. 3547/H.J.R. 59/H.R. 2775/H.J.R. 106, Consolidated Appropriations Act, 2014 - Lobbied to prevent inclusion of Medicare, Medicaid and Social Security benefit cuts and to protect vital health, social services, housing and transportation programs from enhanced reductions from the prior year baseline, and to prevent repeal of certain financial and health care-related regulation. S. 1284, Labor, Health and Human Services Appropriations Act, 2014 - Lobbied to protect vital health and social services programs from enhanced reductions from the prior year baseline, and to prevent repeal of certain financial and health care-related regulation. Discussed potential improvements to the Medicare Savings Programs for low-income beneficiares. (no bill) Discussed pending U.S. trade agreement negotiations, including trade promotional or 'fast track' authority, and their potential impact on Medicare and Medicaid prescription drug programs. (no bill) H.R. 2810/S. 1871 - Discussed SGR repeal and health care extender provisions, including the Qualified Individual low-income Medicare beneficiary assistance program. Discussed fraud, Medicare home healthcare, ways to find savings in Medicare without harming Medicare beneficiaries (care coordination, prescription drugs, waste, fraud and abuse). Discussed you've earned a say, ways to find savings in medicare without harming medicare beneficiaries (care coordination, prescriotion drugs, waste, fraud and abuse). Discussed implementation of provision to require reporting of nursing home staffing data based on payroll data. (no bill) S. 1932/H.R. 3890 - Discussed logistics and attended event to introduce the Better Care, Lower Cost Act. Discussed non-residential settings and Medicaid home and community-based setting final regulation. (no bill) Discussed person-centered planning and family caregiver assessment in Medicaid HCBS state plan option final rule. Submitted comment letter on distaster preparedness requirements for Medicare and Medicaid providers. (no bill) Discussed Money Follows the Person Rebalancing Demonstration and Balancing Incentive Payments Program. (no bill)Discussed Medicare Advantage. H.R. 3616, Protecting Seniors from Medicare Act- Sent letters endorsing bill. H.R. 2810, The SGR Repeal and Medicare Beneficiary Improvement Act - Sent letters endorsing bill. Discussed observation care and "two-midnight rule". H.R. 1070, the Removing Barriers to Colorectal Cancer Screening Act - Discussed and sent letter of endorsement to bill. Discussed the Medicare Part D prescription drug benefit program and changes needed to further lower prescription drug costs and related agency proposed rule changes. (no bill) H.R. 1588/S.740, Medicaid Drug Savings Act - Discussed the requirement for drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. Discussed potential improvements to the Medicare Savings Programs for low-income beneficiaries. (no bill) Discussed pending U.S. Trade agreement negotiations, including trade promotional or "fast track" authority, and their potential impact on Medicare and Medicaid prescription drug programs. (no bill) H.R. 2810/S.1871/H.R. 4015/S.2110 - Discussed SGR repeal and health care extender provisions, including the Qualified Individual low-income Medicare beneficiary assistance program.
Filing targets: Administration on Aging, Agriculture, Dept of (USDA), Bureau of the Census, Centers For Medicare and Medicaid Services (CMS), Commodity Futures Trading Commission (CFTC), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Federal Communications Commission (FCC), Federal Highway Administration (FHA), Federal Reserve System, Federal Trade Commission (FTC), Federal Transit Administration (FTA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Highway Traffic Safety Administration (NHTSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of the Comptroller of the Currency (OCC), Pension Benefit Guaranty Corporation (PBGC), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
Discussed importance of potential savings both to consumers and to the federal government of granting Secretarial Negotiating Authority to Secretary of HHS on Medicare Part D. (no bill)Discussed legislative intent with respect to biologic drugs and the exclusivity period; and discussed importance of potential savings to the health care system generally. (no bill) Discussed need for greater consumer safety protections both in OTC and prescription drugs. (no bill) Discussed need for doctors to get unbiased information on prescription pharmaceuticals through programs like academic detailing. (no bill) Discussed possible savings and better health care outcomes that could result from Medication Therapy Management. (no bill) Pub. Law 111-148 and 111-152 - Discussed implementation of health care legislation to reform the health care system to provide quality healthcare, expand access to long-term services and supports, and reduced prescription drug costs. Discussed greater affordability of generic versions of both generic and biologic drugs. S. 319, Pharmaceutical Market Access and Drug Safety Act of 2011 - Discussed legislation that establishes a framework for the safe, legal importation of lower-priced prescription drugs from abroad. S. 1206, Medicare Drug Savings Act of 2011 - Discussed rebates in Medicare Part D as a cost savings measure in Medicare that does not harm beneficiaries. H. R. 3342, Affordable Medicines Utilization Act of 2011 - Lobbied on legislation to encourage state Medicaid programs to use safe, effective generic medications. S. 27, Preserve Access to Affordable Generics Act of 2011- Lobbied for this legislation preventing abuses in patent settlements between generic and brand name prescription drug companies. S. 1886/H.R. 3468 of 2011- Discussed counterfeit drug penalty enhancement. Discussed prescription drug safety, drug shortage, and medical device safety, and related user fee legislation. S. 2193 of 2012, the Ensuring Safe Medical Devices for Patients Act - Discussed legislation to include devices in the post-market risk identification and analysis system for prescription drugs and to expedite the implementation of the unique device identification system for medical devices. Discussed draft legislation to address the issue of whether generic drug manufacturers have a duty to include new warnings about potentially serious side effects on their labels as they become known by giving generic drug makers the same ability to update their labeling as manufacturers of brand name drugs. (no bill) S.3187, Food and Drug Administration safety and Innovation Act - FDA user fee agreement legislation focusing on the review process for prescription drugs and medical devices, prescription drug safety, drug shortages, medical device safety and access to generic drugs. S.3212, Cody Miller Initiative for Safer Prescriptions Act - To require the Secretary of Health and Human Services to promulgate regulations regarding the authorship, content, format, and dissemination of Patient Medication information. Discussed pay-for-delay agreements as tactic by drug manufacturers to block lower cost drugs from entering the market, and the Fair and Immediate Release of Generics Drugs Act that would address the underlying issue of "parked exclusivities" in the Hatch-Waxman Act (S.1882). Discussed the issue of biosimilar drug naming and how biosimilars should use a common International Non-proprietary name as reference originator biologic products. (no bill) S. 504, the Fair and Immediate Release of Generic Drugs Act/S.214, the Preserve Access to Affordable Generics Act - Discussed the Patient Safety and Generic Labeling Improvement Act. (no bill)Discussed Unique Device Identification (UDI) issues including proposed rules and implementation. (no bill) Discussed oversight of laboratory genetic testing. (no bill) Discussed AARP's concerns with prescription drug costs. (no bill) S.117, Medicare Prescription Drug Price Negotiation Act - Discussed bill that allows medicare to negotiate medicare prescription drug prices with drug companies. S.504/S.214, The Fair and Immediate Release of Generics Drugs Act/Preserve Access to Affordable Generics Act - Discussed legislation to address pay-for-delay agreements used by drug manufacturers to block lower cost drugs from entering the market. Discussed the exclusivity period for biologic drugs. (no bill) Discussed the Patient Safety and Generic Labeling Improvement Act. (no bill) Discussed biologic drug issues including implementation of the new approval pathway for biosimilar drugs. (no bill)
S.452, Medicare Diabetes Prevention Act - Discussed bill with Senate. Discussed draft language on senior mental health with Senate HELP Committee staff. (no bill) Discussed Medicare Reform (no bill) Discussed Age Rating in the ACA and rate shock. (no bill)Lobbied on preserving funding for the ACA; defended meaningful use of the ACA. (no bill) Discussed need to increase health information technology quality measurements and access to qualified systems. (no bill) H.R. 1099, To repeal the Prevention and Public Health Fund - Lobbied against the repeal of the Prevention and Public Health Trust Fund, an important component in state and community efforts to prevent illness and promote health. Discussed Pre-existing Condition Insurance Program. (no bill) Discussed Accountable Care Organization and Medical Shared savings. (no bill) Discussed Rate Review. (no bill) Discussed Internal Appeals and External Review Process. (no bill) Discussed Medicare reimbursement issues. Lobbied in support of Medicare physician payment reform. Discussed legislation to make prescription drugs more affordable to older Americans. S. 1416/H.R. 2645 (112th Congress), Medigap Medical Loss Ratio Improvement Act of 2011. Discussed coverage for screening depression and screening and counseling for alcohol misuse. (no bill) Discussed consumer operated and oriented plan programs. (no bill) Discussed standards related to risk adjustment, reinsurance, and risk mitigation as they relate to exchanges. (no bill) H.R.2077, MLR Repeal Act of 2011 - Expressed opposition to the elimination of provision in the Affordable Care Act (P.L. 111-148)Discussed opposition to draft legislation regarding the elimination of grandfathered status. (no bill) Discussed association health plans with DOL, HHS and DOT. (no bill) Discussed quality and care coordination with HHS. (no bill) Discussed Essential Health Benefits with HHS. (no bill) Discussed employer affordability safe harbor. (no bill) Discussed health insurance exchanges - eligibility, enrollment, premium tax credits. (no bill) Discussed Basic Health Plans. (no bill) Discussed Medigap reform. (no bill) Discussed Pre-existing Condition Insurance Program. (no bill) Discussed role of grandfathered plans. (no bill) Discussed reauthorization of the Older Americans Act and other amendments to the OAA. (no bill) Discussed dual eligibles. (no bill) Discussed support for H.R. 2181, Safe Foods for Seniors Act of 2013. Discussed S.1119, Positive Aging Act of 2013. H.R. 2641, Farm Program bill-Discussed the severed nutrition programs from Farm Bill. S. 562, Seniors Mental Health Access Improvement Act - Discussed the bill for eventual endorsement. Discussed Care Corps. (no bill) Discussed grandparents raising grandchildren and ACA provision extending coverage to those under age 26. (no bill) Discussed need to suport family caregivers and long-term services and supports. (no bill) Discussed repeal of medical device tax. (no bill) Discussed consumer directed care. (no bill) Discussed policy related to dementia. (no bill) Discussed no wrong door system. (no bill) Discussed data on LTSS and women. (no bill)Discussed FTC participation in state scope of practice issues. Also sent follow-up items for their review. (no bill) Discussed Social Security programs. (no bill) Lobbied against cuts to the health care prevention fund. (no bill) Discussed deficit reduction issues dealing with Medicare and Medicaid including concerns over increasing Medicare's age of eligibility, chained CPI, payroll tax holiday extension, and cuts to Medicaid. (no bill) Discussed Affordable Care Medicaid expansion issues. Centers for Medicare and Medicaid Services, Center for Medicaid and CHIP Services. Discussed Medicaid reform, Medicare-Medicaid integration efforts and financial alignment demonstrations, other CMS demonstration initiatives. (no bill) Discussed Medicaid expansion implementation, as included in the ACA (P.L. 111-140). Discussed Medicaid including concerns over cuts to Medicaid flexibility and Medicaid structural reforms to. (no bill) PL 112-240 of 2012, American Taxpayer Relief Act - Discussed the Commission on Long-Term Care and and service delivery workforce and caregiving, financing and related long-term care issues and data. Discussed implementation of the Affordable Care Act, its provisions and H.R. 95 to repeal the Patient Protection and Affordable Care Act. H. R. 933, Consolidated and Further Continuing Appropriations Act, 2013 - Lobbied to protect vital health and social services programs from enhanced reductions from the prior year baseline, and to prevent repeal of certain financial and health care-related regulation. S. Con. Res. 8/ H.Con. Res. 25, Concurrent Resolution on the Budget, 2014 - Lobbied to prevent inclusion of Medicare, Medicaid and Social Security benefit cuts and to protect vital health, social services, housing and transportation programs from enhanced reductions from the prior year baseline, and to prevent repeal of certain financial and health care-related regulation. H.R. 1549, Helping Sick Americans Now Act - Discussed cuts to the health care prevention fund. S. 1284, The Labor, Health and Human Services Appropriations Act, 2014 - Lobbied to protect employment, health and human services and energy assistance programs for seniors, disabled and low income assistance. Discussed Affordable Care Act Medicaid expansion issues, including questions related to the use of premium assistance authority to expand Medicaid. (no bill) H.R. 1263, Excellence in Mental Health Act - Discussed the bill for eventual endorsement. Discussed Affordable Care Act Medicaid expansion issues, including AARP comments on state 1115 waiver proposals to use premium assistance authority to expand Medicaid, Centers for Medicare and Medicaid Services, Center for Medicaid and CHIP Services. Discussed perspectives on proposed ideas for legislation to address health disparities with HHS and CMS officials. H.J.R. 59/H.R. 2775, Continuing Appropriations Act, 2014 - Lobbied to protect employment, health and human services and energy assistance programs for seniors, disabled and low income assistance.
Filing targets: Administration on Aging, Agriculture, Dept of (USDA), Bureau of the Census, Centers For Medicare and Medicaid Services (CMS), Commodity Futures Trading Commission (CFTC), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Federal Communications Commission (FCC), Federal Highway Administration (FHA), Federal Reserve System, Federal Trade Commission (FTC), Federal Transit Administration (FTA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Council on Disability, Natl Highway Traffic Safety Administration (NHTSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of the Comptroller of the Currency (OCC), Pension Benefit Guaranty Corporation (PBGC), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office
Pub.Law 111-148 & 111-152 - Discussed implementation of health care law that would reform the health care system to provide affordable quality health care, reduce drug costs and expand access to long-term services and supports. Discussed how to implement Medicaid provisions of Affordable Care Act. (PL. 111-148)S. 374, Medicare Mental Health Inpatient Equity Act - Lobbied in support of this legislation to eliminate the 190-day lifetime limit on Medicare coverage for in-patient psychiatric hospital services (112th). Discussed improving access to care for underserved population. (no bill) Discussed importance of maintaining low income subsididies and supports in Medicare. (no bill) Discussed the importance of coordinating services for those who qualify for both Medicare and Medicaid in order to ensure that beneficiaries receive all needed benefits but there is no duplication. (no bill) Discussed whether, and under what circumstances, managed care could effectively be used to provide benefits to dual eligible beneficiaries. (no bill) Discussed additional methods for fighting fraud and waste in Health Care. (no bill) Discussed Medigap and need for guaranteed issue for all populations and need to increase medical loss ratio. Discussed durable medical equipment bidding. (no bill) Lobbied for legislation to provide Medicare beneficiaries with additional opportunities to enroll in Medicare Part B.(no bill) Lobbied against the use of the Social Security account number on Government-issued identification cards issued in connection with Medicare, Medicaid, and SCHIP benefits and for other purposes. (no bill) Discussed support to curb waste and fraud from the Medicare and Medicaid programs. (no bill) H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2012 - Discussed the legislation as it pertained to SGR. Discussed family caregiving, long-term care, Older Americans Act, private LTC insurance. (no bill) Discussed Medicaid long-term services and supports. (no bill) Discussed Florida's managed long-term services and supports medicaid waiver and their 1115 waiver proposal. Discussed Senior Navigation and Planning and feedback (S.3684 in 112th Congress/no bill # in 113th Congress). Discussed Medicare Reform. (no bill) H.R. 2305/S. 1123, PRIME ACT (Preventing and Reducing Improper Medicare Expenditures) - Discussed support for bill and urged cosponsorship. Discussed the Medicare Part D prescription drug benefit program and changes needed to further lower prescription drug costs. (no bill) H.R. 1588/S. 740, Medicare Drug Savings Act - Discussed the Medicare Drug Savings Act to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. Discussed potential improvements to the Medicare Savings Programs for low-income befeficiaries. (no bill) Discussed proposals that would establish per-capita caps under Medicaid as well as other Medicaid financing proposals including block grants and changes to the current FMAP structure. (no bill)Discussed Medicare Graduate Nursing Education pilot design. (no bill) Discussed Prescription Drug Affordability. (no bill) Discussed Prescription Drug Shortages. (no bill) H.R. 3342, Affordable Medicines Utilization Act of 2011 - Lobbied to encourage state Medicaid programs to use safe, effective generic medications. H.R. 2576 - Discussion to amend the Internal Revenue Code of 1986 to modify the calculation of modified adjusted gross income for purposes of determining eligibility for certain healthcare-related programs. Discussed opposition to caps on dual eligibles; discussed managed care and dual eligibles. (no bill) Discussed with CMS demonstration programs for dual eligibles and process related to the demonstrations, as well as other work of the Medicare-Medicaid Coordination Office, discussed consumer choice and continuity of care in Medicaid managed long-term services and supports programs, discussed focus groups on dual eligibles. Discussed Medicaid managed care and long-term services and supports broadly. Discussed Hospital & Critical Access Hospitals Conditions of Participation proposed regulations; requested that advanced practice registered nurses and physicians assistants be allowed the full scope of services in hospital admitting and visiting privileges. (no bill) Discussed Hospital Outpatient Therapeutic Services Final Rule underscoring that advanced practice registered nurses and physicians should be allowed to supervise such outpatient service clinics without physician oversight as long as in line with state scope of practice laws. (no bill) Discussed health disparities. (no bill) Discussed Medicaid reform, Medicare/Medicaid "dual eligibles" integration efforts and financial alignment demonstrations; and other CMS demonstration initiatives. (no bill) Discussed the AARP Initiative called "You've Earned a Say". (no bill) S. 3586, Recruiting Individuals to Drive Elders (RIDE) Act - Discussed Medicaid non-emergency transportation bill (112th). Discussed proposals that would establish per-capita caps under Medicaid as well as other Medicaid financing proposals including block grants and changes to the current FMAP structure. (no bill) Discussed extension of funding originally provided under the Medicare Improvement for Patients and Providers Act (P.L. 110-275) to State Health Insurance Assistance Programs (SHIPs), Aging and Disability Resource Centers (ADRICs), and Area Agencies on Aging (AAAs) for Medicare outreach and enrollment counseling. (no bill) Discussed the prevention of cuts to beneficiaries in the Medicare program. (no bill) Discussed the prevention of an increase in the age of eligibility in the Medicare program. (no bill) Discussed the patch to the Sustainable Growth Rate (SGR) in the Medicare program. (no bill) Discussed concerns of block granting Medicaid. (no bill) Discussed the Kansas and Florida managed long-term services and supports waiver proposals and related implementation issues. (no bill). H.R.928/S.408, the Medicare Drug Savings Act - Discussed requirement for drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. Discussed Health Disparities. (no bill) Discussed medicare demonstration project replacing standard medicare cards with Smart Card technology. (no bill) H.R. 574 - The Medicare Physician Payment Innovation Act of 2013.H.R. 1179/S.569, Improving Access to Medicare Act - Discussed support of Improving Access to Medicare Coverage Act and urged cosponsorship. Discussed comments regarding Medicare and You handbook. (no bill) Discussed CMS information regarding healthcare marketplaces. H.R. 1173, Personalize Your Care Act - Discussed the bill and advance care planning issues. Bill provides coverage for voluntary advance care planning consultations. H. R. 933, Consolidated and Further Continuing Appropriations Act, 2013 - Lobbied to protect vital health and social services programs from enhanced reductions from the prior year baseline, and to prevent repeal of certain financial and health care-related regulation. S. Con. Res. 8, Concurrent Resolution on the Budget, 2014 - Lobbied to prevent inclusion of Medicare, Medicaid and Social Security benefit cuts and to protect vital health, social services, housing and transportation programs from enhanced reductions from the prior year baseline, and to prevent repeal of certain financial and health care-related regulation. H.Con. Res. 25, Concurrent Resolution on the Budget, 2014 - Lobbied to prevent inclusion of Medicare, Medicaid and Social Security benefit cuts and to protect vital health, social services, housing and transportation programs from enhanced reductions from the prior year baseline, and to prevent repeal of certain financial and health care-related regulation.Lobbied on expected "QM" safe harbor amendment. (The amendment was not offered) H.R. 2305/S.1123, Preventing and Reducing Improper Medicare and Medicaid Expenditures Act. Bill reduces waste, fraud, and abuse in Medicare and Medicaid programs. Discussed Competitive bidding of durable medical equipment, prosthetics, orthotics, and supplies. (no bill) Discussed repeal of Affordable Care Act provision making prescriptions necessary for over-the-counter drugs purchased with flexible spending accounts. (no bill) Discussed Medicare supplemental coverage. (no bill) Discussed the Medicare Part D prescription drug benefit program and changes needed to further lower prescription drug cost. (no bill) H.R. 1588/S.740, Medicare Drug Savings Act - Would require drug manufacturers to provide rebates for durgs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. Discussed potential improvements to the Medicare Savings Programs for low-income beneficiaries. (no bill) Discussed Recruiting Individuals to Drive Our Elders Act (RIDE) would increase state flexibility by giving states the option to receive federal assistance to reimburse their volunteer drivers for no-load miles. (no bill) Discussed the Medicare Adult Day Services Act. (no bill) Discussed the Commission on Long-Term Care. H.J.R. 59, Continuing Appropriations Resolution, 2014 - Lobbied to prevent inclusion of Medicare, Medicaid and Social Security benefit cuts and to protect vital health, social services, housing and transportation programs from enhanced reductions from the prior year baseline, and to prevent repeal of certain financial and health care-related regulation. S. 1284, Labor, Health and Human Services Appropriations Act, 2014 - Lobbied to protect vital health and social services programs from enhanced reductions from the prior year baseline, and to prevent repeal of certain financial and health care-related regulation.
S.452, Medicare Diabetes Prevention Act - Discussed bill with Senate. Discussed draft language on senior mental health with Senate HELP Committee staff. (no bill) Discussed Medicare Reform (no bill) Discussed Age Rating in the ACA and rate shock. (no bill)Lobbied on preserving funding for the ACA; defended meaningful use of the ACA. (no bill) Discussed need to increase health information technology quality measurements and access to qualified systems. (no bill) H.R. 1099, To repeal the Prevention and Public Health Fund - Lobbied against the repeal of the Prevention and Public Health Trust Fund, is an important component in state and community efforts to prevent illness and promote health. Discussed Pre-existing Condition Insurance Program. (no bill) Discussed Accountable Care Organization and Medical Shared savings. (no bill) Discussed Rate Review. (no bill) Discussed Internal Appeals and External Review Process. (no bill) Discussed Medicare reimbursement issues. Lobbied in support of Medicare physician payment reform. Discussed legislation to make prescription drugs more affordable to older Americans. S. 1416/H.R. 2645 (112th Congress), Medigap Medical Loss Ratio Improvement Act of 2011. Discussed coverage for screening depression and screening and counseling for alcohol misuse. (no bill) Discussed consumer operated and oriented plan programs. (no bill) Discussed standards related to risk adjustment, reinsurance, and risk mitigation as they relate to exchanges. (no bill) H.R.2077, MLR Repeal Act of 2011 - Expressed opposition to the elimination of provision in the Affordable Care Act (P.L. 111-148)Discussed opposition to draft legislation regarding the elimination of grandfathered status. (no bill) Discussed association health plans with DOL, HHS and DOT. (no bill) Discussed quality and care coordination with HHS. (no bill) Discussed Essential Health Benefits with HHS. (no bill) Discussed employer affordability safe harbor. (no bill) Discussed health insurance exchanges - eligibility, enrollment, premium tax credits. (no bill) Discussed Basic Health Plans. (no bill) Discussed Medigap reform. (no bill) Discussed Pre-existing Condition Insurance Program. (no bill) Discussed role of grandfathered plans. (no bill) Discussed reauthorization of the Older Americans Act and other amendments to the OAA. (no bill) Discussed dual eligibles. (no bill) Discussed support for H.R. 2181, Safe Foods for Seniors Act of 2013. Discussed S.1119, Positive Aging Act of 2013. H.R. 2641, Farm Program bill-Discussed the severed nutrition programs from Farm Bill.Discussed inviting FTC to participate in a webinar on how they are and can be engaged on state scope of practice issues. Also sent follow-up items for their review. (no bill) Discussed Medicare and Social Security programs. (no bill) Lobbied against cuts to the health care prevention fund. (no bill) Discussed deficit reduction issues dealing with Medicare and Medicaid including concerns over increasing Medicare's age of eligibility, chained CPI, payroll tax holiday extension, and cuts to Medicaid. (no bill) Discussed Affordable Care Medicaid expansion issues. Centers for Medicare and Medicaid Services, Center for Medicaid and CHIP Services. Discussed Medicaid reform, Medicare-Medicaid integration efforts and financial alignment demonstrations, other CMS demonstration initiatives. (no bill) Discussed Medicaid expansion implementation, as included in the ACA (P.L. 111-140). Discussed Medicaid including concerns over cuts to Medicaid flexibility and Medicaid structural reforms to. (no bill) Discussed Medicare-Medicaid integration efforts and financial alignment demonstrations and other CMS demonstration initiatives. (no bill) PL 112-240 of 2012, American Taxpayer Relief Act - Discussed the Commission on Long-Term Care and and service delivery workforce and caregiving, financing and related long-term care issues and data. Discussed implementation of the Affordable Care Act, its provisions and H.R. 95 to repeal the Patient Protection and Affordable Care Act. H. R. 933, Consolidated and Further Continuing Appropriations Act, 2013 - Lobbied to protect vital health and social services programs from enhanced reductions from the prior year baseline, and to prevent repeal of certain financial and health care-related regulation. S. Con. Res. 8/ H.Con. Res. 25, Concurrent Resolution on the Budget, 2014 - Lobbied to prevent inclusion of Medicare, Medicaid and Social Security benefit cuts and to protect vital health, social services, housing and transportation programs from enhanced reductions from the prior year baseline, and to prevent repeal of certain financial and health care-related regulation. H.R. 1549, Helping Sick Americans Now Act - Discussed cuts to the health care prevention fund. S. 1284, The Labor, Health and Human Services Appropriations Act, 2014 - Lobbied to protect employment, health and human services and energy assistance programs for seniors, disabled and low income assistance. Discussed Affordable Care Act Medicaid expansion issues, including questions related to the use of premium assistance authority to expand Medicaid. (no bill) Discussed Medicare-Medicaid integration efforts and financial alignment demonstrations, other CMS demonstration initiatives. (no bill) H.R. 1263, Excellence in Mental Health Act - Discussed the bill for eventual endorsement. Discussed Affordable Care Act Medicaid expansion issues, including AARP comments on state 1115 waiver proposals to use premium assistance authority to expand Medicaid. (no bill)
Filing targets: Administration on Aging, Agriculture, Dept of (USDA), Bureau of the Census, Centers For Medicare and Medicaid Services (CMS), Commodity Futures Trading Commission (CFTC), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Federal Communications Commission (FCC), Federal Highway Administration (FHA), Federal Reserve System, Federal Trade Commission (FTC), Federal Transit Administration (FTA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Council on Disability, Natl Highway Traffic Safety Administration (NHTSA), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of the Comptroller of the Currency (OCC), Pension Benefit Guaranty Corporation (PBGC), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, White House Office
Pub.Law 111-148 & 111-152 - Discussed implementation of health care law that would reform the health care system to provide affordable quality health care, reduce drug costs and expand access to long-term services and supports. Discussed transitional care program. Discussed how to implement Medicaid provisions of Affordable Care Act. (PL. 111-148)S. 374, Medicare Mental Health Inpatient Equity Act - Lobbied in support of this legislation to eliminate the 190-day lifetime limit on Medicare coverage for in-patient psychiatric hospital services. Discussed improving access to care for underserved population. (no bill) Discussed importance of maintaining low income subsididies and supports in Medicare. (no bill) Discussed the importance of coordinating services for those who qualify for both Medicare and Medicaid in order to ensure that beneficiaries receive all needed benefits but there is no duplication. (no bill) Discussed whether, and under what circumstances, managed care could effectively be used to provide benefits to dual eligible beneficiaries. (no bill) Discussed additional methods for fighting fraud and waste in Health Care. (no bill) Discussed Medigap and need for guaranteed issue for all populations and need to increase medical loss ratio. Discussed durable medical equipment bidding. (no bill) Lobbied for legislation to provide Medicare beneficiaries with additional opportunities to enroll in Medicare Part B.(no bill) Lobbied against the use of the Social Security account number on Government-issued identification cards issued in connection with Medicare, Medicaid, and SCHIP benefits and for other purposes. (no bill) Discussed support to curb waste and fraud from the Medicare and Medicaid programs. (no bill) H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2012 - Discussed the legislation as it pertained to SGR. Discussed family caregiving, long-term care, Older Americans Act, private LTC insurance. (no bill) Discussed Medicaid long-term services and supports. (no bill) Discussed Florida's managed long-term services and supports medicaid waiver and their 1115 waiver proposal. Discussed Senior Navigation and Planning and feedback (S.3684 in 112th Congress/no bill # in 113th Congress). Discussed Medicare Reform. (no bill) H.R. 2305/S. 1123, PRIME ACT (Preventing and Reducing Improper Medicare Expenditures) - Discussed support for bill and urged cosponsorship.Discussed Medicare Graduate Nursing Education pilot design. (no bill) Discussed Prescription Drug Affordability. (no bill) Discussed Prescription Drug Shortages. (no bill) H.R. 3342, Affordable Medicines Utilization Act of 2011 - Lobbied to encourage state Medicaid programs to use safe, effective generic medications. H.R. 2576 - Discussion to amend the Internal Revenue Code of 1986 to modify the calculation of modified adjusted gross income for purposes of determining eligibility for certain healthcare-related programs. Discussed opposition to caps on dual eligibles; discussed managed care and dual eligibles. (no bill) Discussed with CMS demonstration programs for dual eligibles and process related to the demonstrations, as well as other work of the Medicare-Medicaid Coordination Office, discussed consumer choice and continuity of care in Medicaid managed long-term services and supports programs, discussed focus groups on dual eligibles. Discussed Medicaid managed care and long-term services and supports broadly. Discussed Hospital & Critical Access Hospitals Conditions of Participation proposed regulations; requested that advanced practice registered nurses and physicians assistants be allowed the full scope of services in hospital admitting and visiting privileges. (no bill) Discussed Hospital Outpatient Therapeutic Services Final Rule underscoring that advanced practice registered nurses and physicians should be allowed to supervise such outpatient service clinics without physician oversight as long as in line with state scope of practice laws. (no bill) Discussed health disparities. (no bill) Discussed Medicaid reform, Medicare/Medicaid "dual eligibles" integration efforts and financial alignment demonstrations; and other CMS demonstration initiatives. (no bill) Discussed the AARP Initiative called "You've Earned a Say". (no bill) S. 3586, Recruiting Individuals to Drive Elders (RIDE) Act - Discussed Medicaid non-emergency transportation bill. Discussed proposals that would establish per-capita caps under Medicaid as well as other Medicaid financing proposals including block grants and changes to the current FMAP structure. (no bill) Discussed extension of funding originally provided under the Medicare Improvement for Patients and Providers Act (P.L. 110-275) to State Health Insurance Assistance Programs (SHIPs), Aging and Disability Resource Centers (ADRICs), and Area Agencies on Aging (AAAs) for Medicare outreach and enrollment counseling. (no bill) Discussed the prevention of cuts to beneficiaries in the Medicare program. (no bill) Discussed the prevention of an increase in the age of eligibility in the Medicare program. (no bill) Discussed the patch to the Sustainable Growth Rate (SGR) in the Medicare program. (no bill) Discussed concerns of block granting Medicaid. (no bill) Discussed the Kansas and Florida managed long-term services and supports waiver proposals and related implementation issues. (no bill). H.R.928/S.408, the Medicare Drug Savings Act - Discussed requirement for drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. Discussed Health Disparities. (no bill) Discussed medicare demonstration project replacing standard medicare cards with Smart Card technology. (no bill) H.R. 574 - The Medicare Physician Payment Innovation Act of 2013.H.R. 1179/S.569, Improving Access to Medicare Act - Discussed support of Improving Access to Medicare Coverage Act and urged cosponsorship. Discussed comments regarding Medicare and You handbook. (no bill) Discussed cost-sharing for medicaid home and community-based services. (no bill) Discussed CMS information regarding healthcare marketplaces. H.R. 1173, Personalize Your Care Act - Discussed the bill and advance care planning issues. Bill provides coverage for voluntary advance care planning consultations. H. R. 933, Consolidated and Further Continuing Appropriations Act, 2013 - Lobbied to protect vital health and social services programs from enhanced reductions from the prior year baseline, and to prevent repeal of certain financial and health care-related regulation. S. Con. Res. 8, Concurrent Resolution on the Budget, 2014 - Lobbied to prevent inclusion of Medicare, Medicaid and Social Security benefit cuts and to protect vital health, social services, housing and transportation programs from enhanced reductions from the prior year baseline, and to prevent repeal of certain financial and health care-related regulation. H.Con. Res. 25, Concurrent Resolution on the Budget, 2014 - Lobbied to prevent inclusion of Medicare, Medicaid and Social Security benefit cuts and to protect vital health, social services, housing and transportation programs from enhanced reductions from the prior year baseline, and to prevent repeal of certain financial and health care-related regulation.Lobbied on expected "QM" safe harbor amendment. (The amendment was not offered) H.R. 2305/S.1123, Preventing and Reducing Improper Medicare and Medicaid Expenditures Act. Bill reduces waste, fraud, and abuse in Medicare and Medicaid programs. Discussed Competitive bidding of durable medical equipment, prosthetics, orthotics, and supplies. (no bill) Discussed repeal of Affordable Care Act provision making prescriptions necessary for over-the-counter drugs purchased with flexible spending accounts. (no bill) Discussed Medicare supplemental coverage. (no bill) Discussed the Medicare Part D prescription drug benefit program and changes needed to further lower prescription drug cost. (no bill) H.R. 1588/S.740, Medicare Drug Savings Act - Would require drug manufacturers to provide rebates for durgs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. Discussed potential improvements to the Medicare Savings Programs for low-income beneficiaries. (no bill) Discussed Recruiting Individuals to Drive Our Elders Act (RIDE) would increase state flexibility by giving states the option to receive federal assistance to reimburse their volunteer drivers for no-load miles. (no bill)
Discussed legislative intent with respect to Biologic drugs and exclusivity period.(no bill) Discussed importance of potential savings both to consumers and to the federal government of granting Secretarial Negotiating Authority to Secretary of HHS on Medicare Part D. (no bill)Discussed legislative intent with respect to biologic drugs and the exclusivity period; and discussed importance of potential savings to the health care system generally. (no bill) Discussed need for greater consumer safety protections both in OTC and prescription drugs. (no bill) Discussed need to end industry tactics like Pay for Delay which inappropriately extends patents with effect of keeping prices high for consumers and government. (no bill) Discussed need for doctors to get unbiased information on prescription pharmaceuticals through programs like academic detailing. (no bill) Discussed possible savings and better health care outcomes that could result from Medication Therapy Management. (no bill) Pub. Law 111-148 and 111-152 - Discussed implementation of health care legislation to reform the health care system to provide quality healthcare, expand access to long-term services and supports, and reduced prescription drug costs. Discussed greater affordability of generic versions of both generic and biologic drugs. S. 319, Pharmaceutical Market Access and Drug Safety Act of 2011 - Discussed legislation that establishes a framework for the safe, legal importation of lower-priced prescription drugs from abroad. S. 1206, Medicare Drug Savings Act of 2011 - Discussed rebates in Medicare Part D as a cost savings measure in Medicare that does not harm beneficiaries. H. R. 3342, Affordable Medicines Utilization Act of 2011 - Lobbied on legislation to encourage state Medicaid programs to use safe, effective generic medications. S. 27, Preserve Access to Affordable Generics Act of 2011- Lobbied for this legislation preventing abuses in patent settlements between generic and brand name prescription drug companies. S. 1886/H.R. 3468 of 2011- Discussed counterfeit drug penalty enhancement. Discussed prescription drug safety, drug shortage, and medical device safety, and related user fee legislation. S. 2193 of 2012, the Ensuring Safe Medical Devices for Patients Act - Discussed legislation to include devices in the post-market risk identification and analysis system for prescription drugs and to expedite the implementation of the unique device identification system for medical devices. Discussed draft legislation to address the issue of whether generic drug manufacturers have a duty to include new warnings about potentially serious side effects on their labels as they become known by giving generic drug makers the same ability to update their labeling as manufacturers of brand name drugs. (no bill) S.3187, Food and Drug Administration safety and Innovation Act - FDA user fee agreement legislation focusing on the review process for prescription drugs and medical devices, prescription drug safety, drug shortages, medical device safety and access to generic drugs. S.3212, Cody Miller Initiative for Safer Prescriptions Act - To require the Secretary of Health and Human Services to promulgate regulations regarding the authorship, content, format, and dissemination of Patient Medication information. Discussed the importance of potential savings to both consumers and the federal government of granting Secretarial negotiating authority to the HHS Secretary under Medicare Part D. (no bill) Discussed pay-for-delay agreements as tactic by drug manufacturers to block lower cost drugs from entering the market, and the Fair and Immediate Release of Generics Drugs Act that would address the underlying issue of "parked exclusivities" in the Hatch-Waxman Act (S.1882). Discussed the issue of biosimilar drug naming and how biosimilars should use a common International Non-proprietary name as reference originator biologic products. (no bill) S. 504, the Fair and Immediate Release of Generic Drugs Act/S.214, the Preserve Access to Affordable Generics Act - Discussed legislation to address pay-for-delay agreements used by drug manufacturers to block lower cost drugs from entering the market. Discussed the Patient Safety and Generic Labeling Improvement Act. (no bill)Discussed Unique Device Identification (UDI) issues including proposed rules and implementation. (no bill) Discussed oversight of laboratory genetic testing. (no bill) Discussed AARP's concerns with prescription drug costs. (no bill) S.117, Medicare Prescription Drug Price Negotiation Act - Discussed bill that allows medicare to negotiate medicare prescription drug prices with drug companies.
Filing targets: Administration on Aging, Agriculture, Dept of (USDA), Bureau of the Census, Centers For Medicare and Medicaid Services (CMS), Commodity Futures Trading Commission (CFTC), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Federal Communications Commission (FCC), Federal Highway Administration (FHA), Federal Reserve System, Federal Trade Commission (FTC), Federal Transit Administration (FTA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Council on Disability, Natl Highway Traffic Safety Administration (NHTSA), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of the Comptroller of the Currency (OCC), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, White House Office
Discussed legislative intent with respect to Biologic drugs and exclusivity period.(no bill) Discussed importance of potential savings both to consumers and to the federal government of granting Secretarial Negotiating Authority to Secretary of HHS on Medicare Part D. (no bill) Discussed legislative intent with respect to biologic drugs and the exclusivity period; and discussed importance of potential savings to the health care system generally. (no bill) Discussed need for greater consumer safety protections both in OTC and prescription drugs. (no bill) Discussed need to end industry tactics like Pay for Delay which inappropriately extends patents with effect of keeping prices high for consumers and government. (no bill) Discussed need for doctors to get unbiased information on prescription pharmaceuticals through programs like academic detailing. (no bill) Discussed possible savings and better health care outcomes that could result from Medication Therapy Management. (no bill) Pub. Law 111-148 and 111-152 - Discussed implementation of health care legislation to reform the health care system to provide quality healthcare, expand access to long-term services and supports, and reduced prescription drug costs. Discussed greater affordability of generic versions of both generic and biologic drugs. S. 319, Pharmaceutical Market Access and Drug Safety Act of 2011 - Discussed legislation that establishes a framework for the safe, legal importation of lower-priced prescription drugs from abroad. S. 1206, Medicare Drug Savings Act of 2011 - Discussed rebates in Medicare Part D as a cost savings measure in Medicare that does not harm beneficiaries. H. R. 3342, Affordable Medicines Utilization Act of 2011 - Lobbied on legislation to encourage state Medicaid programs to use safe, effective generic medications. S. 27, Preserve Access to Affordable Generics Act - Lobbied for this legislation preventing abuses in patent settlements between generic and brand name prescription drug companies. S. 1886/H.R. 3468, Discussed counterfeit drug penalty enhancement. Discussed prescription drug safety, drug shortage, and medical device safety, and related user fee legislation. S. 2193, the Ensuring Safe Medical Devices for Patients Act - Discussed legislation to include devices in the post-market risk identification and analysis system for prescription drugs and to expedite the implementation of the unique device identification system for medical devices. Discussed draft legislation to address the issue of whether generic drug manufacturers have a duty to include new warnings about potentially serious side effects on their labels as they become known. The bill would accomplish this by giving generic drug makers the same ability to update their labeling as currently exists for manufacturers of brand name drugs. (no bill) S.3187, Food and Drug Administration safety and Innovation Act - FDA user fee agreement legislation focusing on the review process for prescription drugs and medical devices, prescription drug safety, drug shortages, medical device safety and access to generic drugs. S.3212, Cody Miller Initiative for Safer Prescriptions Act - To require the Secretary of Health and Human Services to promulgate regulations regarding the authorship, content, format, and dissemination of Patient Medication information. Discussed prescription drugs. S. 3604, Improving Preventive Care Treatment in Older Adults Act - Discussed legislation to address the inaproppriate use of antipsychotics in nursing home facilities. (no bill) Discussed the importance of potential savings to both consumers and the federal government of granting Secretarial negotiating authority to the HHS Secretary under Medicare Part D. (no bill) Discussed pay-for-delay agreements as tactic by drug manufacturers to block lower cost drugs from entering the market, and the Fair and Immediate Release of Generics Drugs Act that would address the underlying issue of "parked exclusivities" in the Hatch-Waxman Act (S.1882). Discussed the issue of biosimilar drug naming and how biosimilars should use a common International Non-proprietary name as reference originator biologic products. (no bill)
Provided information on the need for nursing education capacity and the retention of newer and older nurses in the workplace (no bill). H.R.3630, SGR - Discussed physician payment reform. Pub.Law 111-148 & 111-152 - Discussed implementation of health care law that would reform the health care system to provide affordable quality health care, reduce drug costs and expand access to long-term services and supports. Discussed transitional care program. Discussed how to implement Medicaid provisions of Affordable Care Act. (PL. 111-148) Lobbied in support of draft legislation that would grant individuals whose COBRA has expired the same Medicare Part B enrollment rights as those who have group coverage. (no bill) S. 374, Medicare Mental Health Inpatient Equity Act - Lobbied in support of this legislation to eliminate the 190-day lifetime limit on Medicare coverage for in-patient psychiatric hospital services. S.3295, the Labor-HHS Appropriations bill for FY 2013 - Lobbied to protect funding for program authorized under the Affordable Care Act, including CMS State Health insurance exchanges, state survey & demonstrations and preventative health. Discussed improving access to care for underserved population. (no bill) Discussed importance of maintaining low income subsididies and supports in Medicare. (no bill) Discussed the importance of coordinating services for those who qualify for both Medicare and Medicaid in order to ensure that beneficiaries receive all needed benefits but there is no duplication. (no bill) Discussed whether, and under what circumstances, managed care could effectively be used to provide benefits to dual eligible beneficiaries. (no bill) Discussed implementation of Anti-Fraud Measures of Affordable Care Act (PL. 111-148), including coordination between HHS, DOJ and state Attorneys General. Discussed additional methods for fighting fraud and waste in Health Care. (no bill) Discussed Medigap and need for guaranteed issue for all populations and need to increase medical loss ratio. Discussed durable medical equipment bidding. (no bill) H.R. 1654, Medicare Enrollment Protection Act - Lobbied for legislation to provide Medicare beneficiaries with additional opportunities to enroll in Medicare Part B. H.R. 978, To amend Title II of the Social Security Act - Lobbied against the use of the Social Security account number on Government-issued identification cards issued in connection with Medicare, Medicaid, and SCHIP benefits and for other purposes. S. 1206/H.R. 2190, The Medicare Drug Savings Act of 2011 - Discussed legislation to require prescription drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. S. 1251, Medicare and Medicaid Fighting Fraud and Abuse to Save Taxpayers' Dollars Act - Discussed support to curb waste and fraud from the Medicare and Medicaid programs. S. 1275, The Medicare and Medicaid FAST Act - Lobbied on legislation to prevent fraud and abuse within the federal health programs. S. 1206/H.R. 2190, The Medicare Drug Savings Act - Discussed legislation that would establish Medicaid drug rebates for the duals. H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2012 - Discussed the legislation as it pertained to SGR. H.R. 8, the American Taxpayer Relief Act of 2012 - Lobbied against inclusion of Social Security, Medicare and Medicaid legislation affecting benefit levels or service delivery in any end-of-the-session budget deal, and urged congress to not reduce spending levels below current services levels for various non-security discretionary programs, including Health Care (including Rx, medical research and premium support), Social Security (administrative expenses), Older Americans Act Supportive Service, Nutrition and Caregiver programs, Low Income Home Energy Assistance, Weatherization, Elderly Housing and Transit/Transportation, Legal and Taxpayer Assistance, Consumer and Worker Protections and Postal Services. Discussed Medicare Graduate Nursing Education pilot design. (no bill) Discussed Prescription Drug Affordability. (no bill) Discussed Prescription Drug Shortages. (no bill) H.R. 3342, Affordable Medicines Utilization Act of 2011 - Lobbied to encourage state Medicaid programs to use safe, effective generic medications. H.R. 2576 - Discussion to amend the Internal Revenue Code of 1986 to modify the calculation of modified adjusted gross income for purposes of determining eligibility for certain healthcare-related programs. Discussed opposition to caps on dual eligibles; discussed managed care and dual eligibles. (no bill) Discussed with CMS demonstration programs for dual eligibles and process related to the demonstrations, as well as other work of the Medicare-Medicaid Coordination Office, discussed home and community setting issue in Medicaid, discussed focus groups on dual eligibles. Discussed Medicaid managed care and long-term services and supports broadly. Discussed Hospital & Critical Access Hospitals Conditions of Participation proposed regulations; requested that advanced practice registered nurses and physicians assistants be allowed the full scope of services in hospital admitting and visiting privileges. (no bill) Discussed Hospital Outpatient Therapeutic Services Final Rule underscoring that advanced practice registered nurses and physicians should be allowed to supervise such outpatient service clinics without physician oversight as long as in line with state scope of practice laws. (no bill) Discussed inviting FTC to participate in a webinar on how they are and can be engaged on state scope of practice issues. Also sent follow-up items for their review. (no bill) Discussed health disparities. (no bill) Discussed Medicaid reform, Medicare/Medicaid "dual eligibles" integration efforts and financial alignment demonstrations; and other CMS demonstration initiatives. (no bill) S.2243, Discussed Medicare Better Health Rewards Program. Discussed You've Earned a Say. (no bill) S. 3271, Discussed Equal Access to Medicare Options Act of 2012. H.R. 2925/S.1551, the Medicare Common Access Card Act - Discussed AARP's support of the bipartisan bill. Discussed Affordable Care Act Medicaid expansion issues. Discussed Medicaid reform, Medicare-Medicaid "dual eligibles" integration efforts and financial alignment demonstrations, other CMS demonstration initiatives. (no bill) S. 3586, Recruiting Individuals to Drive Elders (RIDE) Act - Discussed Medicaid non-emergency transportation bill. Discussed Kansas managed long-term services and supports waiver proposal, Administration. Discussed proposals that would establish per-capita caps under Medicaid as well as other Medicaid financing proposals including block grants and changes to the current FMAP structure. (no bill) Discussed extension of funding originally provided under the Medicare Improvement for Patients and Providers Act (P.L. 110-275) to State Health Insurance Assistance Programs (SHIPs), Aging and Disability Resource Centers (ADRICs), and Area Agencies on Aging (AAAs) for Medicare outreach and enrollment counseling. (no bill) Discussed the prevention of cuts to beneficiaries in the Medicare program. (no bill) Discussed the prevention of an increase in the age of eligibility in the Medicare program. (no bill) Discussed the patch to the Sustainable Growth Rate (SGR) in the Medicare program. (no bill) Discussed concerns of block granting Medicaid. (no bill)
Filing targets: Administration on Aging, Agriculture, Dept of (USDA), Bureau of the Census, Centers For Medicare and Medicaid Services (CMS), Commodity Futures Trading Commission (CFTC), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Federal Communications Commission (FCC), Federal Energy Regulatory Commission (FERC), Federal Highway Administration (FHA), Federal Reserve System, Federal Trade Commission (FTC), Federal Transit Administration (FTA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Highway Traffic Safety Administration (NHTSA), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of the Comptroller of the Currency (OCC), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, White House Office
Discussed legislative intent with respect to Biologic drugs and exclusivity period.(no bill) Discussed importance of potential savings both to consumers and to the federal government of granting Secretarial Negotiating Authority to Secretary of HHS on Medicare Part D. (no bill) Discussed legislative intent with respect to biologic drugs and the exclusivity period; and discussed importance of potential savings to the health care system generally. (no bill) Discussed need for greater consumer safety protections both in OTC and prescription drugs. (no bill) Discussed need to end industry tactics like Pay for Delay which inappropriately extends patents with effect of keeping prices high for consumers and government. (no bill) Discussed need for doctors to get unbiased information on prescription pharmaceuticals through programs like academic detailing. (no bill) Discussed possible savings and better health care outcomes that could result from Medication Therapy Management. (no bill) Pub. Law 111-148 and 111-152 - Discussed implementation of health care legislation to reform the health care system to provide quality healthcare, expand access to long-term services and supports, and reduced prescription drug costs. Discussed greater affordability of generic versions of both generic and biologic drugs. S. 319, Pharmaceutical Market Access and Drug Safety Act of 2011 - Discussed legislation that establishes a framework for the safe, legal importation of lower-priced prescription drugs from abroad. S. 1206, Medicare Drug Savings Act of 2011 - Discussed rebates in Medicare Part D as a cost savings measure in Medicare that does not harm beneficiaries. H. R. 3342, Affordable Medicines Utilization Act of 2011 - Lobbied on legislation to encourage state Medicaid programs to use safe, effective generic medications. S. 27, Preserve Access to Affordable Generics Act - Lobbied for this legislation preventing abuses in patent settlements between generic and brand name prescription drug companies. S. 1886/H.R. 3468, Discussed counterfeit drug penalty enhancement. Discussed prescription drug safety, drug shortage, and medical device safety, and related user fee legislation. S. 2193, the Ensuring Safe Medical Devices for Patients Act - Discussed legislation to include devices in the post-market risk identification and analysis system for prescription drugs and to expedite the implementation of the unique device identification system for medical devices. Discussed draft legislation to address the issue of whether generic drug manufacturers have a duty to include new warnings about potentially serious side effects on their labels as they become known. The bill would accomplish this by giving generic drug makers the same ability to update their labeling as currently exists for manufacturers of brand name drugs. (no bill) S.3187, Food and Drug Administration safety and Innovation Act - FDA user fee agreement legislation focusing on the review process for prescription drugs and medical devices, prescription drug safety, drug shortages, medical device safety and access to generic drugs. S. 1882, Fair and Immediate Release of Generic Drugs Act or the FAIR Generics Act - Discussed pay-for-delay amendment to the FDA user fee agreement legislation based the stand-alone bill. S.3212, Cody Miller Initiative for Safer Prescriptions Act - To require the Secretary of Health and Human Services to promulgate regulations regarding the authorship, content, format, and dissemination of Patient Medication information. Discussed prescription drugs. Discussed legislation to address the inaproppriate use of antipsychotics in nursing home facilities. (no bill) Discussed legislative intent with respect to biologic drugs and the exclusivity period; and discussed importance of potential savings to the health care system generally; discussed the need for greater protections for consumers related to prescription drugs. (no bill)
Provided information on the need for nursing education capacity and the retention of newer and older nurses in the workplace (no bill). H.R.3630, SGR - Discussed physician payment reform; and discussed the implementation of dual-eligibles as through the implementation of various demonstration projects. Pub.Law 111-148 & 111-152 - Discussed implementation of health care law that would reform the health care system to provide affordable quality health care, reduce drug costs and expand access to long-term services and supports. Discussed transitional care program. Discussed how to implement Medicaid provisions of Affordable Care Act. (PL. 111-148) Lobbied in support of draft legislation that would grant individuals whose COBRA has expired the same Medicare Part B enrollment rights as those who have group coverage. (no bill) S. 374, Medicare Mental Health Inpatient Equity Act - Lobbied in support of this legislation to eliminate the 190-day lifetime limit on Medicare coverage for in-patient psychiatric hospital services. S.3295, the Labor-HHS Appropriations bill for FY 2013 - Lobbied to protect funding for program authorized under the Affordable Care Act, including CMS State Health insurance exchanges, state survey & demonstrations and preventative health. Discussed improving access to care for underserved population. (no bill) Discussed importance of maintaining low income subsididies and supports in Medicare. (no bill) Discussed the importance of coordinating services for those who qualify for both Medicare and Medicaid in order to ensure that beneficiaries receive all needed benefits but there is no duplication. (no bill) Discussed whether, and under what circumstances, managed care could effectively be used to provide benefits to dual eligible beneficiaries. (no bill) Discussed implementation of Anti-Fraud Measures of Affordable Care Act (PL. 111-148), including coordination between HHS, DOJ and state Attorneys General. Discussed additional methods for fighting fraud and waste in Health Care. (no bill) Discussed Medigap and need for guaranteed issue for all populations and need to increase medical loss ratio. Discussed medicare physician payment issues. (no bill) Discussed durable medical equipment bidding. (no bill) H.R. 1654, Medicare Enrollment Protection Act - Lobbied for legislation to provide Medicare beneficiaries with additional opportunities to enroll in Medicare Part B. H.R. 978, To amend Title II of the Social Security Act - Lobbied against the use of the Social Security account number on Government-issued identification cards issued in connection with Medicare, Medicaid, and SCHIP benefits and for other purposes. S. 1206/H.R. 2190, The Medicare Drug Savings Act of 2011 - Discussed legislation to require prescription drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. S. 1251, Medicare and Medicaid Fighting Fraud and Abuse to Save Taxpayers' Dollars Act - Discussed support to curb waste and fraud from the Medicare and Medicaid programs. S. 1275, The Medicare and Medicaid FAST Act - Lobbied on legislation to prevent fraud and abuse within the federal health programs. S. 1206/H.R. 2190, The Medicare Drug Savings Act - Discussed legislation that would establish Medicaid drug rebates for the duals. Medicare physician reimbursement issues. (no bill) H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2012 - Discussed the legislation as it pertained to SGR. Discussed Medicare Graduate Nursing Education pilot design. (no bill) Discussed Medicare Physician Payment Reform. (no bill) Discussed Prescription Drug Affordability. (no bill) Discussed Prescription Drug Shortages. (no bill) H.R. 3342, Affordable Medicines Utilization Act of 2011 - Lobbied to encourage state Medicaid programs to use safe, effective generic medications. H.R. 2576 - Discussion to amend the Internal Revenue Code of 1986 to modify the calculation of modified adjusted gross income for purposes of determining eligibility for certain healthcare-related programs. Discussed opposition to caps on dual eligibles; discussed managed care and dual eligibles. (no bill) Discussed with CMS demonstration programs for dual eligibles and process related to the demonstrations, as well as other work of the Medicare-Medicaid Coordination Office, discussed home and community setting issue in Medicaid, discussed focus groups on dual eligibles; discussed implementation of some Medicaid HCBS provisions. Discussed Medicaid managed care and long-term services and supports broadly. Discussed Hospital & Critical Access Hospitals Conditions of Participation proposed regulations; requested that advanced practice registered nurses and physicians assistants be allowed the full scope of services in hospital admitting and visiting privileges. (no bill) Discussed Hospital Outpatient Therapeutic Services Final Rule underscoring that advanced practice registered nurses and physicians should be allowed to supervise such outpatient service clinics without physician oversight as long as in line with state scope of practice laws. (no bill) Discussed inviting FTC to participate in a webinar on how they are and can be engaged on state scope of practice issues. Also sent follow-up items for their review. (no bill) Discussed health disparities. (no bill) Discussed Medicaid reform, Medicare/Medicaid "dual eligibles" integration efforts and financial alignment demonstrations; and other CMS demonstration initiatives. (no bill) Discussed methods for fighting additional fraud and waste in Healthcare. (no bill) Discussed Medicare physician payment issues. (no bill) S.2243, Discussed Medicare Better Health Rewards Program. Discussed You've Earned a Say. (no bill) S. 3271, Discussed Equal Access to Medicare Options Act of 2012. H.R. 2925/S.1551, the Medicare Common Access Card Act - Discussed AARP's support of the bipartisan bill. Discussed Affordable Care Act Medicaid expansion issues. Discussed Medicaid reform, Medicare-Medicaid "dual eligibles" integration efforts and financial alignment demonstrations, other CMS demonstration initiatives. (no bill) S. 3586, Recruiting Individuals to Drive Elders (RIDE) Act - Discussed Medicaid non-emergency transportation bill.
Filing targets: Administration on Aging, Agriculture, Dept of (USDA), Bureau of the Census, Centers For Medicare and Medicaid Services (CMS), Commodity Futures Trading Commission (CFTC), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Federal Communications Commission (FCC), Federal Energy Regulatory Commission (FERC), Federal Highway Administration (FHA), Federal Reserve System, Federal Trade Commission (FTC), Federal Transit Administration (FTA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Highway Traffic Safety Administration (NHTSA), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of the Comptroller of the Currency (OCC), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, White House Office
Provided information on the need for nursing education capacity and the retention of newer and older nurses in the workplace (no bill). H.R.3630, SGR - Discussed physician payment reform; and discussed the implementation of dual-eligibles as through the implementation of various demonstration projects. Pub.Law 111-148 & 111-152 - Discussed implementation of health care law that would reform the health care system to provide affordable quality health care, reduce drug costs and expand access to long-term services and supports. Discussed transitional care program. Discussed how to implement Medicaid provisions of Affordable Care Act. (PL. 111-148) Lobbied in support of draft legislation that would grant individuals whose COBRA has expired the same Medicare Part B enrollment rights as those who have group coverage. (no bill) S. 374, Medicare Mental Health Inpatient Equity Act - Lobbied in support of this legislation to eliminate the 190-day lifetime limit on Medicare coverage for in-patient psychiatric hospital services. S.3295, the Labor-HHS Appropriations bill for FY 2013 - Lobbied to protect funding for program authorized under the Affordable Care Act, including CMS State Health insurance exchanges, state survey & demonstrations and preventative health. Discussed improving access to care for underserved population. (no bill) Discussed importance of maintaining low income subsididies and supports in Medicare. (no bill) Discussed the importance of coordinating services for those who qualify for both Medicare and Medicaid in order to ensure that beneficiaries receive all needed benefits but there is no duplication. (no bill) Discussed whether, and under what circumstances, managed care could effectively be used to provide benefits to dual eligible beneficiaries. (no bill) Discussed implementation of Anti-Fraud Measures of Affordable Care Act (PL. 111-148), including coordination between HHS, DOJ and state Attorneys General. Discussed additional methods for fighting fraud and waste in Health Care. (no bill) Discussed Medigap and need for guaranteed issue for all populations and need to increase medical loss ratio. Discussed medicare physician payment issues. (no bill) Discussed durable medical equipment bidding. (no bill) H.R. 1654, Medicare Enrollment Protection Act - Lobbied for legislation to provide Medicare beneficiaries with additional opportunities to enroll in Medicare Part B. H.R. 978, To amend Title II of the Social Security Act - Lobbied against the use of the Social Security account number on Government-issued identification cards issued in connection with Medicare, Medicaid, and SCHIP benefits and for other purposes. S. 1206/H.R. 2190, The Medicare Drug Savings Act of 2011 - Discussed legislation to require prescription drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. S. 1251, Medicare and Medicaid Fighting Fraud and Abuse to Save Taxpayers' Dollars Act - Discussed support to curb waste and fraud from the Medicare and Medicaid programs. S. 1275, The Medicare and Medicaid FAST Act - Lobbied on legislation to prevent fraud and abuse within the federal health programs. S. 1206/H.R. 2190, The Medicare Drug Savings Act - Discussed legislation that would establish Medicaid drug rebates for the duals. Medicare physician reimbursement issues. (no bill) H.R. 3630, Middle Class Tax Relief and Job Creation Act of 2012 - Discussed the legislation as it pertained to SGR. Discussed Medicare Graduate Nursing Education pilot design. (no bill) Discussed Medicare Physician Payment Reform. (no bill) Discussed Prescription Drug Affordability. (no bill) Discussed Prescription Drug Shortages. (no bill) H.R. 3342, Affordable Medicines Utilization Act of 2011 - Lobbied to encourage state Medicaid programs to use safe, effective generic medications. H.R. 2576 - Discussion to amend the Internal Revenue Code of 1986 to modify the calculation of modified adjusted gross income for purposes of determining eligibility for certain healthcare-related programs. Discussed opposition to caps on dual eligibles; discussed managed care and dual eligibles. (no bill) Discussed Senior Navigation and Planning Act. (no bill) Discussed with CMS demonstration programs for dual eligibles and process related to the demonstrations, as well as other work of the Medicare-Medicaid Coordination Office, discussed opposition to Florida medicaid waivers (including letter), discussed home and community setting issue in Medicaid, discussed focus groups on dual eligibles; discussed implementation of some Medicaid HCBS provisions. Discussed Medicaid managed care and long-term services and supports broadly. Discussed Fair Labor Standards Act and companionship exemption. Discussed Hospital & Critical Access Hospitals Conditions of Participation proposed regulations; requested that advanced practice registered nurses and physicians assistants be allowed the full scope of services in hospital admitting and visiting privileges. (no bill) Discussed Hospital Outpatient Therapeutic Services Final Rule underscoring that advanced practice registered nurses and physicians should be allowed to supervise such outpatient service clinics without physician oversight as long as in line with state scope of practice laws. (no bill) Discussed inviting FTC to participate in a webinar on how they are and can be engaged on state scope of practice issues. Also sent follow-up items for their review. (no bill) Discussed health disparities. (no bill) Discussed Medicaid reform, Medicare/Medicaid "dual eligibles" integration efforts and financial alignment demonstrations; and other CMS demonstration initiatives. (no bill) Discussed methods for fighting additional fraud and waste in Healthcare. (no bill) Discussed Medicare physician payment issues. (no bill) S.2243, Discussed Medicare Better Health Rewards Program. Discussed You've Earned a Say. (no bill) S. 3271, Discussed Equal Access to Medicare Options Act of 2012.
Filing targets: Administration on Aging, Agriculture, Dept of (USDA), Bureau of the Census, Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Federal Communications Commission (FCC), Federal Energy Regulatory Commission (FERC), Federal Highway Administration (FHA), Federal Reserve System, Federal Trade Commission (FTC), Federal Transit Administration (FTA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Highway Traffic Safety Administration (NHTSA), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of the Comptroller of the Currency (OCC), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, White House Office
Provided information on the need for nursing education capacity and the retention of newer and older nurses in the workplace. (no bill) Discussed barriers to care that can result from language differences between providers and patients and/or lack of translation services. (no bill) Discussed need to increase health information technology quality measurements and access to qualified systems. (no bill) S. 1019, Hearing Aid Assistance Tax Credit Act - Discussed Hearing Aid Assistance Tax Credit Act which would provide a $500 credit to people of all ages. H.R. 217, To repeal the Prevention and Public Health Fund - Lobbied against the repeal of the Prevention and Public Health Trust Fund. This fund is an important component in state and community efforts to prevent illness and promote health. Discussed Pre-existing Condition Insurance Program. (no bill) Discussed Accountable Care Organization and Medical Shared savings. (no bill) Discussed Rate Review. (no bill) Discussed Internal Appeals and External Review Process. (no bill) Discussed Medicare reimbursement issues. Lobbied in support of Medicare physician payment reform. Discussed legislation to make prescription drugs more affordable to older Americans. S. 159/H.R. 63, Discussed the Confidence in Long-Term Care Insurance Act/Long-Term Insurance Reform Act which improves the consumer protections of LTC insurance policies and make more and better information available to consumers to help them make informed decisions about such policies. S. 1416/H.R. 2645, Medigap Medical Loss Ratio Improvement Act - Lobbied for bill introduction and helped with crafting. Discussed Internal Claims, Appeals and external Review Process. (no bill) Discussed HIPAA Privacy Rule Accounting under HITECH Act. (no bill) Discussed coverage for screening depression and screening and counseling for alcohol misuse. (no bill) Discussed consumer operated and oriented plan programs. (no bill) Discussed standards related to risk adjustment, reinsurance, and risk mitigation as they relate to exchanges. (no bill) H.R.2077, MLR Repeal Act of 2011 - Expressed opposition to the elimination of provision in the Affordable Care Act (P.L. 111-148)Discussed opposition to draft legislation regarding the elimination of grandfathered status. (no bill) Discussed association health plans with DOL, HHS and DOT. (no bill) Discussed quality and care coordination with HHS. (no bill) Discussed Essential Health Benefits with HHS. (no bill) Discussed employer affordability safe harbor. (no bill) Discussed health insurance exchanges - eligibility, enrollment, premium tax credits. (no bill) Discussed Basic Health Plans. (no bill) Discussed Medigap reform. (no bill) Discussed Pre-existing Condition Insurance Program. (no bill) Discussed role of grandfathered plans. (no bill) Discussed status of the CLASS Program. (no bill) Discussed opposition to repeal of the CLASS Program (no bill, but also as S. 720, the Repeal the CLASS Entitlement Act. Discussed opposition to H.R. 1173, the Fiscal Responsibility and Retirement Security Act, to repeal the CLASS Program and shared stories and information related to long-term services and supports. Discussed reauthorization of the Older Americans Act and other amendments to the OAA. (no bill) S. 1750 -Discussed Home Care Consumer Bill of Rights Act. Discussed cost effectiveness of home and community-based services. (no bill) Discussed reports on family caregiving and Long-Term Services and Supports State Scorecard. (no bill) Discussed Hospital & Critical Access Hospitals Conditions of Participation proposed regulations; requested that advanced practice registered nurses and physicians assistants be allowed the full scope of services in hospital admitting and visiting privileges. (no bill) Discussed Hospital Outpatient Therapeutic Services Final Rule underscoring that advanced practice registered nurses and physicians should be allowed to supervise such outpatient service clinics without physician oversight as long as in line with state scope of practice laws. (no bill) Discussed Medicare GNE demonstration design problems. Discussed inviting FTC to participate in a webinar on how they are and can be engaged on state scope of practice issues. Also sent follow-up items for their review. (no bill) Discussed legislation to make long-term care insurance available under cafeteria plans and flexible spending arrangements and to improve consumer protections. (no bill)
Discussed legislative intent with respect to Biologic drugs and exclusivity period.(no bill) Discussed importance of potential savings both to consumers and to the federal government of granting Secretarial Negotiating Authority to Secretary of HHS on Medicare Part D. (no bill) Discussed need for greater consumer safety protections both in OTC and prescription drugs. (no bill) Discussed need to end industry tactics like Pay for Delay which inappropriately extends patents with effect of keeping prices high for consumers and government. (no bill) Discussed need for doctors to get unbiased information on prescription pharmaceuticals through programs like academic detailing. (no bill) Discussed possible savings and better health care outcomes that could result from Medication Therapy Management. (no bill) Pub. Law 111-148 and 111-152 - Discussed implementation of health care legislation to reform the health care system to provide quality healthcare, expand access to long-term services and supports, and reduced prescription drug costs. Discussed greater affordability of generic versions of both generic and biologic drugs. S. 319, Pharmaceutical Market Access and Drug Safety Act of 2011 - Discussed legislation that establishes a framework for the safe, legal importation of lower-priced prescription drugs from abroad. S. 1206, Medicare Drug Savings Act of 2011 - Discussed rebates in Medicare Part D as a cost savings measure in Medicare that does not harm beneficiaries. H. R. 3342, Affordable Medicines Utilization Act of 2011 - Lobbied on legislation to encourage state Medicaid programs to use safe, effective generic medications. S. 27, Preserve Access to Affordable Generics Act - Lobbied for this legislation preventing abuses in patent settlements between generic and brand name prescription drug companies. S. 1886/H.R. 3468, Discussed counterfeit drug penalty enhancement. Discussed prescription drugs and medical device issues. Discussed prescription drug safety, drug shortage, and medical device safety, and related user fee legislation. S. 2193, the Ensuring Safe Medical Devices for Patients Act - Discussed legislation to include devices in the post-market risk identification and analysis system for prescription drugs and to expedite the implementation of the unique device identification system for medical devices. Discussed draft legislation to address the issue of whether generic drug manufacturers have a duty to include new warnings about potentially serious side effects on their labels as they become known. The bill would accomplish this by giving generic drug makers the same ability to update their labeling as currently exists for manufacturers of brand name drugs. (no bill)
Filing targets: Administration on Aging, Agriculture, Dept of (USDA), Bureau of the Census, Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Federal Communications Commission (FCC), Federal Energy Regulatory Commission (FERC), Federal Highway Administration (FHA), Federal Reserve System, Federal Trade Commission (FTC), Federal Transit Administration (FTA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Highway Traffic Safety Administration (NHTSA), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of the Comptroller of the Currency (OCC), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, White House Office
Provided information on the need for nursing education capacity and the retention of newer and older nurses in the workplace (no bill). Pub.Law 111-148 & 111-152 - Discussed implementation of health care law that would reform the health care system to provide affordable quality health care, reduce drug costs and expand access to long-term services and supports. Discussed transitional care demonstration program. Discussed how to implement Medicaid provisions of Affordable Care Act. (PL. 111-148) Lobbied in support of draft legislation that would grant individuals whose COBRA has expired the same Medicare Part B enrollment rights as those who have group coverage. (no bill) S. 374, Medicare Mental Health Inpatient Equity Act - Lobbied in support of this legislation to eliminate the 190-day lifetime limit on Medicare coverage for in-patient psychiatric hospital services. Consolidated Appropriations Act, FY 2012, H.R. 2055, H.R. 3671, H.R. 2017, Consolidated and Further Appropriations Continuing Appropriations Act, H.R. 2112, Continuing Resolution, FY 2012, H.R. 2608 and H.J. Res. 79, 94 and 95 - Lobbied for funding for agencies and programs within jurisdiction of the Labor-HHS Appropriations bill (H.R. 3055/S. 1599), including Social Security Administration operations, Older Americans Act nutrition, health care delivery reform, CLASS, LIHEAP, Older Americans Act caregiver programs, high risk pool subsidies to states and Medicaid. Discussed improving access to care for underserved population. (no bill) Discussed importance of maintaining low income subsididies and supports in Medicare. (no bill) Discussed the importance of coordinating services for those who qualify for both Medicare and Medicaid in order to ensure that beneficiaries receive all needed benefits but there is no duplication. (no bill) Discussed whether, and under what circumstances, managed care could effectively be used to provide benefits to dual eligible beneficiaries. (no bill) Discussed implementation of Anti-Fraud Measures of Affordable Care Act (PL. 111-148), including coordination between HHS, DOJ and state Attorneys General. Discussed additional methods for fighting fraud and waste in Health Care. (no bill) Discussed Medigap and need for guaranteed issue for all populations and need to increase medical loss ratio. Discussed medicare physician payment issues. (no bill) Discussed durable medical equipment bidding. (no bill) H.R. 1654, Medicare Enrollment Protection Act - Lobbied for legislation to provide Medicare beneficiaries with additional opportunities to enroll in Medicare Part B. H.R. 978, To amend Title II of the Social Security Act - Lobbied against the use of the Social Security account number on Government-issued identification cards issued in connection with Medicare, Medicaid, and SCHIP benefits and for other purposes. H.R. 1683, State Flexibility Act - Lobbied against H.R. 1683, a bill that would eliminate the Medicaid Maintenance of Effort (MOE) requirement included as a part of the Affordable Care Act. S. 1206/H.R. 2190, The Medicare Drug Savings Act of 2011 - Discussed legislation to require prescription drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. S. 1251, Medicare and Medicaid Fighting Fraud and Abuse to Save Taxpayers' Dollars Act - Discussed support to curb waste and fraud from the Medicare and Medicaid programs. S. 1275, The Medicare and Medicaid FAST Act - Lobbied on legislation to prevent fraud and abuse within the federal health programs. S. 1206/H.R. 2190, The Medicare Drug Savings Act - Discussed legislation that would establish Medicaid drug rebates for the duals. Medicare physician reimbursement issues. (no bill) S. 365, Budget Control Act - Lobbied Congress against cuts to Medicare and Medicaid in the Super Committee debate and where savings could be found without harming beneficiaries. Discussed Medicare Graduate Nursing Education pilot design. (no bill) Discussed Medicare Physician Payment Reform. (no bill) Discussed Prescription Drug Affordability. (no bill) Discussed Prescription Drug Shortages. (no bill) H.R. 3342, Affordable Medicines Utilization Act of 2011 - Lobbied to encourage state Medicaid programs to use safe, effective generic medications. H.R. 2576 - Discussion to amend the Internal Revenue Code of 1986 to modify the calculation of modified adjusted gross income for purposes of determining eligibility for certain healthcare-related programs. Discussed opposition to caps on dual eligibles; discussed managed care and dual eligibles. (no bill) Discussed Senior Navigation and Planning Act. (no bill) Discussed no entitlement cuts press event. (no bill) Discussed focus groups on dual eligibles. (no bill) Discussed with CMS demonstration programs for dual eligibles and process related to the demonstrations, as well as other work of the Medicare-Medicaid Coordination Office, invited staff to speak at meetings on Medicaid home and community-based services (HCBS), Medicaid managed long-term services and supports, and state oversight of Medicaid managed care, discussed opposition to Florida medicaid waivers (including letter), inquired on status of a Medicaid waiver and questions regarding implementation of some Medicaid HCBS provisions, discussed workforce issues in relation to Innovation Center work, inquired re: status of 1115 waiver transparency regulations, shared information on family caregiver makeover events (education), discussed home and community setting issue in Medicaid, discussed focus groups on dual eligibles; comment letter on Medicaid Program Eligibility Changes under the Affordable Care Act (PL 111-148). Discussed Medicaid managed care and long-term services and supports broadly, discussed CLASS Program. Discussed Fair Labor Standards Act and companionship exemption. Discussed Hospital & Critical Access Hospitals Conditions of Participation proposed regulations; requested that advanced practice registered nurses and physicians assistants be allowed the full scope of services in hospital admitting and visiting privileges. (no bill) Discussed Hospital Outpatient Therapeutic Services Final Rule underscoring that advanced practice registered nurses and physicians should be allowed to supervise such outpatient service clinics without physician oversight as long as in line with state scope of practice laws. (no bill) Discussed inviting FTC to participate in a webinar on how they are and can be engaged on state scope of practice issues. Also sent follow-up items for their review. (no bill)
Provided information on the need for nursing education capacity and the retention of newer and older nurses in the workplace. (no bill) Discussed barriers to care that can result from language differences between providers and patients and/or lack of translation services. (no bill) Consolidated Appropriations Act, FY 2012, H.R. 2055, H.R. 3671, H.R. 2017, Consolidated and Further Appropriations Continuing Appropriations Act, H.R. 2112, Continuing Resolution, FY 2012, H.R. 2608 and H.J. Res. 79, 94 and 95 - Lobbied for funding for agencies and programs within jurisdiction of the Labor-HHS Appropriations bill (H.R. 3055/S. 1599), including Social Security Administration operations, Older Americans Act nutrition, health care delivery reform, CLASS, LIHEAP, Older Americans Act caregiver programs, high risk pool subsidies to states and Medicaid. Pub. Law 111-148 & 111-152 - Discussed implementation of health disparities data collection provisions of the Affordable Care Act. Pub. Law 111-148 & 111-152 - Discussed implementation of health care legislation that would reform the health care system to provide affordable quality health care and expand access to long term care services. Lobbied in support of comparative effectiveness research. (no bill) Discussed need to increase health information technology quality measurements and access to qualified systems. (no bill) S. 1019, Hearing Aid Assistance Tax Credit Act - Discussed Hearing Aid Assistance Tax Credit Act which would provide a $500 credit to people of all ages. H.R. 217, To repeal the Prevention and Public Health Fund - Lobbied against the repeal of the Prevention and Public Health Trust Fund. This fund is an important component in state and community efforts to prevent illness and promote health. Discussed Pre-existing Condition Insurance Program. (no bill) Discussed Accountable Care Organization and Medical Shared savings. (no bill) Discussed Rate Review. (no bill) Discussed Internal Appeals and External Review Process. (no bill) Discussed Medicare reimbursement issues. Lobbied in support of Medicare physician payment reform. Discussed legislation to make prescription drugs more affordable to older Americans. S. 159/H.R. 63, The Confidence in Long-Term Care Insurance Act - Discussed the Long-Term Insurance Act which improves the consumer protections of LTC insurance policies and make more and better information available to consumers to help them make informed decisions about such policies. S. 1416/H.R. 2645, Medigap Medical Loss Ratio Improvement Act - Lobbied for bill introduction and helped with crafting. Discussed Internal Claims, Appeals and external Review Process. (no bill) Discussed HIPAA Privacy Rule Accounting under HITECH Act. (no bill) Discussed coverage for screening depression and screening and counseling for alcohol misuse. (no bill) Discussed consumer operated and oriented plan programs. (no bill) Discussed standards related to risk adjustment, reinsurance, and risk mitigation as they relate to exchanges. (no bill) H.R.2077, MLR Repeal Act of 2011 - Expressed opposition to the elimination of provision in the Affordable Care Act (P.L. 111-148)Discussed opposition to draft legislation regarding the elimination of grandfathered status. (no bill) Discussed association health plans with DOL, HHS and DOT. (no bill) Discussed quality and care coordination with HHS. (no bill) Discussed Essential Health Benefits with HHS. (no bill) Discussed employer affordability safe harbor. (no bill) Discussed health insurance exchanges - eligibility, enrollment, premium tax credits. (no bill) Discussed Basic Health Plans. (no bill) Discussed Medigap reform. (no bill) Discussed Pre-existing Condition Insurance Program. (no bill) Discussed role of grandfathered plans. (no bill) Discussed implementation of the CLASS Porgram. (no bill) Discussed opposition to repeal of the CLASS Program (no bill, but also as S. 720, the Repeal the CLASS Entitlement Act/ this was also filed as multiple amendments). Discussed opposition to H.R. 1173, the Fiscal Responsibility and Retirement Security Act, to repeal the CLASS Program. Discussed reauthorization of the Older Americans Act and other amendments to the OAA. (no bill) S. 1750 -Discussed Home Care Consumer Bill of Rights Act. Discussed cost effectiveness of home and community-based services. (no bill) Discussed invitation to solutions forum on family caregiving and webinar on elder care and employment. (no bill) Discussed reports on family caregiving and Long-Term Services and Supports State Scorecard. (no bill) Discussed Hospital & Critical Access Hospitals Conditions of Participation proposed regulations; requested that advanced practice registered nurses and physicians assistants be allowed the full scope of services in hospital admitting and visiting privileges. (no bill) Discussed Hospital Outpatient Therapeutic Services Final Rule underscoring that advanced practice registered nurses and physicians should be allowed to supervise such outpatient service clinics without physician oversight as long as in line with state scope of practice laws. (no bill) Discussed Medicare GNE demonstration design problems. Discussed inviting FTC to participate in a webinar on how they are and can be engaged on state scope of practice issues. Also sent follow-up items for their review. (no bill) Discussed legislation to make long-term care insurance available under cafeteria plans and flexible spending arrangements and to improve consumer protections. (no bill)
Filing targets: Administration on Aging, Agriculture, Dept of (USDA), Bureau of the Census, Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Equal Employment Opportunity Commission (EEOC), Federal Communications Commission (FCC), Federal Energy Regulatory Commission (FERC), Federal Highway Administration (FHA), Federal Reserve System, Federal Trade Commission (FTC), Federal Transit Administration (FTA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Highway Traffic Safety Administration (NHTSA), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of the Comptroller of the Currency (OCC), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, White House Office
H.J. Res. 44, H.J. 48, H.R. 2112, H.J. Res. 79, H.R. 2608, H.R. 2017, Continuing Appropriations Amendments, FY 2011 - Lobbied for funding for FDA Office of Generic Drugs and nutrition assistance. Discussed legislative intent with respect to Biologic drugs and exclusivity period.(no bill) Discussed importance of potential savings both to consumers and to the federal government of granting Secretarial Negotiating Authority to Secretary of HHS on Medicare Part D. (no bill) Discussed need for greater consumer safety protections both in OTC and prescription drugs. (no bill) Discussed need to end industry tactics like Pay for Delay which inappropriately extends patents with effect of keeping prices high for consumers and government. (no bill) Discussed need for doctors to get unbiased information on prescription pharmaceuticals through programs like academic detailing. (no bill) Discussed possible savings and better health care outcomes that could result from Medication Therapy Management. (no bill) Pub. Law 111-148 and 111-152 - Discussed implementation of health care legislation to reform the health care system to provide quality healthcare, expand access to long-term services and supports, and reduced prescription drug costs. Discussed greater affordability of generic versions of both generic and biologic drugs. S. 319, Pharmaceutical Market Access and Drug Safety Act of 2011 - Discussed legislation that establishes a framework for the safe, legal importation of lower-priced prescription drugs from abroad. S. 1206, Medicare Drug Savings Act of 2011 - Discussed rebates in Medicare Part D as a cost savings measure in Medicare that does not harm beneficiaries.
Filing targets: Administration on Aging, Agriculture, Dept of (USDA), Bureau of the Census, Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Equal Employment Opportunity Commission (EEOC), Federal Communications Commission (FCC), Federal Energy Regulatory Commission (FERC), Federal Highway Administration (FHA), Federal Reserve System, Federal Transit Administration (FTA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Highway Traffic Safety Administration (NHTSA), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of the Comptroller of the Currency (OCC), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, White House Office
H.J. Res. 44, H.J. 48, H.R. 2112, H.J. Res. 79, H.R. 2608, H.R. 2017, Continuing Appropriations Amendments, FY 2011 - Lobbied for funding for FDA Office of Generic Drugs and nutrition assistance. Discussed legislative intent with respect to Biologic drugs and exclusivity period.(no bill) Discussed importance of potential savings both to consumers and to the federal government of granting Secretarial Negotiating Authority to Secretary of HHS on Medicare Part D. (no bill) Discussed need for greater consumer safety protections both in OTC and prescription drugs. (no bill) Discussed need to end industry tactics like Pay for Delay which inappropriately extends patents with effect of keeping prices high for consumers and government. (no bill) Discussed need for doctors to get unbiased information on prescription pharmaceuticals through programs like academic detailing. (no bill) Discussed possible savings and better health care outcomes that could result from Medication Therapy Management. (no bill) Pub. Law 111-148 and 111-152 - Discussed implementation of health care legislation to reform the health care system to provide quality healthcare, expand access to long-term services and supports, and reduced prescription drug costs. Discussed greater affordability of generic versions of both generic and biologic drugs. S. 319, Pharmaceutical Market Access and Drug Safety Act of 2011 - Discussed legislation that establishes a framework for the safe, legal importation of lower-priced prescription drugs from abroad. S. 1206, Medicare Drug Savings Act of 2011 - Discussed rebates in Medicare Part D as a cost savings measure in Medicare that does not harm beneficiaries.
Provided information on the need for nursing education capacity and the retention of newer and older nurses in the workplace. (no bill) Discussed barriers to care that can result from language differences between providers and patients and/or lack of translation services. (no bill) H.J.Res 44, H.R. 1599, H.J. Res.79, H.R. 2068, H.R. 2017Labor-Health & Human Services, Education and Related Agencies Appropriations bill for FY2012 - Lobbied for funding for LIHEAP. Sent letters to House and Senate LHHS Subcommittees on funding for SSA Administration, Older Americans Act nutrition, health care delivery reform, CLASS, LIHEAP, Older Americans Act caregiver programs and Medicaid. Pub. Law 111-148 & 111-152 - Discussed implementation of health disparities data collection provisions of the Affordable Care Act. Pub. Law 111-148 & 111-152 - Discussed implementation of health care legislation that would reform the health care system to provide affordable quality health care and expand access to long term care services. Lobbied in support of comparative effectiveness research. (no bill) Discussed need to increase health information technology quality measurements and access to qualified systems. (no bill) S. 1019, Hearing Aid Assistance Tax Credit Act - Discussed Hearing Aid Assistance Tax Credit Act which would provide a $500 credit to people of all ages. H.R. 217, To repeal the Prevention and Public Health Fund - Lobbied against the repeal the Prevention and Public Health Trust Fund. This fund is an important component in state and community efforts to prevent illness and promote health. Discussed Pre-existing Condition Insurance Program. (no bill) Discussed Accountable Care Organization and Medical Shared savings. (no bill) Discussed Rate Review. (no bill) Discussed Internal Appeals and External Review Process. (no bill) Discussed Medicare reimbursement issues. Lobbied in support of Medicare physician payment reform. Discussed legislation to make prescription drugs more affordable to older Americans. S. 159, The Confidence in Long-Term Care Insurance Act - Discussed the Long-Term Insurance Act which improves the consumer protections of LTC insurance policies and make more and better information available to consumers to help them make informed decisions about such policies. H.R. 63, The Long-Term Care Insurance Reform Act - Discussed the Long Term Care Insurance Act which improves the consumer protections of LTC insurance policies and make more and better information available to consumers to help them make informed decisions about such policies. S. 1416/H.R. 2645, Medigap Medical Loss Ratio Improvement Act - Lobbied for bill introduction and helped with crafting. Discussed Internal Claims, Appeals and external Review Process. (no bill) Discussed HIPAA Privacy Rule Accounting under HITECH Act. (no bill) Discussed coverage for screening depression and screening and counseling for alcohol misuse. (no bill) Discussed consumer operated and oriented plan programs. (no bill) Discussed standards related to risk adjustment, reinsurance, and risk mitigation as they relate to exchanges. (no bill) H.R.2077, MLR Repeal Act of 2011 - Expressed opposition to the elimination of provision in the Affordable Care Act (P.L. 111-148)Discussed opposition to draft legislation regarding the elimination of grandfathered status. (no bill) Discussed association health plans with DOL, HHS and DOT. (no bill) Discussed quality and care coordination with HHS. (no bill)
Filing targets: Administration on Aging, Agriculture, Dept of (USDA), Bureau of the Census, Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Equal Employment Opportunity Commission (EEOC), Federal Communications Commission (FCC), Federal Energy Regulatory Commission (FERC), Federal Highway Administration (FHA), Federal Reserve System, Federal Transit Administration (FTA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Highway Traffic Safety Administration (NHTSA), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of the Comptroller of the Currency (OCC), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, White House Office
Provided information on the need for nursing education capacity and the retention of newer and older nurses in the workplace. (no bill) Discussed barriers to care that can result from language differences between providers and patients and/or lack of translation services. (no bill) H.J.Res 44, Labor-Health & Human Services, Education and Related Agencies Appropriations bill for FY2012 - Lobbied for funding for LIHEAP. Sent letters to House and Senate LHHS Subcommittees on funding for SSA Administration, Older Americans Act nutrition, health care delivery reform, CLASS, LIHEAP, Older Americans Act caregiver programs and Medicaid. Pub. Law 111-148 & 111-152 - Discussed implementation of health disparities data collection provisions of the Affordable Care Act. Pub. Law 111-148 & 111-152 - Discussed implementation of health care legislation that would reform the health care system to provide affordable quality health care and expand access to long term care services. Lobbied in support of legislation to provide a hearing aid tax credit to individuals. (no bill) Lobbied in support of comparative effectiveness research. (no bill) Discussed need to increase health information technology quality measurements and access to qualified systems. (no bill) S. 1019, Hearing Aid Assistance Tax Credit Act - Discussed Hearing Aid Assistance Tax Credit Act which would provide a $500 credit to people of all ages. H.R. 217, To repeal the Prevention and Public Health Fund - Lobbied against the repeal the Prevention and Public Health Trust Fund. This fund is an important component in state and community efforts to prevent illness and promote health. Discussed medical loss ratio. (no bill) Discussed Pre-existing Condition Insurance Program. (no bill) Discussed Accountable Care Organization and Medical Shared savings. (no bill) Discussed Rate Review. (no bill) Discussed Internal Appeals and External Review Process. (no bill) Discussed Medicare reimbursement issues. Lobbied in support of Medicare physician payment reform. Discussed legislation to make prescription drugs more affordable to older Americans. S. 159, The Confidence in Long-Term Care Insurance Act - Discussed the Long-Term Insurance Act which improves the consumer protections of LTC insurance policies and make more and better information available to consumers to help them make informed decisions about such policies. H.R. 63, The Long-Term Care Insurance Reform Act - Discussed the Long Term Care Insurance Act which improves the consumer protections of LTC insurance policies and make more and better information available to consumers to help them make informed decisions about such policies.
H.J. Res. 44, H.J. 48, Continuing Appropriations Amendments, FY 2011 - Lobbied for funding for FDA Office of Generic Drugs and nutrition assistance. Discussed legislative intent with respect to Biologic drugs and exclusivity period.(no bill) Discussed importance of potential savings both to consumers and to the federal government of granting Secretarial Negotiating Authority to Secretary of HHS on Medicare Part D. (no bill) Discussed need for greater consumer safety protections both in OTC and prescription drugs. (no bill) Discussed need to end industry tactics like Pay for Delay which inappropriately extends patents with effect of keeping prices high for consumers and government. (no bill) Discussed need for doctors to get unbiased information on prescription pharmaceuticals through programs like academic detailing. (no bill) Discussed possible savings and better health care outcomes that could result from Medication Therapy Management. (no bill) Pub. Law 111-148 and 111-152 - Discussed implementation of health care legislation to reform the health care system to provide quality healthcare, expand access to long-term services and supports, and reduced prescription drug costs. Discussed greater affordability of generic versions of both generic and biologic drugs. S. 319, Pharmaceutical Market Access and Drug Safety Act of 2011 - Discussed legislation that establishes a framework for the safe, legal importation of lower-priced prescription drugs from abroad.
Filing targets: Administration on Aging, Agriculture, Dept of (USDA), Bureau of the Census, Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Equal Employment Opportunity Commission (EEOC), Federal Communications Commission (FCC), Federal Energy Regulatory Commission (FERC), Federal Highway Administration (FHA), Federal Reserve System, Federal Transit Administration (FTA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Highway Traffic Safety Administration (NHTSA), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of the Comptroller of the Currency (OCC), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, White House Office
H.J. Res. 44, H.J. 48, Continuing Appropriations Amendments, FY 2011 - Lobbied for funding for FDA Office of Generic Drugs and nutrition assistance. Discussed legislative intent with respect to Biologic drugs and exclusivity period.(no bill) S. 319, Pharmaceutical Market Access and Drug Safety Act of 2011 - Discussed importance of potential savings to consumers through safe importation of prescription drugs and endorsed legislation. Discussed importance of potential savings both to consumers and to the federal government of granting Secretarial Negotiating Authority to Secretary of HHS on Medicare Part D. (no bill) Discussed need for greater consumer safety protections both in OTC and prescription drugs. (no bill) Discussed need to end industry tactics like Pay for Delay which inappropriately extends patents with effect of keeping prices high for consumers and government. (no bill) Discussed need for doctors to get unbiased information on prescription pharmaceuticals through programs like academic detailing. (no bill) Discussed possible savings and better health care outcomes that could result from Medication Therapy Management. (no bill) Pub. Law 111-148 and 111-152 - Discussed implementation of health care legislation to reform the health care system to provide quality healthcare, expand access to long-term services and supports, and reduced prescription drug costs. Discussed greater affordability of generic versions of both generic and biologic drugs.
Provided information on the need for nursing education capacity and the retention of newer and older nurses in the workplace. (no bill) Discussed barriers to care that can result from language differences between providers and patients and/or lack of translation services. (no bill) H.J.Res 44, H.J. Res. 48, Continuing Appropriations Amendments, FY 2011 - Lobbied for funding for various federal programs serving Older Americans, SSA, various health care, employment, aging services and nutrition programs. Together We Care Act - Discussed draft legislation that would create a three-year pilot program to train public housing residents to provide covered home-based health services. (no bill) Pub. Law 111-148 & 111-152 - Discussed implementation of health disparities data collection provisions of the Affordable Care Act. Pub. Law 111-148 & 111-152 - Discussed implementation of health care legislation that would reform the health care system to provide affordable quality health care and expand access to long term care services. Lobbied in support of legislation to provide a hearing aid tax credit to individuals. (no bill) Lobbied in support of comparative effectiveness research. (no bill) Discussed need to increase health information technology quality measurements and access to qualified systems. (no bill) Discussed comparative effectiveness research. (no bill)
Filing targets: Administration on Aging, Agriculture, Dept of (USDA), Bureau of the Census, Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Equal Employment Opportunity Commission (EEOC), Federal Communications Commission (FCC), Federal Energy Regulatory Commission (FERC), Federal Reserve System, Federal Transit Administration (FTA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Highway Traffic Safety Administration (NHTSA), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, White House Office
H.R.3590, Patient Protection and Affordable Care Act - Lobbied in support of and on implementation of health care legislation that would reform the health care system to provide affordable quality health care and expand access to long-term services and supports. Provided information on the need for nursing education capacity and the retention of newer and older nurses in the workplace (no bill). S.1569/H.R.3185, Medicare Graduate Nursing Education Act - Advocated for modernizing Medicare funding so that nursing education funds are directed to advanced nurse practice programs to help produce more highly-skilled nurses to care for the Medicare population. S. 623/HR 1558, Pre-existing Condition Patient Protection Act of 2009 - Lobbied in support of bill that would prohibit insurers from denying health insurance or delaying coverage for people with pre-existing conditions. H.R. 2778, Health Equity and Accountability through Research Act of 2009 - Lobbied in support of bill that would address racial and ethnic disparities in care. S. 979/HR 2360, Small Business Health Options Programs Act - Lobbied in support of bill that would establish a nationwide health insurance purchasing pool for small businesses and the self-employed that would offer a choice of private health plans and make health coverage more affordable, predictable and accessible. S.1213, Patient-Centered Outcomes Research Act - Lobbied in support of bill that would create a public-private partnership to conduct and disseminate comparative effectiveness research. S. 726/H.R. 1427, Promoting Innovation and Access to Life Saving Medicines - Discussed legislation which would create a pathway for approval of safe, effective biosimilar and generic biologic drugs. H.R. 3090, Health Equity and Accountability Act - Discussed need to end racial and ethnic disparities in care. S. 3686, Labor, HHS, Education and Related Agencies Appropriations Act FY 2011 - Lobbied for funding for healthcare services, research and training involving NIH, AHRQ, CMS, HRSA, HHS and AOA. H.R. 3082, H.R. 3081, H.J. Res.101, H.J. Res. 105, Continuing Appropriations and Surface Transportation Extensions Act, 2011 - Lobbied for funding for various federal programs serving Older Americans, most notably SSA Administrative expenses, LIHEAP, aging services, HECM reverse mortgage subsidy and Section 202, Housing for the Elderly. H.R. 4872, Health Care and Education Reconciliation Act - Lobbied in support of health care law which makes improvements such as closing the Part D coverage gap, in the Patient Protection and Affordable Care Act and implementation of some provisions. H.R. 5364, Special Care Dentistry Act - Discussed bill that would require states to provide oral health coverage for aged, blind,or disabled individuals through a separate state adult dental program, with 100% federal match. H.R. 4213, American Workers, State and Business Relief Act/American Jobs and Closing Tax Loopholes Act - Lobbied for extension of UI, COBRA, FMAP, and SGR. H.R. 3081, Continuing Resolution, FY 2011 - Lobbied for funding for SSA, various health care, employment, aging services and nutrition programs. H.R. 4224, Together We Care Act - Bill creates a three-year pilot program to train public housing residents to provide covered home-based health services. H.R. 5853, Fiscal Responsibility and Retirement Security Act - Bill requires review and approval by law prior to collection of premiums under the CLASS program, to require notice to individuals prior to enrollment, and to require termination of the program in the event of actuarial unsoundness, and for other purposes. S. 2814, Home Health Care Planning Improvement Act of 2010 - Bill recognizes and authorizes nurse practitioners, clinical nurse specialists, certified nurse-midwives and physician assistants as eligible health care professionals who can order home health services under Medicare. H.R. 4993, Home Health Care Planning Improvement Act of 2010 - Bill recognizes and authorizes nurse practitioners, clinical nurse specialists, certified nurse-midwives and physician assistants as eligible health care professionals who can order home health services under Medicare.
Filing targets: Administration on Aging, Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Equal Employment Opportunity Commission (EEOC), Federal Communications Commission (FCC), Federal Energy Regulatory Commission (FERC), Federal Reserve System, Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Highway Traffic Safety Administration (NHTSA), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of the Vice President of the United States, SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, White House Office
S.330/H.R.684, Medicare Prescription Drug Savings and Choice Act of 2009 - Discussed legislation which would create a government-operated Medicare prescription drug plan. Provided information on the need for nursing education capacity and the retention of newer and older nurses in the workplace (no bill). Discussed implementation of healthcare coverage for the 50-64 year old population, age rating, and closing the doughnut hole. S.1133/H.R. 2580, Empowering Medicare Patient Choices Act - Discussed legislation that would promote patient decision aids to help people make informed, evidence-based decisions about health care treatment options. S. 960, Medicare Early Access Act of 2009 - Support for legislation to let Americans aged 55-64 who are otherwise without access to group or public coverage buy into Medicare. H.R. 2700, Prescription Coverage Now Act of 2009 - Discussed legislation that would assist low-invome individuals in obtaining subsidized prescription drug coverage under the Medicare prescription drug program by expediting the application and qualification process and by revising the resource standards used to determine eligibility for such subsidies, and for other purposes. S. 1185, Medicare Financial Stability for Beneficiaries Act of 2009 - Discussed legislation that would ensure that low-income beneficiaries have improved access to health care under the Medicare and Medicaid programs. H.R. 2716, Medicare Savings Program Improvement Act of 2009 - Discussed legislation that would provide financial stability for older Americans and people with disabilities through improvements in the Medicare Savings Program. Advocated for modernizing Medicare funding so that nursing education funds are directed to advanced nurse practice programs to help produce more highly-skilled nurses to care for the Medicare population (no bill). Discussed ideas to improve medicare for medicare beneficiaries. (no bill) Discussed Medicare physician payment issues. (no bill) S. 2128, Prevent Healthcare Fraud Act - Discussed Medicare Fraud. Discussed idea of an annual physical for Medicare beneficiaries (no bill). S.975 Seniors and Taxpayers Obligation and Protection Act - Lobbied in support of legislation. S.1256 Home and Community Balanced Incentives Act - Discussed implementation of certain enacted provisions. H.R. 3631, Medicare Premium Fairness Act - Lobbied to pass legislation to allow premiums for Medicare Part B to remain at 2009 levels for all beneficiaries. S. 2926, the Economic Fairness for Seniors Act - Discussed the implications of legislation to provide $250 in economic relief to seniors, veterans and the disabled in response to the lack of a COLA in 2010; allow Medicare Part B premiums to remain at 2009 levels for all beneficiaries and to study the use of a new Consumer Price Index for use in calculating future Social Security COLAs. H.R. 3590, Patient Protection and Affordable Care Act - Lobbied in support of and on new implementation of health care law that would reform the health care system to provide affordable quality health care, reduce drug costs and expand access to long-term services and supports. H.R. 4872, Health Care and Education Reconciliation Act - Lobbied in support of and on implementation of health care law to make improvements in the Patient Protection and Affordable Care Act and implementation of certain provisions. H.R. 4993/S. 2814, Home Health Planning Improvement Act of 2010 - Wrote letters in support of Nurse Practitioners, Clinical Nurse Specialists, and Physician Assistants being able to order Medicare funded home health care. Extension of enhanced FMAP (no bill number) H. R. 3962/P.L. 111-192, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010 - Which among other things, postpones the reduction of Medicare reimbursements for physician services until November 30, 2010. H.R. 6130, Strengthening Medicare Anti-Fraud Measures Act - Discussed medicare fraud. H.R. 5044/S. 3632, Medicare Fraud Enforcement and Prevention Act - Discussed medicare fraud. H.R. 5546, no official title, anti-fraud measure -Discussed medicare fraud. H.R. 5950, Improving Access to Medicare Coverage Act - To count a periof of observation status in a hospital exceeding 24 hours toward satisfying the 3-day inpatient hospital requirement for coverage of skilled nursing facility services under Medicare. H.R. 2773/S. 1295, Medicare Transitional Care Act and S. Amdt. 3273, Protection and Affordable Care Act - To cover transitional care services to improve the quality and care under the Medicare Program. S. 3632, The Medicare and Medicaid Fraud Enforcement and Prevention Act of 2010 - Fraud bill would seek to curtail wasted fraud and abuse in the Medicare and Healthcare Programs. House Amendment to Senate Amendment to H.R. 2847 "Jobs for Main Street Act" - Discussed redirection of some TARP funds to extend unemployment insurance and COBRA eligibility and FMAP assistance to state governments. H.R. 4213 American Workers, State, and Business Relief Act/American Jobs and Closing Tax Loopholes Act - Lobbied for extension of UI, COBRA, FMAP, and SGR. S. 3686, Labor, HHS, Education and related agencies Appropriations Act, FY 2011 - Lobbied for FMAP fix and related health care programs. S. 2814/H.R. 4993, Home Health Care Planning Improvements Act of 2010 - Legislation would allow advanced practice nurses and physician assistants to order medicare supported home health care. Discussed Durable Medical Equipment bidding. (no bill) H.R.5712, Physician Payment and Therapy Relief Act of 2010 - Lobbied in support of legislation that would provide a one-month extension of the existing physician payment update. H.R.4994, Medicare and Medicaid Extenders Act of 2010 - Lobbied in support of legislation that would provide a one year extension of the physician payment update. H.R. 3081, Continuing Resolution FY 2011, H.J.Res. 105, making further continuing appropriations for fiscal year 2011, and H.J.Res. 101 making further continuing appropriations for fiscal year 2011 - Lobbied for FMA fix inclusion in appropriations legislation.
Filing targets: Administration on Aging, Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Equal Employment Opportunity Commission (EEOC), Federal Communications Commission (FCC), Federal Energy Regulatory Commission (FERC), Federal Reserve System, Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Natl Highway Traffic Safety Administration (NHTSA), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of the Vice President of the United States, SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, White House Office
S.330/H.R.684, Medicare Prescription Drug Savings and Choice Act of 2009 - Discussed legislation which would create a government-operated Medicare prescription drug plan. Provided information on the need for nursing education capacity and the retention of newer and older nurses in the workplace (no bill). S.683/H.R.1670, Community Choice Act - Supported Community First Choice Option version of this legislation in health care reform and inquired about eligibility criteria and implementation. S.631/H.R.2223, Patient Safety and Abuse Prevention Act in Patient Protection and Affordable Care Act (P.L.111-148) - Discussed implementation of criminal background checks for employees of long-term care providers in healthcare reform law. Discussed implementation of healthcare coverage for the 50-64 year old population, age rating, and closing the doughnut hole. S.1133/H.R. 2580, Empowering Medicare Patient Choices Act - Discussed legislation that would promote patient decision aids to help people make informed, evidence-based decisions about health care treatment options. S. 960, Medicare Early Access Act of 2009 - Support for legislation to let Americans aged 55-64 who are otherwise without access to group or public coverage buy into Medicare. H.R. 2700, Prescription Coverage Now Act of 2009 - Discussed legislation that would assist low-invome individuals in obtaining subsidized prescription drug coverage under the Medicare prescription drug program by expediting the application and qualification process and by revising the resource standards used to determine eligibility for such subsidies, and for other purposes. S. 1185, Medicare Financial Stability for Beneficiaries Act of 2009 - Discussed legislation that would ensure that low-income beneficiaries have improved access to health care under the Medicare and Medicaid programs. H.R. 2716, Medicare Savings Program Improvement Act of 2009 - Discussed legislation that would provide financial stability for older Americans and people with disabilities through improvements in the Medicare Savings Program. Advocated for modernizing Medicare funding so that nursing education funds are directed to advanced nurse practice programs to help produce more highly-skilled nurses to care for the Medicare population (no bill). Discussed ideas to improve medicare for medicare beneficiaries. (no bill) Discussed Medicare physician payment issues. (no bill) S. 2128, Prevent Healthcare Fraud Act - Discussed Medicare Fraud. Discussed idea of an annual physical for Medicare beneficiaries (no bill). S.975 Seniors and Taxpayers Obligation and Protection Act - Lobbied in support of legislation. S.1256 Home and Community Balanced Incentives Act - Discussed implementation of certain enacted provisions. H.R. 3631, Medicare Premium Fairness Act - Lobbied to pass legislation to allow premiums for Medicare Part B to remain at 2009 levels for all beneficiaries. S. 2926, the Economic Fairness for Seniors Act - Discussed the implications of legislation to provide $250 in economic relief to seniors, veterans and the disabled in response to the lack of a COLA in 2010; allow Medicare Part B premiums to remain at 2009 levels for all beneficiaries and to study the use of a new Consumer Price Index for use in calculating future Social Security COLAs. H.R. 3590, Patient Protection and Affordable Care Act - Lobbied in support of and on new implementation of health care law that would reform the health care system to provide affordable quality health care, reduce drug costs and expand access to long-term services and supports. H.R. 4872, Health Care and Education Reconciliation Act - Lobbied in support of and on implementation of health care law to make improvements in the Patient Protection and Affordable Care Act and implementation of certain provisions. H.R. 4993/S. 2814, Home Health Planning Improvement Act of 2010 - Wrote letters in support of Nurse Practitioners, Clinical Nurse Specialists, and Physician Assistants being able to order Medicare funded home health care. Extension of enhanced FMAP (no bill number) H. R. 3962/P.L. 111-192, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010 - Which among other things, postpones the reduction of Medicare reimbursements for physician services until November 30, 2010. H.R. 6130, Strengthening Medicare Anti-Fraud Measures Act - Discussed medicare fraud. H.R. 5044/S. 3632, Medicare Fraud Enforcement and Prevention Act - Discussed medicare fraud. H.R. 5546, no official title, anti-fraud measure -Discussed medicare fraud. H.R. 5950, Improving Access to Medicare Coverage Act - To count a periof of observation status in a hospital exceeding 24 hours toward satisfying the 3-day inpatient hospital requirement for coverage of skilled nursing facility services under Medicare. H.R. 2773/S. 1295, Medicare Transitional Care Act and S. Amdt. 3273, Protection and Affordable Care Act - To cover transitional care services to improve the quality and care under the Medicare Program. S. 3632, The Medicare and Medicaid Fraud Enforcement and Prevention Act of 2010 - Fraud bill would seek to curtail wasted fraud and abuse in the Medicare and Healthcare Programs. House Amendment to Senate Amendment to H.R. 2847 "Jobs for Main Street Act" - Discussed redirection of some TARP funds to extend unemployment insurance and COBRA eligibility and FMAP assistance to state governments. H.R. 4213 American Workers, State, and Business Relief Act/American Jobs and Closing Tax Loopholes Act - Lobbied for extension of UI, COBRA, FMAP, and SGR. S. 3686, Labor, HHS, Education and related agencies Appropriations Act, FY 2011 - Lobbied for FMAP fix and related health care programs. H.R. 3081, Continuing Resolution, FY 2011 - Lobbied for FMAP fix inclusion in appropriations legislation. S. 2814/H.R. 4993, Home Health Care Planning Improvements Act of 2010 - Legislation would allow advanced practice nurses and physician assistants to order medicare supported home health care. Discussed Durable Medical Equipment bidding. (no bill)
Filing targets: Administration on Aging, Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Energy, Dept of, Federal Communications Commission (FCC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of the Vice President of the United States, SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, White House Office
Filing targets: Administration on Aging, Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Energy, Dept of, Federal Communications Commission (FCC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of the Vice President of the United States, SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, White House Office
S.330/H.R.684, Medicare Prescription Drug Savings and Choice Act of 2009 - Discussed legislation which would create a government-operated Medicare prescription drug plan. Provided information on the need for nursing education capacity and the retention of newer and older nurses in the workplace (no bill). S.683/H.R.1670, Community Choice Act - Supported Community First Choice Option version of this legislation in health care reform and inquired about eligibility criteria. S.245, Retooling the Health Care Workforce for an Aging America Act - Discussed moving forward provisions not in healthcare reform. S.631/H.R.2223, Patient Safety and Abuse Prevention Act - Drafted comment letter on implementation of criminal background checks for employees of long-term care providers in healthcare reform law. Discussed implementation of healthcare coverage for the 50-64 year old population, age rating, and closing the doughnut hole. S.1133/H.R. 2580, Empowering Medicare Patient Choices Act - Discussed legislation that would promote patient decision aids to help people make informed, evidence-based decisions about health care treatment options. S. 960, Medicare Early Access Act of 2009 - Support for legislation to let Americans aged 55-64 who are otherwise without access to group or public coverage buy into Medicare. H.R. 2700, Prescription Coverage Now Act of 2009 - Discussed legislation that would assist low-invome individuals in obtaining subsidized prescription drug coverage under the Medicare prescription drug program by expediting the application and qualification process and by revising the resource standards used to determine eligibility for such subsidies, and for other purposes. S. 1185, Medicare Financial Stability for Beneficiaries Act of 2009 - Discussed legislation that would ensure that low-income beneficiaries have improved access to health care under the Medicare and Medicaid programs. H.R. 2716, Medicare Savings Program Improvement Act of 2009 - Discussed legislation that would provide financial stability for older Americans and people with disabilities through improvements in the Medicare Savings Program. Advocated for modernizing Medicare funding so that nursing education funds are directed to advanced nurse practice programs to help produce more highly-skilled nurses to care for the Medicare population (no bill). Discussed ideas to improve medicare for medicare beneficiaries. (no bill) Discussed Medicare physician payment issues. (no bill) S. 2128, Prevent Healthcare Fraud Act - Discussed Medicare Fraud. Discussed idea of an annual physical for Medicare beneficiaries (no bill). S.975 Seniors and Taxpayers Obligation and Protection Act - Lobbied in support of legislation. S.1256 Home and Community Balanced Incentives Act - Discussed implementation of certain enacted provisions. H.R. 3631, Medicare Premium Fairness Act - Lobbied to pass legislation to allow premiums for Medicare Part B to remain at 2009 levels for all beneficiaries. S. 2926, the Economic Fairness for Seniors Act - Discussed the implications of legislation to provide $250 in economic relief to seniors, veterans and the disabled in response to the lack of a COLA in 2010; allow Medicare Part B premiums to remain at 2009 levels for all beneficiaries and to study the use of a new Consumer Price Index for use in calculating future Social Security COLAs. H.R. 3590, Patient Protection and Affordable Care Act - Lobbied in support of and on new implementation of health care law that would reform the health care system to provide affordable quality health care, reduce drug costs and expand access to long-term services and supports. H.R. 4872, Health Care and Education Reconciliation Act - Lobbied in support of health care law to make improvements in the Patient Protection and Affordable Care Act and implementation of certain provisions. House Amendment to Senate Amendment to H.R. 2847 "Jobs for Main Street Act" - Discussed redirection of some TARP funds to extend unemployment insurance and COBRA eligibility and FMAP assistance to state governments. H.R. 4213 American Workers, State, and Business Relief Act/American Jobs and Closing Tax Loopholes Act - Lobbied for extension of UI, COBRA, FMAP, and SGR.
Filing targets: Administration on Aging, Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Energy, Dept of, Federal Communications Commission (FCC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of the Vice President of the United States, SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, White House Office
S.330/H.R.684, Medicare Prescription Drug Savings and Choice Act of 2009 - Discussed legislation which would create a government-operated Medicare prescription drug plan. Provided information on the need for nursing education capacity and the retention of newer and older nurses in the workplace (no bill). S.683/H.R.1670, Community Choice Act - Supported Community First Choice Option version of this legislation in health care reform. S.245/H.R. 468/S.434/H.R.2688, Retooling the Health Care Workforce for an Aging America Act and possible amendments, in healthcare reform, including Family Caregiving provisions. S.113/H.R.2560, Empowered at Home Act and the Independence at Home Act - Discussed long-term care and chronic care legislation that AARP endorsed and provisions included in health reform legislation. S.631/H.R.2223, Patient Safety and Abuse Prevention Act - Support for legislation in healthcare reform on criminal background checks for employees of long-term care providers and specific bill provisions. S. 697/H.R.1721, Class Act - Discussed provisions of CLASS in House and Senate health reform bills and urged inclusion of CLASS in Senate and House HCR legislation. S.1131/H.R.2560 Independence at Home Act - Discussed AARP's support for this Medicare care coordination bill; and it's inclusion in health reform legislation. Discussed healthcare coverage for the 50-64 year old population, age rating, and closing the doughnut hole. S.1133/H.R. 2580, Empowering Medicare Patient Choices Act - Discussed legislation that would promote patient decision aids to help people make informed, evidence-based decisions about health care treatment options. H.R. 2773/S 1295, Medicare Transitional Care Act of 2009 - Discussed legislation that would reduce unnecessary hospital readmissions, improve quality for Medicare beneficiaries, and reduce wasteful spending in Medicare; worked to incorporate bill and its elements into health reform legislation. S. 960, Medicare Early Access Act of 2009 - Support for legislation to let Americans aged 55-64 who are otherwise without access to group or public coverage buy into Medicare. H.R. 2700, Prescription Coverage Now Act of 2009 - Discussed legislation that would assist low-invome individuals in obtaining subsidized prescription drug coverage under the Medicare prescription drug program by expediting the application and qualification process and by revising the resource standards used to determine eligibility for such subsidies, and for other purposes. S. 1185, Medicare Financial Stability for Beneficiaries Act of 2009 - Discussed legislation that would ensure that low-income beneficiaries have improved access to health care under the Medicare and Medicaid programs. H.R. 2716, Medicare Savings Program Improvement Act of 2009 - Discussed legislation that would provide financial stability for older Americans and people with disabilities through improvements in the Medicare Savings Program. Advocated for modernizing Medicare funding so that nursing education funds are directed to advanced nurse practice programs to help produce more highly-skilled nurses to care for the Medicare population (no bill). S.750 Caring for an Aging America Act - Discussed as possible amendment to health reform bill. S.1257/H.R.2852 Project 2020: Building the Promise of Home and Community Based Services Act - Lobbied in support of legislation. Discussed ideas to improve medicare for medicare beneficiaries. (no bill) Discussed Medicare physician payment issues and SGR. (no bill) S. 2128, Prevent Healthcare Fraud Act - Discussed Medicare Fraud. Discussed idea of an annual physical for Medicare beneficiaries (no bill). S.1009 Medicare Care Transitions Program Act - Discussed provisions of Medicare Care Transitions Program Act. S.975 Seniors and Taxpayers Obligation and Protection Act - Lobbied in support of legislation. S.1256 Home and Community Balanced Incentives Act - Discussed inclusion of this legislation in health reform legislation and advocated for amendment in Senate healthcare reform legislation. H.R. 3631, Medicare Premium Fairness Act - Lobbied to pass legislation to allow premiums for Medicare Part B to remain at 2009 levels for all beneficiaries. S. 2926, the Economic Fairness for Seniors Act - Discussed the implications of legislation to provide $250 in economic relief to seniors, veterans and the disabled in response to the lack of a COLA in 2010; allow Medicare Part B premiums to remain at 2009 levels for all beneficiaries and to study the use of a new Consumer Price Index for use in calculating future Social Security COLAs. H.R. 3590, Patient Protection and Affordable Care Act - Lobbied in support of health care legislation that would reform the health care system to provide affordable quality health care, reduce drug costs and expand access to long-term services and supports. H.R. 4872, Health Care and Education Reconciliation Act - Lobbied in support of health care legislation to make improvements in the Patient Protection and Affordable Care Act. H.R. 3200 America's Affordable Health Choices Act/S. 1679, Americas Health Choices Act/ S.1796, America's Healthy Future Act - Discussed need for affordable quality healthcare, delivery system reform, ending age discrimination in the health insurance industry, "ending rating by health condition or any proxy," closing the doughnut hole, creating a pathway for generic biologics, allowing and funding states to provide home and community based services, creating a transitional benefit in medicare and expanding the asset limit to qualify for low-income programs in medicare, and modifying medicare advantage. House Amendment to Senate Amendment to H.R. 2847 "Jobs for Main Street Act" - Discussed redirection of some TARP funds to extend unemployment insurance and COBRA eligibility and FMAP assistance to state governments.
Filing targets: Administration on Aging, Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Energy, Dept of, Federal Communications Commission (FCC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of the Vice President of the United States, SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, White House Office
S.330/H.R.684, Medicare Prescription Drug Savings and Choice Act of 2009 - Discussed legislation which would create a government-operated Medicare prescription drug plan. Provided information on the need for nursing education capacity and the retention of newer and older nurses in the workplace (no bill). S.683/H.R.1670, Community Choice Act - Supported Community First Choice Option version of this legislation in health care reform. S.245/H.R. 468/S.434/H.R.2688, Retooling the Health Care Workforce for an Aging America Act and possible amendments, in healthcare reform, including Family Caregiving provisions. S.113/H.R.2560, Empowered at Home Act and the Independence at Home Act - Discussed long-term care and chronic care legislation that AARP endorsed and provisions included in health reform legislation. S.631/H.R.2223, Patient Safety and Abuse Prevention Act - Support for legislation in healthcare reform on criminal background checks for employees of long-term care providers and specific bill provisions. S. 697/H.R.1721, Class Act - Discussed provisions of CLASS in House and Senate health reform bills and urged inclusion of CLASS in Senate and House HCR legislation. S.1131/H.R.2560 Independence at Home Act - Discussed AARP's support for this Medicare care coordination bill; and it's inclusion in health reform legislation. Discussed healthcare coverage for the 50-64 year old population, age rating, and closing the doughnut hole. S.1133/H.R. 2580, Empowering Medicare Patient Choices Act - Discussed legislation that would promote patient decision aids to help people make informed, evidence-based decisions about health care treatment options. H.R. 2773/S 1295, Medicare Transitional Care Act of 2009 - Discussed legislation that would reduce unnecessary hospital readmissions, improve quality for Medicare beneficiaries, and reduce wasteful spending in Medicare; worked to incorporate bill and its elements into health reform legislation. S. 960, Medicare Early Access Act of 2009 - Support for legislation to let Americans aged 55-64 who are otherwise without access to group or public coverage buy into Medicare. H.R. 2700, Prescription Coverage Now Act of 2009 - Discussed legislation that would assist low-invome individuals in obtaining subsidized prescription drug coverage under the Medicare prescription drug program by expediting the application and qualification process and by revising the resource standards used to determine eligibility for such subsidies, and for other purposes. S. 1185, Medicare Financial Stability for Beneficiaries Act of 2009 - Discussed legislation that would ensure that low-income beneficiaries have improved access to health care under the Medicare and Medicaid programs. H.R. 2716, Medicare Savings Program Improvement Act of 2009 - Discussed legislation that would provide financial stability for older Americans and people with disabilities through improvements in the Medicare Savings Program. Advocated for modernizing Medicare funding so that nursing education funds are directed to advanced nurse practice programs to help produce more highly-skilled nurses to care for the Medicare population (no bill). S.750 Caring for an Aging America Act - Discussed as possible amendment to health reform bill. S.1257/H.R.2852 Project 2020: Building the Promise of Home and Community Based Services Act - Lobbied in support of legislation. Discussed ideas to improve medicare for medicare beneficiaries. (no bill) Discussed Medicare physician payment issues and SGR. (no bill) S. 2128, Prevent Healthcare Fraud Act - Discussed Medicare Fraud. Discussed idea of an annual physical for Medicare beneficiaries (no bill). S.1009 Medicare Care Transitions Program Act - Discussed provisions of Medicare Care Transitions Program Act. S.975 Seniors and Taxpayers Obligation and Protection Act - Lobbied in support of legislation. S.1256 Home and Community Balanced Incentives Act - Discussed inclusion of this legislation in health reform legislation and advocated for amendment in Senate healthcare reform legislation. H.R. 3631, Medicare Premium Fairness Act - Lobbied to pass legislation to allow premiums for Medicare Part B to remain at 2009 levels for all beneficiaries. S. 2926, the Economic Fairness for Seniors Act - Discussed the implications of legislation to provide $250 in economic relief to seniors, veterans and the disabled in response to the lack of a COLA in 2010; allow Medicare Part B premiums to remain at 2009 levels for all beneficiaries and to study the use of a new Consumer Price Index for use in calculating future Social Security COLAs. H.R. 3590, Patient Protection and Affordable Care Act - Lobbied in support of health care legislation that would reform the health care system to provide affordable quality health care, reduce drug costs and expand access to long-term services and supports. H.R. 4872, Health Care and Education Reconciliation Act - Lobbied in support of health care legislation to make improvements in the Patient Protection and Affordable Care Act. H.R. 3200 America's Affordable Health Choices Act/S. 1679, Americas Health Choices Act/ S.1796, America's Healthy Future Act - Discussed need for affordable quality healthcare, delivery system reform, ending age discrimination in the health insurance industry, "ending rating by health condition or any proxy," closing the doughnut hole, creating a pathway for generic biologics, allowing and funding states to provide home and community based services, creating a transitional benefit in medicare and expanding the asset limit to qualify for low-income programs in medicare, and modifying medicare advantage. House Amendment to Senate Amendment to H.R. 2847 "Jobs for Main Street Act" - Discussed redirection of some TARP funds to extend unemployment insurance and COBRA eligibility and FMAP assistance to state governments.
H.R.3590, Patient Protection and Affordable Care Act - Lobbied in support of health care legislation that would reform the health care system to provide affordable quality health care and expand access to long-term services and supports. Provided information on the need for nursing education capacity and the retention of newer and older nurses in the workplace (no bill). Discussed the need for bipartisan action on health care reform legislation, such as affordable and accessible quality healthcare with a focus on the 50-64 year old population. (no bill) Discussed healthcare reform and issues around the public plan option (no bill). S.1569/H.R.3185 Medicare Graduate Nursing Education Act - Advocated for modernizing Medicare funding so that nursing education funds are directed to advanced nurse practice programs to help produce more highly-skilled nurses to care for the Medicare population. (no bill) S. 623/HR 1558, Pre-existing Condition Patient Protection Act of 2009 - Lobbied in support of bill that would prohibit insurers from denying health insurance or delaying coverage for people with pre-existing conditions. H.R. 2778, Health Equity and Accountability through Research Act of 2009 - Lobbied in support of bill that would address racial and ethnic disparities in care. S. 979/HR 2360, Small Business Health Options Programs Act - Lobbied in support of bill that would establish a nationwide health insurance purchasing pool for small businesses and the self-employed that would offer a choice of private health plans and make health coverage more affordable, predictable and accessible. H.R. 3200, America's Affordable Health Choices Act/S. 1679, Americas Health Choices Act/S.1796 America's Healthy Future Act ) Discussed need for affordable quality healthcare, delivery system reform, ending age discrimination in the health insurance industry, ending rating by health condition or any proxy, closing the doughnut hole, creating a pathway for generic biologics, allowing and funding states to provide home and community based services, creating a transitional benefit or other transitional care provisions in medicare and expanding the asset limit to qualify for low-income programs in medicare, establishing CLASS program. S.1213, Patient-Centered Outcomes Research Act - Lobbied in support of bill that would create a public-private partnership to conduct and disseminate comparative effectiveness research. S. 726/H.R. 1427, Promoting Innovation and Access to Life Saving Medicines - Discussed legislation which would create a pathway for approval of safe, effective biosimilar and generic biologic drugs. H.R. 3090, Health Equity and Accountability Act - Discussed need to end racial and ethnic disparities in care. Labor, HHS, Education and Related Agencies Appropriations Act FY 2011 - Lobbied for funding for healthcare services, research and training involving NIH, AHRQ, CMS, HRSA, HHS and AOA. (no bill) H.R. 4872, Health Care and Education Reconciliation Act - Lobbied in support of health care legislation which makes improvements such as closing the Part D coverage gap, in the Patient Protection and Affordable Care Act.
Filing targets: Administration on Aging, Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Energy, Dept of, Federal Communications Commission (FCC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Office of Management & Budget (OMB), Office of Personnel Management (OPM), Office of the Vice President of the United States, SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, White House Office
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Energy, Dept of, Federal Communications Commission (FCC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, White House Office
S.330/H.R.684, Medicare Prescription Drug Savings and Choice Act of 2009 - Discussed legislation which would create a government-operated Medicare prescription drug plan. Provided information on the need for nursing education capacity and the retention of newer and older nurses in the workplace (no bill). S.683/H.R.1670, Community Choice Act - Supported Community First Choice Option version of this legislation in health care reform. S.245/H.R. 468/S.434/H.R.2688, Retooling the Health Care Workforce for an Aging America Act and possible amendments, in healthcare reform, including Family Caregiving provisions. S.113/H.R.2560, Empowered at Home Act and the Independence at Home Act - Discussed long-term care and chronic care legislation that AARP endorsed and including provisions in health reform legislation. S.631/H.R.2223, Patient Safety and Abuse Prevention Act - Support for legislation and amendment on criminal background checks for employees of long-term care providers and specific bill provisions. S. 697/H.R.1721, Class Act - Discussed provisions of CLASS in House and Senate health reform bills and urged inclusion of CLASS in Senate and House HCR legislation. S.1131/H.R.2560 Independence at Home Act - Discussed AARP's support for this Medicare care coordination bill; and urged it's inclusion in health reform legislation. Discussed healthcare coverage for the 50-64 year old population age rating and closing the doughnut hole. S.1133/H.R. 2580, Empowering Medicare Patient Choices Act - Discussed legislation that would promote patient decision aids to help people make informed, evidence-based decisions about health care treatment options. H.R. 2773/S 1295, Medicare Transitional Care Act of 2009 - Discussed legislation that would reduce unnecessary hospital readmissions, improve quality for Medicare beneficiaries, and reducing wasteful spending in Medicare; worked to incorporate bill and its elements into health reform legislation. S. 960, Medicare Early Access Act of 2009 - To let Americans aged 55-64 who are otherwise without access to grup or public coverage buy into Medicare. H.R. 2700, Prescription Coverage Now Act of 2009 - Discussed legislation that would assist low-invome individuals in obtaining subsidized prescription drug coverage under the Medicare prescription drug program by expediting the application and qualification process and by revising the resource standards used to determine eligibility for such subsidies, and for other purposes. S. 1185, Medicare Financial Stability for Beneficiaries Act of 2009 - Discussed legislation that would ensure that low-income beneficiaries have improved access to health care under the Medicare and Medicaid programs. H.R. 2716, Medicare Savings Program Improvement Act of 2009 - Discussed legislation that would provide financial stability for older Americans and people with disabilities through improvements in the Medicare Savings Program. Advocated for modernizing Medicare funding so that nursing education funds are directed to advanced nurse practice programs to help produce more highly-skilled nurses to care for the Medicare population (no bill). H.R. 3293, Labor, HHS, Education and related agencies Appropriations bill for FY2010-Lobbied for funding for SSA, Older Americans Act programs, Lifespan Respite Care Act, Nursing Education/Workforce Development, National Corporation for Community Service (Kennedy Serve America Act). S.750 Caring for an Aging America Act - Discussed possible amendment to health reform bill. S.1257/H.R.2852 Project 2020: Building the Promise of Home and Community Based Services Act - Lobbied in support of legislation. Discussed ideas to improve medicare for medicare beneficiaries. (no bill) Discussed Medicare physician payment issues and SGR. (no bill) S. 2128, Prevent Healthcare Fraud Act - Discussed Medicare Fraud. Discussed idea of an annual physical for Medicare beneficiaries (no bill). S.1009 Medicare Care Transitions Program Act - Discussed provisions of Medicare Care Transitions Program Act. S.975 Seniors and Taxpayers Obligation and Protection Act - Lobbied in support of legislation. Discussed proposals to address LTC and HCBS in the context of health care reform. (no bill) S.1256 Home and Community Balanced Incentives Act - Discussed inclusion of this legislation in health reform legislation and advocated for amendment in Senate healthcare reform legislation. H.R. 3631, Medicare Premium Fairness Act - Lobbied to pass legislation to allow premiums for Medicare Part B to remain at 2009 levels for all beneficiaries. H.R. 3200 America's Affordable Health Choices Act/S. 1679, Americas Health Choices Act, America's Healthy Future Act (no Senate bill)- Discussed need for affordable quality healthcare, delivery system reform, ending age discrimination in the health insurance industry, "ending rating by health condition or any proxy," closing the doughnut hole, creating a pathway for generic biologics, allowing and funding states to provide home and community based services, creating a transitional benefit in medicare and expanding the asset limit to qualify for low-income programs in medicare, and modifying medicare advantage. S. 2926, Economic Fairness for Seniors Act - Discussed legislation that would allow premiums for Medicare Part B to remain at 2009 levels for all beneficiaries, provide social security beneficiaries with $250 in economic relief in response to the lack of cost of living adjustment for 2010, and convert from the CPI-W to the CPI-E. H.J.Res. 64, Third Continuing Resolution, FY 2010; not enacted - Lobbied for various items to be excepted from lower funding levels during the term of the Continuing Resolution. H.R. 3326, Division B, Defense Appropriations bill for FY 2010 - Lobbied for SNAP participation changes, extension of unemployment benefits and COBRA eligibility, delay in cuts to Medicare physician payments. H.R. 2996, Division B, Interior Appropriations bill lobbied for various items to be excepted from lower funding levels during the term of the Continuing Resolution. House Amendment to Senate Amendment to H.R. 2847 "Jobs for Main Street Act" - Discussed redirection of some TARP funds to extend unemployment insurance and COBRA eligibility and FMAP assistance to state governments. Discussed support for the inclusion of Puerto Rico and the territories in the proposed Health Insurance Exchange, increasing Medicaid funds to Puerto Rico seniors in Medicare Part B. (no bill) Discussed support for the inclusion of Puerto Rico and the territories in the proposed Health Insurance Exchange, increasing Medicaid funds to Puerto Rico and the territories, and the auto-enrollment of Puerto Rico seniors in Medicare Part B. (no bill)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Energy, Dept of, Federal Communications Commission (FCC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, White House Office
S.525/H.R.1298/S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009 - Discussed legislation which would create a system of safe importation of prescription drugs from abroad. S.726/H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act - Discussed legislation which would create a pathway for the approval of safe, effective biosimilar and generic biologic drugs. H.R.1706, Protecting Consumer Access to Generic Drugs Act of 2009 - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes. S. 369, Preserve Access to Affordable Generics Act - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market,and for other purposes. S.515/H.R.1260/S.610, Patent Reform Act of 2009 - Discussed legislation that would amend federal patent law to rewrite provisions concerning the conditions for patentability. Specifically, AARP weighed in on the inequitable conduct provisions of the legislation. S. 301, Physician Payments Sunshine Act of 2009 - Discussed legislation that would provide for disclosure of gifts given by pharmaceutical and device manufacturers to physicians. H.R.2997 Agriculture, Rural Development, FDA and related agencies Appropriations bill for FY2010-Lobbied in support of funding for the Commodity Supplemental Food Program and FDA Office of Generic Drugs. FDA research on bioequivalency of generic epilepsy drugs, rural housing assistance and repair (no bill). S.1315, Federal Food, Drug and Cosmetic Act Amendment/H.R.3777 Drug Price Competition Act - Lobbied to expand the definition of "first applicant" under such Act to allow a generic drug manufacturer that is currently considered an applicant subsequent to a brand-name manufacturer's 180-day exclusivity period to qualify as a first applicant for purposes of filing an abbreviated application for a new drug. Requires such applicant ot submit a substantially complete application that contains and lawfully maintains a certification for such drug. H.R. 3200 America's Affordable Health Choices Act/S. 1679, Americas Health Choices Act, America's Healthy Future Act (no Senate bill)- Discussed need for affordable quality healthcare, delivery system reform, ending age discrimination in the health insurance industry, closing the doughnut hole, creating a pathway for generic biologics, allowing and funding states to provide home and community based services, creating a transitional benefit in medicare and expanding the asset limit to qualify for low-income programs in medicare.
Discussed AARP criteria for a federal role in the regulation of insurance.(no bill) H.R. 3200 America's Affordable Health Choices Act/S. 1679, Americas Health Choices Act, America's Healthy Future Act (no Senate bill)- Discussed need for affordable quality healthcare, delivery system reform, ending age discrimination in the health insurance industry, closing the doughnut hole, creating a pathway for generic biologics, allowing and funding states to provide home and community based services, creating a transitional benefit in medicare and expanding the asset limit to qualify for low-income programs in medicare.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Energy, Dept of, Federal Communications Commission (FCC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, White House Office
S.330/H.R.684, Medicare Prescription Drug Savings and Choice Act of 2009 - Discussed legislation which would create a government-operated Medicare prescription drug plan. Provided information on the need for nursing education capacity and the retention of newer and older nurses in the workplace (no bill). S.683/H.R.1670, Community Choice Act - Engaged in discussions about the bill, possible changes to advance bill in health reform and it's provisions to balance Medicaid. Discussed chronic care issues and caregiver assessment in Medicaid. Discussed ways to provide better care coordination to dual eligibles and possible legislation (no bill). S.245/H.R. 468/S.434/H.R.468 Retooling the Health Care Workforce for an Aging America Act and possible amendment, the Empowered at Home Act and the Independence at Home Act - Discussed long-term care and chronic care legislation that AARP endorsed and shared endorsement letters. Discussed co-sponsors of Medicaid HCBS legislation. S.631/H.R.2223, Patient Safety and Abuse Prevention Act - Support for legislation and amendment on criminal background checks for employees of long-term care providers and specific bill provisions. S. 697/H.R.1721, Class Act - Discussed this bill and versions marked up in committee. Endorsed provisions in HELP and E&C Committee healthcare reform bills. S.1131/H.R.2560 Independence at Home Act - Endorsed and discussed AARP's support for this Medicare care coordination bill; and House Committee amendment and urged co-sponsorship. Discussed healthcare coverage for the 50-64 year old population age rating and closing the doughnut hole. S.1133/H.R. 2580, Empowering Medicare Patient Choices Act - To promote patient decision aids to help people make informed, evidence-based decisions about health care treatment options. H.R. 2773/S 1295, Medicare Transitional Care Act of 2009 - To reduce unnecessary hospital readmissions, improving quality for Medicare beneficiaries, and reducing wasteful spending in Medicare; endorsed committee amendment; worked to incorporate bill and its elements into health reform legislation. S. 960, Medicare Early Access Act of 2009 - To let Americans aged 55-64 who are otherwise without access to grup or public coverage buy into Medicare. H.R. 2700, Prescription Coverage Now Act of 2009 - To assist low-invome individuals in obtaining subsidized prescription drug coverage under the Medicare prescription drug program by expediting the application and qualification process and by revising the resource standards used to determine eligibility for such subsidies, and for other purposes. S. 1185, Medicare Financial Stability for Beneficiaries Act of 2009 - To ensure that low-income beneficiaries have improved access to health care under the Medicare and Medicaid programs. H.R. 2716, Medicare Savings Program Improvement Act of 2009 - To provide financial stability for older Americans and people with disabilities through improvements in the Medicare Savings Program. Advocated for modernizing Medicare funding so that nursing education funds are directed to advanced nurse practice programs to help produce more highly-skilled nurses to care for the Medicare population (no bill). H.R. 3293, Labor, HHS, Education and related agencies Appropriations bill for FY2010-Lobbied for funding for SSA, Older Americans Act programs, Lifespan Respite Care Act, Nursing Education/Workforce Development, National Corporation for Community Service (Kennedy Serve America Act), among other items (no bill numbers). S.750 Caring for an Aging america Act - Lobbied in support of legislation and discussed possible floor amendment.. S.1257/H.R.2852 Project 2020:Building the Promise of Home and Community Based Services Act - Lobbied in support of legislation. Discussed ideas to improve medicare for medicare beneficiaries. (no bill) Discussed Medicare physician payment issues and SGR. Responded to staff inquiry about AARP position on Medicare fraud bill; referred staff to appropriate AARP staff. Discussed idea of an annual physical for Medicare beneficiaries (no bill). S.1009 Medicare Care Transitions Program Act - Discussed provisions of Medicare Care Transitions Program Act. S.975 Seniors and Taxpayers Obligation and Protection Act - Lobbied in support of legislation. Discussed care coordination for dual eligibles and policy ideas to address this (no bill). Discussed proposals to address LTC and HCBS in the context of health care reform. (no bill) S.1150 Advance Planning and Compassionate Care Act - Endorsed advance care planning legislation. S.1263 Senior Navigation and Planning Act legislation - discussed legislation. S.1256 Home and Community Balanced Incentives Act - Discussed inclusion of this legislation in health reform legislation and urged cosponsors, advocated for amendment in committee. H.R. 3631, Medicare Premium Fairness Act - Lobbied to pass legislation to allow premiums for Medicare Part B to remain at 2009 levels for all beneficiaries. H.R. 3200 America's Affordable Health Choices Act/S. 1679, Americas Health Choices Act, America's Healthy Future Act (no Senate bill)- Discussed need for affordable quality healthcare, delivery system reform, ending age discrimination in the health insurance industry, closing the doughnut hole, creating a pathway for generic biologics, allowing and funding states to provide home and community based services, creating a transitional benefit in medicare and expanding the asset limit to qualify for low-income programs in medicare.
S.525/H.R.1298/S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009 - Discussed legislation which would create a system of safe importation of prescription drugs from abroad. S.726/H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act - Discussed legislation which would create a pathway for the approval of safe, effective biosimilar and generic biologic drugs. H.R.1706, Protecting Consumer Access to Generic Drugs Act of 2009 - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes. S. 369, Preserve Access to Affordable Generics Act - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market,and for other purposes. S.515/H.R.1260/S.610, Patent Reform Act of 2009 - Discussed legislation that would amend federal patent law to rewrite provisions concerning the conditions for patentability. Specifically, AARP weighed in on the inequitable conduct provisions of the legislation. S. 301, Physician Payments Sunshine Act of 2009 - Discussed legislation that would provide for disclosure of gifts given by pharmaceutical and device manufacturers to physicians. H.R.2997 Agriculture, Rural Development, FDA and related agencies Appropriations bill for FY2010-Lobbied in support of funding for the Commodity Supplemental Food Program and FDA Office of Generic Drugs. FDA research on bioequivalency of generic epilepsy drugs, rural housing assistance and repair (no bill). S.1315, Federal Food, Drug and Cosmetic Act Amendment/H.R.3777 Drug Price Competition Act - Lobbied to expand the definition of "first applicant" under such Act to allow a generic drug manufacturer that is currently considered an applicant subsequent to a brand-name manufacturer's 180-day exclusivity period to qualify as a first applicant for purposes of filing an abbreviated application for a new drug. Requires such applicant ot submit a substantially complete application that contains and lawfully maintains a certification for such drug. H.R. 3200 America's Affordable Health Choices Act/S. 1679, Americas Health Choices Act, America's Healthy Future Act (no Senate bill)- Discussed need for affordable quality healthcare, delivery system reform, ending age discrimination in the health insurance industry, closing the doughnut hole, creating a pathway for generic biologics, allowing and funding states to provide home and community based services, creating a transitional benefit in medicare and expanding the asset limit to qualify for low-income programs in medicare.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Energy, Dept of, Federal Communications Commission (FCC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, White House Office
S.540/H.R.1346, Medical Device Safety Act - Legislation would make clear congressional intent that state tort claims are not preempted by the FFDCA. S.512, Fairness in Nursing Home Arbitration Act - Bill to prevent pre-dispute arbitration agreements with LTC facility and residents. H.R.1237, Fairness in Nursing Home Arbitration Act - Urged co-sponsorship of bill to prevent pre-dispute arbitration clauses in LTC facility contracts.
S.525/H.R. 1298, Pharmaceutical Market Access and Drug Safety Act of 2009 - Discussed legislation which would create a system of safe importation of prescription drugs from abroad. S.726/H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act - Discussed legislation which would create a pathway for the approval of safe, effective biosimilar and generic biologic drugs. H.R.1706, Protecting Consumer Access to Generic Drugs Act of 2009 - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes. S. 369, Preserve Access to Affordable Generics Act - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market,and for other purposes. S.515/H.R.1260, Patent Reform Act of 2009 - Discussed legislation that would amend federal patent law to rewrite provisions concerning the conditions for patentability. Specifically, AARP weighed in on the inequitable conduct provisions of the legislation. S. 301, Physician Payments Sunshine Act of 2009 - Discussed legislation that would provide for disclosure of gifts given by pharmaceutical and device manufacturers to physicians. H.R.2997 Agriculture, Rural Development, FDA and related agencies Appropriations bill for FY2010-Lobbied in support of funding for the Commodity Supplemental Food Program and FDA Office of Generic Drugs, rural housing assistance and repair.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Energy, Dept of, Federal Communications Commission (FCC), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Housing & Urban Development, Dept of (HUD), Internal Revenue Service (IRS), Labor, Dept of (DOL), Office of Management & Budget (OMB), Office of the Vice President of the United States, SENATE, Securities & Exchange Commission (SEC), Social Security Administration (SSA), Transportation, Dept of (DOT), Treasury, Dept of, White House Office